Guide PDF

2016
GUIDE FOR AVIATION MEDICAL EXAMINERS

Welcome to the Guide for Aviation Medical Examiners. The format of this version of the
Guide provides instant access to information regarding regulations, medical history,
examination procedures, dispositions, and protocols necessary for completion of the
FAA Form 8500-8, Application for Airman Medical Certificate.
To navigate through the Guide PDF by Item number or subject matter, simply click on
the BOOKMARK tab in the left column to search specific certification decision-making
criteria. To expand any BOOKMARK files, click on the corresponding + button located
in the front of the text. To collapse any of the expanded files, click on the + button
again.
The most current version of this guide may be found and downloaded at the following
FAA site:
http://www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/ame/guide/
LAST UPDATE: April 08, 2016
TABLE OF CONTENTS
TABLE OF CONTENTS ........................................................................................... 2
GENERAL INFORMATION .................................................................................. 5
1. Legal Responsibilities of Designated Aviation Medical Examiners ............... 6
2. Authority of Aviation Medical Examiners ....................................................... 7
3. Equipment Requirements.............................................................................. 7
4. Medical Certification Decision Making .......................................................... 8
5. Authorization for Special Issuance and AME Assisted Special Issuance
(AASI) ............................................................................................................. 10
6. Privacy of Medical Information .................................................................... 13
7. Release of Information ................................................................................ 14
8. No "Alternate" Examiners Designated......................................................... 14
9. Who May Be Certified ................................................................................. 14
10. Classes of Medical Certificates ................................................................. 16
11. Operations Not Requiring a Medical Certificate ........................................ 17
12. Medical Certificates AME Completion .................................................... 17
13. Validity of Medical Certificates .................................................................. 18
14. Title 14 CFR 61.53, Prohibition on Operations During Medical Deficiency
........................................................................................................................ 19
15. Reexamination of an Airman ..................................................................... 20
16. Examination Fees ..................................................................................... 20
17. Replacement of Medical Certificates ......................................................... 20
18. Disposition of Applications and Medical Examinations ............................. 21
19. Protection and Destruction of Forms ......................................................... 21
20. Questions or Requests for Assistance ...................................................... 21
21. Airman Appeals......................................................................................... 22
APPLICATION FOR MEDICAL CERTIFICATION ............................................. 26
I. AME Guidance for Positive Identification of Airmen and Application
Procedures...................................................................................................... 27
II. Prior to the Examination .............................................................................. 27
ITEMS 1-2. Application for; Class of Medical Certificate Applied For............. 29
ITEMS 3-10. Identification .............................................................................. 29
ITEMS 11-12. Occupation; Employer ............................................................. 30
ITEM 13. Has Your FAA Airman Medical Certificate Ever Been Denied,
Suspended, or Revoked?................................................................................ 30
ITEMS 14-15. Total Pilot Time ....................................................................... 31
ITEM 16. Date of Last FAA Medical Application ............................................ 31
ITEM 17.a. Do You Currently Use Any Medication (Prescription or
NONprescription)? .......................................................................................... 31
ITEM 17.b. Do You Ever Use Near Vision Contact Lens(es) While Flying? ... 32
ITEM 18. Medical History ............................................................................... 32
ITEM 19. Visits to Health Professional Within Last 3 Years ............................ 39
ITEM 20. Applicant's National Driver Register and Certifying Declaration ...... 40
ITEMS 21-22. Height and Weight .................................................................. 42
LAST UPDATE: March 30, 2016
ITEMS 23-24. Statement of Demonstrated Ability (SODA); SODA Serial

Number ........................................................................................................... 44
ITEMS 25-30. Ear, Nose and Throat (ENT) ................................................... 45
ITEMS 31-34. Eye .......................................................................................... 53
ITEM 36. Heart................................................................................................ 72
ITEM 37. Vascular System.............................................................................. 88
ITEM 38. Abdomen and Viscera ..................................................................... 91
ITEM 39. Anus ................................................................................................ 98
ITEM 40. Skin ................................................................................................. 99
ITEM 41. G-U System ................................................................................... 103
ITEMS 42-43. Musculoskeletal ..................................................................... 120
ITEM 44. Identifying Body Marks, Scars, Tattoos ......................................... 130
ITEM 45. Lymphatics .................................................................................... 131
ITEM 46. Neurologic ..................................................................................... 133
ITEM 47. Psychiatric ..................................................................................... 148
ITEM 48. General Systemic .......................................................................... 162
ITEM 49. Hearing ......................................................................................... 174
ITEMS 50- 54. Ophthalmologic Disorder ...................................................... 178
ITEM 55. Blood Pressure (updated 10/28/15) ............................................... 193
ITEM 56. Pulse ............................................................................................. 195
ITEM 57. Urine Test ...................................................................................... 195
ITEM 58. ECG............................................................................................... 196
APPLICATION REVIEW .................................................................................. 199
ITEM 59. Other Tests Given ........................................................................ 200
ITEM 60. Comments on History and Findings.............................................. 201
ITEM 61. Applicant's Name.......................................................................... 202
ITEM 62. Has Been Issued .......................................................................... 202
ITEM 63. Disqualifying Defects .................................................................... 203
ITEM 64. Medical Examiner's Declaration ................................................... 203
CACI CONDITIONS ......................................................................................... 204
DISEASE PROTOCOLS .................................................................................. 205
PHARMACEUTICALS ..................................................................................... 289
SPECIAL ISSUANCES .................................................................................... 312
SUBSTANCES OF DEPENDENCE/ABUSE.................................................... 347
SYNOPSIS OF MEDICAL STANDARDS ........................................................ 351
STUDENT PILOT RULE CHANGE .................................................................. 353
GLOSSARY ..................................................................................................... 355
ARCHIVES AND UPDATES ............................................................................ 359
Forms: http://www.faa.gov/library/forms
Federal Aviation Administration
Regional and Center Medical Office Addresses:
http://www.faa.gov/licenses_certificates/medical_certification/rfs
FAA Flight Standards District Offices (FSDO's):
http://www.faa.gov/about/office_org/field_offices/fsdo
Title 14 Code of Federal Regulations
Part 67 Medical Standards and Certification:
http://ecfr.gpoaccess.gov/
Convention on International Civil Aviation
International Standards on Personnel Licensing:
The international Standards on Personnel Licensing are contained in Annex 1
Personnel Licensing to the Convention on International Civil Aviation. The FAA
maintains an updated, hard copy of all the ICAO Annexes and also an on-line
subscription. The FAA makes copies of Annex 1 available at seminars and can provide
Examiners access upon request.
http://www.icao.int/safety/AirNavigation/Pages/peltrgFAQ.aspx
GENERAL INFORMATION
Guide for Aviation Medical Examiners

____________________________________________________________________
This section provides input to assist an Aviation Medical Examiner (AME), otherwise
known as an Examiner, in performing his or her duties in an efficient and effective
manner. It also describes Examiner responsibilities as the Federal Aviation
Administration's (FAA) representative in medical certification matters and as the link
between airmen and the FAA.
1. Legal Responsibilities of Designated Aviation Medical Examiners
Title 49, United States Code (U.S.C.) (Transportation), sections 109(9), 40113(a),
44701-44703, and 44709 (1994) formerly codified in the Federal Aviation Act of 1958,
as amended, authorizes the FAA Administrator to delegate to qualified private persons;
i.e. designated Examiners, matters related to the examination, testing, and inspection
necessary to issue a certificate under the U.S.C. and to issue the certificate.
Designated Examiners are delegated the Administrator's authority to examine
applicants for airman medical certificates and to issue or deny issuance of certificates.
Approximately 450,000 applications for airman medical certification are received and
processed each year. The vast majority of medical examinations conducted in
connection with these applications are performed by physicians in private practice who
have been designated to represent the FAA for this purpose. An Examiner is a
designated representative of the FAA Administrator with important duties and
responsibilities. It is essential that Examiners recognize the responsibility associated
with their appointment.
At times, an applicant may not have an established treating physician and the Examiner
may elect to fulfill this role. You must consider your responsibilities in your capacity as
an Examiner as well as the potential conflicts that may arise when performing in this
dual capacity.
The consequences of a negligent or wrongful certification, which would permit an
unqualified person to take the controls of an aircraft, can be serious for the public, for
the Government, and for the Examiner. If the examination is cursory and the Examiner
fails to find a disqualifying defect that should have been discovered in the course of a
thorough and careful examination, a safety hazard may be created and the Examiner
may bear the responsibility for the results of such action.
Of equal concern is the situation in which an Examiner deliberately fails to report a
disqualifying condition either observed in the course of the examination or otherwise
known to exist. In this situation, both the applicant and the Examiner in completing the
application and medical report form may be found to have committed a violation of
Federal criminal law which provides that:
"Whoever in any matter within the jurisdiction of any department or agency of the
United States knowingly and willfully falsifies, conceals, or covers up by any trick,
scheme, or device a material fact, or who makes any false, fictitious or fraudulent
statements or representations, or entry, may be fined up to $250,000 or

____________________________________________________________________
imprisoned not more than 5 years, or both" (Title 18 U.S. Code. Secs. 1001;
3571).
Cases of falsification may be subject to criminal prosecution by the Department of
Justice. This is true whether the false statement is made by the applicant, the
Examiner, or both. In view of the pressures sometimes placed on Examiners by their
regular patients to ignore a disqualifying physical defect that the physician knows to
exist, it is important that all Examiners be aware of possible consequences of such
conduct.
In addition, when an airman has been issued a medical certificate that should not have
been issued, it is frequently necessary for the FAA to begin a legal revocation or
suspension action to recover the certificate. This procedure is time consuming and
costly. Furthermore, until the legal process is completed, the airman may continue to
exercise the privileges of the certificate, thereby compromising aviation safety.
2. Authority of Aviation Medical Examiners
The Examiner is delegated authority to:
Examine applicants for, and holders of, airman medical certificates to determine
whether or not they meet the medical standards for the issuance of an airman
medical certificate.
Issue or deny airman medical certificates to applicants or holders of such
certificates based upon whether or not they meet the applicable medical
standards. The medical standards are found in Title 14 of the Code of Federal
Regulations, part 67.
A medical certificate issued by an Examiner is considered to be affirmed as issued
unless, within 60 days after date of issuance (date of examination), it is reversed by the
Federal Air Surgeon, a RFS, or the Manager, AMCD. However, if the FAA requests
additional information from the applicant within 60 days after the issuance, the
above-named officials have 60 days after receipt of the additional information to reverse
the issuance.
3. Equipment Requirements
For the conduct of the medical examination, Examiners shall have adequate facilities for
performing the required examinations and possess the following equipment prior to
conducting any FAA examinations. History or current findings may indicate a need for
special evaluations. Examiners shall certify at the time of designation, re-designation,
or upon request that they possess (and maintain as necessary) the equipment
specified.

____________________________________________________________________
1. Standard Snellen Test. Types for visual acuity (both near and distant) and
appropriate eye lane. FAA Form 8500-1, Near Vision Acuity Test Card may be used for
near and intermediate vision testing. Metal, opaque plastic, or cardboard occluder.
2. Eye Muscle Test-Light. May be a spot of light 0.5cm in diameter, a regular muscletest light, or an ophthalmoscope.
3. Maddox Rod. May be hand-type.
4. Horizontal Prism Bar. Risley or hand prism are acceptable alternatives.
5. Other vision test equipment that is acceptable as a replacement for 1 through 4
above include any commercially available visual acuities and heterophoria testing
devices.
6. Color Vision Test Apparatus. Pseudoisochromatic plates, American Optical Company
(AOC), l965 edition; AOC-HRR, 2nd edition; Dvorine, 2nd edition; Ishihara, Concise 14 , 24 -, or 38-plate editions; or Richmond (l983 edition, 15-plates). Acceptable substitutes
are: Farnsworth Lantern; OPTEC 900 Color Vision Test; Keystone Orthoscope;
Keystone Telebinocular; OPTEC 2000 Vision Tester (Models 2000 PM, 2000 PAME,
2000 PI) -Tester MUST contain 2000-010 FAR color perception PIP plate to be
approved; OPTEC 2500; Titmus Vision Tester; Titmus i400.
7. A Wall Target consisting of a 50-inch square surface with a matte finish (may be
black felt or dull finish paper) and a 2-mm white test object (may be a pin) in a suitable
handle of the same color as the background. Note: this is not necessary if an AME
chooses the acceptable option of performing field of vision testing by direct
confrontation.
8. Standard physician diagnostic instruments and aids including those necessary to
perform urine testing for albumin and glucose and those to measure height and weight.
9. Electrocardiographic equipment. Senior Examiners must have access to digital
electrocardiographic equipment with electronic transmission capability.
10. Audiometric equipment. All Examiners must have access to audiometric equipment
or a capability of referring applicants to other medical facilities for audiometric testing.
4. Medical Certification Decision Making
The format of the Guide establishes aerospace medical dispositions, protocols, and
AME Assisted Special Issuances (AASI) identified in Items 2158 of the FAA Form
8500. This guidance references specific medical tests or procedure(s) the results of
which are needed by the FAA to determine the eligibility of the applicant to be medically

____________________________________________________________________
certificated. The request for this medical information must not be misconstrued as the
FAA ordering or mandating that the applicant undergo testing, where clinically
inappropriate or contraindicated. The risk of the study based upon the disease state and
test conditions must be balanced by the applicants desire for certification and
determined by the applicant and their healthcare provider(s).
After reviewing the medical history and completing the examination, Examiners must:
Issue a medical certificate,
Deny the application, or
Defer the action to the Manager, AMCD, AAM-300, or the appropriate RFS
Examiners may issue a medical certificate only if the applicant meets all medical
standards, including those pertaining to medical history unless otherwise authorized by
the FAA.
Examiners may not issue a medical certificate if the applicant fails to meet specified
minimum standards or demonstrates any of the findings or diagnoses described in this
Guide as "disqualifying" unless the condition is unchanged or improved and the
applicant presents written documentation that the FAA has evaluated the condition,
found the applicant eligible for certification, and authorized Examiners to issue
certificates.
The following medical conditions are specifically disqualifying under 14 CFR part 67.
However, the FAA may exercise discretionary authority under the provisions of
Authorization of Special Issuance, to issue an airman medical certificate. See
Special Issuances section for additional guidance where applicable.
Angina pectoris;
Bipolar disorder;
Cardiac valve replacement;
Coronary heart disease that has required treatment or, if untreated, that has
been symptomatic or clinically significant;
Diabetes mellitus requiring insulin or other hypoglycemic medication;
Disturbance of consciousness without satisfactory medical explanation of the
cause;
Epilepsy;

____________________________________________________________________
Heart replacement;
Myocardial infarction;
Permanent cardiac pacemaker;
Personality disorder that is severe enough to have repeatedly manifested itself
by overt acts;
Psychosis;
Substance abuse and dependence; and/or
Transient loss of control of nervous system function(s) without satisfactory
medical explanation of cause.
An airman who is medically disqualified for any reason may be considered by the FAA
for an Authorization for Special Issuance of a Medical Certificate (Authorization). For
medical defects, which are static or nonprogressive in nature, a Statement of
Demonstrated Ability (SODA) may be granted in lieu of an Authorization.
The Examiner always may defer the application to the FAA for action. In the interests
of the applicant and of a responsive certification system, however, deferral is
appropriate only if: the standards are not met; if there is an unresolved question about
the history, the findings, the standards, or agency policy; if the examination is
incomplete; if further evaluation is necessary; or if directed by the FAA.
The Examiner may deny certification only when the applicant clearly does not meet the
standards.
5. Authorization for Special Issuance and AME Assisted Special Issuance (AASI)
A. Authorization for Special Issuance of a Medical Certificate (Authorization).
At the discretion of the Federal Air Surgeon, an Authorization for Special Issuance of a
Medical Certificate (Authorization), valid for a specified period, may be granted to a
person who does not meet the established medical standards if the person shows to the
satisfaction of the Federal Air Surgeon that the duties authorized by the class of medical
certificate applied for can be performed without endangering public safety during the
period in which the Authorization would be in force. The Federal Air Surgeon may
authorize a special medical flight test, practical test, or medical evaluation for this
purpose. A medical certificate of the appropriate class may be issued to a person who
fails to meet one or more of the established medical standards if that person possesses
a valid agency issued Authorization and is otherwise eligible. An airman medical
certificate issued in accordance with the special issuance section of part 67 (14 CFR
10

____________________________________________________________________
67.401), shall expire no later than the end of the validity period or upon the withdrawal
of the Authorization upon which it is based. An airman must again show to the
satisfaction of the Federal Air Surgeon that the duties authorized by the class of medical
certificate applied for can be performed without endangering public safety in order to
obtain a new medical certificate and/or a Re-Authorization.
In granting an Authorization, the Federal Air Surgeon may consider the person's
operational experience and any medical facts that may affect the ability of the person to
perform airman duties including:
The factors leading to and surrounding the episode;
The combined effect on the person of failing to meet one or more than one
requirement of part 67; and
The prognosis derived from professional consideration of all available information

regarding the person.
In granting an Authorization, the Federal Air Surgeon specifies the class of medical
certificate authorized to be issued and may do any or all of the following:
Limit the duration of an Authorization;
Condition the granting of a new Authorization on the results of subsequent

medical tests, examinations, or evaluations;
State on the Authorization, and any medical certificate based upon it, any
operational limitation needed for safety; or
Condition the continued effect of an Authorization, and any second- or third-class

medical certificate based upon it, on compliance with a statement of functional
limitations issued to the person in coordination with the Director of Flight
Standards or the Director's designee.
In determining whether an Authorization should be granted to an applicant for a

third-class medical certificate, the Federal Air Surgeon considers the freedom of
an airman, exercising the privileges of a private pilot certificate, to accept
reasonable risks to his or her person and property that are not acceptable in the
exercise of commercial or airline transport pilot privileges, and, at the same time,
considers the need to protect the safety of persons and property in other aircraft
and on the ground
An Authorization granted to a person who does not meet the applicable medical
standards of part 67 may be withdrawn, at the discretion of the Federal Air Surgeon, at
any time if:
11

____________________________________________________________________
There is an adverse change in the holder's medical condition;
The holder fails to comply with a statement of functional limitations or operational

limitations issued as a condition of certification under the special issuance
section of part 67 (14 CFR 67.401);
Public safety would be endangered by the holder's exercise of airman privileges;
The holder fails to provide medical information reasonably needed by the Federal
Air Surgeon for certification under the special issuance section of part 67
(14 CFR 67.401); or
The holder makes or causes to be made a statement or entry that is the basis for
withdrawal of an Authorization under the falsification section of part 67
(14 CFR 67.403).
A person who has been granted an Authorization under the special issuance section of
part 67 (14 CFR 67.401), based on a special medical flight or practical test, need not
take the test again during later medical examinations unless the Federal Air Surgeon
determines or has reason to believe that the physical deficiency has or may have
degraded to a degree to require another special medical flight test or practical test.
The authority of the Federal Air Surgeon under the special issuance section of part 67
(14 CFR 67.401) is also exercised by the Manager, AMCD, and each RFS.
If an Authorization is withdrawn at any time, the following procedures apply:
The holder of the Authorization will be served a letter of withdrawal, stating the
reason for the action;
By not later than 60 days after the service of the letter of withdrawal, the holder of
the Authorization may request, in writing, that the Federal Air Surgeon provide for
review of the decision to withdraw. The request for review may be accompanied
by supporting medical evidence;
Within 60 days of receipt of a request for review, a written final decision either
affirming or reversing the decision to withdraw will be issued; and
A medical certificate rendered invalid pursuant to a withdrawal, in accordance

with the special issuance section of part 67 (14 CFR 67.401) shall be
surrendered to the Administrator upon request.
12

____________________________________________________________________
B. AME Assisted Special Issuance (AASI).
AME Assisted Special Issuance (AASI) is a process that provides Examiners the ability
to re-issue an airman medical certificate under the provisions of an Authorization to an
applicant who has a medical condition that is disqualifying under 14 CFR part 67.
An FAA physician provides the initial certification decision and grants the Authorization
in accordance with 14 CFR 67.401. The Authorization letter is accompanied by
attachments that specify the information that treating physician(s) must provide for the
re-issuance determination. Examiners may re-issue an airman medical certificate under
the provisions of an Authorization, if the applicant provides the requisite medical
information required for determination. Examiners may not issue initial Authorizations.
An Examiner's decision or determination is subject to review by the FAA.
6. Privacy of Medical Information
A. Within the FAA, access to an individual's medical information is strictly on a
"need-to-know" basis. The safeguards of the Privacy Act apply to the application for
airman medical certification and to other medical files in the FAA's possession. The
FAA does not release medical information without an order from a court of competent
jurisdiction, written permission from the individual to whom it applies, or, with the
individual's knowledge, during litigation of matters related to certification. The FAA
does, however, on request, disclose the fact that an individual holds an airman medical
certificate and its class, and it may provide medical information regarding a pilot
involved in an accident to the National Transportation Safety Board (NTSB) (or to a
physician of the appropriate medical discipline who is retained by the NTSB for use in
aircraft accident investigation).
The Examiner, as a representative of the FAA, should treat the applicant's medical
certification information in accordance with the requirements of the Privacy Act.
Therefore, information should not be released without the written consent of the
applicant or an order from a court of competent jurisdiction. Whenever a court order or
subpoena is received by the Examiner, the appropriate RFS or the AMCD should be
contacted In order to ensure proper release of information. Similarly, unless the
applicant's written consent for release routine in nature (e.g., accompanying a standard
insurance company request), the FAA must be contacted before releasing any
information. In all cases, copies of all released information should be retained.
B. Health Insurance Portability and Accountability Act of 1996 (HIPAA) and Examiners
activities for the FAA.
This Act provides specific patient protections and depending upon an Examiners
activation and practice patterns, you may have to comply with additional requirements.
13

____________________________________________________________________
C. Examiners shall certify at the time of designation, re-designation, or upon request
that they shall protect the privacy of medical information.
7. Release of Information
Except in compliance with an order of a court of competent jurisdiction, or upon an
applicant's written request, Examiners will not divulge or release copies of any reports
prepared in connection with the examination to anyone other than the applicant or the
FAA. A copy of the examination may be released to the applicant upon request. Upon
receipt of a court subpoena or order, the Examiner shall notify the appropriate RFS.
Other requests for information will be referred to:
MANAGER
AEROSPACE MEDICAL CERTIFICATION DIVISION, AAM-300
CIVIL AEROMEDICAL INSTITUTE
FEDERAL AVIATION ADMINISTRATION
POST OFFICE BOX 26200
OKLAHOMA CITY, OK 73125-0080
8. No "Alternate" Examiners Designated

The Examiner is to conduct all medical examinations at their designated address only.
An Examiner is not permitted to conduct examinations at a temporary address and is
not permitted to name an alternate Examiner. During an Examiner's absence from the
permanent office, applicants for airman medical certification shall be referred to another
Examiner in the area.
9. Who May Be Certified
a. Age Requirements
There is no age restriction or aviation experience requirement for medical certification.
Any applicant who qualifies medically may be issued a Medical Certificate regardless of
age.
There are, however, minimum age requirements for the various airman certificates (i.e.,
pilot license certificates) are defined in 14 CFR part 61, Certification: Pilots and Flight
Instructors, and Ground Inspectors as follows:
(1) Airline transport pilot (ATP) certificate: 23 years
(2) Commercial pilot certificate: 18 years
(3) Private pilot certificate: powered aircraft - 17 years;
gliders and balloons - 16 years
Note: As of April 1, 2016 (per Final Rule [81 FR 1292]), AMEs will no longer be able to
issue the combined FAA Medical Certificate and Student Pilot Certificate. See Student
Pilot Rule Change.
14

____________________________________________________________________
b. Language Requirements
There is no language requirement for medical certification. However, if the AME has
concerns about the applicants English proficiency, they should contact their local FSDO
and/or the RFS and document this in Block 60.
Effective March 5, 2008, the International Civil Aviation Organization (ICAO) (Annex 1
Personnel Licensing) standards require that all Private, Commercial, or Airline Transport
pilots as well as Flight Engineers and Flight Navigators operating internationally as
required crewmembers of an airplane or helicopter have an airman certificate with an
endorsement of language proficiency. In the case of persons holding a U.S. airman
certificate, the language proficiency endorsement will state English Proficient. An
applicant must meet the ICAO definition of English Proficient, which is equivalent to
the FAAs long-standing, basic English standard.
At each exam, the Examiner must observe the applicants ability to understand and
communicate in English. This may be accomplished by observing the applicant reading
instructions, answering questions, and conversing with the AME.
If there is any doubt regarding the applicants English proficiency:
Providing Part 67 Medical Qualification Standard is met, applicants for an Airman

Medical Certificate may be issued the Airman Medical Certificate.
In all cases:
o The AME must notify the applicant of their concern, document the notification
in Block 60, and advise the applicant to report to the local FSDO for further
testing.
o The AME must also notify the FSDO and/or the RFS and document this in
Block 60. If the AME notifies only the RFS, then the RFS must notify the
FSDO closest to the examining AMEs office. The AME must also document
in Block 60 the name of the person contacted.
The ICAO standard rates individuals from Level 1 (pre-elementary) to Level 6 (expert).
Operational Level 4 is considered the minimum for proficiency. The following is
provided as information only:
1. PRONUNCIATION
Assumes that English is not the applicants first language and that the applicant has a dialect or accent that is
intelligible to the aeronautical community. Pronunciation, stress, rhythm, and intonation are influenced by the
applicants first language, but only sometimes interfere with ease of understanding.
2. STRUCTURE
Relevant grammatical structures and sentence patterns are determined by language functions appropriate to the
task. Basic grammatical structures and sentence patterns are used creatively and are usually well controlled by
15

____________________________________________________________________
the applicant. Errors may occur, particularly in unusual or unexpected circumstances, but rarely interfere with
meaning.
3. VOCABULARY
The applicants vocabulary range and accuracy are usually sufficient to communicate effectively on common,
concrete, and work-related topics. The applicant can often paraphrase successfully when lacking vocabulary in
unusual or unexpected circumstances.
4. FLUENCY
The applicant produces stretches of language at an appropriate tempo. There may be occasional loss of fluency
on transition from rehearsed or formulaic speech to spontaneous interaction, but this does not prevent effective
communication. The applicant can make limited use of discourse markers or connectors. Fillers are not
distracting.
5. COMPREHENSION
Comprehension by the applicant is mostly accurate on common, concrete, and work-related topics when the
dialect, accent or variety used is sufficiently intelligible. When the applicant is confronted with a linguistic or
situational complication or an unexpected turn of events, comprehension may be slower or require clarification
strategies.
6. INTERACTIONS
Responses by the applicant are usually immediate, appropriate, and informative. The applicant initiates and
maintains exchanges even when dealing with an unexpected turn of events. The applicant deals adequately with
apparent misunderstandings by checking, confirming, or clarifying.
10. Classes of Medical Certificates

An applicant may apply and be granted any class of airman medical certificate as long
as the applicant meets the required medical standards for that class of medical
certificate. However, an applicant must have the appropriate class of medical certificate
for the flying duties the airman intends to exercise. For example, an applicant who
exercises the privileges of an airline transport pilot (ATP) certificate must hold a firstclass medical certificate. That same pilot when holding only a third-class medical
certificate may only exercise privileges of a private pilot certificate. Finally, an applicant
need not hold an ATP airman certificate to be eligible for a first-class medical certificate.
Listed below are the three classes of airman medical certificates, identifying the
categories of airmen (i.e., pilot) certificates applicable to each class.
First-Class - Airline Transport Pilot
Second-Class - Commercial Pilot; Flight Engineer; Flight Navigator; or
Air Traffic Control Tower Operator. (Note: This category of air traffic controller
does not include FAA employee air traffic control specialists)
Third-Class - Private Pilot or Recreational Pilot
An airman medical certificate is valid only with the original signature of the AME who
performed the examination or with the digital signature of an authorized FAA physician
(e.g., Regional Flight Surgeon, manager of the Aerospace Medical Certification Division,
Federal Air Surgeon). Note:
16

____________________________________________________________________
Copies are NOT valid.

An AME may only issue ONE originally signed certificate to an airman. A
replacement for a lost or destroyed certificate must be issued by the FAA.
11. Operations Not Requiring a Medical Certificate

Glider and Free Balloon Pilots are not required to hold a medical certificate of any class.
To be issued Glider or Free Balloon Airman Certificates, applicants must certify that
they do not know, or have reason to know, of any medical condition that would make
them unable to operate a glider or free balloon in a safe manner. This certification is
made at the local FAA FSDO.
Sport pilots are required to hold either a valid airman medical certificate or a current
and valid U.S. drivers license. When using a current and valid U.S. drivers license to
qualify, sport pilots must comply with each restriction and limitation on their U.S. drivers
license and any judicial or administrative order applying to the operation of a motor
vehicle.
To exercise sport pilot privileges using a current and valid U.S. drivers license as
evidence of qualification, sport pilots must:
Not have been denied the issuance of at least a third-class airman medical
certificate (if they have applied for an airman medical certificate)
Not have had their most recent airman medical certificate revoked or suspended
(if they have held an airman medical certificate); and
Not have had an Authorization withdrawn (if they have ever been granted an
Authorization).
Sport pilots may not use a current and valid U.S. drivers license in lieu of a valid airman
medical certificate if they know or have reason to know of any medical condition that
would make them unable to operate a light-sport aircraft in a safe manner.
Sport pilot medical provisions are found under 14 CFR 61.3, 61.23, 61.53, and
61.303).
For more information about the sport pilot final rule, see the Certification of Aircraft and
Airmen for the Operation of Light-Sport Aircraft; Final Rule.
12. Medical Certificates AME Completion
Each medical certificate must bear the same date as the date of medical
examination regardless of the date the certificate is actually issued.
Each medical certificate must be type-written either by typewriter or computer
print-out. Handwritten or obviously corrected certificates are not acceptable.
17

____________________________________________________________________
Only use standard limitations as contained within this document or on the

Aerospace Medical Certification System (AMCS).
Each medical certificate must be fully completed prior to being signed.
o Both the AME and applicant must sign the medical certificate in ink.
o The applicant must sign before leaving the AMEs office.
AMEs are required to use the electronic transmission capability of AMCS and must
forward the FAA/Original Copy to the FAA in Oklahoma (see address below). The AME
Work Copy must be retained as the file copy.
FAA AEROSPACE MEDICAL CERTIFICATION DIVISION
AAM-300
P.O. Box 26080
OKLAHOMA CITY, OK 73125
13. Validity of Medical Certificates
An airman medical certificate is valid only with the original signature of the AME who
performed the examination or with the digital signature of an authorized FAA physician
(e.g., Regional Flight Surgeon, manager of the Aerospace Medical Certification Division,
Federal Air Surgeon).
Copies are NOT valid.
An AME may only issue ONE originally signed certificate to an airman. A
replacement for a lost or destroyed certificate must be issued by the FAA.
A. First-Class Medical Certificate: A first-class medical certificate is valid for the
remainder of the month of issue; plus
6-calendar months for operations requiring a first-class medical certificate if the
airman is age 40 or over on or before the date of the examination, or plus
12-calendar months for operations requiring a first-class medical certificate if the
airman has not reached age 40 on or before the date of examination
12-calendar months for operations requiring a second-class medical certificate, or
plus
24-calendar months for operations requiring a third-class medical certificate, or plus
60-calendar months for operations requiring a third-class medical certificate if the
airman has not reached age 40 on or before the date of examination.
B. Second-Class Medical Certificate: A second-class medical certificate is valid for the
18

____________________________________________________________________
12-calendar months for operations requiring a second-class medical certificate, or
plus
C. Third-Class Medical Certificate: A third-class medical certificate is valid for the
Note: Each medical certificate must bear the same date as the date of medical
examination regardless of the date the certificate is actually issued. Each medical
certificate must be type-written, either by typewriter or computer print-out.
14. Title 14 CFR 61.53, Prohibition on Operations During Medical Deficiency
NOTE: 14 CFR 61.53 was revised on July 27, 2004 by adding subparagraph (c)
(a) Operations that require a medical certificate. Except as provided in paragraph
(b) of this section, a person who holds a current medical certificate issued under
part 67 of this chapter shall not act as pilot in command, or in any other capacity
as a required pilot flight crewmember, while that person:
(1) Knows or has reason to know of any medical condition that would make the
person unable to meet the requirements for the medical certificate necessary
for the pilot operation; and/or
(2) Is taking medication or receiving other treatment for a medical condition that
results in the person being unable to meet the requirements for the medical
certificate necessary for the pilot operation.
(b) Operations that do not require a medical certificate. For operations provided for
in 61.23(b) of this part, a person shall not act as pilot in command, or in any
other capacity as a required pilot flight crewmember, while that person knows or
has reason to know of any medical condition that would make the person unable
to operate the aircraft in a safe manner.
(c) Operations requiring a medical certificate or a U.S. driver's license. For
operations provided for in Sec. 61.23(c), a person must meet the provisions of
19

____________________________________________________________________
(1) Paragraph (a) of this section if that person holds a valid medical certificate
issued under part 67 of this chapter and does not hold a current and valid
U.S. driver's license
(2) Paragraph (b) of this section if that person holds a current and valid U.S.
driver's license
15. Reexamination of an Airman
A medical certificate holder may be required to undergo a reexamination at any time if,
in the opinion of the Federal Air Surgeon or authorized representative within the FAA,
there is a reasonable basis to question the airman's ability to meet the medical
standards. An Examiner may NOT order such reexamination.
16. Examination Fees
The FAA does not establish fees to be charged by Examiners for the medical
examination of persons applying for airman medical certification. It is recommended
that the fee be the usual and customary fee established by other physicians in the same
general locality for similar services.
17. Replacement of Medical Certificates
Medical certificates that are lost or accidentally destroyed may be replaced upon proper
application provided such certificates have not expired. The request should be sent to:
FOIA DESK
CIVIL AEROSPACE MEDICAL INSTITUTE
The airman's request for replacement must be accompanied by a remittance of two
dollars ($2) (check or money order) made payable to the FAA. This request must
include:
Airmans full name and date of birth;
Class of certificate;
Place and date of examination;
Name of the Examiner; and
20

____________________________________________________________________
Circumstances of the loss or destruction of the original certificate.
The replacement certificate will be prepared in the same manner as the missing
certificate and will bear the same date of examination regardless of when it is issued.
In an emergency, contact your RFS or the Manager, AMCD, AAM-300, at the above
address or by facsimile at 405-954-4300 for certification verification only.
18. Disposition of Applications and Medical Examinations
All completed applications and medical examinations, unless otherwise directed by the
FAA, must be transmitted electronically via AMCS within 14 days after completion to the
AMCD. These requirements also apply to submissions by International AMEs.
A record of the examination is stored in AMCS, however, Examiners are encouraged to
print a copy for their own files. While not required, the Examiner may also print a
summary sheet for the applicant.
19. Protection and Destruction of Forms
Forms are available electronically in AMCS. Examiners are accountable for all blank
FAA forms they may have printed and are cautioned to provide adequate security for
such forms or certificates to ensure that they do not become available for illegal use.
Examiners are responsible for destroying any existing paper forms they may still have.
NOTE: Forms should not be shared with other Examiners.
20. Questions or Requests for Assistance
When an Examiner has a question or needs assistance in carrying out responsibilities,
the Examiner should contact one of the following individuals:
A. Regional Flight Surgeon (RFS)
Questions pertaining to problem medical certification cases in which the RFS

has initiated action;
Telephone interpretation of medical standards or policies involving an

individual airman whom the Examiner is examining;
Matters regarding designation and re-designation of Examiners and the

Aviation Medical Examiner Program; or
Attendance at Aviation Medical Examiner Seminars.
21

____________________________________________________________________
B. Manager, AMCD, AAM-300
Inquiries concerning guidance on problem medical certification cases;
Information concerning the overall airman medical certification program;
Matters involving FAA medical certification of military personnel; or
Information concerning medical certification of applicants in foreign countries
These inquiries should be made to:

MANAGER
C. Manager, Aeromedical Education Division, AAM-400
Matters regarding designation and re-designation of Examiners;
Requests for medical forms and stationery; or
Requests for airman medical educational material
These inquiries should be made to:

MANAGER
AEROSPACE MEDICAL EDUCATION DIVISION, AAM-400
21. Airman Appeals
A. Request for Reconsideration
An Examiner's denial of a medical certificate is not a final FAA denial. An applicant may
ask for reconsideration of an Examiner's denial by submitting a request in writing to:
22

____________________________________________________________________
FEDERAL AIR SURGEON
ATTN: MANAGER,
The AMCD will provide initial reconsideration. Some cases may be referred to the
appropriate RFS for action. If the AMCD or a RFS finds that the applicant is not
qualified, the applicant is denied and advised of further reconsideration and appeal
procedures. These may include reconsideration by the Federal Air Surgeon and/or
petition for NTSB review.
B. Statement of Demonstrated Ability (SODA)
At the discretion of the Federal Air Surgeon, a Statement of Demonstrated Ability
(SODA) may be granted, instead of an Authorization, to a person whose disqualifying
condition is static or non-progressive and who has been found capable of performing
airman duties without endangering public safety. A SODA does not expire and
authorizes a designated Examiner to issue a medical certificate of a specified class if
the Examiner finds that the condition described on the SODA has not adversely
changed.
In granting a SODA, the Federal Air Surgeon may consider the person's operational
experience and any medical facts that may affect the ability of the person to perform
airman duties including:
The combined effect on the person of failure to meet more than one requirement
of part 67; and
The prognosis derived from professional consideration of all available information

regarding the person.
In granting a SODA under the special issuance section of part 67 (14 CFR 67.401), the
Federal Air Surgeon specifies the class of medical certificate authorized to be issued
and may do any of the following:
State on the SODA, and on any medical certificate based upon it, any operational
limitation needed for safety; or
Condition the continued effect of a SODA, and any second- or third-class medical
certificate based upon it, on compliance with a statement of functional limitations
issued to the person in coordination with the Director of Flight Standards or the
Director's designee.
23

____________________________________________________________________
In determining whether a SODA should be granted to an applicant for a

third-class medical certificate, the Federal Air Surgeon considers the freedom of
an airman, exercising the privileges of a private pilot certificate, to accept
reasonable risks to his or her person and property that are not acceptable in the
exercise of commercial or airline transport pilot privileges, and, at the same time,
considers the need to protect the safety of persons and property in other aircraft
and on the ground.
A SODA granted to a person who does not meet the applicable standards of part 67
may be withdrawn, at the discretion of the Federal Air Surgeon, at any time if:
There is adverse change in the holder's medical condition;
The holder fails to comply with a statement of functional limitations or operational

limitations issued under the special issuance section of part 67 (14 CFR 67.401);
Public safety would be endangered by the holder's exercise of airman privileges;
The holder fails to provide medical information reasonably needed by the Federal
Air Surgeon for certification under the special issuance section of part 67
(14 CFR 67.401);
The holder makes or causes to be made a statement or entry that is the basis for
withdrawal of a SODA under the falsification section of part 67 (14 CFR 67.403);
or
A person who has been granted a SODA under the special issuance section of
part 67 (14 CFR 67.401), based on a special medical flight or practical test need
not take the test again during later medical examinations unless the Federal Air
Surgeon determines or has reason to believe that the physical deficiency has or
may have degraded to a degree to require another special medical flight test or
practical test.
The authority of the Federal Air Surgeon under the special issuance section of part 67
(14 CFR 67.401) is also exercised by the Manager, AMCD, and each RFS.
If a SODA is withdrawn at any time, the following procedures apply:
The holder of the SODA will be served a letter of withdrawal stating the reason
for the action;
By not later than 60 days after the service of the letter of withdrawal, the holder of
the SODA may request, in writing, that the Federal Air Surgeon provide for
review of the decision to withdraw. The request for review may be accompanied
by supporting medical evidence;
24

____________________________________________________________________
Within 60 days of receipt of a request for review, a written final decision either
affirming or reversing the decision to withdraw will be issued; and
A medical certificate rendered invalid pursuant to a withdrawal, in accordance

with the special issuance section of part 67 (14 CFR 67.401 (a)) shall be
surrendered to the Administrator upon request.
C. National Transportation Safety Board (NTSB)

Within 60 days after a final FAA denial of an unrestricted airman medical certificate, an
airman may petition the NTSB for a review of that denial. The NTSB does not have
jurisdiction to review the denial of a SODA or special issuance airman medical
certificate.
A petition for NTSB review must be submitted in writing to:
NATIONAL TRANSPORTATION SAFETY BOARD
490 L'ENFANT PLAZA, EAST SW
WASHINGTON, DC 20594-0001
The NTSB is an independent agency of the Federal Government that has the authority
to review on appeal the suspension, amendment, modification, revocation, or denial of
any certificate or license issued by the FAA Administrator.
An Administrative Law Judge for the NTSB may hold a formal hearing at which the FAA
will present documentary evidence and testimony by medical specialists supporting the
denial decision. The petitioner will also be given an opportunity to present evidence and
testimony at the hearing. The Administrative Law Judges decision is subject to review
by the full NTSB.
25
APPLICATION FOR MEDICAL

CERTIFICATION
Items 1-20 of FAA Form 8500-8

____________________________________________________________________
ITEMS 1- 20 of FAA Form 8500-8
This section contains guidance for items on the Medical History and General
Information page of FAA Form 8500-8, Application for Airman Medical Certificate.
I. AME Guidance for Positive Identification of Airmen and Application Procedures
All applicants must show proof of age and identity under 14 CFR 67.4. On
occasion, individuals have attempted to be examined under a false name. If the
applicant is unknown to the Examiner, the Examiner should request evidence of
positive identification. A Government-issued photo identification (e.g., drivers
license, identification card issued by a drivers license authority, military
identification, or passport) provides age and identity and is preferred. Applicants
may use other government-issued identification for age (e.g., certified copy of a
birth certificate); however, the Examiner must request separate photo
identification for identity (such as a work badge). Verify that the address
provided is the same as that given under Item 5. Record the type of
identification(s) provided and identifying number(s) under Item 60. Make a copy
of the identification and keep it on file for 3 years with the AME work copy.
An applicant who does not have government-issued photo identification may use nonphoto government-issued identification (e.g. pilot certificate, birth certificate, voter
registration card) in conjunction with a photo identification (e.g. work identification card,
student identification card).
If an airman fails to provide identification, the Examiner must report this immediately to
the AMCD, or the appropriate RFS for guidance.
II. Prior to the Examination
Once the applicant successfully completes Items 1-20 of FAA Form 8500-8
through the FAA MedXPress system, he/she will receive a confirmation number
and instructions to print a summary sheet. This data entered through the
MedXPress system will remain valid for 60 days.
Applicants must bring their MedXPress confirmation number, valid photo

identification, and the summary sheet to the Exam. If the applicant does not
bring their confirmation number to the exam, the applicant can retrieve it from
MedXPress or their email account. Examiners should call AMCS Support if the
confirmation number cannot be retrieved.
Examiners must not begin the exam until they have imported the MedXPress
application into AMCS and have verified the identity of the applicant.
27

____________________________________________________________________
III. After the Applicant Completes the Medical History of the FAA Form 8500-8
The Examiner must review all Items 1 through 20 for accuracy. The applicant must
answer all questions. The date for Item 16 may be estimated if the applicant does not
recall the actual date of the last examination. However, for the sake of electronic
transmission, it must be placed in the mm/dd/yyyy format.
Verify that the name on the applicant's identification media matches the name on the
FAA Form 8500-8. If it does not, question the applicant for an explanation. If the
explanation is not reasonable (legal name change, subsequent marriage, etc.), do not
continue the medical examination or issue a medical certificate. Contact your RFS for
guidance.
The applicant's Social Security Number (SSN) is not mandatory. Failure to provide is
not grounds for refusal to issue a medical certificate. (See Item 4). All other items on
the form must be completed.
Applicants must provide their home address on the FAA Form 8500-8. Applicants may
use a private mailing address (e.g., a P.O. Box number or a mail drop) if that is their
preferred mailing address; however, under Item 18 (in the "Explanations" box) of the
FAA Form 8500-8, they must provide their home address.
An applicant cannot make updates to their application once they have certified and
submitted it. If the examiner discovers the need for corrections to the application during
the review, the Examiner is required to discuss these changes with the applicant and
obtain their approval. The examiner must make any changes to the application in
AMCS.
Strict compliance with this procedure is essential in case it becomes necessary for the
FAA to take legal action for falsification of the application.
28

____________________________________________________________________
ITEMS 1-2. Application for; Class of Medical Certificate Applied For

The applicant indicates the class of medical certificate desired. The class of medical
certificate sought by the applicant is needed so that the appropriate medical standards
may be applied. The class of certificate issued must correspond with that for which the
applicant has applied.
The applicant may ask for a medical certificate of a higher class than needed for the
type of flying or duties currently performed. For example, an aviation student may ask
for a first-class medical certificate to see if he or she qualifies medically before entry into
an aviation career. A recreational pilot may ask for a first- or second-class medical
certificate if they desire.
The Examiner applies the standards appropriate to the class sought, not to the airman's
duties - either performed or anticipated. The Examiner should never issue more than
one certificate based on the same examination.
ITEMS 3-10. Identification
Items 3-10 on the FAA Form 8500-8 must be entered as identification. While most of the
items are self-explanatory (as indicated in the MedXPress drop-down menu next to
individual items) specific instructions include:
Item 3. Last Name; First Name; Middle Name

The applicants legal last, first, and middle name* (or initial if appropriate) must
be provided.
*If an applicant has no middle name, leave the middle name box blank. Do not
use nomenclature which indicates no middle name (i.e. NMN, NMI, etc.). If the
applicant has used such a nomenclature on their MedXPress application, delete
it and leave the middle name box blank.
Note: If the applicant's name changed for any reason, the current name is listed
on the application and any former name(s) in the EXPLANATIONS box of Item
18 on the application.
Item 4. Social Security Number (SSN)

The applicant must provide their SSN. If they decline to provide one or are an
international applicant, they must check the appropriate box and a number will be
generated for them. The FAA requests a SSN for identification purposes, record
control, and to prevent mistakes in identification.
29

____________________________________________________________________
Item 6. Date of Birth

The applicant must enter the numbers for the month, day, and year of birth in
order. Name, date of birth, and SSN are the basic identifiers of airmen. When
an Examiner communicates with the FAA concerning an applicant, the Examiner
must give the applicant's full name, date of birth, and SSN if at all possible. The
applicant should indicate citizenship; e.g., U.S.A.
Although nonmedical regulations allow an airman to solo a glider or balloon at
age 14, a medical certificate is not required for glider or balloon operations.
These airmen are required to certify to the FAA that they have no known physical
defects that make them unable to pilot a glider or balloon. This certification is
made at the FAA FSDOs.
There is a maximum age requirement for certain air carrier pilots. Because this
is not a medical requirement but an operational one, the Examiner may issue
medical certificates without regard to age to any applicant who meets the medical
standards.
ITEMS 11-12. Occupation; Employer

Occupational data are principally used for statistical purposes. This information, along
with information obtained from Items 10, 14 and 15 may be important in determining
whether a SODA may be issued, if applicable.
11. Occupation
This should reflect the applicant's major employment. "Pilot" should only be reported
when the applicant earns a livelihood from flying.
12. Employer
The employer's name should be entered by the applicant.
ITEM 13. Has Your FAA Airman Medical Certificate Ever Been Denied,
Suspended, or Revoked?
The applicant shall check "yes" or "no." If "yes" is checked, the applicant should enter
the date of action and should report details in the EXPLANATIONS box of Item 18.
The Examiner may not issue a medical certificate to an applicant who has checked
"yes." The only exceptions to this prohibition are:
The applicant presents written evidence from the FAA that he or she was
subsequently medically certificated and that an Examiner is authorized to issue a
renewal medical certificate to the person if medically qualified; or
30

____________________________________________________________________
The Examiner obtains oral or written authorization to issue a medical certificate

from an FAA medical office
ITEMS 14-15. Total Pilot Time

14. Total Pilot Time to Date
The applicant should indicate the total number of civilian flight hours and whether those
hours are logged (LOG) or estimated (EST).
15. Total Pilot Time Past 6 Months
The applicant should provide the number of civilian flight hours in the 6-month period
immediately preceding the date of this application. The applicant should indicate
whether those hours are logged (LOG) or estimated (EST).
ITEM 16. Date of Last FAA Medical Application
If a prior application was made, the applicant should indicate the date of the last
application, even if it is only an estimate of the year. This item should be completed
even if the application was made many years ago or the previous application did not
result in the issuance of a medical certificate. If no prior application was made, the
applicant should check the appropriate block in Item 16.
ITEM 17.a. Do You Currently Use Any Medication (Prescription or
NONprescription)?
If the applicant checks yes, give name of medication(s) and indicate if the medication
was listed in a previous FAA medical examination.
This includes both prescription and nonprescription medication. (Additional guidelines
for the certification of airmen who use medication may be found throughout the Guide).
For example, any airman who is undergoing continuous treatment with anticoagulants,
antiviral agents, anxiolytics, barbiturates, chemotherapeutic agents, experimental
hypoglycemic, investigational, mood-ameliorating, motion sickness, narcotic, sedating
antihistaminic, sedative, steroid drugs, or tranquilizers must be deferred certification
unless the treatment has previously been cleared by FAA medical authority. In such an
instance, the applicant should provide the Examiner with a copy of any FAA
correspondence that supports the clearance.
31

____________________________________________________________________
During periods in which the foregoing medications are being used for treatment of acute
illnesses, the airman is under obligation to refrain from exercising the privileges of
his/her airman medical certificate unless cleared by the FAA.
Further information concerning an applicant's use of medication may be found under the
items pertaining to specific medical condition(s) for which the medication is used, or you
may contact your RFS.
ITEM 17.b. Do You Ever Use Near Vision Contact Lens(es) While Flying?
The applicant should indicate whether near vision contact lens(es) is/are used while
flying. If the applicant answers "yes," the Examiner must counsel the applicant that use
of contact lens(es) for monovision correction is not allowed. The Examiner must
note in Item 60 that this counseling has been given. Examples of unacceptable use
include:
The use of a contact lens in one eye for near vision and in the other eye for
distant vision (for example: pilots with myopia plus presbyopia).
The use of a contact lens in one eye for near vision and the use of no contact
lens in the other eye (for example: pilots with presbyopia but no myopia).
If the applicant checks "yes" and no further comment is noted on FAA Form 8500-8 by
either the applicant or the Examiner, a letter will automatically be sent to the applicant
informing him or her that such use is inappropriate for flying.
Please note: the use of binocular contact lenses for distance-correction-only is
acceptable. In this instance, no special evaluation or SODA is routinely required for a
distance-vision-only contact lens wearer who meets the standard and has no
complications. Binocular bifocal or binocular multifocal contact lenses are also
acceptable under the Protocol for Binocular Multifocal and Accommodating Devices. If
the applicant checks yes in Item 17.b but actually is using binocular bifocal or
binocular multifocal contact lenses then the Examiner should note this in Item 60.
ITEM 18. Medical History
Each item under this heading must be checked either "yes" or "no." For all items
checked "yes," a description and approximate date of every condition the applicant has
ever been diagnosed with, had, or presently has, must be given in the EXPLANATIONS
box. If information has been reported on a previous application for airman medical
certification and there has been no change in the condition, the applicant may note
"PREVIOUSLY REPORTED, NO CHANGE" in the EXPLANATIONS box, but the
applicant must still check "yes" to the condition.
32

____________________________________________________________________
Of particular importance are conditions that have developed since the last FAA medical
examination. The Examiner must take the time to review the applicant's responses on
FAA Form 8500-8 before starting the applicant's medical examination.
The Examiner should ensure that the applicant has checked all of the boxes in Item 18
as either "yes" or "no." The Examiner should use information obtained from this review
in asking the applicant pertinent questions during the course of the examination.
Certain aspects of the individuals history may need to be elaborated upon. The
Examiner should provide in Item 60 an explanation of the nature of items checked yes
in items 18.a. through 18.y. Please be aware there is a character count limit in Item 60.
If all comments cannot fit in Item 60, the Examiner may submit additional information on
a plain sheet of paper and include the applicants full name, date of birth, signature, any
appropriate identifying numbers (PI, MID or SSN), and the date of the exam.
Supplementary reports from the applicant's physician(s) should be obtained and
forwarded to the AMCD, when necessary, to clarify the significance of an item of history.
The responsibility for providing such supplementary reports rests with the applicant. A
discussion with the Examiner's RFS may clarify and expedite the certification process at
that time.
Affirmative answers alone in Item 18 do not constitute a basis for denial of a medical
certificate. A decision concerning issuance or denial should be made by applying the
medical standards pertinent to the conditions uncovered by the history.
Experience has shown that, when asked direct questions by a physician, applicants are
likely to be candid and willing to discuss medical problems.
The Examiner should attempt to establish rapport with the applicant and to develop a
complete medical history. Further, the Examiner should be familiar with the FAA
certification policies and procedures in order to provide the applicant with sound advice.
18.a. Frequent or severe headaches. The applicant should report frequency,
duration, characteristics, severity of symptoms, neurologic manifestations, whether they
have been incapacitating, treatment, and side effects, if any. (See Item 46)
18.b. Dizziness or fainting spells. The applicant should describe characteristics of
the episode; e.g., spinning or lightheadedness, frequency, factors leading up to and
surrounding the episode, associated neurologic symptoms; e.g., headache, nausea,
LOC, or paresthesias. Include diagnostic workup and treatment if any.
(See Items 25-30 and Item 46)
18.c. Unconsciousness for any reason. The applicant should describe the event(s)
to determine the primary organ system responsible for the episode, witness statements,
initial treatment, and evidence of recurrence or prior episode. Although the regulation
states, an unexplained disturbance of consciousness is disqualifying, it does not mean
33

____________________________________________________________________
to imply that the applicant can be certificated if the etiology is identified, because the
etiology may also be disqualifying in and of itself. (See Item 46).
18.d. Eye or vision trouble except glasses. The Examiner should personally explore
the applicant's history by asking questions, concerning any changes in vision, unusual
visual experiences (halos, scintillations, etc.), sensitivity to light, injuries, surgery, or
current use of medication. Does the applicant report inordinate difficulties with eye
fatigue or strain? Is there a history of serious eye disease such as glaucoma or other
disease commonly associated with secondary eye changes, such as diabetes?
For glaucoma or ocular hypertension, obtain a FAA Form 8500-14, Report of Eye
Evaluation for Glaucoma. For any other medical condition, obtain a FAA Form 8500-7,
Report of Eye Evaluation. Under all circumstances, please advise the examining eye
specialist to explain why the airman is unable to correct to Snellen visual acuity of
20/20. (See Items 31-34, Item 53, and Item 54)
18.e. Hay fever or allergy. The applicant should report frequency and duration of
symptoms, any incapacitation by the condition, treatment, and side effects. The
Examiner should inquire whether the applicant has ever experienced any barotitis (ear
block), barosinusitis, alternobaric vertigo, or any other symptoms that could interfere
with aviation safety. (See Item 26)
18.f. Asthma or lung disease. The applicant should provide frequency and severity of
asthma attacks, medications, and number of visits to the hospital and/or emergency
room. For other lung conditions, a detailed description of symptoms/diagnosis, surgical
intervention, and medications should be provided. (See Item 35)
18.g. Heart or vascular trouble. The applicant should describe the condition to
include, dates, symptoms, and treatment, and provide medical reports to assist in the
certification decision-making process. These reports should include: operative reports
of coronary intervention to include the original cardiac catheterization report, stress
tests, worksheets, and original tracings (or a legible copy). When stress tests are
provided, forward the reports, worksheets and original tracings (or a legible copy) to the
FAA. Part 67 provides that, for all classes of medical certificates, an established
medical history or clinical diagnosis of myocardial infarction, angina pectoris, cardiac
valve replacement, permanent cardiac pacemaker implantation, heart replacement, or
coronary heart disease that has required treatment or, if untreated, that has been
symptomatic or clinically significant, is cause for denial. (See Item 36)
18.h. High or low blood pressure. The applicant should provide history and
treatment. Issuance of a medical certificate to an applicant with high blood pressure
may depend on the current blood pressure levels and whether the applicant is taking
anti-hypertensive medication. The Examiner should also determine if the applicant has
a history of complications, adverse reactions to therapy, hospitalization, etc.
(Details are given in Item 36 and Item 55)
34

____________________________________________________________________
18.i. Stomach, liver, or intestinal trouble. The applicant should provide history and
treatment, pertinent medical records, current status report, and medication. If a surgical
procedure was done, the applicant must provide operative and pathology reports.
(See Item 38)
18.j. Kidney stone or blood in urine. The applicant should provide history and
treatment, pertinent medical records, current status report and medication. If a
procedure was done, the applicant must provide the report and pathology reports.
(See Item 41)
18.k. Diabetes. The applicant should describe the condition to include symptoms and
treatment. Comment on the presence or absence of hyperglycemic and/or
hypoglycemic episodes. A medical history or clinical diagnosis of diabetes mellitus
requiring insulin or other hypoglycemic drugs for control are disqualifying. The Examiner
can help expedite the FAA review by assisting the applicant in gathering medical
records and submitting a current specialty report. (See Item 48)
18.l. Neurological disorders; epilepsy, seizures, stroke, paralysis, etc. The
applicant should provide history and treatment, pertinent medical records, current status
report and medication. The Examiner should obtain details about such a history and
report the results. An established diagnosis of epilepsy, a transient loss of control of
nervous system function(s), or a disturbance of consciousness is a basis for denial no
matter how remote the history. Like all other conditions of aeromedical concern, the
history surrounding the event is crucial. Certification is possible if a satisfactory
explanation can be established. (See Item 46)
18.m. Mental disorders of any sort; depression, anxiety, etc. An affirmative answer
to Item 18.m. requires investigation through supplemental history taking. Dispositions
will vary according to the details obtained. An applicant with an established history of a
personality disorder that is severe enough to have repeatedly manifested itself by overt
acts, a psychosis disorder, or a bipolar disorder must be denied or deferred by the
Examiner. (See Item 47)
18.n. Substance dependence; or failed a drug test ever; or substance abuse or
use of illegal substance in the last 2 years. "Substance" includes alcohol and other
drugs (e.g., PCP, sedatives and hypnotics, anxiolytics, marijuana, cocaine, opioids,
amphetamines, hallucinogens, and other psychoactive drugs or chemicals). For a "yes"
answer to Item 18.n., the Examiner should obtain a detailed description of the history. A
history of substance dependence or abuse is disqualifying. The Examiner must defer
issuance of a certificate if there is doubt concerning an applicant's substance use.
(See Item 47)
18.o. Alcohol dependence or abuse. (See Item 18.n.)
18.p. Suicide attempt. A history of suicidal attempts or suicidal gestures requires
further evaluation. The ultimate decision of whether an applicant with such a history is
35

____________________________________________________________________
eligible for medical certification rests with the FAA. The Examiner should take a
supplemental history as indicated, assist in the gathering of medical records related to
the incident(s), and, if the applicant agrees, assist in obtaining psychiatric and/or
psychological examinations. (See Item 47)
18.q. Motion sickness requiring medication. A careful history concerning the nature
of the sickness, frequency and need for medication is indicated when the applicant
responds affirmatively to this item. Because motion sickness varies with the nature of
the stimulus, it is most helpful to know if the problem has occurred in flight or under
similar circumstances. (See Item 29)
18.r. Military medical discharge. If the person has received a military medical
discharge, the Examiner should take additional history and record it in Item 60. It is
helpful to know the circumstances surrounding the discharge, including dates, and
whether the individual is receiving disability compensation. If the applicant is receiving
veteran's disability benefits, the claim number and service number are helpful in
obtaining copies of pertinent medical records. The fact that the applicant is receiving
disability benefits does not necessarily mean that the application should be denied.
18.s. Medical rejection by military service. The Examiner should inquire about the
place, cause, and date of rejection and enter the information in Item 60. It is helpful if
the Examiner can assist the applicant with obtaining relevant military documents. If a
delay of more than 14-calendar days is expected, the Examiner should transmit FAA
Form 8500-8 to the FAA with a note specifying what documents will be forwarded later.
Disposition will depend upon whether the medical condition still exists or whether a
history of such a condition requires denial or deferral under the FAA medical standards.
18.t. Rejection for life or health insurance. The Examiner should inquire regarding
the circumstances of rejection. The supplemental history should be recorded in Item 60.
Disposition will depend upon whether the medical condition still exists or whether a
history of such a condition requires denial or deferral under the FAA medical standards.
18.u. Admission to hospital. For each admission, the applicant should list the dates,
diagnoses, duration, treatment, name of the attending physician, and complete address
of the hospital or clinic. If previously reported, the applicant may enter "PREVIOUSLY
REPORTED, NO CHANGE." A history of hospitalization does not disqualify an
applicant, although the medical condition that resulted in hospitalization may.
18.v. History of Arrest(s), Conviction(s), and/or Administrative Action(s).
Arrest(s), conviction(s) and/or administrative action(s) affecting driving privileges may
raise questions about the applicant's fitness for certification and may be cause for
disqualification. (See Items 18.n. and 47). A single driving while intoxicated (DWI)
arrest, conviction and/or administrative action usually is not cause for denial provided
there are no other instances or indications of substance dependence or abuse.
36

____________________________________________________________________
The events to be reported are specifically identified in Item 18.v. of FAA Form 8500-8. If
yes is checked, the applicant must describe the arrest(s), conviction(s), and/or
administrative action(s) in the EXPLANATIONS box. The description must include:
The alcohol or drug offense for which the applicant was arrested, convicted, or
the type of administrative action involved (e.g., attendance at an educational or
rehabilitation program in lieu of conviction; license denial, suspension,
cancellation, or revocation for refusal to be tested; educational safe driving
program for multiple speeding convictions; etc.);
The name of the state or other jurisdiction involved; and
The date of the arrest, conviction, and/or administrative action.
Note: If the applicant documented ALL of the above information on previous exams
AND there are no new arrest(s), conviction(s), and/or administrative action(s) since
the last application, the applicant may enter PREVIOUSLY REPORTED, NO
CHANGE.
For all first-time reports of arrest(s), conviction(s), and/or administrative action(s) the
Examiner must do the following prior to issuing an airman medical certificate:
Obtain a detailed history of the applicant's alcohol use, the circumstances
surrounding all alcohol-related incidents (include those reported in 18v and any
others that may have occurred);
Obtain copies of all court records and arrest reports related to the event(s) if the
incident(s) occurred within the 5 years prior to the exam. This includes
copies of relevant military records if the incidents occurred while the applicant
was a member of the U.S. armed forces (includes military court records, records
of non-judicial punishment, and military substance abuse records);
Document those findings in Item 60. (See Item 47);
Forward the court records, arrest reports, and any military records to AMCD; and
Advise the applicant that the reporting of alcohol or drug offenses (i.e., motor
vehicle violation) on the history part of the medical application does not relieve
the airman of responsibility to report each motor vehicle action to the FAA within
60 days of the occurrence to the:
Security and Investigations Division

AMC-700
P.O. Box 25810
Oklahoma City, OK 73125-0810
Deferral Criteria: The Examiner must defer certification for any of the following:
Inability to obtain and review the court and arrest records within 14 days of the
date of the exam
For the alcohol- or drug-related driving incidents:
o Any arrest, conviction, and/or administrative action for which the applicant
registers a blood alcohol level 0.15 or higher
37

____________________________________________________________________
o Any arrest, conviction, and/or administrative action for which the applicant
refused blood alcohol testing
o Any arrest, conviction, and/or administrative action within the preceding 2
years AND IF THERE HAS BEEN ANOTHER arrest, conviction and/or
administrative action AT ANY OTHER TIME
o Total of 3 arrest(s), conviction(s), and/or administrative action(s) within a
lifetime
o Total of 2 arrest(s), conviction(s), and/or administrative action(s) within the
preceding 10 years
If the applicant is deferred, the FAA will require the applicant to:
Provide:
A detailed personal statement regarding his/her past and present patterns
of alcohol or drug use;
A complete copy of his/her current driving record in any state that he/she
has held a drivers license in the last 10 years; and
Copies of any court records and arrest reports related to the event(s) that
have not already been provided to the AME. This includes copies of
relevant military records if any event(s) occurred while the applicant was a
member of the U.S. armed forces. Relevant military records means
military court records, records of non-judicial punishment, and military
substance abuse records
Obtain:
A substance abuse evaluation from an addictionologist or addiction
psychologist/psychiatrist familiar with aviation standards.
Issue Criteria: The Examiner may issue if:
NONE of the Deferral Criteria above are met;

For reported incident(s) when the most recent incident occurred more than
5 years prior to the exam, based on the exam and a detailed interview, the
Examiner determines the applicants history does not indicate a possible
substance abuse or dependence problem; or
For reported incident(s) when the most recent incident occurred within the
preceding 5 years of the exam, based on the exam, detailed interview AND
review of the court record(s) and arrest report(s), the Examiner determines the
applicants history does not indicate a possible substance abuse or dependence
problem.
For guidance on indicators of substance abuse or dependence see:

o Aerospace Medical Dispositions, Item 47 Substance Abuse
o Aerospace Medical Dispositions, Item 47 Substance Dependence
18.w. History of nontraffic convictions. The applicant must report any other
(nontraffic) convictions (e.g., assault, battery, public intoxication, robbery, etc.). The
38

____________________________________________________________________
applicant must name the charge for which convicted and the date of the conviction(s),
and copies of court documents (if available). (See Item 47)
18.x. Other illness, disability, or surgery. The applicant should describe the nature
of these illnesses in the EXPLANATIONS box. If additional records, tests, or specialty
reports are necessary in order to make a certification decision, the applicant should so
be advised. If the applicant does not wish to provide the information requested by the
Examiner, the Examiner should defer issuance.
If the applicant wishes to have the FAA review the application and decide what ancillary
documentation is needed, the Examiner should defer issuance of the medical certificate
and forward the completed FAA Form 8500-8 to the AMCD. If the Examiner proceeds
to obtain documentation, but all data will not be received with the 2 weeks, FAA
Form 8500-8 should be transmitted immediately to the AMCD with a note that additional
documents will be forwarded later under separate cover.
18. y. Medical Disability Benefits. The applicant must report any disability benefits
received, regardless of source or amount. If the applicant checks yes on this item, the
FAA may verify with other Federal Agencies (ie. Social Security Administration,
Veterans Affairs) whether the applicant is receiving a disability benefit that may present
a conflict in issuing an FAA medical certificate. The Examiner must document the
specifics and nature of the disability in findings in Item 60.
ITEM 19. Visits to Health Professional Within Last 3 Years
The applicant should list all visits in the last 3 years to a physician, physician assistant,
nurse practitioner, psychologist, clinical social worker, or substance abuse specialist for
treatment, examination, or medical/mental evaluation. The applicant should list visits for
counseling only if related to a personal substance abuse or psychiatric condition. The
applicant should give the name, date, address, and type of health professional
consulted and briefly state the reason for the consultation. Multiple visits to one health
professional for the same condition may be aggregated on one line.
Routine dental, eye, and FAA periodic medical examinations and consultations with an
employer-sponsored employee assistance program (EAP) may be excluded unless the
consultations were for the applicant's substance abuse or unless the consultations
resulted in referral for psychiatric evaluation or treatment.
When an applicant does provide history in Item 19, the Examiner should review the
matter with the applicant. The Examiner will record in Item 60 only that information
needed to document the review and provide the basis for a certification decision. If the
Examiner finds the information to be of a personal or sensitive nature with no relevancy
to flying safety, it should be recorded in Item 60 as follows:
"Item 19. Reviewed with applicant. History not significant or relevant to application."
39

____________________________________________________________________
If the applicant is otherwise qualified, a medical certificate may be issued by the
Examiner.
FAA medical authorities, upon review of the application, will ask for further information
regarding visits to health care providers only where the physical findings, report of
examination, applicant disclosure, or other evidence suggests the possible presence of
a disqualifying medical history or condition.
If an explanation has been given on a previous report(s) and there has been no change
in the condition, the applicant may enter "PREVIOUSLY REPORTED, NO CHANGE."
Of particular importance is the reporting of conditions that have developed since the
applicant's last FAA medical examination. The Examiner is asked to comment on all
entries, including those "PREVIOUSLY REPORTED, NO CHANGE." These comments
may be entered under Item 60.
ITEM 20. Applicant's National Driver Register and Certifying Declaration
In addition to making a declaration of the completeness and truthfulness of the
applicant's responses on the medical application, the applicant's declaration authorizes
the National Driver Register to release the applicant's adverse driving history
information, if any, to the FAA. The FAA uses such information to verify information
provided in the application. Applicant must certify the declaration outlined in Item 20. If
the applicant does not certify the declaration for any reason, Examiner shall not issue a
medical certificate but forward the incomplete application to the AMCD.
40

____________________________________________________________________
EXAMINATION TECHNIQUES
41

____________________________________________________________________
ITEMS 21- 58 of FAA Form 8500-8

The Examiner must personally conduct the physical examination. This section provides
guidance for completion of Items 21-58 of the Application for Airman Medical Certificate,
FAA Form 8500-8.
The Examiner must carefully read the applicant's history page of FAA Form 8500-8
(Items 1-20) before conducting the physical examination and completing the Report of
Medical Examination. This alerts the Examiner to possible pathological findings.
The Examiner must note in Item 60 of the FAA Form 8500-8 any condition found in the
course of the examination. The Examiner must list the facts, such as dates, frequency,
and severity of occurrence.
When a question arises, the Federal Air Surgeon encourages Examiners first to check
this Guide for Aviation Medical Examiners and other FAA informational documents. If
the question remains unresolved, the Examiner should seek advice from a RFS or
AMCD.
ITEMS 21-22. Height and Weight
21. Height (inches)
22. Weight (pounds)
ITEM 21. Height

Measure and record the applicant's height in inches. Although there are no medical
standards for height, exceptionally short individuals may not be able to effectively reach
all flight controls and must fly specially modified aircraft. If required, the FAA will place
operational limitations on the pilot certificate.
ITEM 22. Weight

Measure and record the applicant's weight in pounds.
42

____________________________________________________________________
BMI CHART AND FORMULA TABLE

Measurement Units
BMI Formula and Calculation
Pounds and inches
Formula: weight (lb) / [height (in)] x 703

Calculate BMI by dividing weight in pounds (lbs) by height in
inches (in) squared and multiplying by a conversion factor of 703.
Example: Weight = 150 lbs, Height = 5'5" (65")
2
Calculation: [150 (65) ] x 703 = 24.96
Kilograms and meters (or centimeters)
Formula: weight (kg) / [height (m)]2

With the metric system, the formula for BMI is weight in kilograms
divided by height in meters squared. Since height is commonly
measured in centimeters, divide height in centimeters by 100 to
obtain height in meters.
Example: Weight = 68 kg, Height = 165 cm (1.65 m)

Calculation: 68 (1.65)2 = 24.98
43

____________________________________________________________________
ITEMS 23-24. Statement of Demonstrated Ability (SODA); SODA Serial Number

23. Statement of Demonstrated Ability (SODA)
Yes
Defect Noted:
No
ITEM 23. Has a SODA ever been issued?

Ask the applicant if a SODA has ever been issued. If the answer is "yes," ask the
applicant to show you the document. Then check the "yes" block and record the nature
and degree of the defect.
SODA's are valid for an indefinite period or until an adverse change occurs that results
in a level of defect worse than that stated on the face of the document.
The FAA issues SODA's for certain static defects, but not for disqualifying conditions or
conditions that may be progressive. The extent of the functional loss that has been
cleared by the FAA is stated on the face of the SODA. If the Examiner finds the
condition has become worse, a medical certificate should not be issued even if the
applicant is otherwise qualified. The Examiner should also defer issuance if it is unclear
whether the applicant's present status represents an adverse change.
The Examiner must take special care not to issue a medical certificate of a higher class
than that specified on the face of the SODA even if the applicant appears to be
otherwise medically qualified. The Examiner may note in Item 60 the applicant's desire
for a higher class.
ITEM 24. SODA Serial Number

24. SODA Serial Number
Enter the assigned serial number in the space provided.
44

____________________________________________________________________
ITEMS 25-30. Ear, Nose and Throat (ENT)
CHECK EACH ITEM IN APPROPRIATE COLUMN
Normal
Abnormal
25. Head, face, neck, and scalp

26. Nose
27. Sinuses
28. Mouth and Throat
29. Ears, general (internal and external canals:
Hearing under Item 49)
30. Ear Drums (Perforation)
I. Code of Federal Regulations

All Classes: 14 CFR 67.105(b)(c), 67.205(b)(c), and 67.305(b)(c)
(b) No disease or condition of the middle or internal ear, nose, oral cavity, pharynx,
or larynx that (1) Interferes with, or is aggravated by, flying or may reasonably be expected to
do so; or
(2) Interferes with, or may reasonably be expected to interfere with, clear and
effective speech communication.
(c) No disease or condition manifested by, or that may reasonably be expected to be
manifested by, vertigo or a disturbance of equilibrium.
II. Examination Techniques
1. The head and neck should be examined to determine the presence of any
significant defects such as:
a. Bony defects of the skull
b. Gross deformities
c. Fistulas
d. Evidence of recent blows or trauma to the head
e. Limited motion of the head and neck
f. Surgical scars
2. The external ear is seldom a major problem in the medical certification of applicants.
Otitis externa or a furuncle may call for temporary disqualification. Obstruction of the
canal by impacted cerumen or cellular debris may indicate a need for referral to an ENT
specialist for examination.
45

____________________________________________________________________
The tympanic membranes should be examined for scars or perforations. Discharge or
granulation tissue may be the only observable indication of perforation. Middle ear
disease may be revealed by retraction, fluid levels, or discoloration. The normal
tympanic membrane is movable and pearly gray in color. Mobility should be
demonstrated by watching the drum through the otoscope during a valsalva maneuver.
3. Pathology of the middle ear may be demonstrated by changes in the appearance
and mobility of the tympanic membrane. The applicant may only complain of stuffiness
of the ears and/or loss of hearing. An upper respiratory infection greatly increases the
risk of aerotitis media with pain, deafness, tinnitus, and vertigo due to lessened aeration
of the middle ear from eustachian tube dysfunction. When the applicant is taking
medication for an ENT condition, it is important that the Examiner become fully aware of
the underlying pathology, present status, and the length of time the medication has
been used. If the condition is not a threat to aviation safety, the treatment consists
solely of antibiotics, and the antibiotics have been taken over a sufficient period to rule
out the likelihood of adverse side effects, the Examiner may make the certification
decision.
The same approach should be taken when considering the significance of prior surgery
such as myringotomy, mastoidectomy, or tympanoplasty. Simple perforation without
associated symptoms or pathology is not disqualifying. When in doubt, the Examiner
should not hesitate to defer issuance and refer the matter to the AMCD. The services of
consultant ENT specialists are available to the FAA to help in determining the safety
implications of complicated conditions.
4. Unilateral Deafness. An applicant with unilateral congenital or acquired deafness
should not be denied medical certification if able to pass any of the tests of hearing
acuity.
5. Bilateral Deafness. It is possible for a totally deaf person to qualify for a private
pilot certificate. When the applicant initially applies for medical certification, the AME
should defer the exam with notes in Block 60 explaining this and include which FSDO
the airman wants to use to take a Medical Flight Test.
The student may practice with an instructor before undergoing a pilot check ride for the
private pilots license. When the applicant is ready to take the check ride, he/she must
have an authorization to take a medical flight test (MFT) from either RFS/AMCD. Upon
successful completion of the MFT, the applicant will be issued a SODA and an
operational restriction will be placed on his/her pilots license that restricts the pilot
from flying into airspace requiring radio communication.
6. Hearing Aids. Under some circumstances, the use of hearing aids may be
acceptable. If the applicant is unable to pass any of the above tests without the use of
hearing aids, he or she may be tested using hearing aids.
46

____________________________________________________________________
7. The nose should be examined for the presence of polyps, blood, or signs of
infection, allergy, or substance abuse. The Examiner should determine if there is a
history of epistaxis with exposure to high altitudes and if there is any indication of loss of
sense of smell (anosmia). Polyps may cause airway obstruction or sinus blockage.
Infection or allergy may be cause for obtaining additional history. Anosmia is at least
noteworthy in that the airman should be made fully aware of the significance of the
handicap in flying (inability to receive early warning of gas spills, oil leaks, or smoke).
Further evaluation may be warranted.
8. Evidence of sinus disease must be carefully evaluated by a specialist because of
the risk of sudden and severe incapacitation from barotrauma.
9. The mouth and throat should be examined to determine the presence of active
disease that is progressive or may interfere with voice communications. Gross
abnormalities that could interfere with the use of personal equipment such as oxygen
equipment should be identified. Also see Protocol for Obstructive Sleep Apnea.
10. The larynx should be visualized if the applicant's voice is rough or husky. Acute
laryngitis is temporarily disqualifying. Chronic laryngitis requires further diagnostic
workup. Any applicant seeking certification for the first time with a functioning
tracheostomy, following laryngectomy, or who uses an artificial voice-producing device
should be denied or deferred and carefully assessed.
III. Aerospace Medical Disposition
The following is a table that lists the most common conditions of aeromedical
significance, and course of action that should be taken by the examiner as defined by
the protocol and disposition in the table.
Conditions AMEs Can Issue (CACI) Certification Worksheets are also found within the
Dispositions tables. These are a series of conditions which allow AMEs to regular issue
if the applicant meets the parameters of the CACI Condition Worksheets. The
worksheets provide detailed instructions to the examiner and outline condition-specific
requirements for the applicant. If the requirements are met, and the applicant is
otherwise qualified, the AME may issue without contacting AMCD first. If the
requirements are not met, the AME must defer the exam and send the supporting
documents to the FAA.
Medical certificates must not be issued to an applicant with medical conditions that
require deferral, or for any condition not listed in the table that may result in sudden or
subtle incapacitation without consulting the AMCD or the RFS. Medical documentation
must be submitted for any condition in order to support an issuance of an airman
47

____________________________________________________________________
ITEM 25. Head, Face, Neck, and Scalp
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Head, Face, Neck, and Scalp

Active fistula of neck,
either congenital or
acquired, including
tracheostomy
Loss of bony
substance involving
the two tables of the
cranial vault
Deformities of the face
or head that would
interfere with the
proper fitting and
wearing of an oxygen
mask
All
All
1st & 2nd
3rd
Submit all pertinent

medical information
and current status
report
medical information
and current status
report
medical information
and current status
report
medical information
Requires FAA Decision
If deformity does not

interfere with
administration of
supplemental O
- Issue
48

____________________________________________________________________
ITEM 26. Nose
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Nose
(Updated 02/24/2015)
Evidence of severe
allergic rhinitis*
All

medical information
and current status
report
Obstruction of sinus
ostia, including polyps,
that would be likely to
result in complete
obstruction
All

medical information and
current status report
For hay fever requiring antihistamines:
The nonsedating antihistamines loratadine, desloratadine, and fexofenadine may be

used while flying if, after an adequate initial "trial period," symptoms are controlled
without adverse side effects.
Applicants with seasonal allergies requiring any other antihistamine (oral and/or nasal)
may be certified by the examiner with the stipulation that they do not exercise the
privileges of airman certificate until they have stopped the medication and wait after the
last dose until:
o
At least five maximal dosing intervals have passed. For example, if the
medication is taken every 4-6 hours, wait 30 hours (5x6) after the last dose to fly.
At least five times the maximum terminal elimination half-life has passed. For
example, if the medication half-life is 6-8 hours, wait 40 hours (5x8) after the last
dose to fly.
Examiners are encouraged to look up the dosing intervals and half-life.
Airmen who are exhibiting symptoms, regardless of the treatment used, must not fly.
In all situations, the examiner must notate the evaluation data in Block 60.
*AME must warn airman to not operate aircraft until four hours after any hay fever
desensitization injection.
49

____________________________________________________________________
ITEM 27. Sinuses
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Sinuses - Acute or Chronic

Sinusitis, intermittent
use of topical or nonsedating medication
All
Document medication,
dose and absence of
side effects
Responds to treatment
without any side effects Issue
Severe - requiring
continuous use of
medication or affected
by barometric changes
All

Sinus Tumor
Benign - Cysts/Polyps
All
If no physiologic effects,
submit documentation
Malignant
All

Asymptomatic, no
observable growth over a
12-month period, no
potential for sinus block Issue
ITEM 28. Mouth and Throat

DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Mouth and Throat

Any malformation or
condition, including
stuttering, that would
impair voice
communication
Palate: Extensive
adhesion of the soft
palate to the pharynx
All

All

See Protocol for

Obstructive Sleep Apnea
50

____________________________________________________________________
ITEM 29. Ears, General
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Inner Ear
Acoustic Neuroma
All
Acute or chronic
disease without
disturbance of
equilibrium and
successful
miringotomy, if
applicable
Acute or chronic
disease that may
disturb equilibrium
Motion Sickness
All
All
All

medical information

If no physiologic effects Issue
If occurred during flight

training and resolved
- Issue
If condition requires
medication - Requires
FAA Decision
Mastoids
Mastoid fistula
All
Mastoiditis, acute or
chronic
All

Middle Ear
Impaired Aeration
All

Otitis Media
All

If acute and resolved

Issue
If active or chronic
- Requires FAA Decision
51

____________________________________________________________________
Outer Ear
Impacted Cerumen
All

Otitis Externa that may

progress to impaired
hearing or become
incapacitating
All

If asymptomatic and
hearing is unaffected
- Issue
Otherwise - Requires
FAA Decision
ITEM 30. Ear Drums

DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Ear Drums
Perforation that has
associated pathology
All
Perforation which has

resolved without any
other clinical symptoms
All
Establish etiology,
treatment, and submit all
pertinent medical
information
medical information
If no physiologic effects Issue
Otologic Surgery: A history of otologic surgery is not necessarily disqualifying for

medical certification. The FAA evaluates each case on an individual basis following
review of the otologist's report of surgery. The type of prosthesis used, the person's
adaptability and progress following surgery, and the extent of hearing acuity attained
are all major factors to be considered. Examiners should defer issuance to an applicant
presenting a history of otologic surgery for the first time, sending the completed report of
medical examination, with all available supplementary information, to the AMCD.
Some conditions may have several possible causes or exhibit multiple symptomatology.
Episodic disorders of dizziness or disequilibrium require careful evaluation and
consideration by the FAA. Transient processes, such as those associated with acute
labyrinthitis or benign positional vertigo may not disqualify an applicant when fully
recovered. (Also see Item 46., Neurologic for a discussion of syncope and vertigo).
52

____________________________________________________________________
ITEMS 31-34. Eye
Normal
Abnormal
31. Eyes, general (vision under Items 50 to 54)

32. Ophthalmoscopic
33. Pupils (Equity and reaction)
34. Ocular motility (Associated parallel movement nystagmus)

All Classes: 14 CFR 67.103(e), 67.203(e), and 67.303(d)
(e) No acute or chronic pathological condition of either the eye or adnexa that
interferes with the proper function of the eye, that may reasonably be
expected to progress to that degree, or that may reasonably be expected to
be aggravated by flying.
For guidance regarding the conduction of visual acuity, field of vision, heterophoria, and
color vision tests, please see Items 50-54.
The examination of the eyes should be directed toward the discovery of diseases or
defects that may cause a failure in visual function while flying or discomfort sufficient to
interfere with safely performing airman duties.
The Examiner should personally explore the applicant's history by asking questions
concerning any changes in vision, unusual visual experiences (halos, scintillations,
etc.), sensitivity to light, injuries, surgery, or current use of medication. Does the
applicant report inordinate difficulties with eye fatigue or strain? Is there a history of
serious eye disease such as glaucoma or other disease commonly associated with
secondary eye changes, such as diabetes? (See Item 53., Field of Vision and Item
54., Heterophoria)
1. It is recommended that the Examiner consider the following signs during the
course of the eye examination:
1. Color redness or suffusion of allergy, drug use, glaucoma, infection,
trauma, jaundice, ciliary flush of Iritis, and the green or brown KayserFleischer Ring of Wilson's disease.
2. Swelling abscess, allergy, cyst, exophthalmos, myxedema, or tumor.
3. Other clarity, discharge, dryness, ptosis, protosis, spasm (tic), tropion, or
ulcer.
53

____________________________________________________________________
2. Ophthalmoscopic examination. It is suggested that a routine be established for
ophthalmoscopic examinations to aid in the conduct of a comprehensive eye
assessment. Routine use of a mydriatic is not recommended.
a. Cornea observe for abrasions, calcium deposits, contact lenses,
dystrophy, keratoconus, pterygium, scars, or ulceration. Contact lenses
should be removed several hours before examination of the eye. (See
Item 50, Distant Vision)
b. Pupils and Iris check for the presence of synechiae and uveitis. Size,
shape, and reaction to light should be evaluated during the
ophthalmoscopic examination. Observe for coloboma, reaction to light, or
disparity in size.
c. Aqueous hyphema or iridocyclitis.
d. Lens observe for aphakia, discoloration, dislocation, cataract, or an
implanted lens.
e. Vitreous note discoloration, hyaloid artery, floaters, or strands.
f. Optic nerve observe for atrophy, hemorrhage, cupping, or papilledema.
g. Retina and choroid examine for evidence of coloboma, choroiditis,
detachment of the retina, diabetic retinopathy, retinitis, retinitis
pigmentosa, retinal tumor, macular or other degeneration, toxoplasmosis,
etc.
3. Ocular Motility. Motility may be assessed by having the applicant follow a point
light source with both eyes, the Examiner moving the light into right and left
upper and lower quadrants while observing the individual and the conjugate
motions of each eye. The Examiner then brings the light to center front and
advances it toward the nose observing for convergence. End point nystagmus is
a physiologic nystagmus and is not considered to be significant. It need not be
reported. (For further consideration of nystagmus, see Item 50., Distant
Vision.)
4. Monocular Vision. An applicant will be considered monocular when there is only
one eye or when the best corrected distant visual acuity in the poorer eye is no
better than 20/200. An individual with one eye, or effective visual acuity
equivalent to monocular, may be considered for medical certification, any class,
through the special issuance section of part 67 (14 CFR 67.401).
In amblyopia ex anopsia, the visual acuity loss is simply recorded in Item 50 of
FAA Form 8500-8, and visual standards are applied as usual. If the standards
are not met, a Report of Eye Evaluation, FAA Form 8500-7, should be submitted
for consideration.
54

____________________________________________________________________
Although it has been repeatedly demonstrated that binocular vision is not a
prerequisite for flying, some aspects of depth perception, either by stereopsis or
by monocular cues, are necessary. It takes time for the monocular airman to
develop the techniques to interpret the monocular cues that substitute for
stereopsis; such as, the interposition of objects, convergence, geometrical
perspective, distribution of light and shade, size of known objects, aerial
perspective, and motion parallax.
In addition, it takes time for the monocular airman to compensate for his or her
decrease in effective visual field. A monocular airmans effective visual field is
reduced by as much as 30% by monocularity. This is especially important
because of speed smear; i.e., the effect of speed diminishes the effective visual
field such that normal visual field is decreased from 180 degrees to as narrow as
42 degrees or less as speed increases. A monocular airmans reduced effective
visual field would be reduced even further than 42 degrees by speed smear.
For the above reasons, a waiting period of 6 months is recommended to permit
an adequate adjustment period for learning techniques to interpret monocular
cues and accommodation to the reduction in the effective visual field.
Applicants who have had monovision secondary to refractive surgery may be
certificated, providing they have corrective vision available that would provide
binocular vision in accordance with the vision standards, while exercising the
privileges of the certificate. The certificate issued must have the appropriate
vision limitations statement.
5. Contact Lenses. The use of contact lens(es) for monovision correction is not
allowed:
The use of a contact lens in one eye for near vision and in the other
eye for distant vision is not acceptable (for example: pilots with myopia
plus presbyopia).
The use of a contact lens in one eye for near vision and the use of no
contact lens in the other eye is not acceptable (for example: pilots with
presbyopia but no myopia).
Additionally, designer contact lenses that introduce color (tinted lenses), restrict
the field of vision, or significantly diminish transmitted light are not allowed.
Please note: the use of binocular contact lenses for distance-correction-only is
acceptable. In this instance, no special evaluation or SODA is routinely required
for a distance-vision-only contact lens wearer who meets the standard and has
no complications. Binocular bifocal or binocular multifocal contact lenses are
acceptable under the Protocol for Binocular Multifocal and Accommodating
Devices.
55

____________________________________________________________________
6. Intraocular Devices. Binocular airman using multifocal or accommodating
ophthalmic devices may be issued an airman medical certificate in accordance
with the Protocol for Binocular Multifocal and Accommodating Devices.
7. Orthokeratology (Ortho-K) is the use of rigid gas-permeable contact lenses,
normally worn only during sleep, to improve vision through reshaping of the
cornea. It is used as an alternative to eyeglasses, refractive surgery, or for those
who prefer not to wear contact lenses while awake. The correction is not
permanent and visual acuity can regress while not wearing the Ortho-K lenses.
There is no reasonable or reliable way to determine standards for the entire
period the lenses are removed. Therefore, to be found qualified, applicants who
use Ortho-K lenses must meet the applicable vision standard while wearing
the Ortho-K lenses AND must wear the Ortho-K lenses while piloting
aircraft. The limitation must use Ortho-K lenses while performing pilot duties
must be placed on the medical certificate.
8. Glaucoma. The Examiner should deny or defer issuance of a medical certificate
to an applicant if there is a loss of visual fields, a significant change in visual
acuity, or newly diagnosed intraocular hypertension.
The FAA may grant an Authorization under the special issuance section of Part
67 (14 CFR 67.401) on an individual basis. The Examiner must obtain a report
of Ophthalmological Evaluation for Glaucoma (FAA Form 8500-14) from an
ophthalmologist. See Glaucoma Worksheet. Because secondary glaucoma is
caused by known pathology such as; uveitis or trauma, eligibility must largely
depend upon that pathology. Secondary glaucoma is often unilateral, and if the
cause or disease process is no longer active and the other eye remains normal,
certification is likely.
Applicants with primary or secondary narrow angle glaucoma are usually denied
because of the risk of an attack of angle closure, because of incapacitating
symptoms of severe pain, nausea, transitory loss of accommodative power,
blurred vision, halos, epiphora, or iridoparesis. Central venous occlusion can
occur with catastrophic loss of vision. However, when surgery such as
iridectomy or iridoclesis has been performed satisfactorily more than 3 months
before the application, the likelihood of difficulties is considerably more remote,
and applicants in that situation may be favorably considered.
An applicant with unilateral or bilateral open angle glaucoma may be certified by
the FAA (with follow-up required) when a current ophthalmological report
substantiates that pressures are under adequate control, there is little or no
visual field loss or other complications, and the person tolerates small to
moderate doses of allowable medications. Individuals who have had filter
surgery for their glaucoma, or combined glaucoma/cataract surgery, can be
considered when stable and without complications. A few applicants have been
56

____________________________________________________________________
certified following their demonstration of adequate control with oral medication.
Neither miotics nor mydriatics are necessarily medically disqualifying.
However, miotics such as pilocarpine cause pupillary constriction and could
conceivably interfere with night vision. Although the FAA no longer routinely
prohibits pilots who use such medications from flying at night, it may be
worthwhile for the Examiner to discuss this aspect of the use of miotics with
applicants. If considerable disturbance in night vision is documented, the FAA
may limit the medical certificate: NOT VALID FOR NIGHT FLYING.
9. Sunglasses. Sunglasses are not acceptable as the only means of correction to
meet visual standards, but may be used for backup purposes if they provide the
necessary correction. Airmen should be encouraged to use sunglasses in bright
daylight but must be cautioned that, under conditions of low illumination, they
may compromise vision. Mention should be made that sunglasses do not protect
the eyes from the effects of ultra violet radiation without special glass or coatings
and that photosensitive lenses are unsuitable for aviation purposes because they
respond to changes in light intensity too slowly. The so-called "blue blockers"
may not be suitable since they block the blue light used in many current panel
displays. Polarized sunglasses are unacceptable if the windscreen is also
polarized.
10. Refractive Procedures. The FAA accepts the following Food and Drug
Administration approved refractive procedures for visual acuity correction:
Radial Keratotomy (RK)

Epikeratophakia
Laser-Assisted In Situ Keratomileusis (LASIK), including Wavefrontguided LASIK
Photorefractive Keratectomy (PRK)
Conductive Keratoplasty (CK)
Please be advised that these procedures have potential adverse effects that
could be incompatible with flying duties, including: corneal scarring or opacities;
worsening or variability of vision; and night-glare.
The FAA expects that airmen will not resume airman duties until their treating
health care professional determines that their post-operative vision has
stabilized, there are no significant adverse effects or complications (such as
halos, rings, haze, impaired night vision and glare), the appropriate vision
standards are met, and they have been reviewed by an Examiner or AMCD.
When this determination is made, the airman should have the treating health
care professional document this in the health care record, a copy of which should
be forwarded to the AMCD before resumption of airman duties. If the health care
professional's determination is favorable and after consultation and review by an
Examiner, the applicant may resume airman duties, unless informed otherwise
by the FAA.
57

____________________________________________________________________
An applicant treated with a refractive procedure may be issued a medical
certificate by the Examiner if the applicant meets the visual acuity standards and
the Report of Eye Evaluation (FAA Form 8500-7) indicates that healing is
complete; visual acuity remains stable; and the applicant does not suffer sequela
such as; glare intolerance, halos, rings, impaired night vision, or any other
complications. There should be no other pathology of the affected eye(s).
If the procedure was done 2 years ago or longer, the FAA may accept the
Examiner's eye evaluation and an airman statement regarding the absence of
adverse sequela.
If the procedure was performed within the last 2 years, the airman must provide a
report to the AMCD from the treating health care professional to document the
date of procedure, any adverse effects or complications, and when the airman
returned to flying duties. If the report is favorable and the airman meets the
appropriate vision standards, the applicant may resume airman duties, unless
informed otherwise by the FAA.
A. Conductive Keratoplasty (CK): CK is used for correction of farsightedness. As this
procedure is not considered permanent and there is expected regression of visual
acuity in time, the FAA may grant an Authorization for special issuance of a medical
certificate under 14 CFR 67.401 to an applicant who has had CK.
The FAA evaluates CK procedures on an individual basis following a waiting period of 6
months. The waiting period is required to permit adequate adjustment period for
fluctuating visual acuity. The Examiner can facilitate FAA review by obtaining all preand post-operative medical records, a Report of Eye Evaluation (FAA Form 8500-7)
from a treating or evaluating eye specialist with comment regarding any adverse effects
or complications related to the procedure.

Applicants with many visual conditions may be found qualified for FAA certification
following the receipt and review of specialty evaluations and pertinent medical records.
Examples include retinal detachment with surgical correction, open angle glaucoma
under adequate control with medication, and narrow angle glaucoma following surgical
correction.
The Examiner may not issue a certificate under such circumstances for the initial
application, except in the case of applicants following cataract surgery. The Examiner
may issue a certificate after cataract surgery for applicants who have undergone
cataract surgery with or without lens(es) implant. If pertinent medical records and a
current ophthalmologic evaluation (using FAA Form 8500-7 or FAA Form 8500-14)
58

____________________________________________________________________
indicate that the applicant meets the standards, the FAA may delegate authority to the
Examiner to issue subsequent certificates.
The following is a table that lists the most common conditions of aeromedical significance, and
course of action that should be taken by the examiner as defined by the protocol and disposition
in the table. Medical certificates must not be issued to an applicant with medical conditions that
require deferral, or for any condition not listed in the table that may result in sudden or subtle
incapacitation without consulting the AMCD or the RFS. Medical documentation must be
submitted for any condition in order to support an issuance of an airman medical certificate.
59

____________________________________________________________________
ITEM 31. Eyes, General
DISEASE/CONDITION
CLASS
EVALUTION DATA
DISPOSITION
Eyes, General
Amblyopia*
Initial certification
Congenital or acquired
conditions (whether acute or
chronic) of either eye or
adnexa, that may interfere
with visual functions, may
progress to that degree, or
may be aggravated by flying
(tumors and ptosis obscuring
the pupil, acute inflammatory
disease of the eyes and lids,
cataracts, or keratoconus.)
All
All
Provide completed FAA Form

8500-7
If applicant does not correct to

standards, DEFER.
Note: applicant should be at

best corrected visual acuity
before evaluation
Provide completed FAA Form
8500-7
Note in Block 60 along with which

FSDO the airman wants to use to
take a MFT
Submit all pertinent medical

information and current status
report
For keratoconus, include if
available results of imaging
studies such as kertatometry,
videokeratography, etc., with
clinical correlation
Any ophthalmic
pathology reflecting a
serious systemic
disease (e.g., diabetic
and hypertensive
retinopathy)
Diplopia
All
Pterygium
All
All
Note: applicant should be at

best corrected visual acuity
before evaluation
report.
(If applicable, see Diabetes and
Hypertensive Protocols)
If applicant provides written
evidence that the FAA has
previously considered and
determined that this condition is
not adverse to flight safety. A
MFT may be requested.
Document findings in Item 60
Contact RFS for approval to Issue

Otherwise - Requires FAA
Decision
If less than 50% of the cornea and

not affecting central vision
- Issue
Decision
*In amblyopia ex anopsia, the visual acuity of one eye is decreased without presence of organic eye disease, usually
because of strabismus or anisometropia in childhood.
60

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Eyes - Procedures
Aphakia/Lens Implants
All
Conductive
Keratoplasty Farsightedness
Intraocular Devices
All
Refractive Procedures
other than CK
All
All

information and current
status report (See additional
disease dependent
requirements)
See Protocol for Conductive
Keratoplasty
If visual acuity meets

standards - Issue
See Protocol for Binocular

Multifocal and
Accommodating Devices
Provide completed FAA
Form 8500-7, type and date
of procedure, statement as
to any adverse effects or
complications (halo, glare,
haze, rings, etc.)
See Protocol for Binocular

Multifocal and
Accommodating Devices
If visual acuity meets
standards, is stable, and no
complications exist - Issue

Decision
See Protocol for Conductive
Keratoplasty

Decision
61

____________________________________________________________________
ITEM 32. Ophthalmoscopic
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Ophthalmoscopic
Chorioretinitis;
Coloboma;
Corneal Ulcer or
Dystrophy;
Optic Atrophy or
Neuritis;
Retinal Degeneration or
Detachment;
Retinitis Pigmentosa;
Papilledema; or Uveitis
Glaucoma (treated or
untreated)
All

All
Review all pertinent

current status report,
including Form 8500-14
Follow CACI Glaucoma Worksheet.

If airman meets all
certification criteria
Issue.
All others require FAA
decision. Submit all
evaluation data.
Initial Special
Issuance - Requires
FAA Decision
Macular Degeneration;
Macular Detachment
All
Tumors
All
Vascular Occlusion;
Retinopathy
All

Followup Special
Issuances - See AASI
Protocol
62

____________________________________________________________________
CACI - Glaucoma Worksheet (Updated 4/29/15)
The Examiner must review a current status report by the treating physician and any supporting documents to determine the
applicants eligibility for certification. If the applicant meets ALL the acceptable certification criteria listed below, the
Examiner can issue. Applicants for first- or second- class must provide this information annually; applicants for third-class
must provide the information with each required exam.
AME MUST REVIEW
Treating ophthalmologist finds the
condition stable on current regimen
and no changes recommended.
Age at diagnosis
FAA Form 8500-14 or equivalent
treating physician report that
documents the considerations below:
Acceptable types of glaucoma
Documented nerve damage or

trabeculectomy (filtration surgery)
Medications
Medication side effects

Intraocular pressure
ANY evidence of defect or reported
Unreliable Visual Fields
ACCEPTABLE CERTIFICATION CRITERIA

[ ] Yes
[ ] 40 or older
[ ] Yes
[ ] Open Angle being monitored and stable, Ocular Hypertension or

Glaucoma Suspect being monitored and stable, or previous history of
Narrow Angle/Angle Closure Glaucoma which has been treated with
iridectomy/iridotomy (surgical or laser) and is currently stable.
NOT acceptable: Normal Tension Glaucoma, secondary glaucoma due
to inflammation, trauma, or the presence of any other significant eye
pathology (e.g. neovascular glaucoma due to proliferative diabetic
retinopathy or an ischemic central vein occlusion or uveitic glaucoma)
[ ] No
[ ] None or Prostaglandin analogs (Xalatan, Lumigan, Travatan or
Travatan Z), Carbonic anhydrase inhibitor (Trusopt and Azopt), Beta
blockers (Timoptic, etc), or Alpha agonist (Alphagan). Combination eye
drops are acceptable
NOT acceptable: Pilocarpine or other miotics, cycloplegics (Atropine),
or oral medications
[ ] None
[ ] 23 mm Hg or less in both eyes
[ ] No
Acceptable visual field tests: Humphrey

24-2 or 30-2 (either SITA or full threshold),
Octopus (either TOP or full threshold).
Other formal visual field testing may be
acceptable but you must call for approval.
Confrontation or screening visual field
testing is not acceptable.
AME MUST NOTE in Block 60 one of the following:
[ ] CACI qualified glaucoma. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified glaucoma. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified glaucoma. I have deferred. (Submit supporting documents.)
63

____________________________________________________________________
ITEM 33. Pupils
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Pupils
Disparity in size or
reaction to light
(afferent pupillary
defect) requires
clarification and/or
further evaluation
Nonreaction to light in
either eye acute or
chronic
Nystagmus 1
All

All
Synechiae, anterior or
posterior
All

EVALUATION DATA
DISPOSITION
All
ITEM 34. Ocular Motility

DISEASE/CONDITION
CLASS
Ocular Motility
Absence of conjugate
alignment in any
quadrant
Inability to converge on
a near object
All
Paralysis with loss of

ocular motion in any
direction
All
All

Nystagmus of recent onset is cause to deny or defer certificate issuance. Any recent neurological or other evaluations
available to the Examiner should be submitted to the AMCD. If nystagmus has been present for a number of years and
has not recently worsened, it is usually necessary to consider only the impact that the nystagmus has upon visual
acuity. The Examiner should be aware of how nystagmus may be aggravated by the forces of acceleration commonly
encountered in aviation and by poor illumination.
64

____________________________________________________________________
ITEM 35. Lungs and Chest
Normal
Abnormal
35. Lungs and chest (Not including breast examination)

(b) No other organic, functional, or structural disease, defect, or limitation that the
Federal Air Surgeon, based on the case history and appropriate, qualified
medical judgment relating to the condition involved, finds (1) Makes the person unable to safely perform the duties or exercise the
privileges of the airman certificate applied for or held; or
(2) May reasonably be expected, for the maximum duration of the airman
medical certificate applied for or held, to make the person unable to
perform those duties or exercise those privileges;
(c) No medication or other treatment that the Federal Air Surgeon, based on the
case history and appropriate, qualified medical judgment relating to the
medication or other treatment involved, finds (1) Makes the person unable to safely perform the duties or exercise the
perform those duties or exercise those privileges.
Breast examination: The breast examination is performed only at the applicant's option or if
indicated by specific history or physical findings. If a breast examination is performed, the results
are to be recorded in Item 60 of FAA Form 8500-8. The applicant should be advised of any
abnormality that is detected, then deferred for further evaluation.
III. Aerospace Medical Dispositions
course of action that should be taken by the examiner as defined by the protocol and disposition in
the table. Medical certificates must not be issued to an applicant with medical conditions that
65

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Allergies
Allergies, severe
All
Hay fever controlled

solely by
desensitization
without
antihistamines or
other medications 1 2
All

report, include duration of
symptoms, name and dosage
of drugs and side effects
report, include duration of
symptoms, name and dosage
of drugs and side effects
Requires FAA
Decision
If responds to
treatment and
without side
effects - Issue
Otherwise Requires FAA
Decision
Applicants with seasonal allergies requiring antihistamines may be certified by the Examiner with the stipulation that
they not exercise privileges of airman certification within 24 hours of experiencing symptoms requiring treatment or
within 24 hours after taking an antihistamine. The Examiner should document this in Item 60.
Individuals who have hay fever that requires only occasional seasonal therapy may be certified by the Examiner with
the stipulation that they not fly during the time when symptoms occur and treatment is required.
Nonsedating antihistamines including loratadine, or fexofenadine may be used while flying, after adequate individual
experience has determined that the medication is well tolerated without significant side effects.
66

____________________________________________________________________
DISEASE/CONDITION CLASS
EVALUATION DATA
DISPOSITION
Asthma
Mild or seasonal
asthmatic symptoms
All

medical information
and current status
report, include PFTs,
duration of symptoms,
name and dosage of
drugs and side effects
for special issuance
consideration
Follow the CACI Asthma Worksheet. If

airman meets all
Issue.
Decision. Submit all
evaluation data.
Initial Special
Issuance - Requires
FAA Decision
Followup
Special Issuances See AASI Protocol
Frequent severe
asthmatic symptoms
All

medical information
and current status
report, include PFTs,
duration of symptoms,
name and dosage of
drugs and side effects
for special issuance
consideration.
Initial Special
Issuance - Requires
FAA Decision
Followup
67

____________________________________________________________________
CACI - Asthma Worksheet (Updated 4/29/15)

The Examiner must review a current status report by the treating physician and any supporting
documents to determine the applicants eligibility for certification. If the applicant meets ALL the
acceptable certification criteria listed below, the Examiner can issue. Applicants for first- or secondclass must provide this information annually; applicants for third-class must provide the information with
each required exam.
AME MUST REVIEW
Treating physician finds the

condition stable on current
regimen and no changes
recommended
[ ] Yes
Symptoms: Stable and wellcontrolled (either on or off

medication)
[ ] Yes for all of the following:

- Frequency of symptoms - no more than 2 days per week
- Use of inhaled short-acting beta agonist (rescue inhaler) no more than 2 times per week
- Use of oral corticosteroids for exacerbations - no more than
2 times per year
- In the last year:
o No in-patient hospitalizations
o No more than 2 outpatient clinic/urgent care visits for
exacerbations (with symptoms fully resolved).
[ ] One or more of the following
- Inhaled long-acting beta agonist
- Inhaled short-acting beta agonist (e.g., albuterol)
- Inhaled corticosteroid
- leukotriene receptor antagonist, (e.g. montelukast [Singulair])
Acceptable Medications
Note: A short course of oral or IM steroids during an exacerbation is

acceptable. Examiner must caution airman not to fly until course of
oral steroids is completed and airman is symptom free.
Pulmonary Function Tests *
[ ] Current within last 90 days
*PFT is not required if the only

treatment is PRN use on one or two
days a week of a short-acting beta
agonist (e.g. albuterol).
[ ] FEV1, FVC, and FEV1/FVC are all equal to or greater than

80% predicted before bronchodilators.

[ ] CACI qualified asthma. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified asthma. Issued per valid SI/ASSI. (Submit supporting documents.)
[ ] NOT CACI qualified asthma. I have deferred. (Submit supporting documents.)
68

____________________________________________________________________
EVALUATION DATA
DISPOSITION
Chronic Obstructive Pulmonary Disease (COPD)

Chronic bronchitis,
emphysema, or
COPD 5
All

medical information
and current status
report. Include an
FVC/FEV1
Initial Special Issuance

Followup
Disease of the Lungs, Pleura, or Mediastinum

Abscesses
Active Mycotic disease
Active Tuberculosis
All
Fistula,
Bronchopleural,
to include
Thoracostomy
Lobectomy
All
Pulmonary Embolism
All
Pulmonary Fibrosis
All
All

medical information
and current status
report
medical information
and current status
report
medical information
and current status
report
See Thromboembolic
Disease Protocol
medical information,
PFTs with diffusion
capacity
See Thromboembolic
Disease Protocol
If >75% predicted and
no impairment - Issue
FAA Decision
Certification may be granted by the FAA when the condition is mild without significant impairment of pulmonary
functions. If the applicant has frequent exacerbations or any degree of exertional dyspnea, certification should be
deferred.
69

____________________________________________________________________
EVALUATION DATA
DISPOSITION
Pleura and Pleural Cavity

Acute fibrinous
pleurisy;
Empyema;
Pleurisy with effusion;
or Pneumonectomy
Malignant tumors or
cysts of the lung,
pleura or
mediastinum
Other diseases or
defects of the lungs
or chest wall that
require use of
medication or that
could adversely
affect flying or
endanger the
applicant's well-being
if permitted to fly
Pneumothorax Traumatic
All

medical information
and current status
report, and PFTs
All

medical information
and current status
report
medical information
and current status
report
If 3 months after
resolution - Issue
Sarcoid, if more than

minimal involvement
or if symptomatic
All
Spontaneous
pneumothorax
All

medical information
and current status
report
medical information
and current status
report
medical information
and current status
report
All
All
A history of a single episode of spontaneous pneumothorax is considered disqualifying for airman medical
certification until there is x-ray evidence of resolution and until it can be determined that no condition that would be
likely to cause recurrence is present (i.e., residual blebs). On the other hand, an individual who has sustained a repeat
pneumothorax normally is not eligible for certification until surgical interventions are carried out to correct the
underlying problem. A person who has such a history is usually able to resume airmen duties 3 months after the
surgery. No special limitations on flying at altitude are applied.
70

____________________________________________________________________
EVALUATION DATA DISPOSITION
Pulmonary
Bronchiectasis
All

medical information
and current status
report
If moderate to severe Requires FAA Decision
Sleep Apnea
Obstructive Sleep
Apnea
All
Requires risk
evaluation, per OSA
Protocol. Document
history and Findings.
If meets OSA Criteria

Issue, if otherwise
qualified
Periodic Limb
Movement, etc.
All

medical information
and current status
report. Include sleep
study with a
polysomnogram, use
of medications and
titration study results,
along with a
statement regarding
Restless Leg
Syndrome
Followup
Special Issuance
See AASI
71

____________________________________________________________________
ITEM 36. Heart
Normal
Abnormal
36. Heart (Precordial activity, rhythm, sounds, and murmurs)
I. Code of Federal Regulations:

First-Class: 14 CFR 67.111(a)(b)(c)
Cardiovascular standards for first-class airman medical certificate are:
(a) No established medical history or clinical diagnosis of any of the following:
(1) Myocardial infarction
(2) Angina pectoris
(3) Coronary heart disease that has required treatment or, if untreated, that has been
symptomatic or clinically significant
(4) Cardiac valve replacement
(5) Permanent cardiac pacemaker implantation; or
(6) Heart replacement
(b) A person applying for first-class airman medical certification must demonstrate an
absence of myocardial infarction and other clinically significant abnormality on
electrocardiographic examination:
(1) At the first application after reaching the 35th birthday; and
(2) On an annual basis after reaching the 40th birthday
(c) An electrocardiogram will satisfy a requirement of paragraph (b) of this
section if it is dated no earlier than 60 days before the date of the application it is to
accompany and was performed and transmitted according to acceptable standards and
techniques.
72

____________________________________________________________________
Second- and Third-Class: 14 CFR 67.211(a)(b)(c)(d)(e)(f) and 67.311(a)(b)(c)(d)(e)(f)
Cardiovascular standards for a second- and third-class airman medical certificate are no
established medical history or clinical diagnosis of any of the following:
(a) Myocardial infarction
(b) Angina pectoris
(c) Coronary heart disease that has required treatment or, if untreated, that has been
symptomatic or clinically significant
(d) Cardiac valve replacement
(e) Permanent cardiac pacemaker implantation; or
(f) Heart replacement

A. General Physical Examination.
1. A brief description of any comment-worthy personal characteristics as well as height, weight,
representative blood pressure readings in both arms, funduscopic examination, condition of
peripheral arteries, carotid artery auscultation, heart size, heart rate, heart rhythm,
description of murmurs (location, intensity, timing, and opinion as to significance), and other
findings of consequence must be provided.
2. The Examiner should keep in mind some of the special cardiopulmonary demands of flight,
such as changes in heart rates at takeoff and landing. High
G-forces of aerobatics or agricultural flying may stress both systems considerably.
Degenerative changes are often insidious and may produce subtle performance decrements
that may require special investigative techniques.
a. Inspection. Observe and report any thoracic deformity (e.g., pectus excavatum),
signs of surgery or other trauma, and clues to ventricular hypertrophy. Check the
hematopoietic and vascular system by observing for pallor, edema, varicosities,
stasis ulcers, and venous distention. Check the nail beds for capillary pulsation and
color.
b. Palpation. Check for thrills and the vascular system for arteriosclerotic changes,
shunts, or AV anastomoses. The pulses should be examined to determine their
character, to note if they are diminished or absent, and to observe for synchronicity.
The medical standards do not specify pulse rates that, per se, are disqualifying for
medical certification. These tests are used, however, to determine the status and
73

____________________________________________________________________
responsiveness of the cardiovascular system. Abnormal pulse rates may be reason
to conduct additional cardiovascular system evaluations.
i. Bradycardia of less than 50 beats per minute, any episode of tachycardia
during the course of the examination, and any other irregularities of pulse
other than an occasional ectopic beat or sinus arrhythmia must be noted and
reported. If there is bradycardia, tachycardia, or arrhythmia further evaluation
may be warranted and deferral may be indicated.
ii. A cardiac evaluation may be needed to determine the applicant's
qualifications. Temporary stresses or fever may, at times, result in abnormal
results from these tests. If the Examiner believes this to be the case, the
applicant should be given a few days to recover and then be retested. If this is
not possible, the Examiner should defer issuance, pending further evaluation.
c. Percussion. Determine heart size, diaphragmatic elevation/excursion, abnormal
densities in the pulmonary fields, and mediastinal shift.
d. Auscultation. Check for resonance, asthmatic wheezing, ronchi, rales, cavernous
breathing of emphysema, pulmonary or pericardial friction rubs, quality of the heart
sounds, murmurs, heart rate, and rhythm. If a murmur is discovered during the
course of conducting a routine FAA examination, report its character, loudness,
timing, transmission, and change with respiration. It should be noted whether it is
functional or organic and if a special examination is needed. If the latter is indicated,
the Examiner should defer issuance of the medical certificate and transmit the
completed FAA Form 8500-8 to the FAA for further consideration. Examiner must
defer to the AMCD or Region if the treating physician or Examiner reports the murmur
is moderate to severe (Grade III or IV). Listen to the neck for bruits.
It is recommended that the Examiner conduct the auscultation of the heart with the
applicant both in a sitting and in a recumbent position.
Aside from murmur, irregular rhythm, and enlargement, the Examiner should be
careful to observe for specific signs that are pathognomonic for specific disease
entities or for serious generalized heart disease. Examples of such evidence are:
(1) the opening snap at the apex or fourth left intercostal space signifying mitral
stenosis; (2) gallop rhythm indicating serious impairment of cardiac function; and
(3) the middiastolic rumble of mitral stenosis.
B. When General Examinations Reveal Heart Problems.

These specifications have been developed by the FAA to determine an applicants eligibility for
airman medical certification. Standardization of examination methods and reporting is essential to
provide sufficient basis for making determinations and the prompt processing of applications.
74

____________________________________________________________________
1. This cardiovascular evaluation (CVE), therefore, must be reported in sufficient detail to permit a
clear and objective evaluation of the cardiovascular disorder(s) with emphasis on the degree of
functional recovery and prognosis. It should be forwarded to the FAA immediately upon
completion. Inadequate evaluation, reporting, or failure to promptly submit the report to the FAA
may delay the certification decision.
a. Medical History. Particular reference should be given to cardiovascular abnormalities
cerebral, visceral, and/or peripheral. A statement must be included as to whether
medications are currently or have been recently used, and if so, the type, purpose, dosage,
duration of use, and other pertinent details must be provided. A specific history of any
anticoagulant drug therapy is required. In addition, any history of hypertension must be fully
developed to also include all medications used, dosages, and comments on side effects.
b. Family, Personal, and Social History. A statement of the ages and health status of
parents and siblings is required; if deceased, cause and age at death should be included.
Also, any indication of whether any near blood relative has had a heart attack,
hypertension, diabetes, or known disorder of lipid metabolism must be provided. Smoking,
drinking, and recreational habits of the applicant are pertinent as well as whether a program
of physical fitness is being maintained. Comments on the level of physical activities,
functional limitations, occupational, and avocational pursuits are essential.
c. Records of Previous Medical Care. If not previously furnished to the FAA, a copy of
pertinent hospital records as well as out-patient treatment records with clinical data, x-ray,
laboratory observations, and originals or copies of all electrocardiographic (ECG) tracings
should be provided. Detailed reports of surgical procedures as well as cerebral and
coronary arteriography and other major diagnostic studies are of prime importance.
d. Surgery. The presence of an aneurysm or obstruction of a major vessel of the body is
disqualifying for medical certification of any class. Following successful surgical intervention
and correction, the applicant may ask for FAA consideration. The FAA recommends that
the applicant recover for at least 3 months for ATCSs and 6 months for airmen.
A history of coronary artery bypass surgery is disqualifying for certification. Such surgery does not
negate a past history of coronary heart disease. The presence of permanent cardiac pacemakers
and artificial heart valves is also disqualifying for certification.
The FAA will consider an Authorization for a Special Issuance of a Medical Certificate
(Authorization) for most cardiac conditions. Applicants seeking further FAA consideration should
be prepared to submit all past records and a report of a complete current cardiovascular evaluation
(CVE) in accordance with FAA specifications.
C. Medication.
Medications acceptable to the FAA for treatment of hypertension in airmen include all Food
and Drug Administration (FDA) approved diuretics, alpha-adrenergic blocking agents, betaadrenergic blocking agents, calcium channel blocking agents, angiotension converting
enzyme (ACE inhibitors) agents, and direct vasodilators.
75

____________________________________________________________________
The following are NOT ACCEPTABLE to the FAA:

o Centrally acting agents (such as reserpine, guanethidine, guanadrel, guanabenz, and
methyldopa).
o The use of flecainide when there is evidence of left ventricular dysfunction or recent
myocardial infarction.
o The use of nitrates for the treatment of coronary artery disease or to modify
hemodynamics.
The Examiner must defer issuance of a medical certificate to any applicant whose
hypertension has not been evaluated, who uses unacceptable medications, whose medical
status is unclear, whose hypertension is uncontrolled, who manifests significant adverse
effects of medication, or whose certification has previously been specifically reserved to the
FAA.

76

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Arrhythmias
Bradycardia
(<50 bpm)
All
Bundle Branch
Block
(Left and Right)
All
History of Implanted
Pacemakers
PAC
(2 or more on ECG)
All
PVCs
(2 or more on
standard ECG)
All
All
Document history and

findings, CVE
Protocol, and submit
any tests deemed
appropriate
See CVE and GXT
Protocols
See GXT Additional

BBB Requirements
See Implanted
Pacemaker Protocol
Requires evaluation,
e.g., check for MVP,
caffeine, pulmonary
disease, thyroid, etc.
Max GXT to include
a baseline ECG
If no evidence of
structural, functional or
coronary heart disease Issue
FAA Decision
If no evidence of
coronary heart disease Issue
FAA Decision
If no evidence of
coronary heart disease
Issue
FAA Decision
If no evidence of
and PVCs resolve with
exercise - Issue
FAA Decision
77

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Arrhythmias
1st Degree
AV Block
2nd Degree
AV Block
All
All
Mobitz I
2nd Degree
AV Block
All
Mobitz II
3rd Degree
AV Block
All
Pre-excitation
All
Radio Frequency
Ablation
All
Supraventricular
Tachycardia
All

findings, CVE
any tests deemed
appropriate

findings, CVE
any tests deemed
appropriate
CVE Protocol in
accordance w/
Hypertensive
Evaluation
Specifications and
24-hour Holter
CVE Protocol in
accordance w/
Hypertensive
Evaluation
Specifications and
24-hour Holter
CVE Protocol, GXT,
and 24-hour Holter
3-month wait, then
24-hour Holter
CHD Protocol
with ECHO and
24-hour Holter
If no evidence of
- Issue
FAA Decision
If no evidence of
- Issue
FAA Decision

If Holter negative for
arrhythmia and no
recurrence Issue
Otherwise Requires FAA Decision
Initial Special
Issuance - Requires
FAA Decision
Followup
78

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Atrial Fibrillation
Atrial Fibrillation:
Chronic
Paroxysmal/Lone
All
History of Resolved
Atrial Fibrillation
>5 years ago
All
CVE Protocol
with EST, ECHO and
24-hour Holter.
Initial Special
Issuance - Requires
FAA Decision
Document previous
workup for CAD and
structural heart
disease
Followup
If no ischemia, history
of emboli, or structural
or functional heart
disease - Issue
FAA Decision
Coronary Heart Disease

Coronary Heart
Disease:
Angina Pectoris
Atherectomy;
Coronary Bypass
Grafting;
Myocardial Infarction;
PTCA;
Rotoblation; and
Stent Insertion
1st & 2nd
See CHD Protocol
3rd
Initial Special
Issuance - Requires
FAA Decision
See CHD Protocol
Followup
79

____________________________________________________________________
Hypertension (HTN)
All Classes
Updated 10/28/15
Disease/Condition
A. No medication
Evaluation Data
If airman meets standards:
ISSUE
Summarize this history
in Block 60.
(If treating physician

discontinued medications 30
days ago or longer.)
B. Treated with 3 or fewer*
acceptable medications.
Disposition
See CACI Hypertension

Worksheet
For additional information, see

Hypertension FAQs
C. Any of the following:
Submit the following to the FAA
for review:
Treated with 4 or
Current status report from
more* acceptable
treating physician with
medications;
treatment plan, prognosis
and how long the condition
has been stable;
HTN is clinically
uncontrolled;
Specific mention if there is
a secondary cause for
HTN or any evidence of a
Unacceptable
co-morbid condition (ex.
medications are used;
diabetes or OSA), or end
organ damage (ex. renal
Side effects are
insufficiency, kidney
present;
disease, eye disease, MI,
CVA heart failure, etc);
Medical status of the
and
airman is unclear; or
List of medications, dates
started and stopped, and
Certification has been
any side effects.
specifically reserved
to the FAA
Follow the CACI

Hypertension
Worksheet.
Annotate Block 60.
DEFER
Submit the information
to the FAA for a
possible Special
Issuance.
Follow up Issuance
Will be per the
airmans authorization
letter
Notes: *Number of medications counts each component. (Example: lisinopril/HCTZ is 2

medications.)
If this airman is new to you or you are not certain of their HTN control, you may request a
current status report from the treating physician for your review.
If the airman did not meet standards on exam, See Item 55. Blood Pressure.
80

____________________________________________________________________
CACI - Hypertension Worksheet (Updated 10/28/15)

The Examiner should review a current status report by the treating physician and any supporting
documents to determine the applicants eligibility for certification. HOWEVER, the AME is not required to
review a current status report from the treating physician IF the AME can otherwise determine that the
applicant has had stable clinical blood pressure control on the current antihypertensive medication for at
least 7 days, without symptoms from the hypertension or adverse medication side-effects, and no treatment
changes are recommended. If the applicant meets ALL the acceptable certification criteria listed below,
the Examiner can issue. Applicants for first- or second- class must provide this information annually;
applicants for third-class must provide the information with each required exam.
AME MUST REVIEW
Treating physician or the AME

finds the condition stable on
current regimen for at least 7 days
and no changes recommended
[ ] Yes
Symptoms
[ ] None
Blood pressure in office
[ ] Less than or equal to 155 systolic and 95 diastolic

(Although 155/95 is acceptable for certification, the airman should be
referred to their primary provider for further management, if the blood
pressure is above clinical practice standards)
Acceptable medication(s)
See Pharmaceuticals Antihypertensive
[ ] Combinations of up to 3 of the following: Alpha blockers, Betablockers, calcium channel blockers, diuretics, ACE inhibitors, ARBs,
direct renin inhibitors, and/or direct vasodilators are allowed.
NOT acceptable: Centrally acting antihypertensive (ex: clonidine)
Side effects from medications
[ ] No

[ ] CACI qualified hypertension. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified hypertension. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified hypertension. I have deferred. (Submit supporting documents.)
81

____________________________________________________________________
HYPERTENSION (HTN) - FREQUENTLY ASKED QUESTIONS (FAQs)
(Last Updated: 10/28/15)
We continue to see deferrals when an airman has HTN and is on medications. Please review the
following FAQs before making a determination.
GENERAL:
1. What is the FAA specified limit for blood pressure during an exam?
The maximum systolic during exam is 155mmHg and the maximum diastolic is
during the exam. (See Item 55. Blood Pressure.)
95mmHg
2. If during the exam the airmans blood pressure is higher than 155/95, do I have to
defer?
Not necessarily. If the airmans blood pressure is elevated in clinic, you have any the
following options:
Recheck the blood pressure. If the airman meets FAA specified limits on the
second attempt, note this in Block 60 along with both readings. If the airman
is still elevated, follow B:
Have the airman return to clinic 3 separate days over a 7-day period. If the
airman meets FAA specified limits during these re-checks, note this and the
readings in Block 60. Also note if there was a reason for the blood pressure
elevation. If the airman does not demonstrate good control on re-checks,
follow C:
Send the airman back to his/her treating physician for re-evaluation. If
medication adjustment is needed, a 7-day no-fly period applies to verify no
problems with the medication. If this can be done within the 14 day exam
transmission period, you could then follow the Hypertension Disposition
Table.
3. Can I hold an exam longer than 14 days to allow the airman time provide the
necessary information?
No.
MEDICATION(S):
4. Can an airman fly while on HTN medication?

Yes, the majority of common blood pressure medications can be approved for flight. If the
airmans blood pressure is controlled with 3 or fewer medications and there are no adverse
medication side effects, the AME can often issue an unrestricted medical certificate (if
otherwise qualified). See Hypertension Disposition Table.
82

____________________________________________________________________
5. What HTN medications are acceptable/not acceptable by the FAA?

See Pharmaceuticals Antihypertensive.
6. The airman had medication(s) adjusted and now meets the standards, but it took
longer than 14 days and the exam was deferred. What can the airman do now?
If the airman is now well controlled and is on 3 or fewer medications, direct
them to the CACI - Hypertension Worksheet. They should obtain the
required information from their treating physician and submit it to the FAA.
If the airman is on 4 or more medications (combination medications count as
the sum of their parts), direct them to the Hypertension Disposition Table.
They should obtain the required information from their treating physician and
submit it to the FAA.
7. What if the treating physician stopped the medications less than 30 days ago?
See Section B of the Hypertensive Disposition Table and follow the CACI - Hypertension
Worksheet.
8. What if the airman stopped the medication on his/her own so they could fly?
Educate your airman (and their treating physician, if needed) that most HTN medications are
acceptable and almost no one is denied for HTN.
9. What if the airman has multiple conditions, e.g. HTN, Obstructive Sleep Apnea, and/or
prior heart attack?
The airman must provide the required information for each condition.
10. What if the airman is on a HTN medication that is not allowed by the FAA?
The treating physician can evaluate if the airman can safely be changed to an acceptable
HTN medication.
If the medication(s) can be changed and the airman meets the required
criteria, they should submit the items as detailed in Section C of the
Hypertensive Disposition Table for FAA review. The treating physician note
should describe the clinical rationale as to why the unacceptable medication
was previously chosen and why it is ok for the airmen to be on a different
medication now.
If the airman cannot safely be changed to an acceptable HTN medication,
defer the exam and send in the documents listed in Section C of the
Hypertensive Disposition Table for FAA review.
83

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Syncope
Syncope
All
CHD Protocol
with ECHO and 24hour Holter;
bilateral carotid
Ultrasound

Syncope, recurrent or not
satisfactorily explained, requires
deferral (even though the syncope
episode may be medically
explained, an aeromedical
certification decision may still be
precluded). Syncope may involve
cardiovascular, neurological, and
psychiatric factors.
Valvular Disease (Updated 02-24-16)

Aortic and Mitral
Insufficiency
Mitral Valve Repair
Single Valve
Replacement (Tissue,
Mechanical, or
Valvuloplasty)
Single Valve
Replacement (Tissue,
Mechanical, or
Valvuloplasty)
All
CHD Protocol
with ECHO
All
st
1 &2
3rd
Multiple Valve
Replacement
All
All Other Valvular

Disease
All
See CACI Mitral

Valve Repair
Worksheet
nd
See Cardiac Valve

Replacement
See Cardiac Valve

Replacement
Document history
and findings, CVE
appropriate tests.
CHD Protocol
with ECHO
Initial Special
Issuance - Requires
FAA Decision
Followup
Special Issuances See AASI
Follow the CACI
Mitral Valve Repair
Worksheet
Annotate Block 60
Initial Special
Issuance - Requires
FAA Decision
Followup
84

____________________________________________________________________
Mitral Valve Repair

All Classes
Updated 02/24/16
DISEASE/CONDITION
A.
5 or more years ago
and no co-morbid conditions*
EVALUATION DATA
DISPOSITION
See CACI Mitral Valve Repair Worksheet. Follow the

CACI Mitral
Valve Repair
Worksheet
Annotate Block
60.
B.
Less than 5 years ago
After a 3 month recovery period submit

the following to the FAA for review:
OR
Any of the co-morbid
conditions below*
Hospital admission history and physical;

Operative report/surgical report;
Hospital discharge summary;
Current status report from the treating
cardiologist which should describe the type
of repair, any complications, current
treatment needed, and follow up plan;
List of medications and side effects, if any;
Cardiac testing performed AFTER the 3
month recovery period and within the last
90 days:
o 24-hour Holter;
o Electrocardiogram (ECG);
o Echo;
o Exercise Stress Test (EST); and
Other imaging reports (if any) for studies
performed by the treating cardiologist (eg.
Cath, CTA, or MRA).
DEFER
Submit the
information to the
FAA for review.
Follow up
Issuance
Will be per the
airmans
authorization
letter
Notes:
*Co-morbid conditions for FAA purposes include:
Cardiac disease (disease of other valves, ischemia, CHF, Left Ventricular Systolic Dysfunction (LVSD), Secondary or
Functional mitral valve disease, arrhythmia, etc.);
Connective tissue disorder (such as Marfans or Ehlers-Danlos, etc.);
Coumadin or other anticoagulation (other than ASA) due to a cardiac condition;
Lung disease such as COPD (considered moderate to severe; any FEV1 or FVC less than 70%) or Pulmonary
Hypertension; or
Residual Mitral valve regurgitation listed as moderate or higher on cardiac echo.
85

____________________________________________________________________
CACI Mitral Valve Repair Worksheet (Updated 2/24/2016)

The Examiner must review a current status report by the treating physician and any supporting documents
to determine the applicants eligibility for certification. If the applicant meets ALL the acceptable
certification criteria listed below, the Examiner can issue. Applicants for first- or second-class must
provide this information annually; applicants for third-class must provide the information with each required
exam.
AME MUST REVIEW
The airman had Mitral Valve Repair surgery 5 or more years ago
for primary mitral valve disease (not secondary MR or functional MR
due to coronary heart disease, MI, ischemic disease, or cardiomyopathy).
A current status report from the treating cardiologist
verifies the airman:
Is asymptomatic and stable;
Has no other current cardiac conditions*;
Has not developed any new conditions, arrhythmias, or complications
that would affect cardiac function;
Requires no more than a routine annual follow-up; and
No additional surgery is anticipated or recommended.
The airman has NO history of:
Connective tissue disorder (Marfans or Ehlers-Danlos, etc.);
Lung disease: COPD (moderate or higher), or pulmonary HTN; or
Other cardiac disease (e.g. Congestive Heart Failure, ischemia, other
valve disease, etc.)
The most recent echo was performed within the last 24 months
shows:
ACCEPTABLE
CERTIFICATION
CRITERIA
[ ] Yes
[ ] Yes
[ ] Yes
[ ] Yes
Mitral valve regurgitation (if present) is classified as mild;

No other abnormalities on echo such as:
o Dilated aorta greater than 4 cm;
o Hypertrophic cardiomyopathy or other cardiomyopathy;
o Left Atrial Enlargement;
o Regurgitation of any valve moderate or higher; or
o Structural abnormalities (dilated ventricle, atria, etc.)
Notes:
If any valve other than mitral was involved, the information must be submitted to the FAA for review.
An annual echo is not required for each FAA exam for this CACI.
Anticoagulation is not routinely required for mitral valve repair. If Coumadin or other anticoagulation (other than ASA) is
required for a cardiac condition, the AME should defer.
*Atrial fibrillation treated with ablation and resolved is allowable.

[ ] CACI qualified Mitral Valve Repair.
[ ] Not CACI qualified Mitral Valve Repair. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified Mitral Valve Repair. I have deferred. (Submit supporting documents.)
86

____________________________________________________________________
Other Cardiac Conditions
The following conditions must be deferred:
1. Cardiac Transplant see Disease Protocols.
2. Cardiac decompensation.
3. Congenital heart disease accompanied by cardiac enlargement, ECG abnormality, or
evidence of inadequate oxygenation.
4. Hypertrophy or dilatation of the heart as evidenced by clinical examination and supported by
diagnostic studies.
5. Pericarditis, endocarditis, or myocarditis.
6. When cardiac enlargement or other evidence of cardiovascular abnormality is found, the
decision is deferred to AMCD or RFS. If the applicant wishes further consideration, a
consultation will be required, preferably from the applicants treating physician. It must
include a narrative report of evaluation and be accompanied by an ECG with report and
appropriate laboratory test results which may include, as appropriate, 24-hour Holter
monitoring, thyroid function studies, ECHO, and an assessment of coronary artery status.
The report and accompanying materials should be forwarded to the AMCD or RFS.
7. Anti-tachycardia devices or implantable defibrillators.
8. With the possible exceptions of aspirin and dipyridamole taken for their effect on blood
platelets, the use of anticoagulants or other drugs for treatment or prophylaxis of fibrillation
may preclude medical certification.
9. A history of cardioversion or drug treatment, per se, does not rule out certification. A
current, complete cardiovascular evaluation (CVE) will be required. A 3-month observation
period must elapse after the procedure before consideration for certification.
10. Any other cardiac disorder not otherwise covered in this section.
11. For all classes, certification decisions will be based on the applicant's medical history and
current clinical findings. Certification is unlikely unless the information is highly favorable to
the applicant. Evidence of extensive multi-vessel disease, impaired cardiac functioning,
precarious coronary circulation, etc., will preclude certification. Before an applicant
undergoes coronary angiography, it is recommended that all records and the report of a
current cardiovascular evaluation (CVE), including a maximal electrocardiographic exercise
stress test, be submitted to the FAA for preliminary review. Based upon this information, it
may be possible to advise an applicant of the likelihood of favorable consideration.
12. A history of low blood pressure requires elaboration. If the Examiner is in doubt, it is usually
better to defer issuance rather than to deny certification for such a history.
87

____________________________________________________________________
ITEM 37. Vascular System
Normal
Abnormal
37. Vascular System

medical judgment relating to the condition involved, finds
(1) Makes the person unable to safely perform the duties or exercise the
perform those duties or exercise those privileges;
1. Inspection. Observe and report any thoracic deformity (e.g., pectus excavatum), signs of
surgery or other trauma, and clues to ventricular hypertrophy. Check the hematopoietic and
vascular system by observing for pallor, edema, varicosities, stasis ulcers, venous
distention, nail beds for capillary pulsation, and color.
2. Palpation. Check for thrills and the vascular system for arteriosclerotic changes, shunts or
AV anastomoses. The pulses should be examined to determine their character, to note if
they are diminished or absent, and to observe for synchronicity.
3. Percussion. N/A.
4. Auscultation. Check for bruits and thrills.
88

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Vascular Conditions
Aneurysm
(Abdominal or Thoracic)
All
Aneurysm
(Status Post Repair)
All
Arteriosclerotic Vascular
disease with evidence
of circulatory
obstruction
All
Buerger's Disease
All
Submit all available

medical
documentation
Submit all
documentation in
accordance with CVE
Protocol, and include
a GXT
Submit all
documentation in
accordance with CVE
Protocol, and include
a GXT, and CAD
ultra sound if
applicable
Document history
and findings
If no impairment and
no symptoms in flight
- Issue
FAA Decision
89

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Vascular Conditions
Peripheral Edema
Raynaud's Disease
Phlebothrombosis or
Thrombophlebitis
All
All
1st &
2nd
3rd
The underlying
medical condition
must not be
disqualifying
If findings can be
explained by normal
physiologic response
or secondary to
medication(s)
- Issue

Document history and If no impairment
findings
- Issue
FAA Decision
See Thrombophlebitis Requires FAA Decision
Protocol
Document history and A single episode
findings
resolved, not currently
treated with
anticoagulants, and a
negative evaluation
- Issue
See Thrombophlebitis If history of multiple
Protocol
episodes - Requires
FAA Decision
90

____________________________________________________________________
ITEM 38. Abdomen and Viscera
Normal
Abnormal
38. Abdomen and viscera (including hernia)

medical judgment relating to the medication or other treatment involved, finds(1) Makes the person unable to safely perform the duties or exercise the
1. Observation: The Examiner should note any unusual shape or contour, skin color, moisture,
temperature, and presence of scars. Hernias, hemorrhoids, and fissure should be noted
and recorded.
A history of acute gastrointestinal disorders is usually not disqualifying once recovery is
achieved, e.g., acute appendicitis.
Many chronic gastrointestinal diseases may preclude issuance of a medical certificate (e.g.,
cirrhosis, chronic hepatitis, malignancy, ulcerative colitis). Colostomy following surgery for
cancer may be allowed by the FAA with special followup reports.
The Examiner should not issue a medical certificate if the applicant has a recent history of
91

____________________________________________________________________
bleeding ulcers or hemorrhagic colitis. Otherwise, ulcers must not have been active within
the past 3 months.
In the case of a history of bowel obstruction, a report on the cause and present status of the
condition must be obtained from the treating physician.
2. Palpation: The Examiner should check for and note enlargement of organs, unexplained
masses, tenderness, guarding, and rigidity.
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Abdomen and Viscera and Anus Conditions

Cholelithiasis
All
Cirrhosis (Alcoholic)
All
Cirrhosis
(Non-Alcoholic)
All
Colitis
(Ulcerative,
Regional Enteritis
or Crohn's
disease) or Irritable
Bowel Syndrome
All

findings
See Substance
Abuse/Dependence
Disposition in Item 47.
medical records,
current status report, to
include history of
encephalopathy;
PT/PTT; albumin; liver
enzymes; bilirubin;
CBC; and other testing
deemed necessary
medical information
and current status
report, include duration
of symptoms, name
and dosage of drugs
and side effects
If asymptomatic Issue
FAA Decision
Follow the CACI Colitis

Worksheet. If Airman
meets all certification
criteria Issue
Followup Special
Issuance - See AASI
Protocol
92

____________________________________________________________________
CACI - Colitis Worksheet (Updated 4/29/15)

each required exam.
AME MUST REVIEW
The general health status of the

applicant due to this condition, as
documented in a current status report
by the treating physician
[ ] Favorable
Symptoms
[ ] None or mild diarrhea with or without mild abdominal pain/cramping

Fatigue which limits activity or severe abdominal symptoms are not
acceptable for certification.
Cause of Colitis
[ ] Crohns Disease, Ulcerative colitis, or Irritable Bowel Syndrome

Any other causes require FAA decision.
Surgery for condition in last 6 weeks
[ ] No
Medications for condition
[ ] One or more of the following:

Oral steroid which does not exceed equivalent of prednisone 20
mg/day (see steroid conversion calculator)
Imuran or Sulfasalazine
Mesalamine (5-aminosalicylic acid such as Asacol, Pentasa, Lialda,
etc.)
Steroid foams or enemas/ budesonide enema
Loperamide less than or equal to 16 mg a day and no side effects
Hyoscyamine - use 1-2 times a week with no side effects and no-fly
48 hours after use
Use of infliximab, use of hyoscyamine greater than 2 times per week,
Prednisone greater than 20 mg/day, or Loperamide greater than 16 mg per
day is NOT acceptable
[ ] CACI qualified colitis. (Documents do not need to be submitted to the FAA.)

[ ] Not CACI qualified colitis. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified. I have deferred. (Submit supporting documents.)
93

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION

Hepatitis
Hepatitis C
All
All

medical records,
current status report to
include any other
testing deemed
necessary
medical information
and current status
report, include duration
of symptoms, name
and dosage of drugs
and side effects
If disease is resolved
without sequela
- Issue
FAA Decision
If disease is resolved
without sequela and
need for medicationsIssue
If applicant has chronic
Hepatitis C, follow the
CACI - Hepatitis C Chronic Worksheet
(PDF). If Airman meets
all certification criteria Issue.
evaluation data.
Followup Special
Protocol
94

____________________________________________________________________
CACI - Hepatitis C - Chronic Worksheet (Updated 4/29/15)

acceptable certification criteria listed below, the Examiner can issue. Applicants for first- or
second- class must provide this information annually; applicants for third-class must provide the
information with each required exam.
AME MUST REVIEW

recommended
[ ] Yes
Complications or symptoms from

Chronic Hepatitis C
[ ] None
[ ] None
Current Labs
[ ] Within last 90 days

[ ] AST (SGOT), ALT (SGPT), Albumin, and PT all within 10% of
normal lab scale.

[ ] CACI qualified Hepatitis C - Chronic. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified Hepatitis C - Chronic. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified Hepatitis C - Chronic. I have deferred. (Submit supporting documents.)
95

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION

Hernia - Inguinal, Ventral
or Hiatal
All

findings
Liver Transplant Recipient
All
Submit items listed on

the Protocol for Liver
Transplant (Recipient)
Liver Transplant Donor
All
Review a current status

report from the
transplant surgeon or
transplant team
physician
If symptomatic; likely to
cause any degree of
obstruction - Requires
FAA Decision
Otherwise - Issue
Initial Special Issuance Requires FAA decision
Follow up Special
Issuance per
Authorization Letter
requirements
Initial certification - If
the current status report
shows there were no
complications, the
airman is off all pain
medications, functional
status has returned to
normal, and the treating
physician has granted a
full release - ISSUE
Note in block 60 and
send a copy of the
current status report to
the FAA for retention in
the file
*If there were
complications, see the
appropriate, related
section(s) within the AME
Guide. Submit additional
reports as necessary.
Liver + kidney
Liver + heart
Liver + other
Combined Transplants
All
Submit the required

items on the transplant
protocol for each
individual organ
transplanted
Follow up Certification
No follow up is required
unless there are changes
in condition
Defer - Requires FAA
Decision
96

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION

Peptic Ulcer
All
See Peptic Ulcer

Protocol
Splenomegaly
All
Provide hematologic
workup
Malignancies
Colon/Rectal Cancer
Other Malignancies
All
All

medical records,
operative/
pathology reports,
current oncological
status report; and
current CEA and
CBC
medical records,
operative/
pathology reports,
current oncological
status report,
including tumor
markers, and any
other testing deemed
necessary
Initial Special
Issuance - Requires
FAA Decision
Followup
An applicant with an ileostomy or colostomy may also receive FAA consideration. A report is
necessary to confirm that the applicant has fully recovered from the surgery and is completely
asymptomatic.
In the case of a history of bowel obstruction, a report on the cause and present status of the
condition must be obtained from the treating physician.
97

____________________________________________________________________
ITEM 39. Anus
Normal
Abnormal
39 Anus (Not including digital examination)

All Classes: 14 CFR 67.113(a), 67.213(b)(c), and 67.313(b)(c)
medical judgment relating to the medication or other treatment involved, finds
1. Digital Rectal Examination: This examination is performed only at the applicant's option
unless indicated by specific history or physical findings. When performed, the following
should be noted and recorded in Item 59 of FAA Form 8500-8.
2. If the digital rectal examination is not performed, the response to Item 39 may be based on
direct observation or history.
98

____________________________________________________________________
ITEM 40. Skin
NORMAL
ABNORMAL
40. Skin

Federal Air Surgeon, based on the case history and appropriate, qualified medical judgment
relating to the condition involved, finds (1) Makes the person unable to safely perform the duties or exercise the
case history and appropriate, qualified medical judgment relating to the medication or other
treatment involved, finds (1) Makes the person unable to safely perform the duties or exercise the
medical certificate applied for or held, to make the person unable to perform those
duties or exercise those privileges.
A careful examination of the skin may reveal underlying systemic disorders of clinical importance.
For example, thyroid disease may produce changes in the skin and fingernails. Cushing's disease
may produce abdominal striae, and abnormal pigmentation of the skin occurs with Addison's
disease.
Needle marks that suggest drug abuse should be noted and body marks and scars should be
described and correlated with known history. Further history should be obtained as needed to
explain findings.
The use of isotretinoin (Accutane) can be associated with vision and psychiatric side effects of
aeromedical concern specifically decreased night vision/night blindness and depression. These
side-effects can occur even after the cessation of isotretinoin. See Aeromedical Decision
Considerations.
99

____________________________________________________________________
The following is a table that lists the most common conditions of aeromedical significance, and course of
action that should be taken by the examiner as defined by the protocol and disposition in the table. Medical
certificates must not be issued to an applicant with medical conditions that require deferral, or for any
condition not listed in the table that may result in sudden or subtle incapacitation without consulting the
AMCD or the RFS. Medical documentation must be submitted for any condition in order to support an
issuance of an airman medical certificate.
Cutaneous
All classes
DISEASE/CONDITION
EVALUATION DATA
DISPOSITION
Dermatomyositis;
Deep Mycotic
Infections;
Eruptive Xanthomas;
Hansen's Disease;
Lupus Erythematosus;
Raynaud's
Phenomenon;
Sarcoid; or Scleroderma
Kaposi's Sarcoma

information and current status report

report.
See HIV Protocol
For applicants using isotretinoin,
there is a mandatory 2-week waiting
period after starting isotretinoin prior
to consideration. This medication
can be associated with vision and
psychiatric side effects of
aeromedical concern - specifically
decreased night vision/night
blindness and depression. These
side-effects can occur even after
cessation of isotretinoin. A report
must be provided with detailed,
specific comment on presence or
absence of psychiatric and vision
side-effects. The AME must
document these findings in Item 60.,
Comments on History and Findings.
Use of isotretinoin
(Accutane)
Any history of psychiatric

side-effect requires FAA
Decision.
If there is no vision,
psychiatric, or other
aeromedically unacceptable
side-effects Issue with
restriction: NOT VALID
FOR NIGHT FLYING.
To remove restriction:
*See note
*Note:
Use of isotretinoin must be permanently discontinued for at least 2 weeks prior to consideration date
(confirmed by the prescribing physician);
An eye evaluation in accordance with specifications in 8500-7; and
Airman must provide a statement of discontinuation
o Confirming the absence of any visual disturbances and psychiatric symptoms, and
o Acknowledging requirement to notify the FAA and obtain clearance prior to performing any
aviation safety-related duties if use of isotretinoin is resumed.
100

____________________________________________________________________
Skin Cancer
All Classes
Updated 8/26/2015
DISEASE/CONDITION
Unknown pathology
EVALUATION DATA
If unable to verify pathology, have airman
collect:
Medical records describing the
diagnosis and treatment; and
Pathology report(s)
Basal cell cancer

(BCC)
AME interview and exam findings consistent

with uncomplicated local BCC or SCC
completely treated (excised, destroyed, or
Mohs procedure) and resolved.
Squamous cell cancer

(SCC)
Uncomplicated skin only
No organ involvement
SCC or BCC
Complicated lesion
Metastatic
lymph node or deep tissue
involvement, aggressive
pathology or other abnormalities
Also see ENT section
Melanoma
Less than
0.75 mm in depth
Submit the following for FAA review:

diagnosis and treatment;
Pathology report(s);
Operative notes;
Current status summary report that
includes current or planned future
treatment & prognosis; and
Copies of any imaging performed
(CT/MRI)
Review:
diagnosis and treatment; and
Pathology report(s)
DISPOSITION
More info needed
Once reports are received, refer to
the appropriate skin cancer
diagnosis in this section.
ISSUE
Note BCC or SCC treated in block
60.
If complicated lesion, see below.
DEFER
Submit reports to FAA for review.
Follow-up certification - based on

Special Issuance Authorization.
ISSUE
If complete resection with clear
margins, no recurrence, no
metastatic disease, and favorable
reports.
OR
Melanoma in Situ
Melanoma
Equal to 0.75 mm or greater in
depth
Metastatic Melanoma
OR
Melanoma of Unknown Primary

Origin
Review and submit the following:

diagnosis and treatment;
Pathology report(s);
Operative notes;
Current status report that includes if
any additional lesions, any
metastatic disease, any current or
future treatment planned; and
Current MRI brain
Info from Melanoma greater than
0.75 mm above;
PET scan; and
Copies of any additional testing
performed by your treating
physician not listed above
Document in block 60 AND submit

reports to FAA for retention in the
file.
DEFER
Submit reports to FAA for review.
Follow-up certification - based on

Special Issuance Authorization.
DEFER
Submit supporting documents for
FAA review.
101

____________________________________________________________________
DISEASE/CONDITION
EVALUATION DATA
DISPOSITION
Urticarial Eruptions
All Classes
Angioneurotic Edema

records and a current status
report to include treatment
Chronic Urticaria
Submit all records and a current

status report to include treatment
102

____________________________________________________________________
ITEM 41. G-U System
41. G-U system (Not including pelvic examination)
NORMAL
ABNORMAL
NOTE: The pelvic examination is performed only at the applicant's option or if indicated by specific history or
physical findings. If a pelvic examination is performed, the results are to be recorded in Item 60 of FAA
Form 8500-8.

The Examiner should observe for discharge, inflammation, skin lesions, scars, strictures, tumors,
and secondary sexual characteristics. Palpation for masses and areas of tenderness should be
performed. The pelvic examination is performed only at the applicant's option or if indicated by
specific history or physical findings. If a pelvic examination is performed, the results are to be
recorded in Item 60 of FAA Form 8500-8. Disorders such as sterility and menstrual irregularity are
not usually of importance in qualification for medical certification.
103

____________________________________________________________________
Specialty evaluations may be indicated by history or by physical findings on the routine
examination. A personal history of urinary symptoms is important; such as:
1.
2.
3.
4.
Pain or burning upon urination

Dribbling or Incontinence
Polyuria, frequency, or nocturia
Hematuria, pyuria, or glycosuria
Special procedures for evaluation of the G-U system should best be left to the discretion of an
urologist, nephrologist, or gynecologist.
(See Item 48.,General Systemic, for details concerning diabetes and Item 57., Urine Test, for
other information related to the examination of urine).
General Disorders
All Classes
DISEASE/CONDITION
Congenital lesions of
the kidney

medical information
and status report
Cystostomy and
Neurogenic bladder
Renal Dialysis
Renal Transplant
If the applicant has an ectopic, horseshoe

kidney, unilateral agenesis, hypoplastic, or
dysplastic and is asymptomatic
Issue

Requires evaluation,
report must include
etiology, clinical
manifestation and
treatment plan
Submit a current status Requires FAA Decision
report, all pertinent
medical reports to
include etiology, clinical
manifestation, BUN,
Ca, PO4,
Creatinine, electrolytes,
and treatment plan
See Renal Transplant Requires FAA Decision
Protocol
104

____________________________________________________________________
Chronic Kidney Disease(CKD)

All Classes
Updated 11/25/15
DISEASE/CONDITION
EVALUATION DATA
A. eGFR 45 to 59
No symptoms or complications and the
underlying cause is not disqualifying.
B. eGFR 35 to 44
See CACI worksheet.
Submit the following to the FAA for review:

OR
physician. It should note if the condition is
stable or if additional treatment or dialysis
is recommended;
Symptoms or
complications with any
List of medications and side effects, if any;
eGFR
Recent lab (within last 90 days)
o Renal function studies(creatinine,
Proteinuria 2+ or higher
BUN and eGFR);
or ACR is 300 or higher
o Albumin as dipstick or ACR; and
o Hemoglobin and hematocrit
Imaging reports (if performed by treating
physician); and
Assessment by treating physician if a
cardiac evaluation is warranted
DISPOSITION
ISSUE
Summarize this
history in block 60.
Follow the CACI
Chronic Kidney
Disease Worksheet
annotate block 60.
C. eGFR 34 or less
ESRD requiring
dialysis or kidney
transplant
DEFER
Submit the
information to the
FAA for a possible
Special Issuance.
Followup Special
Issuance
Will be per the
airmans
Authorization Letter
See table on previous page for more information.

DEFER
Notes: eGFR is a calculated/estimated value. If additional testing shows the actual renal function is higher than the
eGFR, this should be stated in the note from the treating physician.
ACR= albumin creatinine ratio
105

____________________________________________________________________
CACI CKD Chronic Kidney Disease Worksheet Updated 11/25/2015

The Examiner must review a current status report by the treating physician and any
supporting documents to determine the applicants eligibility for certification. If the applicant
meets ALL the acceptable certification criteria listed below, the Examiner can issue.
Applicants for first- or second-class must provide this information annually; applicants for
third-class must provide the information with each required exam.
AME MUST REVIEW
ACCEPTABLE CERTIFICATION
CRITERIA
A current status report from the treating physician

that notes the airman:
Is asymptomatic and stable;
Has not developed any new conditions or
complications that would affect renal function;
Any underlying conditions (such as diabetes,
HTN, glomerulonephritis, PKD, or chronic
obstruction) are well controlled; and
Comments that dialysis or transplant is not
recommended or anticipated at this time.
[ ] Yes
eGFR is 35 or higher
(most recent value, must be within the last 6 months).
[ ] Yes
Albumin on urine dipstick is trace or negative

OR albumin creatinine ratio (ACR) is 29 or less
[ ] Yes
Hemoglobin is at least 10 gm/dL AND hematocrit is

at least 30%
[ ] Yes
Current treatment
[ ] allowed HTN medication

[ ] CACI qualified Chronic Kidney Disease.
[ ] Not CACI qualified Chronic Kidney Disease. Issued per valid SI/AASI. (Submit supporting
documents.)
[ ] NOT CACI qualified Chronic Kidney Disease. I have deferred. (Submit supporting
documents.)
106

____________________________________________________________________
Inflammatory Conditions
All Classes
DISEASE/CONDITION
Acute (Nephritis)
Chronic (Nephritis)
Nephrosis

If > 3 mos. ago, resolved, no sequela, or
medical information
indication of reoccurrence - Issue
and status report
Otherwise - Requires FAA Decision
medical information
and status report
medical information
and status report
107

____________________________________________________________________
Kidney Stone(s)
(Nephrolithiasis, Renal Calculi)
or Renal Colic
All Classes
Updated 9/30/15
DISEASE/CONDITION
A. Most recent
event/diagnosis
5 or more years ago.
No symptoms or current problems. Renal

function has returned to normal. No ongoing
treatment or surveillance needed.
B. Most recent
event/diagnosis
less than 5 years ago
and no complications*
C. All others
EVALUATION DATA
DISPOSITION
ISSUE
Summarize this
history in Block 60.
ISSUE
If a single stone passed or is in the bladder
Summarize this
with no further problems and imaging (such as history in Block 60.
a KUB) verifies no retained stones:
See CACI worksheet

urologist with treatment plan and prognosis;
If underlying cause is identified, the status
report should include diagnosis, treatment
plan, prognosis and adherence to treatment
for this condition;
List of medications and side effects if any;
Operative notes and discharge summary
(if applicable);and
Copies of imaging reports and lab (if
already performed by treating physician)
Follow the CACI Kidney Stones

Worksheet
Note in Block 60.
DEFER
Submit the
information to the
FAA for a possible
Special Issuance.
Follow up Issuance
Will be per the
airmans
authorization letter
Notes:
*Complications include the following:
Hydronephrosis (chronic).
Metabolic/underlying condition requiring treatment/surveillance/monitoring
Procedures (3 or more for kidney stones within the last 5 years)
Renal failure or obstruction (acute or chronic).
Sepsis or recurrent urinary tract infections due to stones
Metabolic evaluations and imaging should be performed as clinically indicated by the treating physician.
Acceptable imaging includes KUB, ultrasound, IVP, or CT/MRI as clinically appropriate per the treating physician.
108

____________________________________________________________________
CACI Kidney Stone(s) Worksheet (Updated 9/30/2015)

AME MUST REVIEW
A current status report from the treating physician
that notes the airmans condition is:
CRITERIA
[ ] Yes
Asymptomatic;
Stable (no increase in number or size of
stones);
Unlikely to cause a sudden incapacitating event;
If surgery has been performed, the airman:
o Is off pain medication(s);
o Has made a full recovery; and
o Has a full release from the surgeon;
No history of complications (including chronic
hydronephrosis; metabolic/underlying condition;
procedures (3 or more in the last 5 years); renal
failure or obstruction; sepsis; or recurrent UTIs
due to stones.)
Is there an underlying cause for stone recurrence?
[ ] No
Current or recommended treatment
[ ] None
After a single stone event - if follow up imaging verifies

no further stone(s) present, annotate this in Block 60.
No further follow up is required unless there is a
change in condition.
Supportive treatments such as hydration

or medications (such as thiazides,
allopurinol, or potassium citrate) to
decrease recurrence (with no side
effects) are allowed.

[ ] CACI qualified Kidney Stones. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified Kidney Stones. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified Kidney Stones. I have deferred. (Submit supporting documents.)
109

____________________________________________________________________
Neoplastic Disorders/Cancer
Bladder Cancer
All Classes
Updated 8/26/2015
DISEASE/CONDITION
A. Non metastatic
and treatment
completed 5 or more
years ago
EVALUATION DATA
No recurrence or ongoing treatment:
B. Non metastatic
See CACI worksheet.
and treatment completed
Local recurrence within the bladder only:
Follow CACI Bladder Cancer Worksheet.
C. Metastatic disease,
Information that needs to be submitted to the

FAA for review:
muscle invasion,
or
Recurrent disease
that has spread
outside the bladder
Current status report from oncologist

describing treatment plan and
prognosis;
List of medications with attention to any
chemotherapy agents and dates used;
Treatment records including clinic notes
or summary letter describing initial
staging and treatment course;
(if applicable);
Pathology report(s) (if applicable); and
MRI/CT or PET scan reports (In some
cases, the actual CDs will be required
in DICOM format for FAA review.)
DISPOSITION
ISSUE
Summarize this
Follow the CACI Bladder Cancer
Worksheet.
Note in Block 60.
DEFER
Initial Issuance Submit the information
to the FAA
Follow up Issuance Will be per the
airmans authorization
letter
Notes: If the airman is currently on radiation or chemotherapy, the treatment course must be completed before
medical certification can be considered.
110

____________________________________________________________________
CACI Bladder Cancer Worksheet (Updated 08/26/2015)

AME MUST REVIEW
CRITERIA
A current status report from the treating physician.

[ ] Yes
If it reveals:
Condition is stable;
If recurrence, there has been NO spread outside
the bladder;
There is no current or historic evidence of any
metastatic disease or muscle invasion;
Active treatment is completed
(chemotherapy/radiation, etc.) and no new
treatment is recommended at this time; and/or
If surgery has been performed, the airman is off
pain medication(s), has made a full recovery,
and has been released by the surgeon.
Symptoms
[ ] None
Current treatment
[ ] None or maintenance intravesical

BCG or mitomycin.
Notes: If it has been 5 or more years since the airman (If these medications are used, the
has had any treatment for this condition, with no
airman should not fly until 24 hours
history of metastatic disease and no reoccurrence,
post treatment and asymptomatic.)
CACI is not required. Note this in Block 60. (See
disposition table.)
If the airman is currently on chemotherapy or radiation
treatment, defer the exam. (See disposition table.

[ ] CACI qualified Bladder cancer. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified Bladder cancer. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified Bladder cancer. I have deferred. (Submit supporting documents.)
111

____________________________________________________________________
Prostate Conditions
All Classes
Updated 8/26/15
DISEASE/CONDITION
EVALUATION DATA
Benign Prostatic
If the airman has findings consistent with
Hypertrophy (BPH) or uncomplicated BPH with no evidence of
elevated PSA
prostate cancer:
DISPOSITION
A.
ISSUE
in Block 60
Notes: See Pharmaceuticals section for list of medications usually allowed.
Prostate Cancer
All Classes
A. Prostate Cancer
Non metastatic
With treatment
completed
5 or more years ago
B. Prostate Cancer
Non metastatic with
treatment
completed less than 5
years ago
C. Prostate Cancer
With
Metastatic disease
Current OR any time
in the past
OR
Recurrence of
disease
Including a biochemical
recurrence (BCR) after
prostatectomy
If NO recurrence or ongoing treatment:

ISSUE
in Block 60.
See CACI worksheet.
Follow the CACI Prostate Cancer

Worksheet
Note in Block 60.

describing treatment plan, how long the
condition has been stable, and prognosis;
List of medications and presence or absence
of side effects with specific attention to any
chemotherapy, steroids, or hormone agents
and dates used;
Treatment records including clinic notes or a
summary letter describing initial staging,
disease course, locations of metastatic
disease, and stability;
Operative notes and discharge summary, if
applicable;
Pathology report(s), if applicable; and
Results of MRI/CT or PET scan reports. (In
some cases, the actual CDs will be required
in DICOM format for FAA review).
DEFER
Initial Special
Issuance Requires
FAA Decision
Follow up Special
Issuance will be per
the airmans
Notes: If the airman is currently on radiation or chemotherapy, the treatment course should be
completed before medical certification can be considered.
112

____________________________________________________________________
CACI Prostate Cancer Worksheet (Updated 8/26/2015)

AME MUST REVIEW
CRITERIA
A current status report from the treating

physician reveals the:
Condition is stable with no spread or
recurrence;
There is no current or historical evidence
of any metastatic disease;
Active treatment is completed
(chemotherapy/radiation, etc.) and no
further treatment is recommended at this
time; and
If surgery has been performed, the airman
o Is off pain medications;
o Has made a full recovery; and
o Has been released by the surgeon
[ ] Yes
Current PSA (within the last 6 months)
[ ] 20 or less if no prostatectomy
[ ] 0.2 or less after prostatectomy
Symptoms
[ ] None
Current treatment
[ ] None or
active surveillance/watchful waiting
or Brachytherapy
Notes: If it has been 5 or more years since the

airman has had any treatment for this condition,
with no history of metastatic disease and no
reoccurrence, CACI is not required. Note this in
Block 60. (See disposition table.)

[ ] CACI qualified prostate cancer. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified prostate cancer. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified prostate cancer. I have deferred. (Submit supporting documents.)
113

____________________________________________________________________
Renal Cancer
All Classes
Updated 9/30/15
DISEASE/CONDITION
A.
Non metastatic with
treatment completed
5 or more years ago
EVALUATION DATA
If no recurrence or ongoing treatment:
B.
Non metastatic with
treatment completed
See CACI worksheet.
C.

Current status report from your treating
oncologist. It should describe the
treatment plan, how long the condition
has been stable, prognosis, and if any
upcoming treatment change is planned or
expected;
List of medications and presence or
absence of side effects with specific
mention of chemotherapy and dates used;
Treatment records including clinic notes or
a summary letter describing initial staging,
disease course, locations of metastatic
disease, and stability;
Operative notes and discharge, if
applicable;
Pathology report(s), if applicable;
Results of MRI/CT or PET scan reports (In
Metastatic disease
Current OR any time in
the past
OR
Recurrence of disease
DISPOSITION
ISSUE
Summarize this
Follow the CACIRenal Cancer
Worksheet
Note in Block 60
DEFER
Submit the
information to the
FAA for a possible
Special Issuance.
Followup Special
Issuance
Will be per the
airmans
some cases, the actual CDs will be required in

DICOM format for FAA review.); and
Copies of most recent lab results

performed by your treating physician.
114

____________________________________________________________________
CACI Renal Cancer Worksheet (Updated 9/30/2015)

AME MUST REVIEW
CRITERIA
Treating physician finds the condition stable on

current regimen and no changes recommended.
[ ] Yes
Any evidence of:

Disease recurrence;
Extra capsular extension;
Metastatic disease;
Stage 4 disease; or
Paraneoplastic syndrome;
[ ] No
Treatment completed and back to full, unrestricted

activities (ECOG performance status or equivalent
is 0).
[ ] Yes

[ ] CACI qualified Renal Cancer. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified Renal Cancer. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified Renal Cancer. I have deferred. (Submit supporting documents.)
115

____________________________________________________________________
Testicular Cancer
All Classes
Updated 8/26/15
DISEASE/CONDITION
EVALUATION DATA
A. Non metastatic
No recurrence or ongoing treatment:
5 or more years ago
B. Non metastatic
See CACI worksheet.
DISPOSITION
ISSUE
Summarize this
Follow the CACI Testicular Cancer
Worksheet
Note in Block 60.
C. Metastatic disease
Current OR any time in
the past
Recurrence of disease

describing treatment plan and
prognosis;
List of medications with attention to any
chemotherapy agents and dates used;
Treatment records including clinic notes
or summary letter describing disease
course and initial staging;
DEFER
Submit the
information to the
FAA for a possible
Special Issuance.
(if applicable);
Pathology report(s) (if applicable);

MRI/CT or PET scan reports (in some
cases, the actual CDs will be required in DICOM
format for FAA review); and
Serum tumor markers results (if

applicable).
Notes: If the airman is currently on radiation or chemotherapy, the treatment course must be
completed before medical certification can be considered.

Watchful waiting is allowed. See CACI Testicular Cancer Worksheet.
116

____________________________________________________________________
CACI Testicular Cancer Worksheet (Updated 8/26/15)

AME MUST REVIEW
A current status report from the treating physician.
If it reveals the:
CRITERIA
[ ] Yes
1. Condition is stable with no spread or recurrence;

2. There is no current or historic evidence of any
metastatic disease;
3. Active treatment is completed
(chemotherapy/radiation, etc.) and no new
treatment is recommended at this time; and
4. If surgery has been performed, the airman is off
pain medication(s), has made a full recovery,
and has been released by the surgeon.
Symptoms
[ ] None
Current treatment
[ ] None, surveillance or watchful

waiting
Notes: If it has been 5 or more years since the airman

has had any treatment for this condition, with no
history of metastatic disease and no reoccurrence,
CACI is not required. Note this in Block 60. (See
disposition table.)
If the airman is currently on chemo or radiation
treatment, defer the exam. (See disposition table.)

[ ] CACI qualified Testicular cancer. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified Testicular cancer. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified Testicular cancer. I have deferred. (Submit supporting documents.)
117

____________________________________________________________________
Other G-U Cancers/Neoplastic Disorders

All Classes
Updated 9/30/15
DISEASE/CONDITION EVALUATION DATA

Other G-U Cancers
Interview airman
when treatment was
completed more than
5 years ago and there is
no history of metastatic
disease. (If less than 5
years, see below.)
DISPOSITION
Other G-U cancers

when treatment was
completed less than 5
years ago or for which
there is a history of
metastatic disease
Requires FAA decision
Submit a current
status report, all
pertinent medical
reports to include
staging, metastatic
work up, and
operative report if
applicable.
Currently cancer-free and released from

oncology care Issue and warn for
recurrence
Summarize in Block 60
All others see below
Nephritis
All Classes
DISEASE/CONDITION
Polycystic Kidney
Disease

medical information
and status report
Pyelitis or
Pyelonephritis

medical information
and status report
medical information
and status report
Pyonephrosis
If renal function is normal and no hypertension

- Issue
If asymptomatic
- Issue
118

____________________________________________________________________
Urinary Systems
All Classes
Updated 9/30/15
DISEASE/CONDITION EVALUATION DATA
DISPOSITION
Hydronephrosis with
impaired renal function

information and status report
Nephrectomy
(non-neoplastic)

information and status report
If the remaining kidney function and

anatomy is normal, without other
system disease, hypertension,
uremia, or infection of the remaining
kidney Issue
Hematuria

information and status report.
If no underlying condition found after

urology evaluation Issue and
submit evaluation to the FAA
If underlying cause found, see that
section.
Proteinuria and
Glycosuria

records; current status to
include names and dosage of
medication(s) and side effects
Trace or 1+ protein
and glucose intolerance ruled out
- Issue
119

____________________________________________________________________
ITEMS 42-43. Musculoskeletal
NORMAL
ABNORMAL
42. Upper and lower extremities (Strength and range of motion)

43. Spine, other musculoskeletal

All Classes: 14 CFR 67.113 (b)(c), 67.213 (b)(c), and 67.313 (b)(c)
relating to the condition involved finds (1) Makes the person unable to safely perform the duties or exercise the
Standard examination procedures should be used to make a gross evaluation of the integrity of the
applicant's musculoskeletal system. The Examiner should note:
1. Pain - neuralgia, myalgia, paresthesia, and related circulatory and neurological findings
2. Weakness - local or generalized; degree and amount of functional loss
3. Paralysis - atrophy, contractures, and related dysfunctions
120

____________________________________________________________________
4. Motion coordination, tremors, loss or restriction of joint motions, and performance
degradation
5. Deformity - extent and cause
6. Amputation - level, stump healing, and phantom pain
7. Prostheses - comfort and ability to use effectively
121

____________________________________________________________________
ITEM 42. Upper and Lower Extremities
DISEASE/CONDITION
CLASS
Upper and Lower Extremities

Amputations
All
Atrophy of any muscles

that is progressive,
Deformities, either
congenital or acquired,
or
Limitation of motion of a
major joint, that are
sufficient to interfere
with the performance
of airman duties
All
Submit a current
status report to
include functional
status (degree of
impairment as
measured by
strength, range of
motion, pain),
medications with side
effects and all
pertinent medical
reports
Submit a current
status report to
include functional
status (degree of
impairment as
measured by
strength, range of
motion, pain),
medication with side
effects, and all
pertinent medical
reports
If applicant has a
SODA issued on the
basis of the amputation
- Issue
FAA Decision
After review of all
medical data, the
FAA may authorize a
special medical
flight test
122

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Upper and Lower Extremities

Neuralgia or Neuropathy,
chronic or acute,
particularly sciatica, if
sufficient to interfere
with function or is likely
to become
incapacitating
All
Osteomyelitis, acute or
chronic, with or without
draining fistula(e)
All
Tremors, if sufficient to
interfere with the
performance of airman
duties 1
All
Submit a current status

report to include functional
status (degree of
impairment as measured
by strength, range of
motion, pain), medications
with side effects and all
pertinent medical reports
status (degree of
status (degree of
For all the above conditions: If the applicant is otherwise qualified, the FAA may issue a limited certificate.
This certificate will permit the applicant to proceed with flight training until ready for a MFT. At that time, at
the applicant's request, the FAA (usually the AMCD) will authorize the student pilot to take a MFT in
conjunction with the regular flight test. The MFT and regular private pilot flight test are conducted by an
FAA inspector. This affords the student an opportunity to demonstrate the ability to control the aircraft
despite the handicap. The FAA inspector prepares a written report and indicates whether there is a safety
problem. If the airman successfully completes the MFT, a medical certificate and SODA will be sent to the
airman from AMCD.
When prostheses are used or additional control devices are installed in an aircraft to assist the amputee,
those found qualified by special certification procedures will have their certificates limited to require that the
devices (and, if necessary, even the specific aircraft) must always be used when exercising the privileges of
the airman certificate.
Essential tremor is not disqualifying unless it is disabling.
123

____________________________________________________________________
Item 43. Spine, Other Musculoskeletal
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Arthritis
Osteoarthritis and variants
on PRN NSAIDS only
All
Osteoarthritis,
Rheumatoid Arthritis, and
variants on medications
other than NSAIDS
All
Symptoms are well

controlled with no
persistent daily
symptoms and no
functional limitations
report to include
functional status (degree
of impairment as
measured by strength,
range of motion, pain),
effects and all pertinent
medical reports
Issue warn for

changes in condition or
additional medications
use
Follow the CACI Arthritis Worksheet. If
airman meets all
Issue.
Decision. Submit all
evaluation data.
Initial Special
Issuance - Requires
FAA Decision
Followup
124

____________________________________________________________________
CACI - Arthritis Worksheet (Updated 4/29/15)

each required exam.
AME MUST REVIEW

recommended
[ ] Yes
Symptoms
[ ] None or mild to moderate symptoms with no significant

limitations to range of motion, lifestyle, or activities
Cause of Arthritis
Acceptable causes are limited to:

[ ] Rheumatoid (limited to joint), psoriatic, or osteoarthritis
Acceptable Medications
[ ] One or more of the following:

Oral steroid which does not exceed equivalent of prednisone
20 mg/day (see steroid conversion calculator), Methotrexate,
hydroxychloroquine (Plaquenil - see mandatory eye evaluation
requirement below), NSAIDS.
Complete blood count (CBC) and

complete metabolic panel
[ ] Within 90 days
[ ] Normal CBC, Liver Function Test, and Creatinine
FAA Report of Eye Evaluation
[ ] 8500-7 Favorable and no concerns
Form 8500-7 is required if

hydroxychloroquine (Plaquenil) is
used.
[ ] N/A

[ ] CACI qualified arthritis. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified arthritis. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified arthritis. I have deferred. (Submit supporting documents.)
125

____________________________________________________________________
Gout and Pseudogout

All Classes
Updated 4/29/2015
DISEASE/CONDITION
EVALUATION DATA
Gout
Pseudogout
Interview and examination reveal:

No persistent symptoms or functional
impairment.
Well controlled
DISPOSITION
ISSUE
Note findings in
Block 60.
Med combinations of NSAIDS, uric

acid reducers (allopurinol, etc.), or uric
acid excreters (probenecid) with no
aeromedically significant side effects.
Gout
Pseudogout
Submit a current status report that

addresses:
Functional impairment
Joint deformity
Kidney stones, recurrent
Meds other than above
Not controlled
Persistent symptoms
Clinical course with severity and

frequency of exacerbations to include
interval between and date of most
recent flare; extent of renal
involvement; current treatment, side
effects, and prognosis; and
DEFER
Submit records to
the FAA for
decision
Follow upper
SI/AASI
Describe extent of joint deformity or

functional impairment and if it would
impair operation of aircraft controls.
126

____________________________________________________________________
DISEASE/CONDITION
CLASS
Collagen Disease
Acute Polymyositis;
Dermatomyositis;
Lupus Erythematosus; or
Periarteritis Nodosa
ALL
Submit a current
status report to
include functional
status, frequency and
severity of episodes,
organ systems
effected, medications
with side effects and
all pertinent medical
reports
Spine, other musculoskeletal

Active disease of bones
and joints
Ankylosis, curvature, or
other marked
deformity of the spinal
column sufficient to
interfere with the
duties
Submit a current
status report to
include functional
status (degree of
impairment as
measured by
strength, range of
motion, pain),
effects and all
pertinent medical
reports
Submit a current
status report to
include functional
status (degree of
impairment as
measured by
strength, range of
motion, pain),
effects and all
pertinent medical
reports
127

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION

Intervertebral Disc
Surgery
Musculoskeletal effects
of:
Cerebral Palsy,
Muscular Dystrophy
Myasthenia Gravis, or
Myopathies
All
See Footnote
See Footnote
All
Submit a current
status report to
include functional
status (degree of
impairment as
measured by
strength, range of
motion, pain),
effects and all
pertinent medical
reports
Submit a current
status report to
include functional
status (degree of
impairment as
measured by
strength, range of
motion, pain),
effects and all
pertinent medical
reports
Other disturbances of
All
musculoskeletal
function, acquired or
congenital, sufficient to
interfere with the
duties or likely to
progress to that
degree
A history of intervertebral disc surgery is not disqualifying. If the applicant is asymptomatic, has
completely recovered from surgery, is taking no medication, and has suffered no neurological
deficit, the Examiner should confirm these facts in a brief statement in Item 60. The Examiner may
then issue any class of medical certificate, providing that the individual meets all the medical
standards for that class.
The paraplegic whose paralysis is not the result of a progressive disease process is considered in
much the same manner as an amputee. The Examiner should defer issuance and may advise the
applicant to request a Medical Flight Test.
Other neuromuscular conditions are covered in more detail in Item 46.
128

____________________________________________________________________
DISEASE/CONDITION
CLASS

Symptomatic herniation
of intervertebral disc
All
Submit a current
status report to
include functional
status (degree of
impairment as
measured by
strength, range of
motion, pain),
effects and all
pertinent medical
reports
129

____________________________________________________________________
ITEM 44. Identifying Body Marks, Scars, Tattoos
NORMAL
ABNORMAL
44. Identifying body marks, scars, tattoos (Size and location)

All Classes: 14 CFR 67.113(b), 67.213(b), and 67.313(b)
relating to the condition finds(1) Makes the person unable to safely perform the duties or exercise the
duties or exercise those privileges
A careful examination for surgical and other scars should be made, and those that are significant
(the result of surgery or that could be useful as identifying marks) should be described. Tattoos
should be recorded because they may be useful for identification.
130

____________________________________________________________________
The Examiner should question the applicant about any surgical scars that have not been previously
addressed, and document the findings in Item 60 of FAA Form 8500-8. Medical certificates must
not be issued to applicants with medical conditions that require deferral without consulting the
AMCD or RFS. Medical documentation must be submitted for any condition in order to support an
issuance of a medical certificate.
Disqualifying Condition: Scar tissue that involves the loss of function, which may interfere with the
safe performance of airman duties.
ITEM 45. Lymphatics
NORMAL
ABNORMAL
45. Lymphatics

131

____________________________________________________________________
A careful examination of the Iymphatic system may reveal underlying systemic disorders of clinical
importance. Further history should be obtained as needed to explain findings.
EVALUATION DATA
DISPOSITION
Lymphoma and Hodgkin's Disease

Lymphoma and
Hodgkin's Disease
All
Submit a current
status report and all
pertinent medical
reports. Include past
and present
treatment(s).
Initial Special
Issuance - Requires
FAA Decision
Followup
Leukemia, Acute and Chronic

Leukemia, Acute and
Chronic All Types
All
Chronic Lymphocytic
Leukemia
All
Submit a current
pertinent medical
reports
Submit a current
pertinent medical
reports
Initial Special
Issuance - Requires
FAA Decision
Followup
132

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Lymphatics
Adenopathy secondary
to Systemic Disease
or Metastasis
All
Lymphedema
All
Lymphosarcoma
All
Submit a current
pertinent medical
reports
Submit a current
pertinent medical
reports. Note if there
are any motion
restrictions of the
involved extremity
Submit a current
pertinent medical
reports. Include past
and present
treatment(s).
ITEM 46. Neurologic

NORMAL
ABNORMAL
46. NEUROLOGIC

All Classes: 14 CFR 67.109 (a)(b), 67.209 (a)(b), and 67.309 (a)(b)
(1) Epilepsy
(2) A disturbance of consciousness without satisfactory medical explanation
of the cause; or
(3) A transient loss of control of nervous system function(s) without
satisfactory medical explanation of the cause;
(b) No other seizure disorder, disturbance of consciousness, or neurologic condition
133

____________________________________________________________________
that the Federal Air Surgeon, based on the case history and appropriate, qualified medical
judgment relating to the condition involved, finds(1) Makes the person unable to safely perform the duties or exercise the
A neurologic evaluation should consist of a thorough review of the applicant's history prior to the
neurological examination. The Examiner should specifically inquire concerning a history of
weakness or paralysis, disturbance of sensation, loss of coordination, or loss of bowel or bladder
control. Certain laboratory studies, such as scans and imaging procedures of the head or spine,
electroencephalograms, or spinal paracentesis may suggest significant medical history. The
Examiner should note conditions identified in Item 60 on the application with facts, such as dates,
frequency, and severity of occurrence.
A history of simple headaches without sequela is not disqualifying. Some require only temporary
disqualification during periods when the headaches are likely to occur or require treatment. Other
types of headaches may preclude certification by the Examiner and require special evaluation and
consideration (e.g., migraine and cluster headaches).
One or two episodes of dizziness or even fainting may not be disqualifying. For example, dizziness
upon suddenly arising when ill is not a true dysfunction. Likewise, the orthostatic faint associated
with moderate anemia is no threat to aviation safety as long as the individual is temporarily
disqualified until the anemia is corrected.
An unexplained disturbance of consciousness is disqualifying under the medical standards.
Because a disturbance of consciousness may be expected to be totally incapacitating, individuals
with such histories pose a high risk to safety and must be denied or deferred by the Examiner. If
the cause of the disturbance is explained and a loss of consciousness is not likely to recur, then
medical certification may be possible.
The basic neurological examination consists of an examination of the 12 cranial nerves, motor
strength, superficial reflexes, deep tendon reflexes, sensation, coordination, mental status, and
includes the Babinski reflex and Romberg sign. The Examiner should be aware of any asymmetry
in responses because this may be evidence of mild or early abnormalities. The Examiner should
evaluate the visual field by direct confrontation or, preferably, by one of the perimetry procedures,
especially if there is a suggestion of neurological deficiency.
134

____________________________________________________________________
A history or the presence of any neurological condition or disease that potentially may incapacitate
an individual should be regarded as initially disqualifying. Issuance of a medical certificate to an
applicant in such cases should be denied or defer, pending further evaluation. A convalescence
period following illness or injury may be advisable to permit adequate stabilization of an individual's
condition and to reduce the risk of an adverse event. Applications from individuals with potentially
disqualifying conditions should be forwarded to the AMCD. Processing such applications can be
expedited by including hospital records, consultation reports, and appropriate laboratory and
imaging studies, if available. Symptoms or disturbances that are secondary to the underlying
condition and that may be acutely incapacitating include pain, weakness, vertigo or in coordination,
seizures or a disturbance of consciousness, visual disturbance, or mental confusion. Chronic
conditions may be incompatible with safety in aircraft operation because of long-term
unpredictability, severe neurologic deficit, or psychological impairment.
DISEASE/CONDITION
CLASS
EVALUATION DATA
Cerebrovascular Disease
Transient Ischemic Attack
(TIA):
All
DISPOSITION
(including the brain stem) 1
All pertinent inpatient and

outpatient medical
records, including work up
for any correctable
underlying cause(s)
Current neurologic
evaluation by a
neurologist with a detailed
written report addressing
motor, sensory, language,
and intellectual/cognitive
function; all medications
(dosage and side effects)
MRA or CTA of the head
and neck
Current FBS and lipids
Carotid artery ultrasound
studies
Cardiovascular Evaluation
Complete neurological evaluations supplemented with appropriate laboratory and imaging studies are required of
applicants with these conditions.
135

____________________________________________________________________
Completed Stroke (ischemic

or hemorrhagic);
All
(CVE) with EST, a 24hour Holter monitor and

M-mode / 2-D
echocardiogram (usually
TTE but TEE optional if
clinically indicated)
Neurocognitive testing:
may be required as
clinically indicated
outpatient medical
for any correctable
underlying cause(s)
Current neurologic
evaluation by a
and intellectual/ cognitive
MRA or CTA of the head
and neck
Current FBS and lipids
Carotid artery ultrasound
studies: required for
ischemic strokes;
otherwise only if clinically
indicated
(CVE) with EST, a 24hour Holter monitor and
M-mode / 2-D
echocardiogram (usually
TTE but TEE optional if
clinically indicated)
NOTE: required for
ischemic stroke; for
hemorrhagic stroke is
required if clinically
indicated (for
example in a
hemorrhagic stroke
due to hypertension,
even if felt to be
transient
hypertension)
Requires FAA decision
Neurocognitive testing to
"SPECIFICATIONS FOR
136

____________________________________________________________________
Subdural, Epidural or
Subarachnoid Hemorrhage
All
NEUROPSYCHOLOGICAL EVALUATIONS
FOR POTENTIAL
NEUROCOGNITIVE
IMPAIRMENT" required
for all strokes
**** For hemorrhagic
strokes, the bleeding must
be resolved as
documented by CT or
MRI
outpatient medical
for any correctable
underlying cause(s)
Current neurologic
evaluation by a
and intellectual/ cognitive
CT or MRI of the head
Additional testing such
as EEG,
neurocognitive testing,
etc., may be required
as clinically indicated
Requires FAA Decison
137

____________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Cerebrovascular Disease
Intracranial Aneurysm
or Arteriovenous
Malformation
All
Intracranial Tumor2
All
Pseudotumor Cerebri
(benign intracranial
hypertension)
All

medical records, current
neurologic report, name
and dosage of
medication(s) and side
effects
and dosage of
effects
and dosage of
effects
A variety of intracranial tumors, both malignant and benign, are capable of causing incapacitation directly by
neurologic deficit or indirectly through recurrent symptomatology. Potential neurologic deficits include weakness, loss
of sensation, ataxia, visual deficit, or mental impairment. Recurrent symptomatology may interfere with flight
performance through mechanisms such as seizure, headaches, vertigo, visual disturbances, or confusion. A history or
diagnosis of an intracranial tumor necessitates a complete neurological evaluation with appropriate laboratory and
imaging studies before a determination of eligibility for medical certification can be established. An applicant with a
History of benign supratentorial tumors may be considered favorably for medical certification by the FAA and returned
to flying status after a minimum satisfactory convalescence of 1 year.
138

____________________________________________________________________
DISEASE/CONDITION
CLASS
Demyelinating Disease 3
Acute Optic Neuritis;
Allergic
Encephalomyelitis;
Landry-Guillain-Barre
Syndrome;
Myasthenia Gravis; or
Multiple Sclerosis
All

medical records,
current neurologic
report, to comment
on involvement and
persisting deficit,
period of stability
without symptoms,
name and dosage of
medication(s) and
side effects
Factors used in determining eligibility will include the medical history, neurological involvement and persisting deficit,
period of stability without symptoms, type and dosage of medications used, and general health. A neurological and/or
general medical consultation will be necessary in most instances.
139

____________________________________________________________________
DISEASE/CONDITION
CLASS
Extrapyramidal, Hereditary, and Degenerative Diseases of the

Nervous System 4
Dystonia primary or
secondary;
Huntington's Disease;
Parkinson's Disease;
Wilson's Disease; or
Gilles de la Tourette
Syndrome;
Alzheimer's Disease;
Dementia (unspecified);
or
Slow viral diseases
i.e., Creutzfeldt
-Jakob's Disease
All
Obtain medical
records and current
neurological status,
complete
neurological
evaluation with
appropriate
laboratory and
imaging studies, as
indicated
May consider Neuropsychological testing
Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System: Considerable variability exists in the
severity of involvement, rate of progression, and treatment of the above conditions. A complete neurological
evaluation with appropriate laboratory and imaging studies, including information regarding the specific neurological
condition, will be necessary for determination of eligibility for medical certification.
140

____________________________________________________________________
DISEASE/CONDITION
CLASS
Headaches 5
Atypical Facial Pain
All
Ocular or complicated
migraine
All
Migraines, Chronic
Tension or Cluster
Headaches
All

medical records,
current neurologic
report, to include
name and dosage of
medication(s) and
side effects
medical records,
current neurologic
report, to include
characteristics,
frequency, severity,
associated with
neurologic
phenomena, name
and dosage of
medication(s) and
side effects
medical records,
current neurologic
report, to include
characteristics,
frequency, severity,
associated with
neurologic
phenomena, and
name and dosage of
medication(s) and
side effects
Follow CACI - Migraine

and Chronic Headache
Worksheet. If airman
meets all certification
criteria Issue.
evaluation data.
Initial Special
Issuance - Requires
FAA Decision
Followup Special
Protocol
Pain, in some conditions, may be acutely incapacitating. Chronic recurring headaches or pain syndromes often
require medication for relief or prophylaxis, and, in most instances, the use of such medications are disqualifying
because they may interfere with a pilot's alertness and functioning. The Examiner may issue a medical certificate to an
applicant with a long-standing history of headaches if mild, seldom requiring more than simple analgesics, occur
infrequently, are not incapacitating, and are not associated with neurological stigmata.
141

____________________________________________________________________
Post-traumatic Headache All
medical records,
current neurologic
report, name and
dosage of
medication(s) and
side effects
142

____________________________________________________________________
CACI - Migraine and Chronic Headache Worksheet (Updated 4/29/15)

each required exam.
AME MUST REVIEW

recommended
[ ] Yes
Acceptable Types of Migraine or

Headache
[ ] Classic/Common Migraine, Chronic Tension headache, Cluster

headache
Frequency
NOT acceptable: Ocular migraine, complicated migraine

[ ] No more than one episode per month
Symptoms
[ ] Only mild symptoms controlled with medication(s) listed below.

[ ] In the last year:
o no in-patient hospitalizations
o no more than 2 outpatient clinic/urgent care visits for
exacerbations (with symptoms fully resolved)
Medications - Preventive
Medications - Abortive
NOT acceptable: neurological or TIA-type symptoms; vertigo;

syncope; and/or mental status change
[ ] None; or daily calcium channel blockers or beta blockers only
for prophylaxis without side effects
[ ] OTC headache medications; warn airman:
24 hour no-fly - Triptans
36 hour no-fly - Metoclopramide (Reglan);
96 hour no-fly - promethazine (Phenergan)
NOT acceptable: Injectable medications and narcotics

[ ] CACI qualified migraine and chronic headaches. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified migraine and chronic headaches. Issued per valid SI/AASI. (Submit supporting
documents.)
[ ] NOT CACI qualified migraine and chronic headaches. I have deferred. (Submit supporting documents.)
143

____________________________________________________________________
DISEASE/CONDITION
CLASS
Hydrocephalus and Shunts

Hydrocephalus,
secondary to a known
injury or disease
process; or normal
pressure
All

medical records,
current neurologic
report, to include
name and dosage of
medication(s) and
side effects
Infections of the Nervous System

Brain Abscess;
Encephalitis;
All
Meningitis; and
Neurosyphilis
Complete
neurological
evaluation with
appropriate
laboratory and
imaging studies
Neurologic Conditions
A disturbance of
consciousness without
satisfactory medical
explanation of the cause
All
Epilepsy6
All
Rolandic Seizure
*See below

medical records,
current neurologic
report, to include
name and dosage of
medication(s) and
side effects
medical records,
to include name and
dosage of
medication(s) and
side effects
Unexplained syncope, single seizure. An applicant who has a history of epilepsy, a disturbance of consciousness
without satisfactory medical explanation of the cause, or a transient loss of control of nervous system function(s)
without satisfactory medical explanation of the cause must be denied or deferred by the Examiner. Rolandic seizures
may be eligible for certification if the applicant is seizure free for 4 years and has a normal EEG. Consultation with the
FAA required.
144

____________________________________________________________________
DISEASE/CONDITION
Febrile Seizure 7
(Single episode)
CLASS
All
Transient loss of nervous All

system function(s)
without satisfactory
medical explanation of
the cause; e.g., transient
global amnesia
EVALUATION DATA
medical records and
a current status
report

medical records,
to include name and
dosage of
medication(s) and
side effects
DISPOSITION
If occurred prior to age
5, without recurrence
and off medications for
3 years - Issue
Otherwise Requires
FAA Decision
Other Conditions
Neurofibromatosis with
Central Nervous
System Involvement
All

medical information
and current status
medical report
Infrequently, the FAA has granted an Authorization under the special issuance section of part 67 (14 CFR 67.401)
when a seizure disorder was present in childhood but the individual has been seizure-free for a number of years.
Factors that would be considered in determining eligibility in such cases would be age at onset, nature and frequency
of seizures, precipitating causes, and duration of stability without medication. Followup evaluations are usually
necessary to confirm continued stability of an individual's condition if an Authorization is granted under the special
issuance section of part 67 (14 CFR 67.401).
145

____________________________________________________________________
Trigeminal Neuralgia
All
medical records,
current neurologic
report, name and
dosage of
medication(s) and
side effects
DISEASE/CONDITION
CLASS
Presence of any neurological condition or disease

that potentially may incapacitate an individual
Head Trauma associated
with:
Epidural or Subdural
Hematoma;
Focal Neurologic Deficit;
Depressed Skull
Fracture;
or
All

medical records,
to include prehospital and
emergency
department records,
operative reports,
neurosurgical
evaluation, name and
dosage of
medication(s) and
side effects
Any loss of
consciousness, alteration
of consciousness, or
amnesia, regardless of
duration
146

____________________________________________________________________
DISEASE/CONDITION
CLASS
Spasticity, Weakness, or Paralysis of the Extremities

Conditions that are
stable and nonprogressive may
be considered for
medical certification
All

medical records,
current neurologic
report, to include
etiology, degree of
involvement, period
of stability,
appropriate
laboratory and
imaging studies
DISEASE/CONDITION
CLASS
Vertigo or Disequilibrium8
Alternobaric Vertigo;
Hyperventilation
Syndrome;
Meniere's Disease and
Acute Peripheral
Vestibulopathy;
All

medical records,
current neurologic
report, name and
dosage of
medication(s) and
side effects
Nonfunctioning
Labyrinths; or
Orthostatic
Hypotension
Numerous conditions may affect equilibrium, resulting in acute incapacitation or varying degrees of chronic recurring
spatial disorientation. Prophylactic use of medications also may cause recurring spatial disorientation and affect pilot
performance. In most instances, further neurological evaluation will be required to determine eligibility for medical
certification.
147

____________________________________________________________________
ITEM 47. Psychiatric
NORMAL
ABNORMAL
47. Psychiatric (Appearance, behavior, mood, communication, and memory)

All Classes: 14 CFR 67.107(a)(b)(c), 67.207(a)(b)(c), and 67.307(a)(b)(c)
(1) A personality disorder that is severe enough to have repeatedly manifested
itself by overt acts.
(2) A psychosis. As used in this section, "psychosis" refers to a mental disorder
in which:
(i) The individual has manifested delusions, hallucinations, grossly bizarre or
disorganized behavior, or other commonly accepted symptoms of this condition; or
(ii) The individual may reasonably be expected to manifest delusions,
hallucinations, grossly bizarre or disorganized behavior, or other commonly accepted
symptoms of this condition.
(3) A bipolar disorder.
(4) Substance dependence, except where there is established clinical evidence,
satisfactory to the Federal Air Surgeon, of recovery, including sustained total abstinence
from the substance(s) for not less than the preceding 2 years. As used in this section (i) "Substance" includes: alcohol; other sedatives and hypnotics; anxiolytics;
opioids; central nervous system stimulants such as cocaine, amphetamines, and
similarly acting sympathomimetics; hallucinogens; phencyclidine or similarly acting
arylcyclohexylamines; cannabis; inhalants; and other psychoactive drugs and
chemicals; and
(ii) "Substance dependence" means a condition in which a person is
dependent on a substance, other than tobacco or ordinary xanthine-containing (e.g.,
caffeine) beverages, as evidenced by(A) Increased tolerance
(B) Manifestation of withdrawal symptoms;
(C) Impaired control of use; or
(D) Continued use despite damage to physical health or impairment of
social, personal, or occupational functioning.
148

____________________________________________________________________
(b) No substance abuse within the preceding 2 years defined as:
(1) Use of a substance in a situation in which that use was physically hazardous,
if there has been at any other time an instance of the use of a substance also in a
situation in which that use was physically hazardous;
(2) A verified positive drug test result, an alcohol test result of 0.04 or greater
alcohol concentration, or a refusal to submit to a drug or alcohol test required by the U.S.
Department of Transportation or an agency of the U.S. Department of Transportation; or
(3) Misuse of a substance that the Federal Air Surgeon, based on case history
and appropriate, qualified medical judgment relating to the substance involved, finds(i) Makes the person unable to safely perform the duties or exercise the
(ii) May reasonably be expected, for the maximum duration of the airman
(c) No other personality disorder, neurosis, or other mental condition that the Federal
Air Surgeon, based on the case history and appropriate, qualified medical judgment relating
to the condition involved, finds(1) Makes the person unable to safely perform the duties or exercise the
medical certificate applied for or held, to make the person unable to perform
those duties or exercise those privileges.
(Also see Items 18.m., 18.n., and 18.p.)
The FAA does not expect the Examiner to perform a formal psychiatric examination. However, the
Examiner should form a general impression of the emotional stability and mental state of the
applicant. There is a need for discretion in the Examiner/applicant relationship consonant with the
FAA's aviation safety mission and the concerns of all applicants regarding disclosure to a public
agency of sensitive information that may not be pertinent to aviation safety. Examiners must be
sensitive to this need while, at the same time, collect what is necessary for a certification decision.
When a question arises, the Federal Air Surgeon encourages Examiners first to check this Guide
for Aviation Medical Examiners and other FAA informational documents. If the question remains
unresolved, the Examiner should seek advice from a RFS or the Manager of the AMCD.
Review of the applicant's history as provided on the application form may alert the Examiner to
gather further important factual information. Information about the applicant may be found in items
149

____________________________________________________________________
related to age, pilot time, and class of certificate for which applied. Information about the present
occupation and employer also may be helpful. If any psychotropic drugs are or have been used,
followup questions are appropriate. Previous medical denials or aircraft accidents may be related
to psychiatric problems.
Psychiatric information can be derived from the individual items in medical history (Item 18). Any
affirmative answers to Item 18.m., Mental disorders of any sort; depression, anxiety, etc.," or
Item 18.p., "Suicide attempt," are significant. Any disclosure of current or previous alcohol or drug
problems requires further clarification. A record of traffic violations may reflect certain personality
problems or indicate an alcohol problem. Affirmative answers related to rejection by military
service or a military medical discharge require elaboration. Reporting symptoms such as
headaches or dizziness, or even heart or stomach trouble, may reflect a history of anxiety rather
than a primary medical problem in these areas. Sometimes, the information applicants give about
their previous diagnoses is incorrect, either because the applicant is unsure of the correct
information or because the applicant chooses to minimize past difficulties. If there was a hospital
admission for any emotionally related problem, it will be necessary to obtain the entire record.
Valuable information can be derived from the casual conversation that occurs during the physical
examination. Some of this conversation will reveal information about the family, the job, and
special interests. Even some personal troubles may be revealed at this time. The Examiner's
questions should not be stilted or follow a regular pattern; instead, they should be a natural
extension of the Examiner's curiosity about the person being examined. Information about the
motivation for medical certification and interest in flying may be revealing. A formal Mental Status
Examination is unnecessary. For example, it is not necessary to ask about time, place, or person
to discover whether the applicant is oriented. Information about the flow of associations, mood, and
memory, is generally available from the usual interactions during the examination. Indication of
cognitive problems may become apparent during the examination. Such problems with
concentration, attention, or confusion during the examination or slower, vague responses should
be noted and may be cause for deferral.
The Examiner should make observations about the following specific elements and should note on
the form any gross or notable deviations from normal:
1. Appearance (abnormal if dirty, disheveled, odoriferous, or unkempt);
2. Behavior (abnormal if uncooperative, bizarre, or inexplicable);
3. Mood (abnormal if excessively angry, sad, euphoric, or labile);
4. Communication (abnormal if incomprehensible, does not answer questions directly);
5. Memory (abnormal if unable to recall recent events); and
6. Cognition (abnormal if unable to engage in abstract thought, or if delusional or
hallucinating).
150

____________________________________________________________________
Significant observations during this part of the medical examination should be recorded in Item 60,
of the application form. The Examiner, upon identifying any significant problems, should defer
issuance of the medical certificate and report findings to the FAA. This could be accomplished by
contacting a RFS or the Manager of the AMCD.
A. General Considerations. It must be pointed out that considerations for safety, which in the
"mental" area are related to a compromise of judgment and emotional control or to diminished
mental capacity with loss of behavioral control, are not the same as concerns for emotional health
in everyday life. Some problems may have only a slight impact on an individual's overall capacities
and the quality of life but may nevertheless have a great impact on safety. Conversely, many
emotional problems that are of therapeutic and clinical concern have no impact on safety.
B. Denials. The FAA has concluded that certain psychiatric conditions are such that their presence
or a past history of their presence is sufficient to suggest a significant potential threat to aviation
safety. It is, therefore, incumbent upon the Examiner to be aware of any indications of these
conditions currently or in the past, and to deny or defer issuance of the medical certificate to an
applicant who has a history of these conditions. An applicant who has a current diagnosis or
history of these conditions may request the FAA to grant an Authorization under the special
issuance section of part 67 (14 CFR 67.401) and, based upon individual considerations, the FAA
may grant such an issuance.
All applicants with any of the following conditions must be denied or deferred:
Attention deficit/hyperactivity, bipolar disorder, personality disorder, psychosis,
substance abuse, substance dependence, suicide attempt.
In some instances, the following conditions may also warrant denial or deferral:
Adjustment disorder; bereavement; dysthymic; or minor depression; use of psychotropic
medications for smoking cessation
For evaluation guidance, see specification sheets in Substances of Dependence/Abuse
(Drugs and Alcohol) Disease Protocols.
NOTE: The use of a psychotropic drug is disqualifying for aeromedical certification purposes.
This includes all sedatives, tranquilizers, antipsychotic drugs, antidepressant drugs (including
SSRIs -see exceptions below), analeptics, anxiolytics, and hallucinogens. The Examiner
should defer issuance and forward the medical records to the AMCD.
C. Use of Antidepressant Medications. The FAA has determined that airmen requesting first,
second, or third class medical certificates while being treated with one of four specific selective
serotonin reuptake inhibitors (SSRIs) may be considered. The Authorization decision is made on
a case-by-case basis. The Examiner may not issue.
If the applicant opts to discontinue use of the SSRI, the Examiner must notate in Block 60,
Comments on History and Findings, on FAA Form 8500-8 and defer issuance. To reapply for
151

____________________________________________________________________
regular issuance, the applicant must be off the SSRI for a minimum of 60 days with a favorable
report from the treating physician indicating stable mood and no aeromedically significant side
effects. See SSRI Decision Path I
An applicant may be considered for an FAA Authorization of a Special Issuance (SI) of a
Medical Certificate (Authorization) if:
1.) The applicant has one of the following diagnoses:
Major depressive disorder (mild to moderate) either single episode or recurrent episode
Dysthymic disorder
Adjustment disorder with depressed mood
Any non-depression related condition for which the SSRI is used
2.) For a minimum of 6 continuous months prior, the applicant has been clinically stable
as well as on a stable dose of medication without any aeromedically significant side
effects and/or an increase in symptoms. If the applicant has been on the medication under
6 months, the Examiner must advise that 6 months of continuous use is required before SI
consideration.
3.) The SSRI used is one the following (single use only):
Fluoxetine (Prozac)
Sertraline (Zoloft)
Citalopram (Celexa)
Escialopram (Lexapro)
If the applicant is on a SSRI that is not listed above, the Examiner must advise that the
medication is not acceptable for SI consideration.
4.) The applicant DOES NOT have symptoms or history of:
Psychosis
Suicidal ideation
Electro convulsive therapy
Treatment with multiple SSRIs concurrently
Multi-agent drug protocol use (prior use of other psychiatric drugs in conjunction with
SSRIs.)
If applicant meets the all of the above criteria and wishes to continue use of the SSRI, advise
the applicant that he/she must be further evaluated by a Human Intervention Motivation Study
(HIMS) AME. See SSRI Decision Path II (HIMS AME). The HIMS AME will also conduct the
follow up evaluation after initial issuance. See SSRI Follow Up Path , SSRI Specification
Sheet, and Disease Protocols, Depression Treated with SSRI Medications.
152

____________________________________________________________________
153

____________________________________________________________________
SSRI Decision Path II (HIMS AME)

Airman is on:
Airman must
contact HIMS AME
Fluoxetine (Prozac)
or
Escitalopram (Lexapro)
or
Sertraline (Zoloft)
or
Citalopram (Celexa)
On SSRI more
than 6 months?
Yes
Nature of underlying
diagnosis and the treatment
Currently on multiple
psychiatric medications
and/or
history of unacceptable
diagnosis or symptoms
No
Advise must be on SSRI at least

6 months, with a stable dosage,
before SI consideration
If airman elects to discontinue
use of SSRI at this point, see
SSRI Decision Path I
Advise NOT Acceptable

Defer
Forward all material and
exam to AMCD for FAA
decision
Acceptable diagnosis
and treatment
Airman MUST provide

statement, evaluation
reports, records, tests,
and letters as outlined
PER SPECIFICATION SHEET
HIMS AME to:

Review all material, conduct detailed evaluation,
make recommendation regarding SI, agree to
continued monitoring per FAA Policy. Defer and
Send package to AMCD for review
FAA Decision
154

____________________________________________________________________
155

____________________________________________________________________
SPECIFICATIONS SSRI
The following items must be submitted:
1. A written statement from you and in your own words describing your history of
antidepressant usage and mental health status.
2. Medical/treatment records related to your history of antidepressant usage from the date
you began treatment to the present.
3. A current detailed evaluation report from your treating/prescribing physician attesting to
and describing your diagnoses, the length and course of treatment, the dosage of the
antidepressant medication taken, and the presence of any side effects experienced
from the antidepressant you currently take and/or that you have taken in the past.
4. If your treating physician is not a board certified psychiatrist, a current detailed
evaluation by a board certified psychiatrist regarding your psychiatric and behavioral
status is required. The psychiatrist must document that he/she has reviewed your
personal written statement, all of your treatment/medical records, and the current
evaluation by your treating/prescribing physician.
5. A neuropsychologists report (following FAAs Specifications Neuropsychological
Evaluations for Treatment with SSRI Medications) with the report of the results of a
CogScreen - Aeromedical Edition (AE) neurocognitive psychological test, including a
copy of the test computer score reports. For more information on the specifications, see
Disease Protocols, Depression Treated with SSRI Medications at:
http://www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/ame/guide/de
c_cons/disease_prot/
6. If you have held a first- or second-class airman medical certificate and have flown for a
commercial carrier within the last 2 years, obtain a letter from airline management
(Chief Pilot or designee) attesting to your competence, crew interaction and mood (if
available).
7. A detailed evaluation by your HIMS AME. The evaluation must address the following:
A statement verifying he/she has reviewed the above documents.

A current psychiatric status of the applicant.
A comment regarding a recommendation for a Special Issuance medical certificate.
The HIMS AME must include a statement agreeing to serve as your independent
medical sponsor.
course of action that should be taken by the examiner as defined by the protocol and
disposition in the table. Medical certificates must not be issued to an applicant with medical
156

____________________________________________________________________
conditions that require deferral, or for any condition not listed in the table that may result in
sudden or subtle incapacitation without consulting the AMCD or the RFS. Medical
documentation must be submitted for any condition in order to support an issuance of an
airman medical certificate.
NOTE See Disease Protocols for specifications for Neurocognitive, Psychiatric, and/or
Psychiatric and Psychological Evaluations.
EVALUATION DATA
DISPOSTION
Psychiatric Conditions
Adjustment Disorders
Attention Deficit
Disorder
All
All

clinical status report.

clinical status report to
include documenting the
period of use, name and
dosage of any
medication(s), and sideeffects. If submitting
neurocognitive test data,
the applicant must have
a drug screen for ADD
medications done within
24 hours of the
neurocognitive testing
and submit the results.
See Disease Protocols,
ADHD/ADD.
If stable, resolved, no
associated disturbance of
thought, no recurrent
episodes, and
psychotropic
medication(s) used for
less than 6 months and
discontinued for at least 3
months - Issue
Decision
157

____________________________________________________________________
EVALUATION DATA
DISPOSTION
Psychiatric Conditions
Bipolar Disorder
All
Bereavement;
All
Dysthymic; or

medical information
and clinical status
report.
Also see 3. below.
medical information
and clinical status
report.
If stable, resolved, no
associated disturbance
of thought, no recurrent
episodes, and;
Minor Depression
a). psychotropic
medication(s) used for
less than 6 months and
discontinued for at least
3 months Issue
b). No use of
psychotropic
medication(s) - Issue
Depression requiring
the use of
antidepressant
medications
All

medical information
and clinical status
report.
FAA Decision
See Use of
Antidepressant
Medication Policy and
Disease Protocols,
Depression Treated with
SSRI Medications.
Personality Disorders
All
Psychosis
All

medical information
and clinical status
report. Also see 1.
below.

medical information
and clinical status
report. Also see 2.
below.
158

____________________________________________________________________
Pyschotropic
medications for
Smoking Cessation
Substance Abuse
All
All
Document period of
use, name and
dosage of
medication(s) and
side-effects.

medical information
and clinical status
report. Also see 6.
If medication(s)
discontinued for at least
30 days and w/o sideeffects - Issue
Otherwise Requires
FAA Decision
below and Disease

Protocols - Substance
Dependence/Abuse.
Substance
Dependence
All

medical information
and clinical status
report. Also see 5.
Below and Disease

Protocols - Substance
Dependence/Abuse.
Suicide Attempt
All

medical information
required.
1. The category of personality disorders severe enough to have repeatedly manifested

itself by overt acts refers to diagnosed personality disorders that involve what is called
"acting out" behavior. These personality problems relate to poor social judgment,
impulsivity, and disregard or antagonism toward authority, especially rules and
regulations. A history of long-standing behavioral problems, whether major (criminal) or
relatively minor (truancy, military misbehavior, petty criminal and civil indiscretions, and
social instability), usually occurs with these disorders. Driving infractions and previous
failures to follow aviation regulations are critical examples of these acts.
Certain personality disorders and other mental disorders that include conditions of
limited duration and/or widely varying severity may be disqualifying. Under this
category, the FAA is especially concerned with significant depressive episodes requiring
treatment, even outpatient therapy. If these episodes have been severe enough to
cause some disruption of vocational or educational activity, or if they have required
medication or involved suicidal ideation, the application should be deferred or denied
issuance.
Some personality disorders and situational dysphorias may be considered disqualifying
for a limited time. These include such conditions as gross immaturity and some
personality disorders not involving or manifested by overt acts.
159

____________________________________________________________________
2. Psychotic Disorders are characterized by a loss of reality testing in the form of
delusions, hallucinations, or disorganized thoughts. They may be chronic, intermittent,
or occur in a single episode. They may also occur as accompanying symptoms in other
psychiatric conditions including but not limited to bipolar disorder (e.g. bipolar disorder
with psychotic features), major depression (e.g. major depression with psychotic
features), borderline personality disorder, etc. All applicants with such a diagnosis
must be denied or deferred.
3. Bipolar Disorders are considered on a continuum as part of a spectrum of disorders
where there are significant alternations in mood. Generally, only one episode of manic
or hypomanic behavior is necessary to make the diagnosis. Please note that
cyclothymic disorder is part of this spectrum. Even if the bipolar disorder does not have
accompanying symptoms that reach the level of psychosis, the disorder can be so
disruptive of judgment and functioning (especially mania) as to pose a significant risk to
aviation safety. Impaired judgment does occur even in the milder form of the disease.
All applicants with a diagnosis of Bipolar Disorder must be denied or deferred.
4. Although they may be rare in occurrence, severe anxiety problems, especially anxiety
and phobias associated with some aspect of flying, are considered significant. Organic
mental disorders that cause a cognitive defect, even if the applicant is not psychotic, are
considered disqualifying whether they are due to trauma, toxic exposure, or
arteriosclerotic or other degenerative changes.
(See Item 18.m.).
5. Substance dependence refers to the use of substances of dependence, which include
alcohol and other drugs (i.e., PCP, sedatives and hypnotics, anxiolytics, marijuana,
cocaine, opioids, amphetamines, hallucinogens, and other psychoactive drugs or
chemicals). Substance dependence is defined and specified as a disqualifying medical
condition. It is disqualifying unless there is clinical evidence, satisfactory to the Federal
Air Surgeon, of recovery, including sustained total abstinence from the substance for
not less than the preceding 2 years.
Substance dependence is evidenced by one or more of the following: increased
tolerance, manifestation of withdrawal symptoms, impaired control of use, or continued
use despite damage to physical health or impairment of social, personal, or
occupational functioning. Substance dependence is accompanied by various
deleterious effects on physical health as well as personal or social functioning. There
are many other indicators of substance dependence in the history and physical
examination. Treatment for substance dependence-related problems, arrests, including
charges of driving under the influence of drugs or alcohol, and vocational or marital
disruption related to drugs or alcohol consumption are important indicators. Alcohol on
the breath at the time of a routine physical examination should arouse a high index of
suspicion. Consumption of drugs or alcohol sufficient to cause liver damage is an
indication of the presence of alcoholism.
160

____________________________________________________________________
6. Substance abuse includes the use of the above substances under any one of the
following conditions:
a. Use of a substance in the last 2 years in which the use was physically hazardous
(e.g., DUI or DWI) if there has been at any other time an instance of the use of a
substance also in a situation in which the use was physically hazardous;
b. If a person has received a verified positive drug test result under an anti-drug
program of the Department of Transportation or one of its administrations; or
c. The Federal Air Surgeon finds that an applicant's misuse of a substance makes
him or her unable to safely perform the duties or exercise the privileges of the
airman certificate applied for or held, or that may reasonably be expected, for the
maximum duration of the airman medical certificate applied for or held, to make
the applicant unable to perform those duties or exercise those privileges.
Substance dependence and substance abuse are specified as disqualifying medical
conditions.
161

____________________________________________________________________
ITEM 48. General Systemic
NORMAL
ABNORMAL
48. General Systemic

(a) No established medical history or clinical diagnosis of diabetes mellitus that
requires insulin or any other hypoglycemic drug for control.
Federal Air Surgeon, based on the case history and appropriate, qualified medical
judgment relating to the condition involved, finds (1) Makes the person unable to safely perform the duties or exercise the
case history and appropriate, qualified medical judgment relating to the medication or
other treatment involved, finds (1) Makes the person unable to safely perform the duties or exercise the
A protocol for examinations applicable to Item 48 is not provided because the necessary
history-taking, observation, and other examination techniques used in examining other
systems have already revealed much of what can be known about the status of the applicant's
endocrine and other systems. For example, the examination of the skin alone can reveal
important signs of thyroid dysfunction, Addison's disease, Cushing's disease, and several
other endocrine disorders. The eye may reflect a thyroid disorder (exophthalmos) or diabetes
(retinopathy).
162

____________________________________________________________________
When the Examiner reaches Item 48 in the course of the examination of an applicant, it is
recommended that the Examiner take a moment to review and determine if key procedures
have been performed in conjunction with examinations made under other items, and to
determine the relevance of any positive or abnormal findings.
course of action that should be taken by the examiner as defined by the protocol and
disposition in the table. Medical certificates must not be issued to an applicant with medical
conditions that require deferral, or for any condition not listed in the table that may result in
sudden or subtle incapacitation without consulting the AMCD or the RFS. Medical
documentation must be submitted for any condition in order to support an issuance of an
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Blood and Blood-Forming Tissue Disease

Anemia
All
Hemophilia
All
Other disease of the

blood or bloodforming tissues that
could adversely affect
performance of
airman duties
Polycythemia
All
All
Submit a current
pertinent medical
reports. Include a
CBC, and any other
tests deemed
necessary
Submit a current
pertinent medical
reports. Include
frequency, severity
and location of
bleeding sites
Submit a current
pertinent medical
reports
Submit a current
pertinent medical
reports; include CBC
163

____________________________________________________________________
DISEASE/CONDITION
CLASS
Diabetes, Pre-Diabetes, Metabolic Syndrome, and/or

Insulin Resistance
Diabetes Insipidus
All

medical records;
current status to
include names and
dosage of
medication(s) and
side effects
Pre-Diabetes (Metabolic
All

medical records;
current status to
include names and
dosage of
medication(s) and
side effects
Follow the CACI - PreDiabetes Worksheet

If airman meets all
Issue.
See Diabetes
Mellitus -Diet
Controlled Protocol
If no glycosuria and
normal HbA1c Issue.
Syndrome, Impaired Fasting

Glucose, Insulin Resistance,
Glucose Elevation/Intolerance,
Polycystic Ovary Syndrome)
Diabetes Mellitus Diet

Controlled
All
See chart of Acceptable

Combinations of Diabetes
Medications
Diabetes Mellitus II Medication Controlled

(Non Insulin)
Diabetes Mellitus I & II Insulin Treated
All
All
See Diabetes
Mellitus II Medication
Controlled (non
insulin) Protocol

evaluation data.

evaluation data.
Initial Special
Issuance - Requires
FAA Decision
Followup Special
Protocol
See chart of
Acceptable
Combinations of
Diabetes Medications
See Diabetes
Mellitus I & II - Insulin
Treated Protocol
164

____________________________________________________________________
CACI - Pre-Diabetes Worksheet (Updated 11/06/15)

(Metabolic Syndrome, Impaired Fasting Glucose, Insulin Resistance,
Glucose Elevation/Intolerance, Polycystic Ovary Syndrome)
AME MUST REVIEW

recommended
[ ] Yes
Symptoms associated with

diabetes
[ ] None
Hypoglycemic events (symptoms

or glucose less than or equal to
70 mg/dl) within the past 12
months.
Fasting blood sugar
[ ] None
Current A1C
[ ] Within last 90 days

[ ]Less than or equal to 6.5 mg/dL
Oral glucose tolerance test, if

performed
[ ] Less than 200 mg/dl at 2 hours

[ ] N/A
[ ] None
[ ] Metformin only (after a 14-day trial period with no side effects)
[ ] Less than 126 mg/dl
AME MUST NOTE in Block 60 either of the following:

[ ] CACI qualified Pre-Diabetes (Metabolic Syndrome, Impaired Fasting Glucose, Insulin Resistance, Glucose
Elevation/Intolerance, Polycystic Ovary Syndrome). (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified Pre-Diabetes (Metabolic Syndrome, Impaired Fasting Glucose, Insulin Resistance, Glucose
Elevation/Intolerance, Polycystic Ovary Syndrome). Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified Pre-Diabetes ((Metabolic Syndrome, Impaired Fasting Glucose, Insulin Resistance, Glucose
Elevation/Intolerance, Polycystic Ovary Syndrome). I have deferred. (Submit supporting documents.)
165

____________________________________________________________________
DISEASE/CONDITION
CLASS
Endocrine Disorders
Acromegaly
All
Addison's Disease
All
Cushing's Disease or
Syndrome
All
Hypoglycemia, whether
functional or a result of
pancreatic tumor
All
Hyperparathyroidism
All
Hypoparathyroidism
All

medical records;
current status to
include names and
dosage of
effects
medical records;
current status to
include names and
dosage of
effects
medical records;
current status to
include names and
dosage of
effects
medical records;
current status to
include names and
dosage of
effects
medical records;
current status;include
names and dosage of
effects, and current
serum calcium and
phosphorus levels
medical records;
current status; include
names and dosage of
effects and current
serum calcium and
phosphorus levels
If status post-surgery,
disease controlled, stable
and no sequela
- Issue
FAA Decision
166

____________________________________________________________________
DISEASE/CONDITION
CLASS
Endocrine Disorders
Hyperthyroidism
All
Hypothyroidism
All

medical records;
current status to
include names and
dosage of
medication(s) and
side effects and
current TFTs
medical records;
current status to
include names and
dosage of
medication(s) and
side effects and
current TFTs
Initial Special
Issuance Requires
FAA Decision
Followup Special
Issuances See AASI
Protocol
Follow the CACI Hypothyroidism
Worksheet.
If
airman meets all
Issue.
evaluation data.
Initial Special
Issuance Requires
FAA Decision
Proteinuria & Glycosuria
All

medical records;
current status to
include names and
dosage of
medication(s) and
side effects
Followup Special
Issuances See AASI
Protocol
Trace or 1+ protein
and glucose
intolerance ruled out
- Issue
FAA Decision
167

____________________________________________________________________
CACI - Hypothyroidism Worksheet (Updated 07/29/15)

AME MUST REVIEW

recommended
[ ] Yes
Symptoms and signs
[ ] None of the following: fatigue, mental status impairment, or

symptoms related to pulmonary, cardiac, or visual systems
Acceptable medications
[ ] Levothyroxine sodium (Synthroid, Levothyroid), porcine thyroid

(Armour), liothyronine sodium (Cytomel), or liotrix (Thyrolar)
Normal TSH within the last one

year
[ ] Yes

[ ] CACI qualified hypothyroidism. (Documents do not need to be submitted to the FAA.)
[ ] Not CACI qualified hypothyroidism. Issued per valid SI/AASI. (Submit supporting documents.)
[ ] NOT CACI qualified hypothyroidism. I have deferred. (Submit supporting documents.)
168

____________________________________________________________________
Gender Dysphoria
All Classes
Updated 01/27/16
CONDITION
EVALUATION DATA
A.
Completed gender reassignment
surgery 5 or more years ago
If there is no evidence of a mental health

diagnosis and the airman is doing well on
current treatment:
DISPOSITION
ISSUE
Annotate Block 60
OR
Treated with hormone therapy
for 5 or more years
B.
Treated with Hormone therapy*
for less than 5 years

A completed FAA Gender Dysphoria
Mental Health Status Report or an
evaluation from the treating physician,
using World Professional Association for
Transgender Health guidelines (WPATH),
which addresses items listed in the Mental
Health Status Report.
OR
Gender reassignment
surgery less than 5 years ago
OR
Updated evaluations AFTER:
History of a coexisting
mental health concern
Hormone therapy:
If on hormones, a current status report
describing the length of time on the
medication and side effects, if any.
Surgery:
If surgery has been performed within the
last one year, a status report from the
surgeon or current treating physician
showing full release, off any sedation or
pain medication, and any surgical
complications (e.g. DVT/PE/cardiac,
etc.).
OR
History of mental health
treatment such as psychotherapy
or medications for any condition
other than Gender Dysphoria
(Information is required if the airman
has ever had a mental health
diagnosis [including substance use
disorder] or has received treatment
for a mental health condition at any
time. If treatment was short-term
counseling for Gender Dysphoria
only, note in Block 60.)
DEFER
Submit the
information to the
FAA for review.
Follow up
Issuance
Will be per the
airmans
authorization
letter
Notes:
The AME may ISSUE (no further information is needed), if the airman:
Was evaluated for or diagnosed with Gender Dysphoria and has never undergone treatment (counseling or support group for GD does
not require information);
Has no history of other mental health diagnoses or treatment; and
Is otherwise qualified
*Side effects from hormone therapy can be aeromedically significant. The airman should be warned not to fly per Title 14 CFR 61.53 if they
experience medication side effects.
169

____________________________________________________________________
FAA Gender Dysphoria Mental Health Status Report
(Updated 01/29/16)
Name _____________________________________
Birthdate ____________________________
Applicant ID# _______________________________
PI# _________________________________
The following information must be addressed in the treating providers evaluation. Evaluation should be performed in
accordance with a comprehensive mental health assessment following the World Professional Association for Transgender
Health (WPATH) guidelines. Submit either this form* or supporting documentation addressing each item to your AME or to the
FAA at:
Aerospace Medical Certification Division AAM-300
PO Box 26080
1.
I am a board certified psychiatrist or licensed psychologist AND I meet the

criteria for a qualified mental health professional per WPATH
(current version) guidelines.
2.
This airman meets the DSM-5 diagnostic criteria for Gender Dysphoria
and the condition is not secondary to, or better accounted for, by other
diagnoses.
3.
PSYCHIATRIC HISTORY:
Current mental health diagnosis or coexisting mental health concerns..............
Previous mental health diagnosis or coexisting mental health concerns................
ER visit or hospitalization for any psychiatric illness or condition ever.........
Any suicide attempt(s) ever.................
Substance Use disorder per DSM-5
(e.g. alcohol, cannabis, stimulants, hallucinogens, opioids)
4.
PSYCHIATRIC TREATMENT: (List start and end dates on each. For medications,
also note name, dose, and side effects, if any.)
Current use.
Previous use..
Psychotherapy for any condition other than GD (e.g. depression, anxiety)..
Other treatments (e.g. cognitive therapy, talk therapy, electroconvulsive therapy)
[ ] Yes
[ ] No-explain
[ ] Yes
[ ] No-explain
[
[
[
[
[
] None
] None
] None
] None
] None
[
[
[
[
[
] Yes-explain
] Yes-explain
] Yes-explain
] Yes-explain
] Yes-explain
[
[
[
[
] None
] None
] None
] None
[
[
[
[
] Yes-explain
] Yes-explain
] Yes-explain
] Yes-explain
5.
CURRENT STATUS: Airman is doing well. There are no mental health

concerns. Psychotherapy (if any) is for gender dysphoria only. No other
treatment is needed (do not include support group or support
group counseling).
[ ] Yes
[ ] No-explain
6.
Any evidence of cognitive dysfunction or is a formal neuropsychological

evaluation indicated?
[ ] None
[ ] Yes-explain
7.
Do you have ANY concerns regarding this airman?
[ ] None
[ ] Yes-explain
___________________________________________
Treating Provider Signature
___________________________________
Date of Evaluation
________________________________________
Name or Office Stamp
____________________________________
Phone Number
*For any response which requires further explanation, submit supporting documentation. In some
cases, actual records will be required.
170

____________________________________________________________________
Human Immunodeficiency Virus (HIV)

All Classes
Updated 05/27/15
DISEASE/CONDITION
HIV medication taken for
long-term prevention or PreExposure Prophylaxis (PrEP)
in an HIV negative airman*
Note: This does NOT include use
for short-term Post-Exposure
Prophylaxis (PEP) - (ex: healthcare
exposure.)
*Note: This applies to airmen only,
not FAA ATCS.
Human Immunodeficiency
Virus (HIV)
EVALUATION DATA
report from the prescribing
physician that verifies:
HIV status is
negative;
Appropriate lab
studies are being
monitored;
Medication is
Truvada
(tenofovir-emtricitabine);
and
No side effects
from the
medication.
DISPOSTITIONS
ISSUE
Note this in Block 60 and submit
the initial current status and lab
report to FAA for retention in the
airmans file.
Inform the airman that if they
develop any problems with the
medication, change in
prophylactic medications, or
seroconvert to HIV+ status they
must report this to the FAA.
For continued certification:
If no change in medication and
HIV status remains negative, the
AME may issue and note this in
Block 60.
See HIV Protocol
DEFER
See HIV Protocol
DEFER
Use this disposition if the airman

has a history of HIV only.
Acquired
Immunodeficiency
Syndrome (AIDS)
Use this disposition if the airman
has EVER had a history of AIDS.
171

____________________________________________________________________
Neoplasms
All Classes
DISEASE/CONDITION
EVALUATION DATA DISPOSTITIONS
Breast Cancer

medical records,
operative/
pathology reports,
current oncological
status report,
including tumor
markers, and any
other testing; include
duration of
symptoms, name and
dosage of drugs and
side effects
Initial Special Issuance - Requires

FAA Decision
Followup
Also see:
Acoustic Neuroma
Colon/ Rectal Cancer and other
Abdominal Malignancies
G-U System Cancers
Kaposis Sarcoma
Leukemias and Lymphomas
Malignant Melanomas
Eye Tumors
172

____________________________________________________________________
Pregnancy
Pregnancy under normal circumstances is not disqualifying. It is recommended that the
applicant's obstetrician be made aware of all aviation activities so that the obstetrician can
properly advise the applicant. The Examiner may wish to counsel applicants concerning
piloting aircraft during the third trimester. The proper use of lap belt and shoulder harness
warrants discussion.
173

____________________________________________________________________
ITEM 49. Hearing
49. Hearing
Record Audiometric Speech

Discrimination Score Below
Conversational
Voice Test at 6 Feet
Pass
Fail

(a) The person shall demonstrate acceptable hearing by at least one of the following
tests:
(1) Demonstrate an ability to hear an average conversational voice in a quiet
room, using both ears, at a distance of 6 feet from the examiner, with the
back turned to the examiner.
(2) Demonstrate an acceptable understanding of speech as determined by
audiometric speech discrimination testing to a score of at least 70 percent
obtained in one ear or in a sound field environment.
(3) Provide acceptable results of pure tone audiometric testing of unaided
hearing acuity according to the following table of worst acceptable
thresholds, using the calibration standards of the American National
Standards Institute, 1969 (11 West 42nd Street, New York, NY 10036):
Frequency (Hz)
500 Hz
1000 Hz
2000 Hz
3000 Hz
Better ear (Db)
35
30
30
40
Poorer ear (Db)
35
50
50
60
(b) No disease or condition of the middle or internal ear, nose, oral cavity, pharynx,
or larynx that(1) Interferes with, or is aggravated by, flying or may reasonably be expected to
do so; or
(2) Interferes with, or may reasonably be expected to interfere with, clear and
effective speech communication.
(c) No disease or condition manifested by, or that may reasonably be expected to be
manifested by, vertigo or a disturbance of equilibrium.
174

____________________________________________________________________
II. Examination Equipment and Techniques
A. Order of Examinations
1. The applicant must demonstrate an ability to hear an average conversational voice
in a quiet room, using both ears, at a distance of 6 feet from the Examiner, with the
back turned to the Examiner.
2. If an applicant fails the conversational voice test, the Examiner may administer pure
tone audiometric testing of unaided hearing acuity according to the following table of
worst acceptable thresholds, using the calibration standards of the American
National Standards Institute, 1969:
Frequency (Hz)
500 Hz
1000 Hz
2000 Hz
3000 Hz
Better ear (Db)
35
30
30
40
Poorer ear (Db)
35
50
50
60
If the applicant fails an audiometric test and the conversational voice test had not
been administered, the conversational voice test should be performed to determine if
the standard applicable to that test can be met.
3. If an applicant is unable to pass either the conversational voice test or the pure tone
audiometric test, then an audiometric speech discrimination test should be
administered. A passing score is at least 70 percent obtained in one ear at an
intensity of no greater than 65 Db.
B. Discussion
1. Conversational voice test. For all classes of certification, the applicant must
demonstrate hearing of an average conversational voice in a quiet room, using both
ears, at 6 feet, with the back turned to the Examiner. The Examiner should not use
only sibilants (S-sounding test materials). If the applicant is able to repeat correctly
the test numbers or words, "pass" should be noted and recorded on FAA
Form 8500-8, Item 49. If the applicant is unable to hear a normal conversational
voice then "fail" should be marked and one of the following tests may be
administered.
2. Standard. For all classes of certification, the applicant may be examined by pure
tone audiometry as an alternative to conversational voice testing or upon failing the
conversational voice test. If the applicant fails the pure tone audiometric test and
has not been tested by conversational voice, that test may be administered. The
requirements expressed as audiometric standards according to a table of acceptable
thresholds (American National Standards Institute [ANSI], 1969, calibration) are as
follows:
175

____________________________________________________________________
EAR(All classes of medical certification)
Frequency (Hz)
Better ear (Db)
Poorer ear (Db)
500 Hz
35
35
1000 Hz
30
50
2000 Hz
30
50
3000 Hz
40
60
3. Audiometric Speech Discrimination. Upon failing both conversational voice and pure
tone audiometric test, an audiometric speech discrimination test should be
administered (usually by an otologist or audiologist). The applicant must score at
least 70 percent at intensity no greater than 65 Db in either ear.
C. Equipment
1. Approval. The FAA does not approve or designate specific audiometric equipment
for use in medical certification. Equipment used for FAA testing must accurately and
reliably cover the required frequencies and have adequate threshold step features.
Because every audiometer manufactured in the United States for
screening and diagnostic purposes is built to meet appropriate standards, most
audiometers should be acceptable if they are maintained in proper calibration and
are used in an adequately quiet place.
2. Calibration. It is critical that any audiometer be periodically calibrated to ensure its
continued accuracy. Annual calibration is recommended. Also recommended is the
further safeguard of obtaining an occasional audiogram on a "known" subject or staff
member between calibrations, especially at any time that a test result unexpectedly
varies significantly from the hearing levels clinically expected. This testing provides
an approximate "at threshold" calibration. The Examiner should ensure that the
audiometer is calibrated to ANSI standards or if calibrated to the older ASA/USASI
standards, the appropriate correction is applied (see paragraph 3 below).
3. ASA/ANSI. Older audiometers were often calibrated to meet the standards specified
by the USA Standards Institute (USASI), formerly the American Standards
Association (ASA). These standards were based upon a U.S. Public Health Service
survey. Newer audiometers are calibrated so that the zero hearing threshold level is
now based on laboratory measurements rather than on the survey. In 1969, the
American National Standards Institute (ANSI) incorporated these new
measurements. Audiometers built to this standard have instruments or dials that
read in ANSI values. For these reasons, it is very important that every audiogram
submitted (for values reported in Item 49 on FAA Form 8500-8) include a note
indicating whether it is ASA or ANSI. Only then can the FAA standards be
appropriately applied. ASA or USASI values can be converted to ANSI by adding
corrections as follows:
Frequency (Hz) 500 Hz
Decibels Added* 14
1,000 Hz 2,000 Hz 3,000 Hz

10
8.5
8.5
* The decibels added figure is the amount added to ASA or USASI at each
specific frequency to convert to ANSI or older equivalent ISO values.
176

____________________________________________________________________
1. Special Issuance of Medical Certificates. Applicants who do not meet the auditory
standards may be found eligible for a SODA. An applicant seeking a SODA must
make the request in writing to the Aerospace Medicine Certification Division, AAM300. A determination of qualifications will be made on the basis of a special medical
examination by an ENT consultant, a MFT, or operational experience.
2. Bilateral Deafness. See Items 25-30. If otherwise qualified, when the student pilot's
instructor confirms the student's eligibility for a private pilot checkride, the applicant
should submit a written request to the AMCD for an authorization for a MFT. This
test will be given by an FAA inspector in conjunction with the checkride. If the
applicant successfully completes the test, the FAA will issue a third-class medical
certificate and SODA. Pilot activities will be restricted to areas in which radio
communication is not required.
3. Hearing Aids. If the applicant requires the use of hearing aids to meet the standard,
issue the certificate with the following restriction:
VALID ONLY WITH USE OF HEARING AMPLIFICATION
Some pilots who normally wear hearing aids to assist in communicating while on the
ground report that they elect not to wear them while flying. They prefer to use the
volume amplification of the radio headphone. Some use the headphone on one ear
for radio communication and the hearing aid in the other for cockpit communications.
177

____________________________________________________________________
ITEMS 50- 54. Ophthalmologic Disorder
ITEM 50. Distant Vision
50. Distant Vision
Right
Left
Both
20/
20/
20/
Corrected to 20/
Corrected to 20/
Corrected to 20/

First- and Second-Classes: 14 CFR 67.103(a) and 67.203(a)
(a) Distant visual acuity of 20/20 or better in each eye separately, with or without
corrective lenses. If corrective lenses (spectacles or contact lenses) are necessary
for 20/20 vision, the person may be eligible only on the condition that corrective
lenses are worn while exercising the privileges of an airman certificate
Third-Class: 14 CFR 67.303(a)
(a) Distant visual acuity of 20/40 or better in each eye separately, with or without
corrective lenses. If corrective lenses (spectacles or contact lenses) are necessary
for 20/40 vision, the person may be eligible only on the condition that corrective
lenses are worn while exercising the privileges of an airman certificate.
Equipment:
1. Snellen 20-foot eye chart may be used as follows:
a. The Snellen chart should be illuminated by a 100-watt incandescent lamp placed
4 feet in front of and slightly above the chart.
b. The chart or screen should be placed 20 feet from the applicant's eyes and the 20/20
line should be placed 5 feet 4 inches above the floor.
c. A metal, opaque plastic, or cardboard occluder should be used to cover the eye not
being examined.
d. The examining room should be darkened with the exception of the illuminated chart
or screen.
e. If the applicant wears corrective lenses, the uncorrected acuity should be determined
first, then corrected acuity. If the applicant wears contact lenses, see the
178

____________________________________________________________________
recommendations in Chapter 3. Items 31-34, Section II, #5,
f.
Common errors:
1. Failure to shield the applicant's eyes from extraneous light.
2. Permitting the applicant to view the chart with both eyes.
3. Failure to observe the applicant's face to detect squinting.
4. Incorrect sizing of projected chart letters for a 20-foot distance.
5. Failure to focus the projector sharply.
6. Failure to obtain the corrected acuity when the applicant wears glasses.
7. Failure to note and to require the removal of contact lenses.

2. Acceptable Substitutes for Distant Vision Testing: any commercially available visual
acuities and heterphoria testing devices.
There are specific approved substitute testers for color vision, which may not
include some commercially available vision testing machines. For an
approved list, see Item 52. Color Vision.
3. Directions furnished by the manufacturer or distributor should be followed when
using the acceptable substitute devices for the above testing.
Examination Techniques:
1. Each eye will be tested separately, and both eyes together.
A. When corrective lenses are required to meet the standards, an appropriate limitation
will be placed on the medical certificate. For example, when lenses are needed for
distant vision only:
HOLDER SHALL WEAR CORRECTIVE LENSES
For multiple vision defects involving distant and/or intermediate and/or near vision
when one set of monofocal lenses corrects for all, the limitation is:
For combined defective distant and near visual acuity where multifocal lenses are
required, the appropriate limitation is:
179

____________________________________________________________________
HOLDER SHALL WEAR LENSES THAT CORRECT FOR DISTANT VISION AND
POSSESS GLASSES THAT CORRECT FOR NEAR VISION
For multiple vision defects involving distant, near, and intermediate visual acuity
when more than one set of lenses is required to correct for all vision defects, the
appropriate limitation is:
POSSESS GLASSES THAT CORRECT FOR NEAR AND INTERMEDIATE VISION
B. An applicant who fails to meet vision standards and has no SODA that covers the
extent of the visual acuity defect found on examination may obtain further FAA
consideration for grant of an Authorization under the special issuance section of
part 67 (14 CFR 67.401) for medical certification by submitting a report of an eye
evaluation. The Examiner can help to expedite the review procedure by forwarding
a copy of FAA Form 8500-7, Report of Eye Evaluation, that has been completed by
an eye specialist (optometrist or ophthmologist) 1.
C. Applicants who do not meet the visual standards should be referred to a specialist
for evaluation. Applicants with visual acuity or ocular muscle balance problems may
be referred to an eye specialist of the applicant's choice. The FAA Form 8500-7,
Report of Eye Evaluation, should be provided to the specialist by the Examiner.
Any applicant eligible for a medical certificate through special issuance under
these guidelines shall pass a MFT, which may be arranged through the
appropriate agency medical authority.
D. Amblyopia. In amblyopia ex anopsia, the visual acuity of one eye is decreased
without presence of organic eye disease, usually because of strabismus or
anisometropia in childhood. In amblyopia ex anopsia, the visual acuity loss is simply
recorded in Item 50 of FAA form 8500-8, and visual standards are applied as usual.
If the standards are not met, a report of eye evaluation, FAA Form 8500-7, should be
submitted for consideration.
In obtaining special eye evaluations in respect to the airman medical certification program or the air traffic
controller health program, reports from an eye specialist are acceptable when the condition being evaluated
relates to a determination of visual acuity, refractive error, or mechanical function of the eye.
The FAA Form 8500-7, Report of Eye Evaluation, is a form that is designed for use by either optometrists or
ophthalmologists.
180

____________________________________________________________________
ITEM 51.a. Near Vision
51.a. Near Vision
Right
Left
Both
20/
20/
20/
Corrected to 20/
Corrected to 20/
Corrected to 20/
20/
20/
20/
Corrected to 20/
Corrected to 20/
Corrected to 20/
ITEM 51.b. Intermediate Vision

51.b. Intermediate Vision 32 Inches
Right
Left
Both

First- and Second-Classes: 14 CFR 67.103(b) and 67.203(b)
(b) Near vision of 20/40 or better, Snellen equivalent, at 16 inches in each eye
separately, with or without corrective lenses. If age 50 or older, near vision of 20/40
or better, Snellen equivalent, at both 16 inches and 32 inches in each eye
separately, with or without corrective lenses.
Third-Class: 14 CFR 67.303(b)
(b) Near vision of 20/40 or better, Snellen equivalent, at 16 inches in each eye
separately, with or without corrective lenses.
II. Equipment and Examination Techniques
Equipment:
1. FAA Form 8500-1, Near Vision Acuity Test Chart, dated April 1993.
2. For testing near at 16 inches and intermediate at 32 inches, acceptable substitutes:
any commercially available visual acuities and heterophoria testing devices. For
testing of intermediate vision, some equipment may require additional apparatus.
include some commercially available vision testing machines. For an approved
list, see Item, 52. Color Vision.
181

____________________________________________________________________
1. Near visual acuity and intermediate visual acuity, if the latter is required, are
determined for each eye separately and for both eyes together. Test values are
recorded both with and without corrective glasses/lenses when either are worn or
required to meet the standards. If the applicant is unable to meet the intermediate
acuity standard unaided, then he/she is tested using each of the corrective lenses or
glasses otherwise needed by that person to meet distant and/or near visual acuity
standards. If the aided acuity meets the standard using any of the lenses or
glasses, the findings are recorded, and the certificate appropriately limited. If an
applicant has no lenses that bring intermediate and/or near visual acuity to the
required standards, or better, in each eye, no certificate may be issued, and the
applicant is referred to an eye specialist for appropriate visual evaluation and
correction.
2. FAA Form 8500-1, Near Vision Acuity Test Chart, dated April 1993, should be used
as follows:
a. The examination is conducted in a well-lighted room with the source of light
behind the applicant.
b. The applicant holds the chart 16 inches (near) and 32 inches (intermediate)
from the eyes in a position that will provide uniform illumination. To ensure
that the chart is held at exactly 16 inches or 32 inches from the eyes, a string
of that length may be attached to the chart.
c. Each eye is tested separately, with the other eye covered. Both eyes are
then tested together.
d. The smallest type correctly read with each eye separately and both eyes
together is recorded in linear value. In performing the test using FAA
Form 8500-1, the level of visual acuity will be recorded as the line of smallest
type the applicant reads accurately. The applicant should be allowed no
more than two misread letters on any line.
e. Common errors:
1.
2.
3.
4.
Inadequate illumination of the test chart.

Failure to hold the chart the specified distance from the eye.
Failure to ensure that the untested eye is covered.
Failure to determine uncorrected and corrected acuity when the
applicant wears glasses.
f. Practical Test. At the bottom of FAA Form 8500-1 is a section for

Aeronautical Chart Reading. Letter types and charts are reproduced from
aeronautical charts in their actual size.
182

____________________________________________________________________
This may be used when a borderline condition exists at the certifiable limits of
an applicant's vision. If successfully completed, a favorable certification
action may be taken.
3. Acceptable substitute equipment may be used. Directions furnished by the
manufacturer or distributor should be followed when using the acceptable substitute
devices for the above testing.
When correcting glasses are required to meet the near and intermediate vision standards,
an appropriate limitation will be placed on the medical certificate. Contact lenses that
correct only for near or intermediate visual acuity are not considered acceptable for aviation
duties.
If the applicant meets the uncorrected near or intermediate vision standard of 20/40, but
already uses spectacles that correct the vision better than 20/40, it is recommended that
the Examiner enter the limitation for near or intermediate vision corrective glasses on the
certificate.
For all classes, the appropriate wording for the near vision limitation is:
HOLDER SHALL POSSESS GLASSES THAT CORRECT FOR NEAR VISION
Possession only is required, because it may be hazardous to have distant vision obscured
by the continuous wearing of reading glasses.
For first- and second-class, the appropriate wording for combined near and intermediate
vision limitation is:
HOLDER SHALL POSSESS GLASSES THAT CORRECT FOR NEAR AND
INTERMEDIATE VISION
For multiple defective distant, near, and intermediate visual acuity when unifocal glasses or
contact lenses are used and correct all, the appropriate limitation is:
For multiple vision defects involving distance and/or near and/or intermediate visual acuity
when more than one set of lenses is required to correct for all vision defects, the
appropriate limitation is:
POSSESS GLASSES THAT CORRECT FOR NEAR AND INTERMEDIATE VISION
183

____________________________________________________________________
ITEM 52. Color Vision
52. Color Vision
Pass
Fail

First- and Second-Classes: 14 CFR 67.103(c) and 67.203(c)
(c) Color vision: Ability to perceive those colors necessary for the safe performance
of airman duties.
Third-Class: 14 CFR 67.303(c)
(c) Color vision: Ability to perceive those colors necessary for the safe performance
of airman duties.
TESTS APPROVED FOR AIRMEN ARE NOT ALL ACCEPTABLE FOR AIR TRAFFIC CONTROLLERS
(ATCS - FAA employee 2152 series and contract tower air traffic controllers). For ATCS color vision
criteria, see Acceptable Test Instruments for Color Vision Screening of ATCS chart at the end of
this section or contact a Regional Flight Surgeon.
The following equipment and techniques apply TO AIRMEN ONLY:
EQUIPMENT
Pseudoisochromatic
plates
TEST
Test book should be held 30 from
applicant
Plates should be illuminated by at
least 20 candles, preferably by a
Macbeth Easel Lamp or a Verilux
True Color Light (F15T8VLX)
Only three seconds are allowed
for the applicant to interpret and
respond to a given plate
American Optical
Company [AOC]
AOC-HRR
Richmond-HRR
Dvorine
Ishihara
Richmond, 15-plates
EDITION
PLATES
1965
1-15
2nd
4th
2nd
14 Plate
24 Plate
38 Plate
1983
1-11
5-24
1-15
1-11
1-15
1-21
1-15
184

____________________________________________________________________
Acceptable Substitutes: (May be used following the directions accompanying the
instruments) Farnsworth Lantern; OPTEC 900 Color Vision Test; Keystone Orthoscope;
Keystone Telebinocular; OPTEC 2000 Vision Tester (Model Nos. 2000 PM, 2000 PAME,
and 2000 PI) - Tester MUST contain 2000-010 FAR color perception PIP plate to be
approved; OPTEC 2500; Titmus Vision Tester; Titmus i400.
TESTS APPROVED FOR AIRMEN ARE NOT ALL ACCEPTABLE FOR AIR TRAFFIC CONTROLLERS
(ATCS - FAA employee 2152 series and contract tower air traffic controllers). For ATCS color vision
criteria, see Acceptable Test Instruments for Color Vision Screening of ATCS chart at the end of
this section or contact a Regional Flight Surgeon.
The following criteria apply TO AIRMEN ONLY:
An applicant meets the color vision standard if he/she passes any of the color vision tests
listed in Examination Techniques, Item 52. Color Vision. If an applicant fails any of these
tests, inform the applicant of the option of taking any of the other acceptable color vision
tests listed in Item 52. Color Vision Examination Equipment and Techniques before
requesting the Specialized Operational Medical Tests in Section D below.
Inform the applicant that if he/she takes and fails any component of the Specialized
Operational Medical Tests in Section D, then he/she will not be permitted to take any
of the remaining listed office-based color vision tests in Examination Techniques,
Item 52. Color Vision as an attempt to remove any color vision limits or restrictions
on their airman medical certificate. That pathway is no longer an option to the airman,
and no new result will be considered.
An applicant does not meet the color vision standard if testing reveals:
A. All Classes
1. AOC (1965 edition) pseudoisochromatic plates: seven or more errors on plates 1-15.
2. AOC-HRR (second edition): Any error in test plates 7-11. Because the first 4 plates
in the test book are for demonstration only, test plate 7 is actually the eleventh plate
in the book. (See instruction booklet.)
3. Dvorine pseudoisochromatic plates (second edition, 15 plates): seven or more errors
on plates 1-15.
4. Ishihara pseudoisochromatic plates: Concise 14-plate edition: six or more errors on
plates 1-11; the 24-plate edition: seven or more errors on plates 1-15; the 38-plate
edition: nine or more errors on plates 1-21.
5. Richmond (1983 edition) pseudoisochromatic plates: seven or more errors on plates
1-15.
6. OPTEC 900 Vision Tester and Farnsworth Lantern test: an average of more than
one error per series of nine color pairs in series 2 and 3. (See instruction booklet.)
185

____________________________________________________________________
7. Titmus Vision Tester, Titmus i400, OPTEC 2000 Vision Tester, Keystone
Orthoscope, or Keystone View Telebinocular: any errors in the six plates.
8. Richmond-HRR, 4th edition: two or more errors on plates 5-24. Plates 1-4 are for
demonstration only; plates 5-10 are screening plates; and plates 11-24 are
diagnostic plates.
B. Certificate Limitation. If an applicant fails to meet the color vision standard as interpreted
above, but is otherwise qualified, the Examiner must issue a medical certificate bearing the
limitation:
NOT VALID FOR NIGHT FLYING OR BY COLOR SIGNAL CONTROL
C. The color vision screening tests above (Section A) are not to be used for the purpose of
removing color vision limits/restrictions from medical certificates of airmen who have failed
the Specialized Operational Medical Tests below (Section D). See bold paragraph in the
introduction of this section (above).
D. Specialized Operational Medical Tests for Applicants Who Do Not Meet the Standard.
Applicants who fail the color vision screening test as listed, but desire an airman medical
certificate without the color vision limitation, may be given, upon request, an opportunity to
take and pass additional operational color perception tests. If the airman passes the
operational color vision perception test(s), then he/she will be issued a Letter of Evidence
(LOE).
The operational tests are determined by the class of medical certificate requested.
The request should be in writing and directed to AMCD or RFS. See NOTE for
description of the operational color perception tests.
Applicants for a third-class medical certificate need only take the Operational Color
Vision Test (OCVT).
The applicant is permitted to take the OVCT only once during the day. If the
applicant fails, he/she may request to take the OVCT at night. If the applicant elects
to take the OCVT at night, he/she may take it only once.
For an upgrade to first- or second-class medical certificate, the applicant must first
pass the OCVT during daylight and then pass the color vision Medical Flight Test
(MFT). If the applicant fails the OCVT during the day, he/she will not be allowed to
apply for an upgrade to First- or Second-Class certificate. If the applicant fails the
color vision MFT, he/she is not permitted to upgrade to a first- or second-class
certificate.
E. An LOE may restrict an applicant to a third-class medical certificate. Airmen shall not be
issued a medical certificate of higher class than indicated on the LOE. Exercise care in
reviewing an LOE before issuing a medical certificate to an airman.
186

____________________________________________________________________
F. Color Vision Correcting Lens (e.g. X-Chrom). Such lenses are unacceptable to the FAA
as a means for correcting a pilot's color vision deficiencies.
G. Any tests not specifically listed above are unacceptable methods of testing for FAA
medical certificate. Examples of unacceptable tests include, but are not limited to, the
OPTEC 5000 Vision Tester (color vision portion), Farnsworth Lantern Flashlight, yarn
tests, and AME-administered aviation Signal Light Gun test (AME office use is prohibited).
Web-based color vision applications, downloaded, or printed versions of color vision
tests are also prohibited. Examiners must use actual and specific color vision plates and
testing machinery for applicant evaluations.
NOTE: An applicant for a third-class airman medical certificate who has defective color vision and
desires an airman medical certificate without the color vision limitation must demonstrate the ability
to pass an Operational Color Vision Test (OCVT) during the day. The OCVT consists of the
following:
1. A Signal Light Test (SLT): Identify in a timely manner aviation red, green, and white
2. Aeronautical chart reading: Read and correctly interpret in a timely manner aeronautical
charts, including print in various sizes, colors, and typefaces; conventional markings in
several colors; and, terrain colors
An applicant for a first- or second- class airman medical certificate who has defective color
vision and desires an airman medical certificate without the color vision limitation must first
demonstrate the ability to pass the OCVT during the day (as above) and then must pass a
color vision Medical Flight Test (MFT). The color vision MFT is performed in the aircraft,
including in-flight testing. It consists of the following:
1. Read and correctly interpret in a timely manner aviation instruments or displays
2. Recognize terrain and obstructions in a timely manner
3. Visually identify in a timely manner the location, color, and significance of aeronautical lights
such as, but not limited to, lights of other aircraft in the vicinity, runway lighting systems, etc.
Applicants who take and pass both the OCVT during the day and the color vision MFT will be given
a letter of evidence (LOE) valid for all classes of medical certificates and will have no limitation or
comment made on the certificate regarding color vision as they meet the standard for all classes.
Applicants who take and pass only the OCVT during the day will be given an LOE valid only for
third-class medical certificate.
An applicant who fails the SLT portion of the OCVT during daylight hours may repeat the test at
night. Should the airman pass the SLT at night, the restriction:
NOT VALID FOR FLIGHT DURING DAYLIGHT HOURS BY COLOR SIGNAL CONTROL
will be placed on the replacement medical certificate. The airman must have taken the daylight
hours test first and failed prior to taking the night test.
187

____________________________________________________________________
Color Vision Testing Flowchart

Failed
Color Vision
Screening Test
Test
Limitation
Medical certificate limitation: Not valid for

night flying or by color signal controls.
Airman opts to take

Operational Color Vision
Test (OCVT) DAY
Pass ?
Letter of Evidence (LOE); Class 3 only.

(Must pass Color Vision Medical Flight
Test for upgrade.)
YES
Airman opts to take
Color Vision Medical Flight Test
NO
Medical certificate limitation remains: Not valid

for night flying or by color signal controls.
Pass ?
YES
LOE;
Upgrade
to Class 1
or Class 2
NO
No upgrade. LOE and

certificate remain Class 3
Airman opts to take

OCVT NIGHT
YES
Pass ?
Medical certificate limitation: Not valid for flight

during daylight hours by color signal controls.
NO
Medical certificate limitation remains: Not valid

for night flying or by color signal controls.
188

____________________________________________________________________
ACCEPTABLE TEST INSTRUMENTS FOR COLOR VISION SCREENING OF ATCS
(FAA EMPLOYEE 2152 SERIES and CONTRACT TOWER ATCSs)
Color Vision Test
Does not meet the standard (fails) if:
Richmond-HRR, 4th edition

All Ishihara test plates approved for
airmen:
14-Plate (plates 1-11)
Any error on plates 5-10
Supplier
Richmond
Products
Ishihara
More than 6 errors on plates 1-11

No errors on the 6 total trials on plates 4
and 5
Any errors on any of the 6 plates
Keystone
View
Titmus
OPTEC 2000
Any errors on any of the 6 Stereo Optical

Co., Inc., plates
AOC-HRR, 2nd, 1-11
Any errors on plates 5-10
Dvorine 2nd Edition

Special Instructions
Test Administration
Stereo
Optical
Co., Inc.
Richmond
Products
Richmond
Products
Keystone View Telebinocular

Titmus testers approved for airmen:
Titmus
The Examiner must document the color vision test

instrument used, version, answer sheet with the actual
subject responses and the score. If MEDExpress is used
the examiner may fax or mail the results to the Flight
Surgeon or may document the findings in block 60.
AME Office Inspection
AME office inspections: The inspector must visually
inspect the condition of the color vision test instrument,
for fading, finger prints, pen or pencil smudges; and lights
used. Only a Macbeth Easel or a Verilux True Daylight
Illuminator (F15T8VLX) are acceptable. Room lights
must be off.
False Negatives
Any test device with a restricted test set, like the Titmus
testers, generally have a high false alarm test. If a
disproportionally high number of subjects are failing, it
may be necessary to review the acceptability of that test
instrument. Regional Medical Offices are expected to
monitor this situation.
UNACCEPTABLE TEST INSTRUMENTS FOR COLOR VISION SCREENING OF ATCS
(FAA EMPLOYEE 2152 SERIES and CONTRACT TOWER ATCSs)
AOC-PIP
Mast
OPTEC 900, 2500*, 5000*
Bausch & Lomb Vision Tester

D-15
Prism
StereoOptic
Titmus
i400*
Vision
Chart color
letters
FALANT
Richmond-HRR Versions 2 and 3
H-O Chart
Schilling
Any computer applications, downloaded, or printed versions of color vision tests are prohibited.
189

____________________________________________________________________
ITEM 53. Field of Vision
53. Field of Vision
Normal
Abnormal

First- and Second-Classes: 14 CFR 67.103(d) and 67.203(d)
(d) Field of Vision: Normal
Third-Class: 14 CFR 67.303(d)
(d) Field of Vision: No acute or chronic pathological condition of either eye or adnexa
that interferes with the proper function of an eye, that may reasonably be expected
to progress to that degree, or that may reasonably be expected to be aggravated by
flying.
1. Fifty-inch square black matte surface wall target with center white fixation point;
2 millimeter white test object on black-handled holder:
1. The applicant should be seated 40 inches from the target.
2. An occluder should be placed over the applicant's right eye.
3. The applicant should be instructed to keep the left eye focused on the fixation
point.
4. The white test object should be moved from the outside border of the wall
target toward the point of fixation on each of the eight 4-degree radials.
5. The result should be recorded on a worksheet as the number of inches from
the fixation point at which the applicant first identifies the white target on each
radial.
6. The test should be repeated with the applicant's left eye occluded and the
right eye focusing on the fixation point.
2. Alternative Techniques:
a. A standard perimeter may be used in place of the above procedure. With this
method, any significant deviation from normal field configuration will require
evaluation by an eye specialist.
190

____________________________________________________________________
b. Direct confrontation. This is the least acceptable alternative since this tests
for peripheral vision and only grossly for field size and visual defects. The
Examiner, standing in front of the applicant, has the applicant look at the
Examiner's nose while advancing two moving fingers from slightly behind and
to the side of the applicant in each of the four quadrants. Any significant
deviation from normal requires ophthalmological evaluation.
A. Ophthalmological Consultations.
If an applicant fails to identify the target in any presentation at a distance of less than
23 inches from the fixation point, an eye specialist's evaluation must be requested. This is
a requirement for all classes of certification. The Examiner should provide FAA Form 850014, Ophthalmological Evaluation for Glaucoma, for use by the ophthalmologist if glaucoma
is suspected.
B. Glaucoma.
The FAA may grant an Authorization under the special issuance section of part 67
(14 CFR 67.401) on an individual basis. The Examiner can facilitate FAA review by
obtaining a report of Ophthalmological Evaluation for Glaucoma
(FAA Form 8500-14) from a treating or evaluating ophthalmologist.
NOTE: See AASI for History of Glaucoma
If considerable disturbance in night vision is documented, the FAA may limit the medical
certificate: NOT VALID FOR NIGHT FLYING
C. Other Pathological Conditions.
See Items 31-34.
191

____________________________________________________________________
ITEM 54. Heterophoria
54. Heterophoria 20 (in prism diopters)
Esophoria
Exophoria
Right Hyperphoria
Left Hyperphoria

First- and Second-Classes: 14 CFR 67.103(f) and 67.203(f)
(f) Bifoveal fixation and vergence-phoria relationship sufficient to prevent a break in
fusion under conditions that may reasonably be expected to occur in performing
airman duties. Tests for the factors named in this paragraph are not required except
for persons found to have more than 1 prism diopter of hyperphoria, 6 prism diopters
of esophoria, or 6 prism diopters of exophoria. If any of these values are exceeded,
the Federal Air Surgeon may require the person to be examined by a qualified eye
specialist to determine if there is bifoveal fixation and an adequate vergence-phoria
relationship. However, if otherwise eligible, the person is issued a medical certificate
pending the results of the examination.
Third-Class: No Standards
Equipment:
1. Red Maddox rod with handle.
2. Horizontal prism bar with graduated prisms beginning with one prism diopter and
increasing in power to at least eight prism diopters.
3. Acceptable substitutes: any commercially available visual acuities and heterophoria
testing devices.
include some commercially available vision testing machines. For an
approved list, See Item, 52. Color Vision.
Test procedures to be used accompany the instruments. If the Examiner needs specific
instructions for use of the horizontal prism bar and red Maddox rod, these may be obtained
from a RFS.
192

____________________________________________________________________
1. First- and second-class: If an applicant exceeds the heterophoria standards (1 prism
diopter of hyperphoria, 6 prism diopters of esophoria, or 6 prism diopters of
exophoria), but shows no evidence of diplopia or serious eye pathology and all other
aspects of the examination are favorable, the Examiner should not withhold or deny
the medical certificate. The applicant should be advised that the FAA may require
further examination by a qualified eye specialist.
2. Third-class: Applicants for a third-class certificate are not required to undergo
heterophoria testing. However, if an applicant has strabismus or a history of
diplopia, the Examiner should defer issuance of a certificate and forward the
application to the AMCD. If the applicant wishes further consideration, the Examiner
can help expedite FAA review by providing the applicant with a copy of FAA
Form 8500-7, Report of Eye Evaluation.
ITEM 55. Blood Pressure (updated 10/28/15)
55. Blood Pressure
Systolic
Diastolic
(Sitting mm of Mercury)

(b). No other organic, functional, or structural disease, defect, or limitation that the
judgment relating to the condition involved, finds (1). Makes the person unable to safely perform the duties or exercise the
(2). May reasonably be expected, for the maximum duration of the airman
(c). No medication or other treatment that the Federal Air Surgeon, based on the
case history and appropriate, qualified medical judgment relating to the medication
or other treatment involved finds (1). Makes the person unable to safely perform the duties or exercise the
(2). May reasonably be expected, for the maximum duration of the airman
193

____________________________________________________________________
Measurement of blood pressure is an essential part of the FAA medical certification
examination. The average blood pressure while sitting should not exceed 155 mm mercury
systolic and 95 mm mercury diastolic maximum pressure for all classes. A medical
assessment is specified for all applicants who need or use antihypertensive medication to
control blood pressure. (See Section III. B. below.)
In accordance with accepted clinical procedures, routine blood pressure should be taken
with the applicant in the seated position. An applicant should not be denied or deferred
first-, second-, or third-class certification unless subsequent recumbent blood pressure
readings exceed those contained in this Guide. Any conditions that may adversely affect
the validity of the blood pressure reading should be noted.
A. Examining Options
1. An applicant whose pressure does not exceed 155 mm mercury systolic and 95 mm
mercury diastolic maximum pressure, who has not used antihypertensive medication
for 30 days, and who is otherwise qualified should be issued a medical certificate by
the Examiner.
2. If the airmans blood pressure is elevated in clinic, you have any of the following
options:
Recheck the blood pressure. If the airman meets FAA specified limits on the
second attempt, note this in Block 60 along with both readings.
Have the airman return to clinic 3 separate days over a 7-day period. If the
airman meets FAA specified limits during these re-checks, note this and the
readings in Block 60. Also note if there was a reason for the blood pressure
elevation.
Send the airman back to his/her treating physician for re-evaluation. If

medication adjustment is needed, a 7-day no-fly period applies to verify no
problems with the medication. If this can be done within the 14 day exam
transmission period, you could then follow the Hypertension Disposition
Table.
The Examiner must defer issuance of a medical certificate to any applicant whose
hypertension has not been evaluated, who uses unacceptable medications, whose
medical status is unclear, whose hypertension is uncontrolled, who manifests
194

____________________________________________________________________
significant adverse effects of medication, or whose certification has previously been
specifically reserved to the FAA.
B. Initial and Followup Evaluation for Hypertensives Under Treatment See CACI - Hypertension Worksheet (in the dispositions table, Item 36. Heart)
ITEM 56. Pulse
56. Pulse
(Resting)
The medical standards do not specify pulse rates that, per se, are disqualifying for medical
certification. These tests are used, however, to determine the status and responsiveness
of the cardiovascular system. Abnormal pulse rates may be reason to conduct additional
cardiovascular system evaluations.
The pulse rate is determined with the individual relaxed in a sitting position.
If there is bradycardia, tachycardia, or arrhythmia, further evaluation is warranted and
deferral may be indicated (see Item 36., Heart). A cardiac evaluation may be needed to
determine the applicants qualifications. Temporary stresses or fever may, at times, result
in abnormal pulse readings. If the Examiner believes this to be the case, the applicant
should be given a few days to recover and then be retested. If this is not possible, the
Examiner should defer issuance, pending further evaluation.
ITEM 57. Urine Test
57. Urine Test (if abnormal, give results)
Albumin
Normal
Sugar
Abnormal

All Classes: 14 CFR 67.113(a)(b), 67.213(a)(b), and 67.313(a)(b)
(a) No established medical history or clinical diagnosis of diabetes mellitus that
requires insulin or any other hypoglycemic drug for control.
judgment relating to the condition involved, finds:
195

____________________________________________________________________
Any standard laboratory procedures are acceptable for these tests.
Glycosuria or proteinuria is cause for deferral of medical certificate issuance until additional
studies determine the status of the endocrine and/or urinary systems. If the glycosuria has
been determined not to be due to carbohydrate intolerance, the Examiner may issue the
certificate. Trace or 1+ proteinuria in the absence of a history of renal disease is not cause
for denial.
The Examiner may request additional urinary tests when they are indicated by history or
examination. These should be reported on FAA Form 8500-8 or attached to the form as an
addendum.
See Item 48., General Systemic.
ITEM 58. ECG
58. ECG (Date)
MM
DD
YYYY

First-Class: 14 CFR 67.111(b)(c)
(b) A person applying for first-class medical certification must demonstrate an
absence of myocardial infarction and other clinically significant abnormality on
electrocardiographic examination:
(1) At the first application after reaching the 35th birthday; and
(2) On an annual basis after reaching the 40th birthday.
(c) An ECG will satisfy a requirement of paragraph (b) of this section if it is dated no
earlier than 60 days before the date of the application it is to accompany and was
performed and transmitted according to acceptable standards and techniques.
196

____________________________________________________________________
Note: All applicants for certification may be required to provide ECGs when indicated by
history or physical examination.
A. Date. The date of the most recent ECG shall be entered in Item 58 of FAA Form 85008 for all first-class applicants.
1. If a first-class applicant is due for a periodic ECG, the Examiner performs and
transmits a current tracing according to established procedures. (See Section II. D.
below).
However, some applicants (such as airline transport pilots who are employed by air
carriers with medical departments) may have their company transmit a current ECG
directly to the FAA. The Examiner need not require such an applicant to undergo
another ECG examination and, if the applicant is otherwise qualified, a medical
certificate may be issued. The Examiner should attach a statement to FAA
Form 8500-8 to verify that a tracing has been transmitted from another source. The
date of that ECG should be entered in Item 58.
2. If a first-class applicant is not required to have a periodic ECG with the current
examination, the Examiner should record the date of the preceding ECG in Item 58.
3. If a second- or third-class applicant gives a history of having had an
electrocardiogram, the test and date may be entered in Item 59. More importantly,
the Examiner should indicate in Item 60 of FAA Form 8500-8 the history and its
significance, if any.
4. If the applicant provides no statement and refuses to have a current ECG submitted
by the Examiner, the Examiner should defer issuance of the medical certificate.
When an ECG is due but is not submitted, the FAA will not affirm the applicant's
eligibility for medical certification until the requested ECG has been received and
interpreted as being within normal limits. Failure to respond to FAA requests for a
required current ECG will result in denial of certification.
B. Currency
1. In order to meet regulatory requirements, a first-class applicant's periodic ECG must
have been performed and transmitted within 60 days prior to the date of the firstclass application (FAA Form 8500-8). The AMCD verifies currency of all periodic
ECGs.
2. There is no provision for issuance of a first-class medical certificate based upon a
promise that an ECG will be obtained at a future date. In such circumstances, the
Examiner should defer issuance and transmit the completed FAA Form 8500-8 to
the AMCD
197

____________________________________________________________________
C. Interpretation
1. All ECGs required to establish eligibility for medical certification must be forwarded
for interpretation to the Manager of the AMCD. This does not preclude submission
of an interpretation by or through the Examiner.
2. Interpretation is accomplished by the staff and consultant cardiologists at the AMCD.
Abnormalities are investigated to determine their significance, if any.
D. Technique and Reporting Format for Required ECGs on First-class Applicants
The method for recording and transmitting ECGs is by digital electronic data transfer by the
Examiner to the AMCD. Senior Examiners who perform first-class medical examinations
are required to have access to this capability.
International Examiners who submit ECGs should use the following format for preparation
and submission:
1. See FAA Form 8065-1, Instructions for Preparation and Submittal of
Electrocardiogram. However, the FAA also will accept 3-channel or 12-channel
strips uncut or mounted on standard mounting paper. The following steps are
essential to expedite processing of these tracings:
a. All leads must be properly identified.
b. Applicant and Examiner identification must be complete and the tracing
must be dated.
2. Such hard-copy ECGs are microfilmed for permanent retention in the AMCD. Only
tracings that can be microfilmed are acceptable.
3. Provide a Resting tracing. Tracings must be stapled to the ECG report form to
ensure that all leads are appropriately coded and interpreted.
198
APPLICATION REVIEW

___________________________________________________________________________
ITEMS 59-64 of FAA Form 8500-8

This section provides guidance for the completion of Items 59-64 of the
FAA Form 8500-8. The Examiner is responsible for conducting the examination.
However, he or she may delegate to a qualified physician's assistant, nurse, aide, or
laboratory assistant the testing required for Items 49-58. Regardless of who performs
the tests, the Examiner is responsible for the accuracy of the findings, and this
responsibility may not be delegated.
The medical history page of FAA Form 8500-8 must be completed and certified by the
applicant or it will not appear in AMCS. After all routine evaluations and tests are
completed, the Examiner should review FAA Form 8500-8. If the form is complete and
accurate, the Examiner should add final comments, make qualification decision
statements, and certify the examination.
ITEM 59. Other Tests Given
59. Other Tests Given

All Classes: 14 CFR 67.413(a)(b)
(a) Whenever the Administrator finds that additional medical information or history is
necessary to determine whether an applicant for or the holder of a medical certificate
meets the medical standards for it, the Administrator requests that person to furnish
that information or to authorize any clinic, hospital, physician, or other person to
release to the Administrator all available information or records concerning that
history. If the applicant or holder fails to provide the requested medical information
or history or to authorize the release so requested, the Administrator may suspend,
modify, or revoke all medical certificates the airman holds or may, in the case of an
applicant, deny the application for an airman medical certificate.
(b) If an airman medical certificate is suspended or modified under paragraph (a) of this
section, that suspension or modification remains in effect until the requested
information, history, or authorization is provided to the FAA and until the Federal Air
Surgeon determines whether the person meets the medical standards under this
part.
LAST UPDATE March 30, 2015
200

___________________________________________________________________________

Additional medical information may be furnished through additional history taking,
further clinical examination procedures, and supplemental laboratory procedures.
On rare occasions, even surgical procedures such as biopsies may be indicated. As a
designee of the FAA Administrator, the Examiner has limited authority to apply
14 CFR 67.413 in processing applications for medical certification. When an Examiner
determines that there is a need for additional medical information, based upon history
and findings, the Examiner is authorized to request prior hospital and outpatient records
and to request supplementary examinations including laboratory testing and
examinations by appropriate medical specialists. The Examiner should discuss the
need with the applicant. The applicant should be advised of the types of additional
examinations required and the type of medical specialist to be consulted. Responsibility
for ensuring that these examinations are forwarded and that any charges or fees are
paid will rest with the applicant. All reports should be forwarded to the AMCD, unless
otherwise directed (such as by a RFS).
Whenever, in the Examiner's opinion, medical records are necessary to evaluate an
applicant's medical fitness, the Examiner should request that the applicant sign an
authorization for the Release of Medical Information. The Examiner should forward this
authorization to the custodian of the applicant's records so that the information
contained in the record may be obtained for attachment to the report of medical
examination.
ITEM 60. Comments on History and Findings
Comments on all positive history or medical examination findings must be reported by
Item Number. Item 60 provides the Examiner an opportunity to report observations
and/or findings that are not asked for on the application form. Concern about the
applicant's behavior, abnormal situations arising during the examination, unusual
findings, unreported history, and other information thought germane to aviation safety
should be reported in Item 60. The Examiner should record name, dosage, frequency,
and purpose for all currently used medications.
If possible, all ancillary reports such as consultations, ECGs, x-ray release forms, and
hospital or other treatment records should be attached. If the delay for those items
would exceed 14 days, the Examiner should forward all available data to the AMCD,
with a note specifying what additional information is being prepared for submission at a
later date.
If there are no significant medical history items or abnormal physical findings, the
Examiner should indicate this by checking the appropriate block.
201

___________________________________________________________________________
ITEM 61. Applicant's Name

Item 61. Applicants Name
The legal name applicant's name should be entered.

ITEM 62. Has Been Issued
Item 62. Has Been Issued
Medical Certificate
No Medical Certificate Issued
Deferred for Further Evaluation
Has Been Denied
Letter of Denial Issued (Copy Attached)
The Examiner must check the proper box to indicate if the Medical Certificate has been
issued. The Examiner must indicate denial or deferral by checking one of the two lower
boxes. If denied, a copy of the Examiner's Letter of Denial, should be forwarded to the
AMCD.
A. Applicant's Refusal. When advised by an Examiner that further examination and/or
medical records are needed, the applicant may elect not to proceed. The Examiner
should note this in Block 60. No certificate should be issued and the Examiner
should forward the application form to the AMCD, even if the application is
incomplete.
B. Anticipated Delay. When the Examiner anticipates a delay of more than 14 days in
obtaining records or reports concerning additional examinations, the exam should be
transmitted to AMCD with a note in Block 60 stating that additional information is still
needed. The exam should be transmitted deferred. No medical certificate should
be issued.
C. Issuance. When the Examiner receives all the supplemental information requested
and finds that the applicant meets all the FAA medical standards for the class
sought, the Examiner should issue a medical certificate.
D. Deferral. If upon receipt of the information the Examiner finds there is a need for
even more information or there is uncertainty about the significance of the findings,
certification should be deferred. The Examiner's concerns should be noted in Block
60 and the application transmitted as deferred to the AMCD for further consideration.
E. Denial. When the Examiner concludes that the applicant is clearly ineligible for
certification, the applicant should be denied, using the AME Letter of Denial. Use of
this form will provide the applicant with the reason for the denial and with appeal
rights and procedures. (See General Information 4. Medical Certification Decision
Making)
202

___________________________________________________________________________
ITEM 63. Disqualifying Defects

The Examiner must check the Disq box on the Comments Page beside any
disqualifying defect. Comments or discussion of specific observations or findings may
be reported in Item 60. If all comments cannot fit in Item 60, the Examiner may submit
additional information on a plain sheet of paper and include the applicants full name,
date of birth, signature, any appropriate identifying numbers (PI, MID or SSN), and the
date of the exam.
If the Examiner denies the applicant, the Examiner must issue a Letter of Denial, to the
applicant, and report the issuance of the denial in Item 60.
ITEM 64. Medical Examiner's Declaration
The FAA designates specific individuals as Examiners and this status may not be
delegated to staff or to a physician who may be covering the designee's practice.
Before transmitting to AMCD, the Examiner must certify the exam and enter all
appropriate information including his or her AME serial number.
203

___________________________________________________________________________
CACI CONDITIONS
(Updated 6/24/15)
Conditions AMEs Can Issue (CACI) is a series of conditions which allow AMEs to
regular issue if the applicant meets the parameters of the CACI Condition Worksheet.
The worksheets provide detailed instructions to the examiner and outline conditionspecific requirements for the applicant.
1. Review the disposition table BEFORE the CACI worksheet to verify a CACI is
required.
2. If all the CACI criteria are met and the applicant is otherwise qualified, the
AME may issue on the first exam or the first time the condition is reported to the
AME without contacting AMCD/RFS. Document the appropriate notes in Block
60 and keep the supporting documents in your files; they do not need to be
submitted to the FAA at this time.
3. If the requirements are not met, the AME must defer the exam and send the
supporting documents to the FAA.
CACIs with Certification Worksheets:
ARTHRITIS
HYPOTHYROIDISM
ASTHMA
KIDNEY STONE(S)
BLADDER CANCER
MIGRAINE AND CHRONIC HEADACHE
CHRONIC KIDNEY DISEASE
MITRAL VALVE REPAIR
COLITIS
PRE-DIABETES
GLAUCOMA
PROSTATE CANCER
HEPATITIS C CHRONIC
RENAL CANCER
HYPERTENSION
TESTICULAR CANCER
204

___________________________________________________________________________
DISEASE PROTOCOLS
205

___________________________________________________________________________
PROTOCOLS
The following lists the Guide for Aviation Medical Examiners Disease Protocols, and
course of action that should be taken by the Examiner as defined by aeromedical
decision considerations. (Also see condition-specific CACI Certification Worksheets,
which can be found in the Dispositions Section.)
ALLERGIES, SEVERE
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
BINOCULAR MULTIFOCAL AND ACCOMMODATING DEVICES
CARDIAC TRANSPLANT
CARDIOVASCULAR EVALUATION (CVE)
CONDUCTIVE KERATOPLASTY
CORONARY HEART DISEASE (CHD)
DEPRESSION TREATED WITH SSRI MEDICATIONS
DIABETES MELLITUS - DIET CONTROLLED
DIABETES MELLITUS Type II - MEDICATION CONTROLLED (Non Insulin)
DIABETES MELLITUS Type I or Type II - INSULIN TREATED
GRADED EXERCISE STRESS TEST REQUIREMENTS (Maximal)
GRADED EXERCISE STRESS TEST REQUIREMENTS (Bundle Branch Block)
HUMAN IMMUNODEFICIENCY VIRUS (HIV)
IMPLANTED PACEMAKER
LIVER TRANSPLANT (RECIPIENT)
METABOLIC SYNDROME MEDICATION CONTROLLED
MUSCULOSKELETAL EVALUATION
NEUROCOGNITIVE IMPAIRMENT
OBSTRUCTIVE SLEEP APNEA (OSA)*
PEPTIC ULCER
PSYCHIATRIC EVALUATION
PSYCHIATRIC AND PSYCHOLOGICAL EVALUATIONS
RENAL TRANSPLANT
SUBSTANCES of DEPENDENCE/ABUSE (Drugs and Alcohol)
THROMBOEMBOLIC DISEASE
VALVE REPLACEMENT
* OSA Reference Materials are located at the end of the Protocols below
206

___________________________________________________________________________
PROTOCOL FOR ALLERGIES, SEVERE

In the case of severe allergies, the Examiner should deny or defer certification and
provide a report to the Aerospace Medical Certification Division, AAM-300, that details
the period and duration of symptoms and the nature and dosage of drugs used for
treatment and/or prevention.
207

___________________________________________________________________________
SPECIFICATIONS FOR NEUROPSYCHOLOGICAL

EVALUATIONS FOR ADHD OR ADD
Why is a neuropsychological evaluation required? Attention-Deficit/Hyperactivity
Disorder (ADHD), formerly Attention Deficit Disorder (ADD), and medications used for
treatment may produce cognitive deficits that would make an airman unsafe to perform
pilot duties. This guideline outlines the requirements for a neuropsychological
evaluation.
Who may perform a neuropsychological evaluation? Neuropsychological
evaluations must be conducted by a licensed clinical psychologist who is either board
certified or board eligible in clinical neuropsychology. Board eligible means that the
clinical neuropsychologist has the education, training, and clinical practice experience
that would qualify him or her to sit for board certification with the American Board of
Clinical Neuropsychology, the American Board of Professional Neuropsychology, and/or
the American Board of Pediatric Neuropsychology.
Will I need to provide any of my medical records? You should make records
available to the neuropsychologist prior to the evaluation, to include:
Copies of all records regarding prior psychiatric/substance-related
hospitalizations, observations, or treatment not previously submitted to the FAA.
A complete copy of your agency medical records. You should request a copy of
your agency records be sent directly to the psychiatrist and psychologist by the
Aerospace Medical Certification Division (AMCD) in Oklahoma City, OK. For
further information regarding this process, please call (405) 954-4821, select the
option for duplicate medical certificate or copies of medical records, then select
the option for certified copies of medical records.
What must the neuropsychological evaluation report include? At a minimum:
A review of all available records, including academic records, records of prior
psychiatric hospitalizations, and records of periods of observation or treatment
(e.g., psychiatrist, psychologist, or pediatric neuropsychiatrist treatment notes).
Records must be in sufficient detail to permit a clear evaluation of the nature and
extent of any previous mental disorders.
A thorough clinical interview to include a detailed history regarding: psychosocial
or developmental problems; academic and employment performance; legal
issues; substance use/abuse (including treatment and quality of recovery);
aviation background and experience; medical conditions, and all medication use;
and behavioral observations during the interview and testing.
A mental status examination.
Interpretation of a full battery of neuropsychological and psychological tests
including, but not limited to, the core test battery (specified below).
An integrated summary of findings with an explicit diagnostic statement, and the
neuropsychologists opinion(s) and recommendation(s) regarding clinically or
208

___________________________________________________________________________
aeromedically significant findings and the potential impact on aviation safety

consistent with the Federal Aviation Regulations.
The results of a urine drug screening test for ADHD/ADD medications, including
psychostimulant medications. The sample must be collected at the conclusion of
the neurocognitive testing or within 24 hours afterward.
What is required in the core test battery? The core test battery listed below
provides a standardized basis for the FAAs review of cases, and must include:
The complete Wechsler Adult Intelligence Scales (Processing Speed and
Working Memory Indexes must be scored)
Trail Making Test, Parts A and B (Reitan Trails A & B should be used since
aviation norms are available for the original Reitan Trails A & B, but not for
similar tests [e.g., Color Trails; Trails from Kaplan-Delis Executive Function, etc.])
Executive function tests to include:
(1) Category Test or Wisconsin Card Sorting Test, and
(2) Stroop Color-Word Test
Paced Auditory Serial Addition Test (PASAT).
A continuous performance test (i.e., Test of Variables of Attention [TOVA], or
Conners Continuous Performance Test [CPT-II], or Integrated Visual and
Auditory Continuous Performance Test [IVA+]), or Gordon Diagnostic System
[GDS].
Test of verbal memory (WMS-IV subtests, Rey Auditory Verbal Learning Test, or
California Verbal Learning Test-II).
Test of visual memory (WMS-IV subtests, Brief Visuospatial Memory TestRevised, or Rey Complex Figure Test).
Tests of Language including Boston Naming Test and Verbal Fluency (COWAT
and a semantic fluency task).
Psychomotor testing including Finger Tapping and Grooved Pegboard or Purdue
Pegboard.
Personality testing, to include the Minnesota Multiphasic Personality Inventory
(MMPI-2). (The MMPI-2-RF is not an approved substitute. All scales, subscales,
content, and supplementary scales must be scored and provided. Computer
scoring is required. Abbreviated administrations are not acceptable.)
Additional testing: If problems are noted on tests of reading or math, follow-up
testing with appropriate achievement tests should be conducted (e.g.,
Woodcock-Johnson Tests of Achievement-III; Nelson-Denny Reading Test,
especially Fluency and Comprehension; WRAT-IV Math; PIAT Reading
Comprehension).
CogScreen-Aeromedical Edition (CogScreen-AE) is recommended but not
required.
NOTES: (1) All tests administered must be the most current edition of the test unless
specified otherwise; (2) At the discretion of the examiner, additional tests may be
clinically necessary to assure a complete assessment.
209

___________________________________________________________________________
What must be submitted? The neuropsychologists report as noted above, plus the
supporting documentation below:
Copies of all computer score reports (e.g., Pearson MMPI-2 Extended Score
Report, TOVA, CPT-II or IVA+ Report).
An appended score summary sheet that includes all scores for all tests
administered. When available, pilot norms must be used. If pilot norms are not
available for a particular test, then the normative comparison group (e.g., general
population, age/education-corrected) must be specified. Also, when available,
percentile scores must be included.
Recommendations should be strictly limited to the psychologists area of expertise.
Psychologists with questions are encouraged to call Chris Front, Psy.D, FAA
Psychologist, at (202) 267-3767.
What else does the neuropsychologist need to know?
The FAA will not proceed with a review of the test findings without the above
data.
The data and clinical findings will be carefully safeguarded in accordance with
the APA Ethical Principles of Psychologists and Code of Conduct (2002) as well
as applicable federal law.
The raw neurocognitive testing data may be required at a future date for expert
review by one of the FAAs consulting clinical neuropsychologists. In that event,
authorization for release of the data by the airman to the expert reviewer will
need to be provided.
Additional Helpful Information
1. Will additional testing be required in the future? If eligible for unrestricted medical
certification, no additional testing would be required. However, pilots found eligible
for Special Issuance will be required to undergo periodic re-evaluations. The letter
authorizing special issuance will outline required testing, which may be limited to
specific tests or expanded to include a comprehensive test battery.
2. Useful references for the neuropsychologist:
MOST COMPREHENSIVE SINGLE REFERENCE:
Aeromedical Psychology (2013). C.H. Kennedy & G.G. Kay (Editors). Ashgate.
Pilot norms on neurocognitive tests: Kay, G.G. (2002). Guidelines for the
Psychological Evaluation of Aircrew Personnel. Occupational Medicine, 17 (2),
227-245.
Aviation-related psychological evaluations: Jones, D. R. (2008). Aerospace
Psychiatry. In J. R. Davis, R. Johnson, J. Stepanek & J. A. Fogarty (Eds.),
Fundamentals of Aerospace Medicine (4th Ed.), (pp. 406-424). Philadelphia:
Lippencott Williams & Wilkins.
210

___________________________________________________________________________
PROTOCOL FOR BINOCULAR MULTIFOCAL

AND ACCOMMODATING DEVICES
This Protocol establishes the authority for the Examiner to issue an airman medical certificate to
binocular applicants using multifocal or accommodating ophthalmic devices.
Devices acceptable for aviation-related duties must be FDA approved and include:
Intraocular Lenses (multifocal or accommodating intraocular lens implants)
Bifocal/Multifocal contact lenses
Examiners may issue as outlined below:
Adaptation period before certification:

- Surgical lens implantation minimum 3 months post-operative
- Contact lenses (bifocal or multifocal) minimum one month of use
Must provide a report to include the FAA Form 8500-7, Report of Eye Evaluation, from
the operating surgeon or the treating eye specialist. This report must attest to stable
visual acuity and refractive error, absence of significant side effects/complications, need
of medications, and freedom from any glare, flares or other visual phenomena that could
affect visual performance and impact aviation safety
The following visual standards, as required for each class, must be met for each eye:
Distant
First- and Second-Class

20/20 or better in each eye separately, with or without correction
Third-Class
20/40 or better in each eye separately, with or without correction
Near
All Classes
20/40 or better in each eye separately (Snellen equivalent), with or
without correction, as measured at 16 inches
Intermediate First- and Second-Class

20/40 or better in each eye separately (Snellen equivalent), with or
without correction at age 50 and over, as measured at 32 inches
Third-Class
No requirement
Note: The above does not change the current certification policy on the use of monofocal nonaccommodating intraocular lenses.
211

___________________________________________________________________________
PROTOCOL FOR CARDIAC TRANSPLANT

The Examiner must defer issuance. Issuance is considered for Third-class applicants only.
FAA Cardiology Panel will review. Applicants found qualified will be required to provide annual
followup evaluations. All studies must be performed within 30 days of application.
Requirements for consideration:
A 1 year recovery period shall elapse after the cardiac transplant before consideration
A current report from the treating transplant cardiologist regarding the status of the
cardiac transplant, including all pre- and post-operative reports. A statement regarding
functional capacity, modifiable cardiovascular risk factors, and prognosis for
incapacitation
Current blood chemistries (fasting blood sugar, hemoglobin A1C concentration, and
blood lipid profile to include total cholesterol, HDL, LDL, and triglycerides), within 30
days
Any tests performed or deemed necessary by all treating physicians (e.g., myocardial
biopsy)
Coronary Angiogram
Graded Exercise Stress Test (see disease protocol) and stress echocardiogram
A current 24-hour Holter monitor evaluation to include selective representative tracings
Complete documentation of all rejection history, whether treated or not; include hospital
records and reports of any tests done
A complete history regarding any infectious process
All complete history regarding any malignancy
List of all present medications and dosages, including side effects.
It is the responsibility of each applicant to provide the medical information required to determine
his/her eligibility for airman medical certification. A medical release form may help in obtaining
the necessary information. Please ensure full name appears on any reports or correspondence.
All information shall be forwarded in one mailing to either:
Medical Appeals Section, AAM-313
Aerospace Medical Certification Division
Post Office Box 26080
Oklahoma City OK 73125-9914

6700 S MacArthur Blvd., Room B-13
Oklahoma City OK 73169AASI FOR
212

___________________________________________________________________________
PROTOCOL FOR CARDIOVASCULAR EVALUATION (CVE)

A current cardiovascular evaluation (CVE) must include:
A personal and family medical history assessment
Clinical cardiac and general physical examination
An assessment and statement regarding the applicants medications, functional

capacity, and modifiable cardiovascular risk factors
Prognosis for incapacitation
Blood chemistries (fasting blood sugar, current blood lipid profile to include total
cholesterol, HDL, LDL, and triglycerides) performed within the last 90 days
213

___________________________________________________________________________
PROTOCOL FOR CONDUCTIVE KERATOPLASTY

Conductive Keratoplasty (CK) is a refractive surgery procedure. It is acceptable for
aeromedical certification, with Special Issuance, after review by the FAA.
The following criteria are necessary for initial certification:
The airman is not qualified for six months post procedure
The airman must provide all medical records related to the procedure
A current status report by the surgical eye specialist with special note regarding
complications of the procedure or the acquired monocularity, or vision complaints
by the airman
A current FAA Form 8500-7, Report of Eye Evaluation
A medical flight test may be necessary (consult with the FAA)
Annual followups by the surgical eye specialist
214

___________________________________________________________________________
PROTOCOL FOR EVALUATION OF

CORONARY HEART DISEASE (CHD)
For the purpose of airman certification coronary heart disease (CHD) is divided into 4
broad categories, with or without myocardial infarction (MI):
Open revascularization of any coronary artery(s) and left main coronary
artery stenting (with or without MI). Open revascularization includes coronary
artery bypass grafting (CABG; on- or off-pump), minimally invasive procedures
by incision, and robot operations. Left main coronary artery stenting carries the
same risk of future cardiac events as CABG, thus it is treated the same for
certification or qualification purposes
Percutaneous intervention (with or without MI). This includes angioplasty
(PTCA) and bare metal or drug-eluting stents
MI without any open or percutaneous intervention
MI from non-coronary artery disease causes. Examples include epinephrine
injection, cardiac trauma, complications of catheterization, Factor V Leiden, etc.
Recovery time before consideration and required tests will vary by the airman medical
certificate applied for and the categories above.
A. Required recovery times for all classes:
a. 6 months: Open revascularization of any coronary artery(s) or left main
coronary artery stenting
b. 3 months:
Percutaneous intervention excluding left main coronary artery
interventions
Myocardial infarction (MI), uncomplicated, without any open or
percutaneous intervention procedures
MI from non-coronary artery disease
B. Required documentation for all pilots with MI due to non-coronary artery disease:
a. Current status report from the treating physician
b. Copies of all medical records (inpatient and outpatient) pertaining to the
event, including all labs, tests, or study results and reports.
C. Required documentation for all pilots with any of the remaining conditions above:
a. The required documentation, including GXT and cardiac catheterization,
must be accomplished no sooner than either 6 months or 3 months postevent, depending on the underlying condition as listed in Paragraph A.
above
b. Copies of all medical records (inpatient and outpatient) pertaining to the
event, including all labs, tests, or study results and reports.
c. Current status report from the treating cardiologist (cardiovascular
evaluation (CVE)) including:
Personal and family medical history assessment; clinical cardiac
and general physical examination; assessment and statement
215

___________________________________________________________________________
regarding the applicant's functional capacity and prognosis for

incapacitation
Documentation of counselling on modifiable cardiovascular risk
factors
All medications and side-effects, if any
Labs (lipids, blood glucose)
d. Current Bruce Protocol Stress Test (GXT):
Third-class airmen - maximal plain GXT
First and unlimited second-class airmen require maximal
radionuclide GXT.
For specific GXT requirements see Guidelines for GXT
D. Additional required documentation for first and unlimited* second - class airmen
a. For conditions requiring 6-month recovery:
6-month post event cardiac catheterization
6-month post event maximal radionuclide GXT (see above)
b. For conditions requiring 3-month recovery:
3-month post event cardiac catheterization
3-month post event maximal radionuclide GXT (see above)
c. The applicant should indicate if a lower class medical certificate is
acceptable (if they are found ineligible for the class sought)
E. Additional required documentation for percutaneous coronary intervention:
The applicant must provide the operative or post procedure report. If a STENT
was placed, the report must include make of STENT, implant location(s), and the
length and diameter of each STENT.
A SPECT myocardial perfusion exercise stress test using technetium agents and/or
thallium may be required for consideration for any class if clinically indicated or if the
exercise stress test is abnormal by any of the usual parameters. The interpretive report
and all SPECT images, preferably in black and white, must be submitted.
Note: If cardiac catheterization and/or coronary angiography have been performed, all
reports and actual films (if films are requested) must be submitted for review. Copies
should be made of all films to safeguard against loss. Films should be labeled with the
applicants name and return address.
* Limited second-class medical certificate refers to a second-class certificate with a
functional limitation such as Not Valid for Carrying Passengers for Compensation
or Hire, "Not Valid for Pilot in Command, Valid Only When Serving as a Pilot
Member of a Fully Qualified Two-Pilot Crew," etc.
216

___________________________________________________________________________
SPECIFICATIONS FOR NEUROPSYCHOLOGICAL

EVALUATIONS FOR TREATMENT WITH SSRI MEDICATIONS
Why is a neuropsychological evaluation required? Depression and other conditions
treated with selective serotonin reuptake inhibitor (SSRI) medications, as well as the
SSRIs themselves, may produce cognitive deficits that would make an airman unsafe to
perform pilot duties. This guideline outlines the requirements for a neuropsychological
evaluation.
hospitalizations, observations or treatment not previously submitted to the FAA.
Interpretation of testing including, but not limited to, the tests as specified
below.
LAST UPDATE May 27, 2015
217

___________________________________________________________________________

What is required for testing?
CogScreen-AE (a brief test battery developed specifically for use with pilots to
assess the neurocognitive domains most critical to flight performance). If the
neuropsychologist interprets the clinical interview and CogScreen-AE results to
show no evidence of neuropsychological impairment or deficiencies, then no
further neurocognitive testing needs to be conducted at that time as part of the
evaluation.
If the neuropsychologist interprets the clinical interview and CogScreen-AE
results as raising concerns about or showing neuropsychological impairment or
deficiencies, then the neuropsychologist should perform a full battery of testing.
The required testing must include:
The Wechsler Adult Intelligence Scales (Processing Speed and Working Memory
Indexes must be scored)
(1) Category Test or Wisconsin Card Sorting Test; and
A continuous performance test (i.e., Test of Variables of Attention [TOVA],
[GDS].
Test of visual memory (WMS-IV subtests, Brief Visuospatial Memory TestRevised, or Rey Complex Figure Test.)
Tests of Language, to include the Boston Naming Test and testing for verbal
fluency (i.e., the COWAT and a semantic fluency task).
Psychomotor testing, to include Finger Tapping and either Grooved Pegboard or
Purdue Pegboard.
Personality testing to include Minnesota Multiphasic Personality Inventory
(MMPI-2). (The MMPI-2-RF is not an approved substitute. All scales,
subscales, content, and supplementary scales must be scored and provided.
Computer scoring is required. Abbreviated administrations are not
acceptable.)
NOTES: (1) All tests administered must be the most current edition of the test unless specified
otherwise; (2) At the discretion of the examiner, additional tests may be clinically necessary to
assure a complete assessment.
218

___________________________________________________________________________
Copies of all computer score reports (e.g., Pearson MMPI-2 Extended Score
Report, CogScreen-AE Report).
administered. When available, pilot norms must be used. If pilot norms are
not available for a particular test, then the normative comparison group (e.g.,
general population, age/education-corrected) must be specified. Also, when
available, percentile scores must be included.
data.
Raw psychological testing data may be required at a future date for expert review
by one of the FAAs consulting clinical psychologists. In that event, authorization
for release of the data by the airman to the expert reviewer will need to be
provided.
1. Depressive disorders and medications used to treat depression are medically
disqualifying for pilots. However, the Federal Air Surgeon has established a policy
for Authorizations for Special Issuance of medical certificates for pilots treated with
selective serotonin reuptake inhibitor (SSRI) medications who meet specific criteria.
2. Where can I find the policy? The current policy is published in the Guide for Aviation
Medical Examiners at Item 47. Psychiatric Conditions - Use of Antidepressant
Medications.
3. What will be required if special issuance is authorized? Pilots found eligible for
Special Issuance will be required to undergo periodic re-evaluations. Requirements
for re-evaluation testing will be specified in the letter authorizing special issuance,
and may be limited to the CogScreen-AE or expanded to include additional tests.
Pilot norms on neurocognitive tests: Kay, G.G. (2002). Guidelines for the Psychological
Evaluation of Aircrew Personnel. Occupational Medicine, 17 (2), 227-245.
Aviation-related psychological evaluations: Jones, D. R. (2008). Aerospace Psychiatry.
In J. R. Davis, R. Johnson, J. Stepanek & J. A. Fogarty (Eds.), Fundamentals of
Aerospace Medicine (4th Ed.), (pp. 406-424). Philadelphia: Lippencott Williams &
Wilkins.
219

___________________________________________________________________________
PROTOCOL FOR DIABETES MELLITUS DIET CONTROLLED

A medical history or clinical diagnosis of diabetes mellitus may be considered previously
established when the diagnosis has been or clearly could be made because of
supporting laboratory findings and/or clinical signs and symptoms. When an applicant
with a history of diabetes is examined for the first time, the Examiner should explain the
procedures involved and assist in obtaining prior records and current special testing.
Applicants with a diagnosis of diabetes mellitus controlled by diet alone are considered
eligible for all classes of medical certificates under the medical standards, provided they
have no evidence of associated disqualifying cardiovascular, neurological, renal, or
ophthalmological disease. Specialized examinations need not be performed unless
indicated by history or clinical findings. The Examiner must document these
determinations on FAA Form 8500-8.
220

___________________________________________________________________________
PROTOCOL FOR HISTORY DIABETES MELLITUS TYPE II

MEDICATION-CONTROLLED (NON INSULIN)
This protocol is used for all diabetic applicants treated with oral agents or incretin
mimetic medications (such as exenatide), herein referred to as medication(s).
An applicant with a diagnosis of diabetes mellitus controlled by medication may be
considered by the FAA for an Authorization of a Special Issuance of a Medical
Certificate (Authorization). For medications currently allowed, see chart of Acceptable
Combinations of Diabetes Medications.
When medication is started the following time periods must elapse prior to certification
to assure stabilization, adequate control, and the absence of side effects or
complications from the medication.
Metformin only. A 14 day period must elapse.
Any other single diabetes medication requires a 60-day period.
The initial Authorization decision is made by the AMCD and may not be made by the
Examiner. An Examiner may re-issue a subsequent airman medical certificate under
the provisions of the Authorization.
The initial Authorization determination will be made on the basis of a DIABETES or
HYPERGLYCEMIA ON ORAL MEDICATIONS STATUS REPORT signed and
completed by the airmans treating provider or a report from the treating physician. The
report must contain a statement regarding the medication used, dosage, the absence or
presence of side effects and clinically significant hypoglycemic episodes, and an
indication of satisfactory control of the diabetes. The results of an A1C hemoglobin
determination within the past 30 days must be included. Note must also be made of the
presence of cardiovascular, neurological, renal, and/or ophthalmological disease. The
presence of one or more of these associated diseases will not be, per se, disqualifying
but the disease(s) must be carefully evaluated to determine any added risk to aviation
safety.
Re-issuance of a medical certificate under the provisions of an Authorization will also be
made on the basis of reports from the treating physician. The contents of the report
must contain the same information required for initial issuance and specifically
reference the presence or absence of satisfactory control, any change in the dosage or
type of medication, and the presence or absence of complications or side effects from
the medication. In the event of an adverse change in the applicant's diabetic status
(poor control or complications or side effects from the medication), or the appearance of
an associated systemic disease, an Examiner must defer the case with all
documentation to the AMCD for consideration.
221

___________________________________________________________________________
If, upon further review of the deferred case, AMCD decides that re-issuance is
appropriate, the Examiner may again be given the authority to re-issue the medical
certificate under the provisions of the Authorization based on data provided by the
treating physician, including such information as may be required to assess the status of
associated medical condition(s).
At a minimum, followup evaluation by the treating physician of the applicant's diabetes
status is required annually for all classes of medical certificates.
An applicant with diabetes mellitus - Type II should be counseled by his or her Examiner
regarding the significance of the disease and its possible complications.
The applicant should be informed of the potential for hypoglycemic reactions and
cautioned to remain under close medical surveillance by his or her treating physician.
The applicant should also be advised that should their medication be changed or the
dosage modified, the applicant should not perform airman duties until the applicant and
treating physician has concluded that the condition is:
under control;
stable;
presents no risk to aviation safety; and
consults with the Examiner who issued the certificate, AMCD or RFS.
222

___________________________________________________________________________
DIABETES or HYPERGLYCEMIA ON ORAL MEDICATIONS

STATUS REPORT
(Updated 5/27/2015)
Name ________________________________ Birthdate ______________________

Applicant ID# __________________________ PI#___________________________
Please have the provider who treats your diabetes enter the information in the space below.
Return the completed form to your AME or to the FAA at:
Using US Postal Service:
or
Aerospace Medical Certification Division AAM-300
Mike Monroney Aeronautical Center
PO BOX 25082
Oklahoma City, OK 73125
1.
2.
3.
4.
Using special mail (UPS, FedEx, etc.)

Aerospace Medical Certification Division-AAM-300
Civil Aerospace Medical Institute, Bldg. 13
6700 S. MacArthur Blvd, Room 308
Provider printed name _______________________ and phone #

Date of last clinical encounter for diabetes
Date of most recent DIABETES MEDICATION change
Hemoglobin A1C lab value ___________________ and date
____________
____________
____________
____________
(A1C lab value must be taken more than 30 days after medication change and within 90 days of
re/certification)
5. List ALL current medications (for any condition) *

______________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
If YES is circled on any of the questions below, please attach narrative, tests, etc.
6. Any side effects from medications
Yes
No
7. ANY episode of hypoglycemia in the past year
Yes
No
8. Any evidence of progressive diabetes induced end organ disease
Cardiac.
Neurological.
Ophthalmological.
Peripheral neuropathy
Renal disease..
9. Does this patient take ANY form of insulin
10. Any clinical concerns?
__________________________________
Treating Provider Signature
Yes
Yes
Yes
Yes
Yes
No
No
No
No
No
Yes
Yes
No
No
________________
Date
*Note: See Acceptable Combinations of Diabetes Medications for airman.
223

___________________________________________________________________________
PROTOCOL FOR INSULIN-TREATED

DIABETES MELLITUS - TYPE I & TYPE II
Consideration will be given only to those individuals who have been clinically stable on their
current treatment regimen for a period of 6 months or more. The FAA has an established policy
that permits the special issuance medical certification to some insulin treated applicants.
Individuals certificated under this policy will be required to provide medical documentation
regarding their history of treatment, accidents, and current medical status. If certificated, they
will be required to adhere to monitoring requirements and are prohibited from operating aircraft
outside the United States. The following is a summary of the evaluation protocol and an outline
of the conditions that the FAA will apply for third class applicants. First and second class
applicants will be evaluated on a case-by-case basis by the Federal Air Surgeons Office.
A. Initial Certification
1. The applicant must have had no recurrent (two or more) episodes of hypoglycemia in
the past 5 years and none in the preceding 1 year which resulted in loss of
consciousness, seizure, impaired cognitive function or requiring intervention by
another party, or occurring without warning (hypoglycemia unawareness).
2. The applicant will be required to provide copies of all medical records as well as
accident and incident records pertinent to their history of diabetes.
3. A report of a complete medical examination preferably by a physician who
specializes in the treatment of diabetes will be required. The report must include, as
a minimum:
a. Two measurements of glycosylated hemoglobin (total A1 or A1c concentration
and the laboratory reference range), separated by at least 90 days. The most
recent measurement must be no more than 90 days old.
b. Specific reference to the applicants insulin dosages and diet.
c. Specific reference to the presence or absence of cerebrovascular,
cardiovascular, or peripheral vascular disease or neuropathy.
d. Confirmation by an eye specialist of the absence of clinically significant eye
disease.
e. Verification that the applicant has been educated in diabetes and its control
and understands the actions that should be taken if complications, especially
hypoglycemia, should arise. The examining physician must also verify that
the applicant has the ability and willingness to properly monitor and manage
his or her diabetes.
f.
If the applicant is age 40 or older, a report, with ECG tracings, of a maximal

graded exercise stress test.
g. The applicant shall submit a statement from his/her treating physician,

Examiner, or other knowledgeable person attesting to the applicant's
224

___________________________________________________________________________
dexterity and ability to determine blood glucose levels using a recording
glucometer.
NOTE: Student pilots may wish to ensure they are eligible for medical certification prior to
beginning or resuming flight instruction or training. In order to serve as a pilot in command, you
must have a valid medical certificate for the type of operation performed.
B. Subsequent Medical Certification
1. For documentation of diabetes management, the applicant will be required to carry
and use a whole blood glucose measuring device with memory and must report to
the FAA immediately any hypoglycemic incidents, any involvement in accidents that
result in serious injury (whether or not related to hypoglycemia); and any evidence of
loss of control of diabetes, change in treatment regimen, or significant diabetic
complications. With any of these occurrences, the individual must cease flying until
cleared by the FAA.
2. At 3-month intervals, the airman must be evaluated by the treating physician. This
evaluation must include a general physical examination, review of the interval
medical history, and the results of a test for glycosylated hemoglobin concentration.
The physician must review the record of the airman's daily blood glucose
measurements and comment on the results. The results of these quarterly
evaluations must be accumulated and submitted annually unless there has been a
change. (See No. 1 above - If there has been a change the individual must report the
change(s) to the FAA and wait for an eligibility letter before resuming flight duties).
3. On an annual basis, the reports from the examining physician must include
confirmation by an eye specialist of the absence of significant eye disease.
4. At the first examination after age 40 and at 5-year intervals, the report, with ECG
tracings, of a maximal graded exercise stress test must be included in consideration
of continued medical certification.
C. Monitoring and Actions Required During Flight Operations
To ensure safe flight, the insulin using diabetic airman must carry during flight a recording
glucometer; adequate supplies to obtain blood samples; and an amount of rapidly
absorbable glucose, in 10 gm portions, appropriate to the planned duration of the flight. The
following actions shall be taken in connection with flight operations:
1. One-half hour prior to flight, the airman must measure the blood glucose
concentration. If it is less than 100 mg/dl the individual must ingest an appropriate
(not less than 10 gm) glucose snack and measure the glucose concentration
one-half hour later. If the concentration is within 100 -- 300 mg/dl, flight operations
may be undertaken. If less than 100, the process must be repeated; if over 300, the
flight must be canceled.
2. One hour into the flight, at each successive hour of flight, and within one half hour
prior to landing, the airman must measure their blood glucose concentration. If the
concentration is less than 100 mg/dl, a 20 gm glucose snack shall be ingested. If the
concentration is 100 -- 300 mg/dl, no action is required. If the concentration is greater
225

___________________________________________________________________________
than 300 mg/dl, the airman must land at the nearest suitable airport and may not
resume flight until the glucose concentration can be maintained in the 100 -- 300
mg/dl range. In respect to determining blood glucose concentrations during flight, the
airman must use judgment in deciding whether measuring concentrations or
operational demands of the environment (e.g., adverse weather, etc.) should take
priority. In cases where it is decided that operational demands take priority, the
airman must ingest a10 gm glucose snack and measure his or her blood glucose
level 1 hour later. If measurement is not practical at that time, the airman must ingest
a 20 gm glucose snack and land at the nearest suitable airport so that a
determination of the blood glucose concentration may be made.
(Note: Insulin pumps are acceptable)
226

___________________________________________________________________________
Protocol for Maximal Graded Exercise Stress Test

Requirements
If a plain GXT is required and is uninterpretable for any reason, a radionuclide GXT will
then be required before further consideration
GXT requirements:
o 100% of predicted maximal heart rate unless medically contraindicated or
prevented either by symptoms or medications
o Complete Stage 3 (equivalent to at least 9 minutes)
o Studies of less than 85% of maximum predicted heart rate and less than 9
minutes of exercise (6 minutes for age 70 or greater) may serve a basis for
denial
o Beta blockers and calcium channel blockers (specifically diltiazem and
verapamil), or digitalis preparations should be discontinued for 24-48 hours prior
to testing (if not contraindicated and only with the consent of the treating
physician) in order to obtain maximum heart rate
If the GXT is done on beta blockers, calcium blockers, or pharmais drugs,
the applicant must provide explanation from the treating cardiologist as to
why the medication(s) cannot be held.
The worksheet with blood pressure/pulse recordings at various stages, interpretive
report, and actual ECG tracings* must be submitted
o Tracings must include a rhythm strip, a full 12-lead ECG recorded at rest (supine
and standing), one or more times during each stage of exercise, at the end of
each stage, at peak exercise, and every minute during recovery for at least 5
minutes or until the tracings return to baseline level.*Computer generated,
sample-cycle ECG tracings are unacceptable in lieu of the standard tracings. If
submitted alone, this may result in deferment until this requirement is met
In patients with bundle branch blocks, LVH, or diffuse ST/T wave changes at rest, it will be
necessary to provide a stress echo or nuclear stress test.
Remember, a phone call to either AMCD or RFS may avoid unnecessary deferral.
Reasons for not renewing an AASI:
The applicant is unable to achieve at least 85% of maximal heart rate on stress testing
or less than 9 minutes (6 minutes if age 70 or greater);
The applicant develops 1 mm or greater ST segment depression at any time during
stress testing, unless the applicant has additional medical evidence such as a nuclear
imaging study or a stress echocardiogram showing the absence of reversible ischemia
or wall motion abnormalities reviewed and reported by a qualified cardiologist;
The nuclear stress testing shows evidence of reversible ischemia, a stress
echocardiogram shows exercised induced wall motion abnormalities, or either study
demonstrates a negative change from the prior study of the same type;
The ejection fraction on a nuclear stress test or stress echocardiogram is 40% or less; or
a 10% decrease from a prior study; or
The applicant reports any other disqualifying medical condition or undergoes therapy not
previously reported
227

___________________________________________________________________________
Protocol for Graded Exercise Stress Test

Bundle Branch Block Requirements
If the Bundle Branch Block (BBB) has been previously documented and evaluated, no
further evaluation is required. A medical certificate should not be issued to any class if
the applicant has a new onset of a BBB. A right BBB in an otherwise healthy person 30
years of age or younger should not require a CVE. All other individuals who do have a
right BBB require a CVE but a radionuclide study should not be required unless the
standard exercise stress test cannot be interpreted. A stress echocardiogram may be
sufficient in most cases. A left BBB in a person of any age should have a CVE and
should include a radionuclide perfusion study. Those individuals who have a negative
work-up may be issued the appropriate class of medical certificate. No followup
is required. If any future changes occur, a new current CVE will be required.
If areas of ischemia are noted, a coronary angiogram may be indicated for definitive
diagnosis. According to the current literature, approximately 40% of individuals with
LBBB will demonstrate a false positive thallium reperfusion defect in the septal area. If
significant CAD is diagnosed, refer to Special Issuance guidelines. Some cases may be
forwarded to a FAA-selected cardiology consultant specialist for review and
recommendation for medical certification.
228

___________________________________________________________________________
PROTOCOL FOR HISTORY OF HUMAN

IMMUNODEFICIENCY VIRUS (HIV) RELATED CONDITIONS
Persons on antiretroviral medication will be considered only if the medication is
approved by the U.S. Food and Drug Administration and is used in accordance with an
acceptable drug therapy protocol. Acceptable protocols are cited in Guidelines for the
Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents developed by the
Department of Health and Human Services Panel on Clinical Practices for Treatment of
HIV Infection.
For persons taking HIV medication for long-term prevention or Pre-Exposure
Prophylaxis (PrEP), see Item 48. General Systemic - Human Immunodeficiency Virus
(HIV).
Application for special issuance must include reports of examination by a physician
knowledgeable in the treatment of HIV-infected persons and a medical history
emphasizing symptoms and treatment referable to the immune and neurologic system.
In addition, these reports must include a "viral load" determination by polymerase chain
reaction (PCR), CD4+ lymphocyte count, a complete blood count, and the results of
liver function tests. An assessment of cognitive function (preferably by Cogscreen or
other test battery acceptable to the Federal Air Surgeon) must be submitted. Additional
cognitive function tests may be required as indicated by results of the cognitive tests. At
the time of initial application, viral load must not exceed 1,000 copies per milliliter of
plasma, and cognitive testing must show no significant deficit(s) that would preclude the
safe performance of airman duties.
Application for special issuance must include reports of examination by a physician
knowledgeable in the treatment of HIV-infected persons and a medical history
emphasizing symptoms and treatment referable to the immune and neurologic system.
For initial consideration, see the following Human Immunodeficiency Virus (HIV)
Specification Sheet for the required clinical reports and documentation (including
cognitive testing).
If granted Authorization for Special Issuance, follow-up requirements will be specified in
the Authorization letter. However, the usual requirements will be:
First 2 years of surveillance: see the Under 2 Year Surveillance HIV

Specification Sheet
After the first 2 years of surveillance: see the After 2 Years Surveillance HIV
Specification Sheet
229

___________________________________________________________________________
HUMAN IMMUNODEFICIENCY VIRUS (HIV) SPECIFICATION

Persons who are infected with the HIV and who do not have a diagnosis of Acquired
Immunodeficiency Syndrome (AIDS) may be considered for any class medical
certificate, if otherwise qualified. Persons on an antiretroviral medication will be
considered only if the medication is approved by the U.S. Food and Drug Administration
and is used in accordance with an acceptable drug therapy protocol. Current studies
should be submitted no later than 30-days from test date. In order to be considered for
a medical certificate the following data must be provided:
1. A current report from a physician knowledgeable in the treatment of HIV-infected
persons and a medical history emphasizing symptoms and treatment referable to the
immune system;
2. Current viral load determination by polymerase chain reaction (PCR) for persons
who have had an AIDS defining illness 2 determinations, 1 month apart);
3. Current CD4 (for persons who have had an AIDS defining illness, 2 determinations, 1
month apart) and lymphocyte count;
4. Current complete blood count (CBC) with differential;
5. Results of current liver function tests;
6. BUN and creatine;
7. a. A current assessment of cognitive function (preferably by
CogScreen-AE [Aeromedical Edition] or other test battery) must be
provided with the Initial application. Follow-up neurologicalpsychological evaluations are required annually for first and
second-class pilots and every other year for third-class.
b. If CogScreen-AE is not available, we suggest the following:
1. MMPI
2. WAIS-R
3. Memory Test (one of the following)
a. Wechsler Memory Scale
b. Rey auditory Verbal Learning Test
4. Trails Making Test (A&B)
5. Category Test (booklet or machine)
6. Sensory-Motor Screening
7. Language Functioning Test (one of the following)
a. Speech Sounds Perception Test
b. Aphasia Screening Test
All of the above should be submitted together in one mailing to:

Using US Postal Service:
or
Aeromedical Certification Branch-AAM-311
Mike Munroney Aeronautical Center
PO BOX 25082
Using special mail (UPS, FedEx, etc.)

Aeromedical Certification Branch-AAM-311
Mike Munroney Aeronautical Center
6700 S. MacArthur Blvd, Room B-59
1. For applicants with a history of cytomegalovirus (CMR) retinitis, a current ophthalmological evaluation
with visual fields must be provided with the initial application and at 6 month-intervals thereafter.
230

___________________________________________________________________________
UNDER 2 YEAR SURVEILLANCE HIV SPECIFICATION

Please provide our office with a current status report from a treating physician
knowledgeable and experienced in the treatment of HIV-infected persons. This report
should include the information outlined below, along with any separate additional
testing.
The results should be sent to the Aerospace Medical Certification Division (AMCD) After
review, if the airman is determined qualified, AMCD/Regional Flight Surgeon (RFS) will
send a letter to the airman authorizing the Aviation Medical Examiner (AME) to issue a
new time-limited medical certificate, as applicable.
Both the initial and subsequent medical determinations may only be made by the RFS
or AMCD.
The current status report should include:
Every 3 months: determinations of viral load, CD4 cell count, a clinical

assessment of cognitive function, and any other laboratory and clinical tests
deemed necessary by the treating physician. These results may be aggregated
and included in the written current status report every 6 months unless there is
an adverse change;
Every 6 months a written current status report from the treating physician
knowledgeable and experienced in the treatment of HIV-infected persons. To
include the following: a medical history emphasizing symptoms and treatment
referable to the immune system, any signs or symptoms of atherosclerotic
cardiovascular disease, and diabetes mellitus or insulin resistance and a clinical
assessment of cognitive function;
Formal cognitive/neuropsychiatric testing, preferably with CogScreen-AE [Note:

initial and periodic testing should be done with the same test instruments each
time in order to allow valid comparisons over time]. Formal cognitive function
testing if due; and
Any other tests advised by the treating physician.
231

___________________________________________________________________________
AFTER 2 YEARS SURVEILLANCE HIV SPECIFICATION

Please provide our office with a current status report from a treating physician
knowledgeable and experienced in the treatment of HIV-infected persons. This report
should include the information outlined below, along with any separate additional
testing.
The results should be sent to the Aerospace Medical Certification Division (AMCD) After
review, if the airman is determined qualified, AMCD/Regional Flight Surgeon (RFS) will
send a letter to the airman authorizing the Aviation Medical Examiner (AME) to issue a
new time-limited medical certificate, as applicable.
Both the initial and subsequent medical determinations may only be made by the RFS
or AMCD.
The current status report should include:
Every 6 months: determinations of viral load, CD4 cell count, a clinical

assessment of cognitive function and any other laboratory and clinical tests
deemed necessary by the treating physician. These results may be aggregated
and included in a written current status report every 12 months unless there is an
adverse change;
Every 12 months a written current status report from the treating physician
knowledgeable and experienced in the treatment of HIV-infected persons. To
include the following: a medical history emphasizing symptoms and treatment
referable to the immune system, any signs or symptoms of atherosclerotic
cardiovascular disease, and diabetes mellitus or insulin resistance and a clinical
assessment of cognitive function;
Formal cognitive/neuropsychiatric testing, preferably with CogScreen-AE [Note:

initial and periodic testing should be done with the same test instruments each
time in order to allow valid comparisons over time]. Formal cognitive function
testing if due; and
Any other tests advised by the treating physician.
232

___________________________________________________________________________
PROTOCOL FOR EVALUATION OF

IMPLANTED PACEMAKER
A 2-month recovery period must elapse after the pacemaker implantation to allow for
recovery and stabilization. Submit the following:
1. Copies of hospital/medical records pertaining to the requirement for the
pacemaker, make of the generator and leads, model and serial number,
admission/discharge summaries, operative report, and all ECG tracings.
2. Evaluation of pacemaker function to include description and documentation of
underlying rate and rhythm with the pacer turned "off" or at its lowest setting
(pacemaker dependency), programmed pacemaker parameters, surveillance
record, and exclusion of myopotential inhibition and pacemaker induced
hypotension (pacemaker syndrome), Powerpack data including beginning of life
(BOL) and elective replacement indicator/end of life (ERI/EOL).
3. Readable samples of all electronic pacemaker surveillance records post surgery
or over the past 6 months, or whichever is longer. It must include a sample strip
with pacemaker in free running mode and unless contraindicated, a sample strip
with the pacemaker in magnetic mode.
4. An assessment and statement from a physician regarding general physical and
cardiac examination to include symptoms or treatment referable to the
cardiovascular system; the airman's interim and current cardiac condition,
functional capacity, medical history, and medications.
5. A report of current fasting blood sugar and a current blood lipid profile to include:
total cholesterol, HDL, LDL, and triglycerides.
6. A current Holter monitor evaluation for at least 24-consecutive hours, to include
select representative tracings.
7. A current M-mode, 2-dimensional echocardiogram with Doppler.
8. A current Maximal Graded Exercise Stress Test Requirements
9. It is the responsibility of each applicant to provide the medical information
required to determine his/her eligibility for airman medical certification. A medical
release form may help in obtaining the necessary information.
233

___________________________________________________________________________
All information shall be forwarded in one mailing to:


Oklahoma City OK 73169
No consideration can be given for special issuance until all the required data has been
received.
The use of the airman's full name and date of birth on all correspondence and reports
will aid the agency in locating the proper file.
234

___________________________________________________________________________
PROTOCOL FOR LIVER TRANSPLANT (RECIPIENT)

(Updated 7/29/15)
The Examiner must defer initial issuance. An applicant with a history of liver transplant
must submit the following for consideration of a medical certificate. Applicants found
qualified will be required to provide annual follow up evaluations per their authorization
letter.
Requirements for initial consideration:
A six (6) month post-transplant recovery period with documented stability for the
last three (3) months;
Pre-transplant treatment notes that identify the diagnosis, indication for

transplant, and any sequelae prior to transplant. If alcohol was a contributing
factor (abuse or dependence), submit evidence of treatment and recovery;
Hospital reports to include admission note, operative note, and hospital

discharge summary;
A current status report from the treating physician that describes:

o The status of the transplant, functional capacity, modifiable risk factors,
and prognosis for incapacitation; and
o Any recent or expected change in treatment plan
Complication history such as:

o Rejection or graft versus host disease/GVHD;
o Infection Hepatitis C (HCV) or CMV; and/or
o Malignancy due to hepatocellular carcinoma (HCC) or following transplant
and initiation of immune-suppressants
Current medication list to include names and dosage of immunosuppressive

medications, the presence or absence of any side effects, and how long the
airman has been on these medications.
Lab and images to include copies of most recent lab performed by the treating
physician (CBC, CMP with LFTs) and any other tests deemed necessary by the
treating physician such as imaging or liver biopsy
235

___________________________________________________________________________
PROTOCOL FOR MEDICATION CONTROLLED

METABOLIC SYNDROME
(Glucose Intolerance, Impaired Glucose tolerance, Impaired Fasting Glucose,
Insulin Resistance, and Pre-Diabetes)
This protocol is used for all applicants with Glucose Intolerance, Impaired Glucose
tolerance, Impaired Fasting Glucose, Insulin Resistance, and/or Pre-Diabetes treated with oral
agents or incretin mimetic medications (exenatide), herein referred to as medication(s).
An applicant with a diagnosis of diabetes mellitus controlled by medication may be
considered by the FAA for an Authorization of a Special Issuance of a Medical
Certificate (Authorization). For medications currently allowed, see chart of Acceptable
Combinations of Diabetes Medications.
When medication is started the following time periods must elapse prior to certification
to assure stabilization, adequate control, and the absence of side effects or
complications from the medication.
Metformin only. A 14 day period must elapse.
Any other single diabetes medication requires a 60-day period.
The initial Authorization decision is made by the AMCD and may not be made by the
Examiner. An Examiner may re-issue a subsequent airman medical certificate under
the provisions of the Authorization.
The initial Authorization determination will be made on the basis of a report from the
treating physician. There must be sufficient information to rule out diabetes mellitus.
For favorable consideration, the report must contain a statement regarding the
medication used, dosage, the absence or presence of side effects and clinically
significant hypoglycemic episodes, and an indication of satisfactory control of the
metabolic syndrome. The results of an A1C hemoglobin determination within the past
30 days must be included. Note must also be made of the presence of cardiovascular,
neurological, renal, and/or ophthalmological disease. The presence of one or more of
these associated diseases will not be, per se, disqualifying but the disease(s) must be
carefully evaluated to determine any added risk to aviation safety.
Re-issuance of a medical certificate under the provisions of an Authorization will also be
made on the basis of reports from the treating physician. The contents of the report
must contain the same information required for initial issuance and specifically
reference the presence or absence of satisfactory control, any change in the dosage or
type of medication, and the presence or absence of complications or side effects from
the medication. In the event of an adverse change in the applicant's status
(development of diabetes mellitus, poor control or complications or side effects from the
medication), or the appearance of an associated systemic disease, an Examiner must
defer the case with all documentation to the AMCD for consideration.
236

___________________________________________________________________________
If, upon further review of the deferred case, AMCD decides that re-issuance is
appropriate, the Examiner may again be given the authority to re-issue the medical
certificate under the provisions of the Authorization based on data provided by the
treating physician, including such information as may be required to assess the status of
associated medical condition(s).
At a minimum, followup evaluation by the treating physician of the applicant's metabolic
syndrome status is required annually for all classes of medical certificates.
An applicant with metabolic syndrome should be counseled by his or her Examiner
regarding the significance of the disease and its possible complications, including the
possibility of developing diabetes mellitus.
The applicant should be informed of the potential for hypoglycemic reactions and
cautioned to remain under close medical surveillance by his or her treating physician.
The applicant should also be advised that should their medication be changed or the
dosage modified, the applicant should not perform airman duties until the applicant and
treating physician has concluded that the condition is:
under control;
stable;
presents no risk to aviation safety; and
consults with the Examiner who issued the certificate, AMCD or RFS.
237

___________________________________________________________________________
PROTOCOL FOR MUSCULOSKELETAL EVALUATION

The Examiner should defer issuance.
An applicant with a history of musculoskeletal conditions must submit the following if
consideration for medical certification is desired:
Current status report
Functional status report
Degree of impairment as measured by strength, range of motion, pain
NOTE: If the applicant is otherwise qualified, the FAA may issue a limited certificate.
This certificate will permit the applicant to proceed with flight training until ready for a
medical flight test. At that time, and at the applicant's request, the FAA (usually the
AMCD) will authorize the student pilot to take a medical flight test in conjunction with the
regular flight test. The medical flight test and regular private pilot flight test are
conducted by an FAA inspector. This affords the student an opportunity to demonstrate
the ability to control the aircraft despite the handicap. The FAA inspector prepares a
written report and indicates whether there is a safety problem. A medical certificate and
statement of demonstrated ability (SODA) may be provided to the airman from
AMCD/RFS office if the MFT is successful and the airman is otherwise qualified.
When prostheses are used or additional control devices are installed in an aircraft to
assist the amputee, those found qualified by special certification procedures will have
their certificates limited to require that the device(s) (and, if necessary, even the specific
aircraft) must always be used when exercising the privileges of the airman certificate.
238

___________________________________________________________________________
SPECIFICATIONS FOR
NEUROPSYCHOLOGICAL EVALUATIONS
FOR POTENTIAL NEUROCOGNITIVE IMPAIRMENT
Why is a neuropsychological evaluation required? Head trauma, stroke,
encephalitis, multiple sclerosis, other suspected acquired or developmental conditions,
and medications used for treatment, may produce cognitive deficits that would make an
airman unsafe to perform pilot duties. This guideline outlines the requirements for a
neuropsychological evaluation.
including, but not limited to, the core test battery (specified below).
239

___________________________________________________________________________

CogScreen-Aeromedical Edition (CogScreen-AE).
Working Memory Indexes must be scored),
[GDS].
California Verbal Learning Test-II),
Test of visual memory (WMS-IV subtests, Brief Visuospatial Memory TestRevised, or Rey Complex Figure Test),
and a semantic fluency task),
Pegboard.
Copies of all computer score reports (e.g., CogScreen-AE score report, Pearson
MMPI-2 Extended Score Report, TOVA, CPT-II or IVA+ Report).
240

___________________________________________________________________________

data.
The raw neurocognitive testing data may be required at a future date for expert
review by one of the FAAs consulting clinical neuropsychologists. In that event,
authorization for release of the data by the airman to the expert reviewer will
need to be provided.
5. Will additional testing be required in the future? If eligible for unrestricted medical
certification, no additional testing would be required. However, pilots found eligible
for Special Issuance will be required to undergo periodic re-evaluations. The letter
authorizing special issuance will outline required testing, which may be limited to
specific tests or expanded to include a comprehensive test battery.
227-245.
241

___________________________________________________________________________
PROTOCOL FOR OBSTRUCTIVE SLEEP APNEA

Quick Start for AMES
Sleep apnea has significant safety implications due to cognitive impairment secondary
to the lack of restorative sleep and is disqualifying for airman medical certification. The
condition is part of a group of sleep disorders with varied etiologies. Specifically, sleep
apneas are characterized by abnormal respiration during sleep. The etiology may be
obstructive, central or complex in nature. However, no matter the cause, the
manifestations of this disordered breathing present safety risks that include, but are not
limited to, excessive daytime sleepiness (daytime hypersomnolence), cardiac
dysrhythmia, sudden cardiac death, personality disturbances, refractory hypertension
and, as mentioned above, cognitive impairment. Certification may be considered once
effective treatment is shown.
This protocol is designed to evaluate airmen who may be presently at risk for
Obstructive Sleep Apnea (OSA) and to outline the certification requirements for airmen
diagnosed with OSA. While this protocol focuses on OSA, the AME must also be
mindful of other sleep-related disorders such as insomnia, parasomnias, sleep-related
movement disorders (e.g. restless leg syndrome and periodic leg movement), central
sleep apnea and other hypersomnias, circadian rhythm sleep disorders, etc., that may
also interfere with restorative sleep. All sleep disorders are also potentially medically
disqualifying if left untreated. If one of these other sleep-related disorders is initially
identified during the examination, the AME must contact their RFS or AMCD for
guidance.
Risk Information
The American Academy of Sleep Medicine has established the risk criteria (utilizing
Tables 2 and 3) for OSA. When applying Table 2 and 3, the AME is expected to employ
their clinical judgment.
Educational information for airmen can be found in the FAA Pilot Safety Brochure on
Obstructive Sleep Apnea. Supplemental information for AMEs can be found in OSA
Reference Materials, which can be found at end of the Protocols section.
Persons with physical findings such as a retrograde mandible, large tongue or tonsils,
neuromuscular disorders, or connective tissue anomalies are at risk of OSA requiring
treatment despite a normal or low BMI. OSA is also associated with conditions such as
refractory hypertension requiring more than two medications for control, diabetes
mellitus, and atrial fibrillation. Over 90% of individuals with a BMI of 40 or greater have
OSA requiring treatment. Up to 30% of individuals with OSA have a BMI less than 30.
242

___________________________________________________________________________
AME Actions - On every exam, the Examiner must triage the applicant into one
of 6 groups:
If the applicant is on a Special Issuance Authorization for OSA (Group/Box 1

of OSA flow chart), select Group 1 on the AME Action Tab:
o Follow AASI/SI for OSA
o Notate in Block 60; and
o Issue, if otherwise qualified
If the applicant has had a prior sleep assessment (Group/Box 2 of OSA flow
chart), select Group 2 on the AME Action Tab:
o If the airman is under treatment, provide the requirements of the AASI
and advise the airman they must get the Authorization of Special
Issuance;
o Give the applicant Specification Sheet A and advise that a letter will be
sent from the Federal Air Surgeon requesting more information. The
letter will state that the applicant has 90 days to provide the information
to the FAA/AME;
o Notate in Box 60;
If the applicant does not have an AASI/SI or has not had a previous
assessment, the AME must:
o Calculate BMI; and
o Consider AASM risk criteria Table 2 & 3
o If the AME determines the applicant is not currently at risk for OSA
(Group/Box 3 of OSA flow chart), select Group 3 on the AME Action
Tab:
Notate in Block 60; and
Issue, if otherwise qualified
o If the applicant is at risk for OSA but in the opinion of the AME the
applicant is at low risk for OSA , the AME must (Group/Box 4 of OSA
flow chart), select Group 4 on the AME Action Tab:
Discuss OSA risks with applicant;

Provide resource and educational information, as appropriate;
Issue, if otherwise qualified; and
Notate in Block 60
If the applicant is at high risk for OSA, the AME must (Group/Box 5 of OSA
243

___________________________________________________________________________
o Give the applicant Specification Sheet B and advise that a letter will be
sent from the Federal Air Surgeon requesting more information. The
letter will state that the applicant has 90 days to provide the information
to the FAA/AME
If the AME observes or the applicant reports symptoms which are severe
enough to represent an immediate risk to aviation safety of the national
airspace (Group/Box 6 of OSA flow chart), select Group 6 on the AME
Action Tab.
o Notate in Block 60
o THE AME MUST DEFER
244

___________________________________________________________________________
245

___________________________________________________________________________
Obstructive Sleep Apnea Specification Sheet A

Information Request
Your application for airman medical certification submitted this date indicates that you
have been treated or previously assessed for Obstructive Sleep Apnea (OSA).
You must provide the following information to the Aerospace Medical Certification
Division (AMCD) or your Regional Flight Surgeon within 90 days:
All reports and records regarding your assessment for OSA by your primary care
physician and/or a sleep specialist.
If you are currently being treated, also include:

o A signed Airman Compliance with Treatment form or equivalent;
o The results and interpretive report of your most recent sleep study; and
o A current status report from your treating physician indicating that OSA
treatment is still effective.
For CPAP/ BIPAP/ APAP:

A copy of the cumulative annual PAP device report. Target goal
should show use for at least 75% of sleep periods and an average
minimum of 6 hours use per sleep period.
For Dental Devices or for Positional Devices:

Once Dental Devices with recording / monitoring capability are
available, reports must be submitted.
To expedite the processing of your application, please submit the

aforementioned information in one mailing using your reference number (PI,
MID, or APP ID).
Using Regular Mail (US Postal Service)

AAM-300
Civil Aerospace Medical Institute
PO BOX 25082
or
Using Special Mail (FedEx, UPS, etc.)

AAM-300
6700 S. MacArthur Blvd., Room 308
246

___________________________________________________________________________
OBSTRUCTIVE SLEEP APNEA SPECIFICATION SHEET B

ASSESSMENT REQUEST
Due to your risk for Obstructive Sleep Apnea (OSA), and to review your eligibility to have a
medical certificate, you must provide the following information to the Aerospace Medical
Certification Division (AMCD) or your Regional Flight Surgeons Office for review within 90 days:
A current OSA assessment in accordance with the American Academy of Sleep

Medicine (AASM) by your AME, personal physician, or a sleep medicine specialist.
If it is determined that a sleep study is necessary, it must be either a Type I laboratory

polysomnography or a Type II (7 channel) unattended home sleep test (HST) that
provides comparable data and standards to laboratory diagnostic testing. It must be
interpreted by a sleep medicine specialist and must include diagnosis and
recommendation(s) for treatment, if any.
In communities where a Level II HST is unavailable, the FAA will accept a level III HST.
If the HST is positive for OSA, no further testing is necessary and treatment in
accordance with the AASI must be followed. However, if the HST is equivocal, a higher
level test such as an in-lab sleep study will be needed unless a sleep medicine specialist
determines no further study is necessary and documents the rationale.
If your sleep study is positive for a sleep-related disorder, you may not exercise the
privileges of your medical certificate until you provide:
A signed Airman Compliance with Treatment form or equivalent;
The results and interpretive report of your most recent sleep study; and
A current status report from your treating physician addressing compliance, tolerance of
treatment, and resolution of OSA symptoms.
If you are not diagnosed with a sleep-related disorder or the study was negative for a
sleep-related disorder, you may continue to exercise the privileges of your medical certificate,
but the evaluation report along with the results of any study, if conducted, must be sent to the
FAA at the address below. All information provided will be reviewed and is subject to further
FAA action.
In order to expedite the processing of your application, please submit the aforementioned
information in one mailing using your reference number (PI, MID, or APP ID).
AAM-300
PO BOX 25082
or

AAM-300
247

___________________________________________________________________________
PROTOCOL FOR PEPTIC ULCER

An applicant with a history of an active ulcer within the past 3-months or a bleeding
ulcer within the past 6-months must provide evidence that the ulcer is healed if
consideration for medical certification is desired.
Evidence of healing must be verified by a report from the attending physician that
includes the following information:
Confirmation that the applicant is free of symptoms
Radiographic or endoscopic evidence that the ulcer has healed
The name and dosage medication(s) used for treatment and/or prevention, along
with a statement describing side effects or removal
This information should be submitted to the AMCD. Under favorable circumstances, the
FAA may issue a certificate with special requirements. For example, an applicant with a
history of bleeding ulcer may be required to have the physician submit followup reports
every 6-months for 1 year following initial certification.
The prophylactic use of medications including simple antacids, H-2 inhibitors or
blockers, proton pump inhibitors, and/or sucralfates may not be disqualifying, if free
from side effects.
An applicant with a history of gastric resection for ulcer may be favorably considered if
free of sequela.
248

___________________________________________________________________________
SPECIFICATIONS FOR PSYCHIATRIC EVALUATIONS

Why is a psychiatric evaluation required? Mental disorders, as well as the
medications used for treatment, may produce symptoms or behavior that would make
an airman unsafe to perform pilot duties. This guideline outlines the requirements for
these evaluations.
available to the psychiatrist prior to their evaluations, to include:
your agency records be sent directly to the psychiatrist by the Aerospace
Medical Certification Division (AMCD) in Oklahoma City, OK. For further
information regarding this process, please call (405) 954-4821, select the option
for duplicate medical certificate or copies of medical records, then select the
option for certified copies of medical records.
THE PSYCHIATRIC EVALUATION
Who may perform a psychiatric evaluation? Psychiatric evaluations must be
Psychiatry and Neurology or the American Board of Osteopathic Neurology and
Psychiatry.
We strongly advise using a psychiatrist with experience in aerospace psychiatry
and/or familiarity with aviation standards. Using a psychiatrist without this
background may limit the usefulness of the report.
If we have specified that additional qualifications in addiction psychiatry or
forensic psychiatry are required, please ensure that the psychiatrist is aware of
these requirements and has the qualifications and experience to conduct the
evaluation.
What must the psychiatric evaluation report include? At a minimum:
(e.g., psychiatrist, psychologist, social worker, counselor, or neuropsychologist
treatment notes). Records must be in sufficient detail to permit a clear evaluation
of the nature and extent of any previous mental disorders.
and behavioral observations during the interview.
psychiatrists opinion(s) and recommendation(s) for treatment, medication,
therapy, counseling, rehabilitation, or monitoring should be explicitly stated.
249

___________________________________________________________________________
Opinions regarding clinically or aeromedically significant findings and the

potential impact on aviation safety must be consistent with the Federal Aviation
Regulations.
What must be submitted by the psychiatrist? The psychiatrists comprehensive and
detailed report, as noted above, plus copies of supporting documentation.
Recommendations should be strictly limited to the psychiatrists area of expertise.
Psychiatrists with questions are encouraged to call Charles Chesanow, D.O., FAA Chief
Psychiatrist, at (202) 267-3767.
250

___________________________________________________________________________
SPECIFICATIONS FOR PSYCHIATRIC AND

PSYCHOLOGICAL EVALUATIONS
Why are both a psychiatric and a psychological evaluation required? Mental
disorders, as well as the medications used for treatment, may produce symptoms or
behavior that would make an airman unsafe to perform pilot duties. Due to the
differences in training and areas of expertise, separate evaluations and reports are
required from both a qualified psychiatrist and a qualified clinical psychologist for
determining an airmans medical qualifications. This guideline outlines the requirements
for these evaluations.
available to both the psychiatrist and clinical psychologist prior to their evaluations, to
include:
conducted by a qualified psychiatrist who is board-certified by the American Board of
Psychiatry.
We strongly advise using a psychiatrist with experience in aerospace psychiatry.
Using a psychiatrist without this background may limit the usefulness of the
report.
If we have specified that additional qualifications in addiction psychiatry or
forensic psychiatry are required, please ensure that the psychiatrist is aware of
these requirements and has the qualifications and experience to conduct the
evaluation.

251

___________________________________________________________________________

Regulations.

THE PSYCHOLOGICAL EVALUATION
Who may perform a psychological evaluation? Clinical psychological evaluations
must be conducted by a clinical psychologist who possesses a doctoral degree (Ph.D.,
Psy.D., or Ed.D.), has been licensed by the state to practice independently, and has
expertise in psychological assessment. We strongly advise using a psychologist with
experience in aerospace psychology. Using a psychologist without this background
may limit the usefulness of the report.
What must the psychological evaluation include? At a minimum:
Interpretation of a full battery of psychological tests including, but not limited
to, the core test battery (specified below).

psychologists opinion(s) and recommendation(s) for treatment, medication,
252

___________________________________________________________________________

Regulations.
a. Intellectual/Neurocognitive domain, to include both:
The Wechsler Adult Intelligence Scale (recent edition; Processing Speed and
Working Memory Indexes must be scored).
The Trail Making Test, Parts A & B (Reitan Trails A & B should be used since
similar tests [e.g., Color Trails; Trails from Kaplan-Delis Executive Function,
etc.].)
b. Personality domain, to include the Minnesota Multiphasic Personality Inventory-2.
(The MMPI-2-RF is not an approved substitute. All scales, subscales, content,
and supplementary scales must be scored and provided. Computer scoring is
required. Abbreviated administrations are not acceptable.)
c. For cases in which there are questions regarding reality testing/thought disorder
and/or defensive invalid profiles were produced on the self-report measure(s), the
Rorschach (Rorschach Performance Assessment System [R-PAS]) is preferred.
Exners Comprehensive System is also accepted.
d. For cases in which the clinical history or presentation indicates a possible
personality disorder, the Millon Clinical Multiaxial Inventory-III (MCMI-III).
e. Additional tests that the psychologist deems clinically necessary (based upon
presenting problem, clinical history and/or clinical presentation) to assure a
complete assessment.
f. Findings suggesting deficits in the Intellectual/Neurocognitive domain, the
examiner should either:
1) Refer the airman for a neuropsychological evaluation by a qualified clinical
neuropsychologist in order to determine the extent and likely aeromedical
significance of any neurocognitive deficit(s); or
2) If the examiner is a qualified clinical neuropsychologist, administer a
comprehensive battery of neuropsychological tests.
Note: Requirements for neuropsychological testing are listed in the addendum
below.
253

___________________________________________________________________________
supporting documentation below.
For self-report measures: Copies of all computer score reports (e.g., Pearson
MMPI-2 Extended Score Report, Pearson MCMI-III Profile Report with Grossman
Facet Scores),
For performance measures: Copies of entire protocol (e.g., Rorschach response
sheets, location charts, and associated computer score reports,)
For intellectual/neurocognitive measures: An appended score summary sheet
that includes all scores for all tests administered. When available, pilot norms
must be used. If pilot norms are not available for a particular test, then the
normative comparison group (e.g., general population, age/education-corrected)
must be specified. Also, when available, percentile scores must be included.
What else does the psychologist need to know?
data.
provided.
Additional Helpful Information:
Will additional evaluations or testing be required in the future? If eligible for unrestricted
medical certification, no additional evaluations would be required. However, pilots
found eligible for Special Issuance will be required to undergo periodic re-evaluations.
The letter authorizing special issuance will outline the specific evaluations or testing
required.
Useful references for the psychologist:

Pilot norms on neurocognitive tests: Kay, G.G. (2002). Guidelines for the Psychological
Evaluation of Aircrew Personnel. Occupational Medicine, 17 (2), 227-245.
Aviation-related psychological evaluations: Jones, D. R. (2008). Aerospace Psychiatry.
In J. R. Davis, R. Johnson, J. Stepanek & J. A. Fogarty (Eds.),
Fundamentals of Aerospace Medicine (4th Ed.), (pp. 406-424). Philadelphia: Lippencott
Williams & Wilkins.
254

___________________________________________________________________________
ADDENDUM IF NEUROPSYCHOLOGICAL TESTING IS INDICATED

Requirements for the evaluation. Requirements for providing records to the
neuropsychologist, conducting the evaluation, and submitting reports are the same as
noted above for the clinical psychologist.
CogScreen-Aeromedical Edition (CogScreen-AE).
Working Memory Indexes must be scored).
[GDS].
Test of visual memory (WMS-IV subtests, Brief Visuospatial Memory TestRevised, or Rey Complex Figure Test).
and a semantic fluency task).
Pegboard.
255

___________________________________________________________________________
What must be submitted? The neuropsychologists report, plus
256

___________________________________________________________________________
PROTOCOL FOR RENAL TRANSPLANT

An applicant with a history of renal transplant must submit the following if consideration
for medical certification is desired:
1. Hospital admission, operative report and discharge summary
2. Current status report including:
The etiology of the primary renal disease
History of hypertension or cardiac dysfunction
Sequela prior to transplant
A comment regarding rejection or graft versus host disease (GVHD)
Immunosuppressive therapy and side effects, if any
The results of the following laboratory results: CBC, BUN, creatinine, and
electrolytes
257

___________________________________________________________________________
PROTOCOL FOR SUBSTANCES OF

DEPENDENCE/ABUSE (DRUGS - ALCOHOL)
The Examiner must defer issuance.
An applicant with a history of substances of dependence/abuse (drugs - alcohol) must
submit the following if consideration for medical certification is desired:
A current status report from a physician certified in addictive disorders and

familiar with aviation standards
A personal statement attesting to the substance and amount, and date last used
If attended a rehabilitation clinic/center, provide dates and copies of treatment

plan
NOTE: The applicant may be required to submit additional information before medical
disposition can be rendered. See Specifications on following pages.
258

___________________________________________________________________________
SPECIFICATIONS FOR PSYCHIATRIC AND

NEUROPSYCHOLOGICAL EVALUATIONS FOR
SUBSTANCE ABUSE/DEPENDENCE
Why are both a psychiatric and a neuropsychological evaluation required?
Substance use disorders, including abuse and dependence, not in satisfactory recovery
make an airman unsafe to perform pilot duties. These evaluations are required to
assess the disorder, quality of recovery, and potential other psychiatric conditions or
neurocognitive deficits. Due to the differences in training and areas of expertise,
separate evaluations and reports are required from both a qualified psychiatrist and a
qualified clinical psychologist for determining an airmans medical qualifications. This
guideline outlines the requirements for these evaluations.
available to both the psychiatrist and clinical neuropsychologist prior to their
evaluations, to include:
conducted by a qualified psychiatrist who is board-certified by the American Board of
Psychiatry, and must either be board certified in Addiction Psychiatry or have received
training in the Human Intervention Motivation Study (HIMS) program. Preference is
given for those who have completed HIMS training. Using a psychiatrist without this
background may limit the usefulness of the report.
259

___________________________________________________________________________
Regulations.

THE NEUROPSYCHOLOGICAL EVALUATION
the American Board of Pediatric Neuropsychology. The clinical neuropsychologist also
must have completed HIMS training.
including but not limited to the core test battery (specified below).
260

___________________________________________________________________________
CogScreen-Aeromedical Edition (CogScreen-AE)
Working Memory Indexes must be scored)
(5) Category Test or Wisconsin Card Sorting Test, AND
Paced Auditory Serial Addition Test (PASAT)
[GDS].
California Verbal Learning Test-II)
Test of visual memory (WMS-IV subtests, Brief Visuospatial Memory TestRevised, or Rey Complex Figure Test)
and a semantic fluency task)
Pegboard
(MMPI-2)
(The MMPI-2-RF is not an approved substitute. All scales, subscales, content, and
supplementary scales must be scored and provided. Computer scoring is
required. Abbreviated administrations are not acceptable.)
NOTES: (1) All tests administered must be the most current edition of the test
unless specified otherwise; (2) At the discretion of the examiner, additional tests may
be clinically necessary to assure a complete assessment.
261

___________________________________________________________________________

What else does the psychologist need to know?
data.
provided.
7. Will additional evaluations or testing be required in the future? If eligible for
unrestricted medical certification, no additional evaluations would be required.
However, pilots found eligible for Special Issuance will be required to undergo
periodic re-evaluations. The letter authorizing special issuance will outline the
specific evaluations or testing required.
8. Useful references for the psychologist:
227-245.
262

___________________________________________________________________________
PROTOCOL FOR THROMBOEMBOLIC DISEASE

An applicant with a history of thromboembolic disease must submit the following if
consideration for medical certification is desired:
1. Hospital admission and discharge summary
2. Current status report including:
Detailed family history of thromboembolic disease
Neoplastic workup, if clinically indicated
PT/PTT
Protein S & C
Leiden Factor V
If still anticoagulated with warfarin (Coumadin), submit all (no less than monthly)
INRs from time of hospital discharge to present
For applicants who are just beginning warfarin (Coumadin) treatment the following is
required:
Minimum observation time of 6 weeks after initiation of warfarin therapy;
Must also meet any required observation time for the underlying condition; AND
6 INRs, no more frequently than 1 per week
263

___________________________________________________________________________
PROTOCOL FOR CARDIAC VALVE REPLACEMENT

Applicants with tissue and mechanical valve replacement(s) are considered after the
following:
A 6-month recovery period shall elapse after the valve replacement to ensure
recovery and stabilization. First- and second-class initial applicants are reviewed
by the Federal Air Surgeons cardiology panel;
Copies of hospital/medical records pertaining to the valve replacement; include
make, model, serial number and size, admission/discharge summaries, operative
report, and pathology report;
If applicable, a current evaluation from the attending physician regarding the use
of Coumadin to confirm stability without complications, drug dose history and
schedule, and International Normalized Ratio (INR) values (within acceptable
range) accomplished at least monthly during the past 6-month period of
observation;
A current report from the treating physician regarding the status of the cardiac
valve replacement. This report should address your general cardiovascular
condition, any symptoms of valve or heart failure, any related abnormal physical
findings, and must substantiate satisfactory recovery and cardiac function without
evidence of embolic phenomena, significant arrhythmia, structural abnormality, or
ischemic disease.
A current 24-hour Holter monitor evaluation to include select representative
tracings;
Current M-mode, 2-dimensional echocardiogram with Doppler. Submit the video
resulting from this study;
A current maximal GXT See GXT Protocol;
If cardiac catheterization and coronary angiography have been performed, all
reports and films must be submitted, if requested, for review by the agency.
Copies should be made of all films as a safeguard against loss;.
Following heart valve replacement, first- and second-class certificate holders
shall be followed at 6-month intervals with clinical status reports and at 12-month
intervals with a CVE, standard ECG, and Doppler echocardiogram. Holter
monitoring and GXT's may be required periodically if indicated clinically. For
third-class certificate holders, the above followup testing will be required annually
unless otherwise indicated.
Single, Mechanical and Valvuloplasty - See AASI for Cardiac Valve
Replacement;
Multiple Heart Valve Replacement. Applicants who have received multiple heart
valve replacements must be deferred, however, the AMCD may consider
certification of all classes of applicants who have undergone a Ross procedure
(pulmonic valve transplanted to the aortic position and pulmonic valve replaced
by a bioprosthesis).
264

___________________________________________________________________________
It is the responsibility of each applicant to provide the medical information required to

determine his/her eligibility for airman medical certification. A medical release form may
help in obtaining the necessary information.
All information shall be forwarded in one mailing to:

Oklahoma City OK 73169
No consideration can be given for Authorization for Special Issuance of a Medical

Certificate until all the required data has been received.
Use your full name on any reports or correspondence will aid us in locating your file.
265

__________________________________________________________________________
REFERENCE MATERIALS FOR

OBSTRUCTIVE SLEEP APNEA (OSA)
Table of Contents
1. Guidance
a. OSA Protocol and Decisions Consideration table
b. Quick-Start for AMEs
c. OSA Flow Chart
d. AASM Tables 2 and 3
e. AME Actions
f. Specification Sheet A
g. Specification Sheet B
2. AASI
a. AASI
b. Airman Compliance with Treatment form (signature document)
3. Supplemental and Educational Information
a. Frequently Asked Questions (FAQs)
b. BMI Calculator and Chart
c. Questionnaires
i. Berlin
ii. Epworth Sleepiness Scale
iii. STOP BANG
d. FAA OSA Brochure
4. For AMEs Who Elect to Perform OSA Assessment
a. AASM Guidelines
b. AME Statement (signature document)
LAST UPDATE December 20, 2014

___________________________________________________________________________
Decision Considerations
Disease Protocols Obstructive Sleep Apnea
Quick Start for AMES
Sleep apnea has significant safety implications due to cognitive impairment secondary to the
lack of restorative sleep and is disqualifying for airman medical certification. The condition is
part of a group of sleep disorders with varied etiologies. Specifically, sleep apneas are
characterized by abnormal respiration during sleep. The etiology may be obstructive,
central or complex in nature. However, no matter the cause, the manifestations of this
disordered breathing present safety risks that include, but are not limited to, excessive
daytime sleepiness (daytime hypersomnolence), cardiac dysrhythmia, sudden cardiac
death, personality disturbances, refractory hypertension and, as mentioned above, cognitive
impairment. Certification may be considered once effective treatment is shown.
This protocol is designed to evaluate airmen who may be presently at risk for Obstructive
Sleep Apnea (OSA) and to outline the certification requirements for airmen diagnosed with
OSA. While this protocol focuses on OSA, the AME must also be mindful of other sleeprelated disorders such as insomnia, parasomnias, sleep-related movement disorders (e.g.
restless leg syndrome and periodic leg movement), central sleep apnea and other
hypersomnias, circadian rhythm sleep disorders, etc., that may also interfere with restorative
sleep. All sleep disorders are also potentially medically disqualifying if left untreated. If one
of these other sleep-related disorders is initially identified during the examination, the AME
must contact their RFS or AMCD for guidance.
Risk Information
The American Academy of Sleep Medicine has established the risk criteria (utilizing Tables
2 and 3) for OSA. When applying Table 2 and 3, the AME is expected to employ their
clinical judgment.
Educational information for airmen can be found in the FAA Pilot Safety Brochure on
Obstructive Sleep Apnea.
Persons with physical findings such as a retrograde mandible, large tongue or tonsils,
neuromuscular disorders, or connective tissue anomalies are at risk of OSA requiring
treatment despite a normal or low BMI. OSA is also associated with conditions such as
refractory hypertension requiring more than two medications for control, diabetes mellitus,
and atrial fibrillation. Over 90% of individuals with a BMI of 40 or greater have OSA
requiring treatment. Up to 30% of individuals with OSA have a BMI less than 30.

___________________________________________________________________________
DISEASE/CONDITION
CLASS
EVALUATION DATA
DISPOSITION
Sleep Apnea
Obstructive Sleep
Apnea
All
Requires risk
evaluation, per OSA
Protocol. Document
history and Findings.
If meets OSA Criteria

Issue, if otherwise
qualified
Periodic Limb
Movement, etc.
All

medical information
and current status
report. Include sleep
study with a
polysomnogram, use
of medications and
titration study results,
along with a
statement regarding
Restless Leg
Syndrome
Followup
Special Issuance
See AASI

___________________________________________________________________________
OSA QUICK-START for AMEs

The AME while performing the triage function must conclude one of six possible
determinations. The AME is not required to perform the assessment or to comment on the
presence or absence of OSA. For more information, view this instructional video on the
screening process.
Step 1 - Determine into which group (1-6) the airman falls.
Applicant Previously Assessed:
Group 1: Has OSA diagnosis and is on Special Issuance. Reports to follow.
Group 2: Has OSA diagnosis OR has had previous OSA assessment. NOT on
Special Issuance. Reports to follow.
Applicant Not at Risk:
Group 3: Determined to NOT be at risk for OSA at this examination.
Applicant at Risk/Severity to be assessed:
Group 4: Discuss OSA risk with airman and provide educational materials.
Group 5: At risk for OSA. AASM sleep apnea assessment required.
Applicant Risk/Severity Extremely High:
Group 6: Deferred. Immediate safety risk. AASM sleep apnea assessment
required. Reports to follow.
Step 2 Document findings in Block 60.
Step 3 Check appropriate triage box in the AME Action Tab.
Step 4 Issue, if otherwise qualified.
In assessing airmen for groups 4 and 5, the AME is expected to use their own clinical
judgment, using AASM information, when making the triage decision.
Some AMEs have voiced the desire to perform the OSA assessment. While we do not
recommend it, the AME may perform the OSA assessment provided that it is in accordance
with the clinical practice guidelines established by the American Academy of Sleep
Medicine.*
*If a sleep study is conducted, it must be interpreted by a sleep medicine specialist.

___________________________________________________________________________

___________________________________________________________________________

___________________________________________________________________________
AME Actions - On every exam, the Examiner must triage the applicant into one of 6 groups:
If the applicant is on a Special Issuance Authorization for OSA (Group/Box 1 of OSA

o Follow AASI/SI for OSA
If the applicant has had a prior OSA assessment (Group/Box 2 of OSA flow chart),
select Group 2 on the AME Action Tab:
o If the airman is under treatment, provide the requirements of the AASI and advise
the airman they must get the Authorization of Special Issuance;
o Give the applicant Specification Sheet A and advise that a letter will be sent from
the Federal Air Surgeon requesting more information. The letter will state that the
applicant has 90 days to provide the information to the FAA/AME;
o Notate in Box 60;
If the applicant does not have an AASI/SI or has not had a previous assessment, the
AME must:
o Calculate BMI; and
o Consider AASM risk criteria Table 2 & 3
o If the AME determines the applicant is not currently at risk for OSA (Group/Box 3
of OSA flow chart), select Group 3 on the AME Action Tab:
o
If the applicant is at risk for OSA but in the opinion of the AME the applicant is at
low risk for OSA , the AME must (Group/Box 4 of OSA flow chart), select Group
4 on the AME Action Tab:
If the applicant is at high risk for OSA, the AME must (Group/Box 5 of OSA flow chart),
select Group 5 on the AME Action Tab:
o
o
o
Discuss OSA risks with applicant;

Provide resource and educational information, as appropriate;
Give the applicant Specification Sheet B and advise that a letter will be sent from
the Federal Air Surgeon requesting more information. The letter will state that the
applicant has 90 days to provide the information to the FAA/AME
If the AME observes or the applicant reports symptoms which are severe enough to
represent an immediate risk to aviation safety of the national airspace (Group/Box 6 of
OSA flow chart), select Group 6 on the AME Action Tab.
o
Notate in Block 60
THE AME MUST DEFER

___________________________________________________________________________
Obstructive Sleep Apnea Specification Sheet A

Information Request
Your application for airman medical certification submitted this date indicates that you have
been treated or previously assessed for Obstructive Sleep Apnea (OSA).
You must provide the following information to the Aerospace Medical Certification Division
(AMCD) or your Regional Flight Surgeon within 90 days:
All reports and records regarding your assessment for OSA by your primary care
physician and/or a sleep specialist.
If you are currently being treated, also include:

o A signed Airman Compliance with Treatment form or equivalent;
o The results and interpretive report of your most recent sleep study; and
o A current status report from your treating physician indicating that OSA
treatment is still effective.

A copy of the cumulative annual PAP device report. Target goal should
show use for at least 75% of sleep periods and an average minimum of
6 hours use per sleep period.
For Dental Devices or for Positional Devices:

Once Dental Devices with recording / monitoring capability are
available, reports must be submitted.
To expedite the processing of your application, please submit the aforementioned

Using Regular Mail (US Postal Service) or Using Special Mail (FedEx, UPS, etc.)
AAM-300
AAM-300
PO BOX 25082

___________________________________________________________________________
OBSTRUCTIVE SLEEP APNEA SPECIFICATION SHEET B

ASSESSMENT REQUEST
Due to your risk for Obstructive Sleep Apnea (OSA), and to review your eligibility to have a
medical certificate, you must provide the following information to the Aerospace Medical
Certification Division (AMCD) or your Regional Flight Surgeons Office for review within 90
days:
A current OSA assessment in accordance with the American Academy of Sleep

Medicine (AASM) by your AME, personal physician, or a sleep medicine specialist.
If it is determined that a sleep study is necessary, it must be either a Type I laboratory

polysomnography or a Type II (7 channel) unattended home sleep test (HST) that
provides comparable data and standards to laboratory diagnostic testing. It must be
interpreted by a sleep medicine specialist and must include diagnosis and
recommendation(s) for treatment, if any.
If your sleep study is positive for a sleep-related disorder, you may not exercise the
privileges of your medical certificate until you provide:
A signed Airman Compliance with Treatment form or equivalent;
The results and interpretive report of your most recent sleep study; and
A current status report from your treating physician addressing compliance, tolerance
of treatment, and resolution of OSA symptoms.
If you are not diagnosed with a sleep-related disorder or the study was negative for a
sleep-related disorder, you may continue to exercise the privileges of your medical
certificate, but the evaluation report along with the results of any study, if conducted, must
be sent to the FAA at the address below. All information provided will be reviewed and is
subject to further FAA action.
In order to expedite the processing of your application, please submit the aforementioned
AAM-300
PO BOX 25082
or

AAM-300

___________________________________________________________________________
AME Assisted - All Classes Obstructive Sleep Apnea (OSA)

Examiners may re-issue an airman medical certificate to airmen currently on an AASI for OSA if the
airman provides the following:
An Authorization granted by the FAA;
Signed Airman Compliance with Treatment form or equivalent from the airman attesting to
absence of OSA symptoms and continued daily use of prescribed therapy; and
A current status report from the treating physician indicating that OSA treatment is still
effective.
o

A copy of the cumulative annual PAP device report which shows actual time
used (rather than a report typically generated for insurance providers which
only shows if use is greater or less than 4 hours). Target goal should show
use for at least 75% of sleep periods and an average minimum of 6 hours use
per sleep period.
For persons with an established diagnosis of OSA who do not have a

recording CPAP, a one year exception will be allowed to provide a personal
statement that they regularly use CPAP and before each shift when
performing flight or safety duties.
For Dental Devices and/or for Positional Devices:

No conditions known to be co-morbid with OSA (e.g., diabetes mellitus, hypertension
treated with more than two medications, atrial fibrillation, etc). Once Dental Devices
with recording / monitoring capability are available, reports must be submitted.
For Surgery:
For successfully treated surgical patients, a statement attesting to the continued
absence of OSA symptoms is required.
Defer to the AMCD or the Region for further review if:
Concerns about adequacy of therapy or non-compliance;

Significant weight gain or development of conditions known to be co-morbid with OSA
(e.g., diabetes mellitus, hypertension treated with more than two medications, atrial
fibrillation, etc).
Note: The Examiner may request AMCD review to discontinue the AASI if there are indications that
the airman no longer has OSA (e.g., significant weight loss and a negative study or surgical
intervention followed by 3 years of symptom abatement and absence of significant weight
gain or co-morbid conditions). In most cases, a follow-up sleep study will be required to
remove the AASI.

___________________________________________________________________________
AIRMAN COMPLIANCE WITH TREATMENT

OBSTRUCTIVE SLEEP APNEA (OSA)
I ____________________________ (print name) certify that (check one):
___ I have been using __________________ (CPAP/ Dental / or Positional Device) for OSA
as prescribed. I am tolerating the therapy well and have no symptoms of OSA (e.g. daytime
sleepiness or lack of mental attention or concentration).
___ I have been surgically treated for OSA and I have no symptoms of OSA (e.g. daytime
sleepiness or lack of mental attention or concentration).
I understand and acknowledge that I will receive the new requirements for continuation of
my special issuance of Obstructive Sleep Apnea and I will comply with the requirements at
my next FAA medical certificate renewal or reapplication.
Applicant Name: _________________________________________
Date of Birth: ____________________________________________
Reference Number: (PI, MID, or APP ID): _________________________
Applicant Signature _______________________________________ Date _______

___________________________________________________________________________
OSA FREQUENTLY ASKED QUESTIONS (FAQS)

(Last Updated: 04/03/15)
GENERAL:
1. Where can I view the video explaining the process?
The instructional video for AMEs is available here or at: http://www.faa.gov/tv/?mediaId=1029
2. Where can I find the specification sheets and educational material?
All OSA reference materials can be found at:
http://www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/ame/guide/dec_cons/disease_prot/osa/ref_materials/
3. Does this process involve other sleep disorder conditions? (E.g. Period Limb
Movement Disorder, narcolepsy, central sleep apnea, etc.)
No. This process is for obstructive sleep apnea only. If it is clear that the airman suffers from
a different sleep disorder, DEFER and submit any supporting documentation for FAA
decision.
TRIAGE:
4. I am not a sleep specialist. How am I supposed to determine if an airman is high risk
enough to send for a sleep evaluation? How many risk factors must be present before
additional testing is required?
The AME should triage the airman based on the FAA OSA Flow Chart, supporting clinical
guidelines, and good clinical judgment to determine the appropriate category for the airman.
5. The airman was assessed 5 years ago for OSA but did not have a polysomnogram.
The evaluation was negative. Is he required to have an updated sleep evaluation or a
sleep study?
No. If there has been NO CHANGE in his/her risk factors, follow Group/Box 2 of the flow
chart and submit a copy of the previous assessment. However, if there has been a change in
risk factors (e.g. elevated BMI, new atrial fibrillation, refractory hypertension, etc.), triage
using the flow chart to determine if the airman needs a repeat assessment.
6. If I mark the radio button (1-6) and have no concerns, do I still need to put notes in
Block 60 regarding the OSA triage?
Yes. It is only required for Group/Box 4 to document that education was given. However, it
may be useful to document the rationale for triage decisions, especially for Group/Box 2, 5,
and 6.
SLEEP EVALUATION AND SLEEP STUDY:
7. Is a sleep evaluation the same as a sleep study?
No. Please reference the AASM guidelines. A sleep evaluation is needed when the triage
process indicates that the airman is at high risk for OSA. The sleep evaluation is used to
determine if a sleep study is warranted.

___________________________________________________________________________
8. Do I have to turn in the AME Assessment Statement for every airman?
No. This statement page is only used by an AME who PERFORMS the sleep evaluation (in
accordance with AASM guidelines) and finds that the airman does not have evidence of
OSA. This is NOT to be used for the routine triage function.
9. Does the FAA require a specific type of sleep study if one is warranted?
Yes. The FAA requires that the test be either a Type I laboratory polysomnography or a Type
II (7 channel) unattended home sleep test (HST) that provides comparable data and
standards to laboratory diagnostic testing. It does not have to be a chain of custody study.
10.
What if the doctor or insurance provider is only willing to do a level III Home Sleep
Test (HST)?
In communities where a Level II HST is unavailable, the FAA will accept a level III HST. If
the HST is positive for OSA, no further testing is necessary and treatment in accordance with
the AASI must be followed. However, if the HST is equivocal, a higher level test such as an
in-lab sleep study will be needed unless a sleep medicine specialist determines no further
study is necessary and documents the rationale.
11.
If I do the sleep evaluation and determine the airman needs a sleep study, as the AME,
can I interpret the sleep study?
The AME may only interpret the sleep study if he/she is a sleep medicine specialist.
CERTIFICATE, EXTENSION, AND DENIAL PROCESS:

12.
If an airman is in Group/Box 5 (at risk for OSA) they have 90 days to comply with
getting an evaluation. Does the AME issue a time-limited, 90 day certificate?
No. Issue a regular (not time limited) certificate, if the airman is otherwise qualified. The
AME MAY NOT issue a time-limited certificate without an authorization from the FAA.
13.
I evaluated the airman and triaged him into Group/ Box 5. He had a sleep study and is
doing well on CPAP treatment. Does he have to wait for a time-limited certificate
before he can return to flight duties?
No. Once the airman is compliant with and doing well on treatment, he has met the
requirements for 14 CFR 61.53. The airman may return to flight status with the current
certificate issued by the AME, PROVIDED that ALL the required information regarding OSA
evaluation and treatment has been submitted to the FAA for review.
14.
Once the AME issues a regular certificate, who is responsible for keeping track of the
90 days?
The FAA will keep track of the 90 days.
15.
The airman has a prior SI/AASI for OSA that only asks for a current status report. Can I
issue this year if he does not bring in any other information on the OSA?
Yes. The AME may issue this year based on the previous SI/AASI if those requirements were
met.
16.
Can the airman continue to submit only a current status report until his current AASI
expires?
No. An airman currently on an SI/AASI for OSA will receive a new SI/AASI letter this year. At
that point, he/she will have to comply with the new documentation requirements.

___________________________________________________________________________
17.
What if the airman cannot get a sleep evaluation in 90 days?

The airman may request a one-time, 30-day extension by phone by calling AMCD at (405)
954-4821 and selecting Option 1 when prompted. They may also mail a request to AMCD
(see Specification Sheet B for address) or by contacting their RFS office.
18.
If I give the airman Specification Sheet A or B and he does not submit the required
evaluation within 90 days and after the 30 day extension (if requested), what will
happen?
The airman will receive a failure to provide (FTP) denial.
TREATMENT AND FOLLOW UP:

19.
How long does an airman have to be on CPAP with a new diagnosis of OSA before
they can return to flying?
The airman may submit the completed compliance statement and required documents to the
FAA for review as soon as they are tolerating the therapy without difficulty and have no
symptoms of OSA.
20.
The airman has mild or moderate sleep apnea. Is he required to use CPAP?
In most cases an AHI of 15 or more will require CPAP.
21.
If the airman has a sleep study and is diagnosed with OSA does he/she get a new
certificate?
Yes. Once a diagnosis of OSA is established, a Special Issuance is required. When the
airman submits the required supporting documents to the FAA, he/she will be evaluated for a
Special Issuance.
22.
If an airman has a previously unreported history of OSA being treated with CPAP, can
the AME issue?
Yes. Issue a regular certificate (Group/Box 2), if the airman is otherwise qualified, and
submit the required information for FAA decision.
23.
What if the airman is high risk and has had a previous sleep study that was positive,
but not one of the approved tests? He is currently on CPAP and doing well. Does he
have to get a new sleep study?
Follow Group/Box 2 and submit the required information for FAA decision.
24.
The airman had a sleep study in the past and did not have sleep apnea. It was not an
approved test type. Will he have to get another sleep study?
The AME should follow the triage flow chart. If the airman is determined to be Group/Box 5
or 6, he/she will need a sleep evaluation. If a sleep study is warranted, it will need to be an
approved test type (see FAQ #9). Submit the required information for FAA decision.
25.
The airman has OSA and was on CPAP in the past. He has now lost weight and is only
on a dental device. What do I do now?
Follow Group/Box 2 and submit the required information for FAA decision.

___________________________________________________________________________
Measurement Units
BMI Formula and Calculation
Pounds and inches
Formula: weight (lb) / [height (in)] x 703

Calculate BMI by dividing weight in pounds (lbs) by height in
inches (in) squared and multiplying by a conversion factor of 703.
Example: Weight = 150 lbs, Height = 5'5" (65")
2
Calculation: [150 (65) ] x 703 = 24.96
Kilograms and meters (or

centimeters)
Formula: weight (kg) / [height (m)]2

With the metric system, the formula for BMI is weight in kilograms
divided by height in meters squared. Since height is commonly
measured in centimeters, divide height in centimeters by 100 to
obtain height in meters.
Example: Weight = 68 kg, Height = 165 cm (1.65 m)

Calculation: 68 (1.65)2 = 24.98

___________________________________________________________________________
Berlin Questionnaire
Height (m)
Male / Female
Weight (kg)
Age
Please choose the correct response to each question.

Category 1
1. Do you snore?
a. Yes
b. No
c. Dont know
If you answered yes:
Category 2
6. How often do you feel tired or
fatigued after your sleep?
a. Almost every day
b. 3-4 times per week
c. 1-2 times per week
d. 1-2 times per month
e. Rarely or never
2. You snoring is:

a. Slightly louder than breathing
b. As loud as talking
c. Louder than talking
7. During your waking time, do you

feel tired, fatigued or not up to
par?
a. Almost every day
e. Rarely or never
3. How often do you snore?

a. Almost every day
e. Rarely or never
8. Have you ever nodded off or fallen asleep

while driving a vehicle?
a. Yes
b. No
4. Has your snoring ever bothered

other people?
a. Yes
b. No
c. Dont know
9. How often does this occur?

a. Almost every day
e. Rarely or never
5. Has anyone noticed that you stop breathing

during your sleep?
a. Almost every day
e. Rarely or never
Category 3
If you answered yes:
10. Do you have high blood

pressure?
Yes
No
Dont know

___________________________________________________________________________
Scoring Berlin Questionnaire

The questionnaire consists of 3 categories related to the risk of having sleep
apnea. Patients can be classified into High Risk or Low Risk based on their
responses to the individual items and their overall scores in the symptom
categories.
Categories and Scoring:
Category 1: Items 1, 2, 3, 4, and 5;
Item 1: if Yes, assign 1 point
Item 2: if c or d is the response, assign 1 point
Item 3: if a or b is the response, assign 1 point
Item 4: if a is the response, assign 1 point
Item 5: if a or b is the response, assign 2 points
Add points. Category 1 is positive if the total score is 2 or more points.
Category 2: items 6, 7, 8 (item 9 should be noted separately).
Item 8: if a is the response, assign 1 point
Add points. Category 2 is positive if the total score is 2 or more points.
Category 3 is positive if the answer to item 10 is Yes or if the BMI of the patient is
greater than 30kg/m2.
(BMI is defined as weight (kg) divided by height (m) squared, i.e.., kg/m2).
High Risk: if there are 2 or more categories where the score is positive.
Low Risk: if there is only 1 or no categories where the score is positive.
Epworth Sleepiness Scale

The original version of the ESS was first published in 1991. However, it soon became clear that
some people did not answer all the questions, for whatever reason. They may not have had much
experience in some of the situations described in ESS items, and they may not have been able to
provide an accurate assessment of their dozing behaviour in those situations. However, if one
question is not answered, the whole questionnaire is invalid. It is not possible to interpolate
answers, and hence item-scores, for individual items. This meant that up to about 5 % of ESS
scores were invalid in some series.
In 1997, an extra sentence of instructions was added to the ESS, as follows:
It is important that you answer each question as best you can.
With this exhortation, nearly everyone was able to give an estimate of their dozing behaviour in all
ESS situations. As a result, the frequency of invalid ESS scores because of missed itemresponses was reduced to much less than 1%.

___________________________________________________________________________
The 1997 version of the ESS is now the standard one for use in English or any other language. It is
available in pdf here.

___________________________________________________________________________
STOP BANG Questionnaire

Height inches/cm:
Age:
Male/Female
BMI:
Weight lb/kg:
Collar size of shirt: S, M, L, XL, or inches/cm neck circumference:
1. Snoring
Do you snore loudly (louder than talking or loud enough to be heard
through closed doors)?
Yes No
2. Tired
Do you often feel tired, fatigued, or sleepy during daytime?
Yes No
3. Observed - Has anyone observed you stop breathing during your sleep?
Yes No
4. Blood pressure
Do you have or are you being treated for high blood pressure?
Yes No
5. BMI -BMI more than 35 kg/m2?
Yes No
6. Age - Age over 50 years old?
Yes No
7. Neck circumference - Neck circumference greater than 40 cm?
Yes No
8. Gender Male?
Yes No
* Neck circumference is measured by staff
High risk of OSA: answering yes to three or more items

Low risk of OSA: answering yes to less than three items
Adapted from:
STOP Questionnaire
A Tool to Screen Patients for Obstructive Sleep Apnea
Frances Chung, F.R.C.P.C.,* Balaji Yegneswaran, M.B.B.S., Pu Liao, M.D., Sharon A. Chung, Ph.D.,
Santhira Vairavanathan, M.B.B.S.,_ Sazzadul Islam, M.Sc.,_ Ali Khajehdehi, M.D., Colin M. Shapiro, F.R.C.P.C.#
Anesthesiology 2008; 108:81221 Copyright 2008, the American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc.

___________________________________________________________________________

___________________________________________________________________________

___________________________________________________________________________
For AMEs Who Elect to Perform the OSA Assessment

Evaluating the risk of Obstructive Sleep Apnea (OSA) requires clinical judgment based on an
integrated assessment of history, symptoms, AND physical/clinical findings. If an AME
elects to perform the assessment for OSA, he/she must follow the American Academy of Sleep
Medicine guidelines.
After completing the assessment, if the diagnosis of OSA is not made, the AME must sign and
submit the AME Assessment Statement - OSA. If the AME confirms the presence of OSA, then
full clinical note with test results, if performed, must be submitted.
History of findings that suggest increased risk of OSA include:
Hypertension requiring more than 2 medications for control or refractory hypertension
Type 2 Diabetes
Atrial fibrillation or nocturnal dysrhythmias
Congestive heart failure
Stroke
Pulmonary hypertension
Motor vehicle accidents, especially those associated with sleepiness/drowsiness
Under consideration for bariatric surgery
Symptoms that suggest an increased risk of OSA include:
Snoring
Daytime sleepiness
Witnessed apneas
Complaints of awakening with sensation of gasping or choking
Non-refreshing sleep
Frequent awakening (sleep fragmentation) or difficulty staying asleep (maintenance insomnia)
Morning headaches
Decreased concentration
Problems or difficulty with memory or memory loss
Irritability
Physical/clinical findings that suggest increased risk of OSA include:
High score on an OSA screening questionnaire (e.g., Berlin, Epworth)
Increased neck circumference (>17 inches in men, >16 inches in women)
A Modified Mallampati score of 3 or 4 (assessment of the oral cavity)
Retrognathia
Lateral peritonsilar narrowing
Macroglossia
Tonsillar hypertrophy
Elongated/enlarged uvula
High arched/narrow hard palate
Nasal abnormalities such as polyps, deviation and turbinate hypertrophy
Obesity (AASM guidelines)

___________________________________________________________________________
AME ASSESSMENT STATEMENT OSA

AMEs who elect to perform an OSA assessment and find that the applicant does not meet
the American Academy of Sleep Medicine (AASM) diagnostic criteria for OSA, must submit
this statement to the FAA.
Airman/ Patient Name __________________ DOB: ____________

Reference Number (PI, MID, or App ID): ______________________
_____ (initial) I have performed an OSA assessment in accordance with AASM guidelines
and have determined that there is no evidence of OSA requiring treatment at this time. (If a
sleep study was performed it must be attached).
____________________________________________________________________
____________________________________________________________________
PHYSICIAN NAME ____________________________________________________

Address: ____________________________________________________________
Office Telephone Number: ______________________________________________
PHYSICIAN
SIGNATURE________________________________________DATE____________
Mail this form to:
AAM-300
PO BOX 25082
or

AAM-300

___________________________________________________________________________
PHARMACEUTICALS

___________________________________________________________________________
PHARMACEUTICAL MEDICATIONS
As an Examiner you are required to be aware of the regulations and Agency policy and have
a responsibility to inform airmen of the potential adverse effects of medications and to
counsel airmen regarding their use. There are numerous conditions that require the chronic
use of medications that do not compromise aviation safety and, therefore, are permissible.
Airmen who develop short-term, self-limited illnesses are best advised to avoid performing
aviation duties while medications are used.
Aeromedical decision-making includes an analysis of the underlying disease or condition
and treatment. The underlying disease has an equal and often greater influence upon the
determination of aeromedical certification. It is unlikely that a source document could be
developed and understood by airmen when considering the underlying medical condition(s),
drug interactions, medication dosages, and the sheer volume of medications that need to be
considered.
Do Not Issue - Do Not Fly

The information in this section is provided to advise Aviation Medical Examiners (AMEs)
about two medication issues:
Medications for which they should not issue applicants without clearance from the
Federal Aviation Administration (FAA), AND
Medications for which for which they should advise airmen to not fly and provide
additional safety information to the applicant.
The lists of medications in this section are not meant to be all-inclusive or comprehensive,
but rather address the most common concerns.
Do Not Issue. AMEs should not issue airmen medical certificates to applicants who are
using these medications. If there are any questions, please call the Regional Flight
Surgeons office or the Aerospace Medicine Certification Division.
Anticholinergics (oral)
Antiseizure medications, even if used for non-seizure conditions
Centrally acting antihypertensives, including but not limited to clonidine, reserpine,
guanethidine, guanadrel, guanabenz, and methyldopa
Bromocriptine
Dopamine agonists used for Parkinsons disease or other medical indications:
Pramipexole (Mirapex), ropinirole (Requip) and rotigotine (NeuPro). All carry
warnings for suddenly falling asleep during activities of daily living
Mefloquine (Lariam)
Over-active bladder medications. Almost all of these medications are antimuscarinic.
Antimuscarinic medications carry strong warnings about potential for sedation and
impaired cognition
Varenicline (Chantix)

___________________________________________________________________________
An open prescription for regular or intermittent use of any drug or substance

classified under the Controlled Substances Act (Schedules I V).
o This includes medical marijuana, even if legally allowed or prescribed under
state law.
o Note: exceptions would be for documented temporary use of the drug solely
for a medical procedure or for a medical condition, and the medication has
been discontinued.
Most psychiatric or psychotropic medications, including but not limited to
antipsychotics, most antidepressants (see SSRI policy), antianxiety drugs, mood
stabilizers, attention deficit disorder (ADD) or attention deficit hyperactivity disorder
(ADHD) medications, sedative-hypnotics and tranquilizers
High doses of oral steriods (greater than 20 mg prednisone or prednisone-equivalent
per day)
Agents for treating cancer, including chemotherapeutics, biologics, etc., whether used
for induction, maintenance, or suppressive therapy
Antiangina medications
Any medication newly approved by the Food and Drug Administration (FDA) (those
drugs issued initial FDA marketing approval within the past 12 months). We require at
least one-year of post-marketing experience with a new drug before we will consider
whether we can safely certificate an applicant using the drug. New antibiotics, lipidlowering drugs, and antihypertensive medications can be considered earlier than one
year. Please contact the RFS or AMCD for guidance on specific applicants.
Do Not Fly. Airmen should not fly while using any of the medications in the Do Not Issue
section above or using any of the medications or classes/groups of medications listed
below. All of these medications below may cause sedation (drowsiness) or impair cognitive
function, seriously degrading pilot performance. This impairment can occur even when the
individual feels alert and is apparently functioning normally in other words, the airman can
be unaware of impair.
For aviation safety, airmen should not fly following the last dose of any of the
medications below until a period of time has elapsed equal to:
5-times the maximum pharmacologic half-life of the medication; or
5-times the maximum hour dose interval if pharmacologic half-life information is
not available. For example, there is a 30-hour wait time for a medication that is
taken every 4 to 6 hours (5 times 6)
Sleep aids. All the currently available sleep aids, both prescription and over-the-counter
(OTC), can cause impairment of mental processes and reaction times, even when the
individual feels fully awake.
See wait times for currently available prescription sleep aids
Diphenhydramine (e.g., Benadryl) - Many OTC sleep aids contain
diphenhydramine as the active ingredient. The wait time after diphenhydramine is
60 hours (based on maximum pharmacologic half- life).

___________________________________________________________________________
Allergy medications. Antihistamines found in many allergy and other types of

medications can cause sedation and may not be used for flight. This applies to nasal
formulations as well as oral.
Exception: Nonsedating antihistamines (loratadine, desloratadine, and fexofenadine)
may be used while flying, if symptoms are controlled without adverse side effects after
an adequate initial trial period.
Label warnings. Airmen should not fly while using any medication, prescription or OTC,
that carries a label precaution or warning that it may cause drowsiness or advises the
user be careful when driving a motor vehicle or operating machinery. This
applies even if label states until you know how the medication affects you and even if
the airman has used the medication before with no apparent adverse effect. Such
medications can cause impairment even when the airman feels alert and unimpaired
(see unaware of impair above).
Pre-medication or pre-procedure drugs. This includes all drugs used as an aid to
outpatient surgical or dental procedures.
Narcotic pain relievers. This includes but is not limited to morphine, codeine,
oxycodone (Percodan; Oxycontin), and hydrocodone (Vicodin, etc.).
Muscle relaxants. This includes but is not limited to carisoprodol (Soma) and
cyclobenzaprine (Flexeril).
Over-the-counter active dietary supplements such as Kava-Kava and Valerian.

___________________________________________________________________________
The list of medications referenced below provides aeromedical guidance about specific
medications or classes of pharmaceutical preparations and is applied by using sound
aeromedical clinical judgment. This list is not meant to be totally inclusive or comprehensive.
No independent interpretation of the FAA's position with respect to a medication included or
excluded from the following should be assumed.
ACNE MEDICATIONS
ALLERGY Antihistamines
ALLERGY Immunotherapy
ANTACIDS
ANTICOAGULANTS
ANTIDEPRESSANTS
ANTIHYPERTENSIVE
CONTRACEPTIVES AND HORMONE REPLACEMENT
THERAPY
DIABETES MELLITUS Type II Medication Controlled (Not
Insulin)
DIABETES MELLITUS Insulin Treated
GLAUCOMA MEDICATIONS
ERECTILE DYSFUNCTION AND BENIGN PROSTATIC
HYPERPLASIA MEDICATIONS
MALARIA MEDICATION
SEDATIVES
SLEEP AIDS

___________________________________________________________________________
ACNE MEDICATIONS
I. CODE OF FEDERAL REGULATIONS
First-Class Airman Medical Certificate: 67.113(c)
Second-Class Airman Medical Certificate: 67.213(c)
Third-Class Airman Medical Certificate: 67.313(c)
II. MEDICAL HISTORY:
Topical acne medications, such as Retin A, and oral antibiotics, such as tetracycline,
used for acne are acceptable if the applicant is otherwise qualified.
For applicants using oral isotretinoin (Accutane), there is a mandatory 2-week waiting
period after starting isotretinoin prior to consideration. This medication can be
associated with vision and psychiatric side effects of aeromedical concern specifically decreased night vision/ night blindness and depression. These sideeffects can occur even after cessation of isotretinoin. A report must be provided with
detailed, specific comment on presence or absence of psychiatric and vision sideeffects. The AME must document these findings in Block 60, Comments on History
and Findings. Some applicants will have to be deferred. For applicants issued, there
must be a NOT VALID FOR NIGHT FLYING restriction on the medical certificate. A
waiting period and detailed information is required to remove this restriction. The
restriction cannot be removed until all the requirements are met. See Pharmaceutical
Considerations below.
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 40, Skin.
IV. PROTOCOL: N/A
V. PHARMACEUTICAL CONSIDERATIONS:
Use of oral isotretinoin must be permanently discontinued for at least 2 weeks

prior to consideration date (confirmed by the prescribing physician) and;
Eye evaluation must be done in accordance with specifications in 8500-7 and;
The airman must provide a signed statement of discontinuation that:
o Confirms the absence of any visual disturbances and psychiatric
symptoms, and
o Acknowledges requirement to notify the FAA and obtain clearance prior
to performing any aviation safety-related duties if use of isotretinoin is
resumed

___________________________________________________________________________
ALLERGY ANTIHISTAMINES
First-Class Airman Medical Certificate: 67.105(b)(c)
Second-Class Airman Medical Certificate: 67.205(b)(c)
Third-Class Airman Medical Certificate: 67.305(b)(c)
II. MEDICAL HISTORY: Item 18.e., Hay fever or allergy
The applicant should report frequency and duration of symptoms, any incapacitation by the
condition, treatment, and side effects. The Examiner should inquire whether the applicant has
ever experienced any barotitis (ear block), barosinusitis, alternobaric vertigo, or any other
symptoms that could interfere with aviation safety.
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 26, Nose
Also, see Aerospace Medical Disposition table and Item 35, Lungs and Chest
IV. PROTOCOL: See Disease Protocols Allergies, Severe
For hay fever requiring antihistamines:
The nonsedating antihistamines loratadine, desloratadine, and fexofenadine may be
used while flying if, after an adequate initial trial period, symptoms are controlled
without adverse side effects.
Applicants with seasonal allergies requiring any other antihistamine (oral and/or nasal)
may be certified by the examiner only as follows:
With the stipulation that they do not exercise the privileges of airman
certificate while taking the medication, AND
Wait after the last dose until either:
o At least five maximal dosing intervals* have passed. For example, if the
medication is taken every 4-6 hours, wait 30 hours (5x6) after the last dose
to fly, or,
o At least five times the maximum terminal elimination half-life has passed.
For example, if the medication half-life* is 6-8 hours, wait 40 hours (5x8)
after the last dose to fly.
* Examiners are encouraged to look up the dosing intervals and half-life.
For hay fever controlled by Desensitization, AME must warn airman to not operate
aircraft until four hours after each injection.
Airmen who are exhibiting symptoms, regardless of the treatment used, must not
fly.
In all situations, the examiner must notate the evaluation data in Block 60

___________________________________________________________________________
ALLERGY - IMMUNOTHERAPY
II. MEDICAL HISTORY: Item 18.e., Hay fever or allergy.
The applicant should report frequency and duration of symptoms, any incapacitation by
the condition, treatment, and side effects. The Examiner should inquire whether the
applicant has ever experienced any barotitis (ear block), barosinusitis, alternobaric
vertigo, or any other symptoms that could interfere with aviation safety.
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 26, Nose, Aerospace
Medical Disposition table
Also, see Aerospace Medical Disposition table and Item 35, Lungs and Chest
IV. PROTOCOL - See Disease Protocols Allergies, Severe
V. PHARMACEUTICAL CONSIDERATIONS
For conditions controlled by desensitization, AME must warn the airman to not
operate aircraft until four hours after each injection.
Sublingual immunotherapy (SLIT) used for allergic rhinitis is not acceptable

___________________________________________________________________________
ANTACIDS
II. MEDICAL HISTORY: Item 18.i.,Stomach, liver, or intestinal trouble.
The applicant should provide history and treatment, pertinent medical records, current
status report, and medication. If a surgical procedure was done, the applicant must
provide operative and pathology reports.
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 38, Abdomen and
Viscera, Aerospace Medical Disposition Table.
IV. PROTOCOL: See Peptic Ulcer
The prophylactic use of medications including simple antacids, H-2 inhibitors or
blockers, proton pump inhibitors, and/or sucralfates may not be disqualifying, if free
from side effects.

___________________________________________________________________________
ANTICOAGULANTS
II. MEDICAL HISTORY: Item 18.g. Heart or vascular trouble.
The applicant should describe the condition to include, dates, symptoms, treatment,
and provide medical reports to assist in the certification decision-making process.
These reports should include, as indicated by the applicable underlying condition(s)
and class applied for: 24-hour Holter monitor, operative reports of any coronary
intervention (including the original cardiac catheterization report), stress tests (including
worksheets and original tracings or a legible copy). For myocardial perfusion imaging,
we require the interpretive report and copies of the actual images in both grey-scale
and color (in digital format or hard copy.) Per Part 67, for all classes of medical
certificates, there is cause for denial if there is an established medical history or clinical
diagnosis of myocardial infarction, angina pectoris, cardiac valve replacement,
permanent cardiac pacemaker implantation, heart replacement, or coronary heart
disease (CHD) that has required treatment (or if untreated, that has been symptomatic
or clinically significant).
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 36, Heart, Aerospace
Medical Disposition table
IV. PROTOCOL: As per the specific underlying condition(s), see Disease Protocols
For applicants who are just beginning warfarin (Coumadin) treatment the following is
required:
Minimum observation time of 6 weeks after initiation of warfarin therapy;
Must also meet any required observation time for the underlying condition; AND
6 INRs, no more frequently than 1 per week
For applicants who are on an established use of warfarin (Coumadin), status report
from the treating physician should address and include:
Drug dose history and schedule;
Comment regarding side effects; AND
A minimum of monthly International Normalized Ratio (INRs) results for the
immediate prior 6 months.

___________________________________________________________________________
ANTIDEPRESSANTS
First-Class Airman Medical Certificate: 67.107
Second-Class Airman Medical Certificate: 67.207
Third-Class Airman Medical Certificate: 67.307
II. MEDICAL HISTORY: Item 18.m., Mental disorders of any sort; depression, anxiety,
etc.
An affirmative answer to Item 18.m. requires investigation through supplemental history
taking. Dispositions will vary according to the details obtained. An applicant with an
established history of a personality disorder that is severe enough to have repeatedly
manifested itself by overt acts, a psychosis disorder, or a bipolar disorder must be
denied or deferred by the Examiner.
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 47., Psychiatric,
Aerospace Medical Disposition table.
IV. PROTOCOL: See Aerospace Medical Dispositions, Item 47., Psychiatric
Conditions
The use of a psychotropic drug is disqualifying for aeromedical certification purposes
this includes all antidepressant drugs, including selective serotonin reuptake inhibitors
(SSRIs). However, the FAA has determined that airmen requesting first, second, or
third class medical certificates while being treated with one of four specific SSRIs may
be considered (see Item 47., Psychiatric Conditions Use of Antidepressant
Medications). The Authorization decision is made on a case-by-case basis. The
Examiner may not issue.

___________________________________________________________________________
ANTIHYPERTENSIVE
(Updated 10/28/15)

II. MEDICAL HISTORY: Item 18.h., High or low blood pressure.
III. AEROMEDICAL DECISION CONSIDERATIONS:
See Item 36. Heart, Hypertension
Also see Item 55. Blood Pressure
IV. PROTOCOL: N/A. See Hypertension Disposition table
Seven-day (7) no fly/ground trial is required when starting a new hypertension
(HTN) medication to verify no side effects.
AME should issue (if otherwise qualified) if the airmen is on 3 or fewer
medications
Uses of beta-adrenergic blockers ARE allowed with insulin, meglitinides, or
sulfonylureas.
ACCEPTABLE HTN Medications

(when certification criteria are met)
Alpha adrenergic blockers

Angiotensin converting enzyme (ACE)
inhibitors
Angiotensin II receptor antagonists
(ARBs)
Beta-adrenergic blockers
Calcium channel blockers

Direct renin inhibitors
Direct vasodilators
Diuretics
UNACCEPTABLE HTN Medications

(as a single agent or in any combination product)
DO NOT ISSUE
Clonidine (ex. Catapres/Clorpres)
guanabenz
guanfacine/Tenex
methyldopa
Nitrates (ex. nitroglycerin/isosorbide dinitrate/isosorbide mononitrate)
resperine

___________________________________________________________________________
CONTRACEPTIVES AND
HORMONE REPLACEMENT THERAPY
II. MEDICAL HISTORY: Use of Oral or Repository Contraceptives or Hormonal
Replacement Therapy are not disqualifying for medical certification. If the applicant is
experiencing no adverse symptoms or reactions to hormones and is otherwise
qualified, the Examiner may issue the desired certificate.
III. AEROMEDICAL DECISION CONSIDERATIONS: See Medical History above and
Item 48., General Systemic, Gender Dysphoria
IV. PROTOCOL: N/A
V. PHARMACEUTICAL CONSIDERATIONS: See Medical History above.

___________________________________________________________________________
DIABETES MELLITUS - INSULIN TREATED

First-Class Airman Medical Certificate: 67.113(a)(b)(c)
Second-Class Airman Medical Certificate: 67.213(a)(b)(c)
Third-Class Airman Medical Certificate: 67.313(a)(b)(c)
II. MEDICAL HISTORY: Item 18.k., Diabetes.
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 48,
General Systemic Aerospace Medical Disposition table.
IV. PROTOCOL: See Diabetes Mellitus Type I or Type II - Insulin-Treated Protocol
Insulin pumps are an acceptable form of treatment.
Combinations of anti-diabetes medication (s): The chart of Acceptable
Combinations of Diabetes Medications (pdf) summarizes the acceptable
medications for both monotherapy and combination therapy. The chart
organizes medications into groups based on similarity of mechanisms of actions
and/or therapeutic effects.

___________________________________________________________________________
DIABETES MELLITUS TYPE II MEDICATION CONTROLLED (NOT INSULIN)

First-Class Airman Medical Certificate: 67.113 (a)(b)(c)
Second-Class Airman Medical Certificate: 67.213(a)(b)(c)
Third-Class Airman Medical Certificate: 67.313(a)(b)(c)
II. MEDICAL HISTORY: Item 18.k. Diabetes.
The applicant should describe the condition to include symptoms and treatment.
Comment on the presence or absence of hyperglycemic and/or hypoglycemic
episodes. A medical history or clinical diagnosis of diabetes mellitus requiring insulin
or other hypoglycemic drugs for control is disqualifying. The Examiner can help
expedite the FAA review by assisting the applicant in gathering medical records and
submitting a current specialty report such as the DIABETES or HYPERGLYCEMIA ON
ORAL MEDICATIONS STATUS REPORT. See Item 48, Diabetes
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 48, Diabetes

IV. DISEASE PROTOCOL: See Diabetes Mellitus Type II - Medication Controlled
V. PHARMACEUTICAL CONSIDERATIONS: Combinations of anti-diabetes
medication (s): The chart of Acceptable Combinations of Diabetes Medications (pdf)
summarizes the acceptable medications for both monotherapy and combination
therapy. The chart organizes medications into groups based on similarity of
mechanisms of actions and/or therapeutic effects.

___________________________________________________________________________
Acceptable Combinations of Diabetes Medications (Updated 10/22/14)

Use: no more than one medication from each group (A-E) below. Up to 3 medications total are considered
acceptable for routine treatment according to generally accepted standards of care for diabetes (American
Diabetes Association; American Association of Clinical Endocrinologists). For applicants receiving
complex care (e.g., 4-drug therapy), refer the case to AMCD.
Initial certification of all applicants with diabetes melitus (DM) requires FAA decision
For applicants on AASI for DM, follow the AASI
Consult with FAA for any medications not on this chart
Fixed-dose combination medications count as 2 medications
PRECAUTIONS
Biguanide
- Metformin (e.g. Glucophage,
Fortamet, Glutetza, Riomet)
Thiazolidinediones (TZD)
- pioglitazone (Actos)
- rosiglitazone (Avandia)
Group A
Group B
GLP-1 mimetics
- exenatide (Byetta)
- exenatide-ED (Bydureon)
- liraglutide (Victoza)
Group C
DPP-4 inhibitors
- sitagliptin (Januvia)
- saxagliptin (Onglyza)
- linagliptin (Tradjenta)
- alogliptin (Nesina)
Alpha-glucosidase inhibitors
- acarbose (Precose)
- miglitol (Glyset)
Group C not allowed

with Meglitinides
Group D
Sulfonylureas (SFU)
- chlorpropamide (Diabenase)
- glyburide (Diabeta)
- glimepiride (Amaryl)
- glipizide (Glucotrol)
- tolbutamide (Orinase)
- tolazamide (Tolinase)
Meglitinides
- repaglinide (Prandin)
- nateglinide (Starlix)
Group E
Meglitinides not
allowed with Group C
Insulin
- All forms
- Initial certification requires FAA
decision
Note: Amylinomimetics (e.g., pramlintide (Symlin) are not considered acceptable for medical certification.

___________________________________________________________________________
ERECTILE DYSFUNCTION AND

BENIGN PROSTATIC HYPERPLASIA MEDICATIONS
(Updated 6/24/15)

II. MEDICAL HISTORY: Use of medication for erectile dysfunction (ED) and/or benign
prostatic hyperplasia (BPH) may not be disqualifying for medical certification if there
are no side effects, the underlying condition is not aeromedically significant, and the
applicant is otherwise qualified. If the medication is used for any other condition, do
not issue FAA approval is required.
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 41. G-U System,
IV. PROTOCOL: N/A
V. PHARMACEUTICAL CONSIDERATIONS: The use of medications below for G-U
conditions including ED and BPH may not be disqualifying, if free from side effects. For
the required minimum wait time after use, see the table below.
If the medications below are used for any other non G-U condition (e.g.,
pulmonary arterial hypertension [PAH]) the examiner must defer issuance of a
Alpha blockers are allowed for daily use if there no side effects. No minimum wait time
is required after use once the airman has successfully passed the 7-day ground trial
period required for all hypertension medication.
If alpha blockers are used in combination with PDE5 inhibitors (common examples are
listed below), the airman should not fly until verification that no hypotensive episodes or
other side effects are noted.
Nitrates are not allowed.
ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA

PDE-5 INHIBITOR MEDICATION WAIT TIMES
Trade Name
Generic Name
Cialis (daily use)

Cialis (prn use)
Levitra
Staxyn
Stendra
Viagra
Tadalafil
Tadalafil
Vardenafil
Vardenafil
Avanafil
Sildenafil
Required minimum waiting time after last dose before

resuming pilot or ATCS duties
Daily use is not acceptable for aeromedical purposes
36 hours
8 hours
8 hours
8 hours
8 hours

___________________________________________________________________________
GLAUCOMA MEDICATIONS
Second-Class Airman Medical Certificate: 67.213 (b)(c)
II. MEDICAL HISTORY: Item 18.,d, Medical History, Eye or vision trouble except
glasses.
The applicant should provide history and treatment, pertinent medical records, current
status report, and medication and dosage.
III. AEROMEDICAL DECISION CONSIDERATIONS: See Item 32, Ophthalmoscopic
IV. PROTOCOL: N/A
A few applicants have been certified following their demonstration of adequate control
with oral medication. Neither miotics nor mydriatics are necessarily medically
disqualifying. However, miotics such as pilocarpine cause pupillary constriction and
could conceivably interfere with night vision.
Although the FAA no longer routinely prohibits pilots who use such medications from
flying at night, it may be worthwhile for the Examiner to discuss this aspect of the use
of miotics with applicants. If considerable disturbance in night vision is documented,
the FAA may limit the medical certificate: NOT VALID FOR NIGHT FLYING.

___________________________________________________________________________
MALARIA MEDICATIONS
II. MEDICAL HISTORY: This medication is absolutely disqualifying for pilots and air
traffic controllers (ATCSs). Mefloquine (Lariam) is associated with adverse
neuropsychiatric side-effects, even weeks after the drug is discontinued. Because of
the association with adverse neuropsychiatric side-effects, even weeks after
discontinuation, a pilot who elects to use mefloquine for malaria prophylaxis or who
contracts malaria and is treated with mefloquine will be disqualified for pilot duties for
the duration of use of mefloquine and for 4 weeks after the last dose. In this instance,
the pilot must contact the FAA or his/her Aviation Medical Examiner prior to returning
to flight duties after use.
III. AEROMEDICAL DECISION CONSIDERATIONS: For return to pilot or ATCS duties
there must be no history of neurologic or psychiatric symptoms during and or after
mefloquine use. Examples of symptoms related to mefloquine use include: dizziness
or vertigo, tinnitus, and loss of balance; anxiety, paranoia, depression, restlessness or
confusion, hallucinations and psychotic behavior.
IV. PROTOCOL: N/A
Use of mefloquine must be discontinued for at least 4 weeks prior to
consideration and:
The airman or contract tower ATCS must contact the FAA agency flight surgeon
or their AME before resuming pilot or contract tower ATCS duties
The agency ATCS must contact the agency flight surgeon for clearance
determination prior to resuming safety sensitive duties
For return to pilot or ATCS duties there must be no history of neurologic or
psychiatric symptoms during and or after mefloquine use

___________________________________________________________________________
SEDATIVES
II. MEDICAL HISTORY and CONVICTIONS OR ADMINISTRATIVE ACTIONS.
Medical History: Item 18.n., Substance Dependence; or failed a drug test ever; or
substance abuse or use of illegal substance in the last 2 years.
"Substance" includes alcohol and other drugs (e.g., PCP, sedatives and hypnotics,
anxiolytics, marijuana, cocaine, opioids, amphetamines, hallucinogens, and other
psychoactive drugs or chemicals). For a "yes" answer to Item 18.n., the Examiner
should obtain a detailed description of the history. A history of substance dependence
or abuse is disqualifying. The Examiner must defer issuance of a certificate if there is
doubt concerning an applicant's substance use.
Convictions or Administrative Actions: Item 18.v., Conviction and/or Administrative
Action History
The events to be reported are specifically identified in Item 18.v. of FAA Form 8500-8.
If "yes" is checked, the applicant must describe the conviction(s) and/or administrative
action(s) in the EXPLANATIONS box. The description must include:
The alcohol or drug offense for which the applicant was convicted or the type of
administrative action involved (e.g., attendance at an educational or
rehabilitation program in lieu of conviction; license denial, suspension,
cancellation, or revocation for refusal to be tested; educational safe driving
program for multiple speeding convictions; etc.);
The date of the conviction and/or administrative action
If there have been no new convictions or administrative actions since the last
application, the applicant may enter "PREVIOUSLY REPORTED, NO CHANGE."
Convictions and/or administrative actions affecting driving privileges may raise
questions about the applicant's fitness for certification and may be cause for
disqualification.
A single driving while intoxicated (DWI) conviction or administrative action usually is
not cause for denial if there are no other instances or indications of substance
dependence or abuse. The Examiner should inquire regarding the applicant's alcohol
use history, the circumstances surrounding the incident, and document those findings
in Item 60.

___________________________________________________________________________
NOTE: The Examiner should advise the applicant that the reporting of alcohol or drug offenses
(i.e., motor vehicle violation) on the history part of the medical application does not relieve the
airman of responsibility to report each motor vehicle action to the FAA within 60 days of the
occurrence to the Civil Aviation Security Division, AAC-700; P.O. Box 25810; Oklahoma City,
OK 73125-0810.

IV. PROTOCOL: See Substances of Dependence/Abuse Protocol
A. Aerospace Medical Dispositions, Item 47. Psychiatric Conditions

___________________________________________________________________________
SLEEP AIDS
II. MEDICAL HISTORY: Use of sleep aids is a potential risk to aviation safety due to
effects of the sleep aid itself or the underlying reason/condition for using the sleep aid.
All the currently available sleep aids, both prescription and over the counter, can cause
impairment of mental processes and reaction times, even when the individual feels fully
awake. (As examples, see the Food and Drug Administration drug safety
communications on zolpidem and eszopiclone)
Medical conditions that chronically interfere with sleep are disqualifying regardless of
whether a sleep aid is used or not. Examples may include primary sleep disorders
(e.g., insomnia, sleep apnea) or psychological disorders (e.g., anxiety, depression).
While sleep aids may be appropriate and effective for short term symptomatic relief,
the primary concern should be the diagnosis, treatment, and resolution of the
underlying condition before clearance for aviation duties.
Occasional or limited use of sleep aids, such as for circadian rhythm disruption in
commercial air operations, is allowable for pilots and air traffic controllers. Daily/nightly
use of sleep aids is not allowed regardless of the underlying cause or reason. See
Pharmaceutical Considerations below.
III. AEROMEDICAL DECISION CONSIDERATIONS: N/A
IV. PROTOCOL: N/A
Because of the potential for impairment, we require a minimum wait time between the
last dose of a sleep aid and performing pilot or ATCS duties. This wait time is based on
the pharmacologic elimination half-life of the drug (half-life is the time it takes to clear
half of the absorbed dose from the body). The minimum required wait time after the last
dose of a sleep aid is 5-times the maximum elimination half-life.
The table on the following page lists several commonly prescribed sleep aids along
with the required minimum wait times for each.

___________________________________________________________________________
SLEEP AID WAIT TIMES

Trade Name
Generic Name
Ambien
Ambien CR
Edluar
zolpidem*
zolpidem (extended release)
zolpidem (dissolves under the
tongue)
zolpidem (for middle of the
night awakening)
eszopiclone
temazepam
ramelteon
zaleplon
zolpidem (as oral spray)
Intermezzo
Lunesta
Restoril
Rozerem
Sonata
Zolpimist
Required minimum waiting time after last

dose before resuming pilot or ATCS duties
24 hours
24 hours
36 hours
36 hours
30 hours
72 hours
24 hours
6 hours
48 hours
* NOTE: The different formulations of zolpidem have different half-lives, thus different wait times.

__________________________________________________________________________
SPECIAL ISSUANCES
AASIs for ALL CLASSES
AASIs for THIRD-CLASS
AASI COVERSHEET

___________________________________________________________________________
Authorization for Special Issuance of a Medical Certificate and

AME Assisted Special Issuance (AASI)
A. Special Issuance.
At his discretion, the Federal Air Surgeon may grant an Authorization for Special
Issuance of a Medical Certificate (Authorization), with a specified validity period, to an
applicant who does not meet the established medical standards. The applicant must
demonstrate to the satisfaction of the Federal Air Surgeon that the duties authorized by
the class of medical certificate applied for can be performed without endangering public
safety for the validity period of the Authorization. The Federal Air Surgeon may
authorize a special medical flight test, practical test, or medical evaluation for this
purpose. An airman medical certificate issued under the provisions of an Authorization
expires no later than the Authorization expiration date or upon its withdrawal. An
airman must again show to the satisfaction of the Federal Air Surgeon that the duties
authorized by the class of medical certificate applied for can be performed without
endangering public safety in order to obtain a new airman medical
certificate/Authorization under Title 14 of the Code of Federal Regulations (14 CFR)
67.401.
See Title 14 of the Code of Federal Regulations (14 CFR) 67.401.
B. AME Assisted Special Issuance (AASI).
to re-issue an airman medical certificate under the provisions of an
Authorization to an applicant who has a medical condition that is disqualifying under 14
CFR Part 67.
re-issuance determination. Examiners may re-issue an airman medical certificate
under the provisions of an Authorization, if the applicant provides the requisite medical
information required for determination. Examiners may not issue initial Authorizations.
An Examiner's decision or determination is subject to review by the FAA
LAST UPDATE: November 25, 2015
313

___________________________________________________________________________

The following pages of the Guide for Aviation Medical Examiners introduce the AME
Assisted Special Issuance (AASI) process.
The Guide refers to a number of selected medical conditions that are initially
disqualifying (if the applicant does not meet the issue criteria in the Aerospace
Medicine Dispositions Tables or the Certification Worksheets) and must be deferred to
the AMCD or RFS. If this is a first-time application for an AASI for a disqualifying
disease/condition, and the applicant has all of the requisite medical information
necessary for a determination, the Examiner must defer, and submit all of the
documentation to the AMCD or your RFS.
Following the granting of an Authorization for Special Issuance of a Medical Certificate
(Authorization) by the AMCD or RFS, an Examiner may reissue a medical certificate to
an applicant with a medical history of an initially disqualifying condition once the AASI's
specialized criteria is met and the applicant is otherwise qualified.
ARTHRITIS and/ or PSORIASIS
GLAUCOMA
ASTHMA
HEPATITIS C
ATRIAL FIBRILLATION
HYPERTENSION
BLADDER CANCER
HYPERTHYROIDISM
BREAST CANCER
HYPOTHYROIDISM
CHRONIC KIDNEY DISEASE
LYMPHOMA and HODGKINS DISEASE
CHRONIC LYMPHOCYTIC LEUKEMIA
MELANOMA
CHRONIC OBSTRUCTIVE
PULMONARY DISEASE
MIGRAINE HEADACHES
MITRAL and AORTIC INSUFFICIENCY
COLITIS
(Ulcerative or Crohns Disease) or Irritable
Bowel Syndrome
PAROXYSMAL ATRIAL TACHYCARDIA
COLON CANCER
PROSTATE CANCER
DEEP VENOUS THROMBOSIS (DVT),

PULMONARY EMBOLISM (PE), and/ or
HYPERCOAGULOPATHIES
RENAL CALCULI
DIABETES MELLITUS TYPE II

Medication Controlled (Not Insulin)
SLEEP APNEA
RENAL CARCINOMA
TESTICULAR CANCER
314

___________________________________________________________________________
AASI FOR ARTHRITIS AND/ OR PSORIASIS

to re-issue an airman medical certificate under the provisions of an Authorization for
Special Issuance of a Medical Certificate (Authorization) to an applicant who has a
medical condition that is disqualifying under Title 14 of the Code of Federal Regulations
(14 CFR) part 67.
attachments which specify the information that treating physician(s) must provide for the
re-issuance determination. If this is a first-time application for an AASI for the above
disease/condition, and the applicant has all the requisite medical information necessary
for a determination, the Examiner must defer and submit all of the documentation to the
AMCD or RFS for the initial determination.
Examiners may re-issue an airman medical certificate under the provisions of an
Authorization, if the applicant provides the following:

The type of arthritis or psoriasis;
A general assessment of the condition and its effect on daily activities;
The name and dosage of medication(s) used for treatment and/or prevention with
comment regarding side effects; and
For arthritis - comments regarding range of motion of neck, upper and lower
extremities, hands, etc.
The Examiner must defer to the AMCD or Region if:
The applicant has developed any associated systemic manifestations;

For arthritis - new joints have become involved;
The applicant required change in medication used for control of the disease; or
The applicant is taking steroid doses equivalent to more than 20 mg of prednisone per
day (steroid conversion calculator)
315

___________________________________________________________________________
AASI FOR ASTHMA

Note: If the applicant has mild symptoms that are infrequent, have not required hospitalization,
or use of steroid medication, and no symptoms in flight, the Examiner may issue an airman
medical certificate. See Item 35., Lungs and Chest Aerospace Medical Disposition.
If the applicant does not meet the above criteria, the Examiner must follow the AASI process.
AME Assisted Special Issuance (AASI) is a process that provides Examiners the ability to reissue an airman medical certificate under the provisions of an Authorization for Special
Issuance of a Medical Certificate (Authorization) to an applicant who has a medical condition
that is disqualifying under Title 14 of the Code of Federal Regulations (14 CFR) part 67.
An FAA physician provides the initial certification decision and grants the Authorization in
accordance with 14 CFR 67.401. The Authorization letter is accompanied by attachments
that specify the information that treating physician(s) must provide for the re-issuance
determination. If this is a first-time application for an AASI for the above disease/condition, and
the applicant has all the requisite medical information necessary for a determination, the
Examiner must defer and submit all of the documentation to the AMCD or RFS for the initial
determination.
Examiners may re-issue an airman medical certificate under the provisions of an Authorization,
if the applicant provides the following:

The applicants current medical status that addresses frequency of attacks and whether
the attacks have resulted in emergency room visits or hospitalizations;
The Examiner should caution the applicant to cease flying with any exacerbation as
warned in 61.53;
Results of pulmonary function testing, if deemed necessary, performed within the last
90 days
The symptoms worsen;

There has been an increase in frequency of emergency room, hospital, or outpatient
visits;
The FEV1 is less than 70% predicted value;
The applicant requires 3 or more medications for stabilization; or
The applicant is taking steroid doses equivalent to more than 20 mg of prednisone per
day (steroid conversion calculator)
LAST UPDATE August 16, 2013
316

___________________________________________________________________________
AASI FOR ATRIAL FIBRILLATION

(14 CFR) part 67.

A summary of the applicants medical condition since the last FAA medical
examination, including a statement regarding any further episodes of atrial
fibrillation;
comment regarding side effects;
A report of a current 24-hour Holter Monitor performed within the last 90 days;
A minimum of monthly International Normalized Ratio (INR) results for the
immediate prior 6 months, for airmen being treated with warfarin (Coumadin).
Holter Monitor demonstrates: HR >120 BPM or Pauses >3 seconds;

More than 20% of INR values are <2.0 or >3.0; or
The applicant develops emboli, thrombosis, bleeding that required medical
intervention, or any other cardiac condition previously not diagnosed or reported.
317

___________________________________________________________________________
AASI FOR BLADDER CANCER

(14 CFR) part 67.
An Authorization granted by the FAA; and

A current status report performed within 90 days that must include all the
required followup items and studies as listed in the Authorization letter and that
confirms absence of recurrent disease
There has been any recurrence of the cancer; or

Any new treatment is initiated
318

___________________________________________________________________________
AASI FOR BREAST CANCER

medical condition that is disqualifying under Title 14 of the Code of Federal
Regulations (14 CFR) part 67.
for a determination, the Examiner must defer and submit all of the documentation to
the AMCD or RFS for the initial determination.

A current status report performed within the last 90 days that must include all
the required followup items and studies as listed in the Authorization letter and
that confirms absence of recurrent disease.

Any new treatment is initiated.
319

___________________________________________________________________________
AASI FOR CHRONIC KIDNEY DISEASE (CKD)

(Updated 11/25/2015)
(14 CFR) part 67.
accordance with 14 CFR 67.401. The Authorization letter is accompanied by
A current status report from the treating physician detailing:
o How long the condition has been stable and asymptomatic;
o If there has been any significant change in eGFR or renal function;
o Any interval development of other complications or abnormal physical
exam findings (such as diabetes, uncontrolled HTN, or clinically significant
proteinuria);
o Most recent lab results including eGFR, creatinine, hemoglobin, hematocrit
and urine albumin or ACR;
o The name and dosage of medication(s) and presence or absence of any
side effects; and
o Statement from the treating physician if there is any evidence of
cardiovascular disease
The condition is no longer stable (per the treating physician note);
Dialysis has been started or transplant has occurred;
The airman is taking a medication that is not acceptable (See Pharmaceuticals
Antihypertensive) or has aeromedically significant side effects from the
medication;
Anemia with hemoglobin less than 10 gm/dL or hematocrit less than 30% is
present; or
The eGFR is 29 or less; (if this occurs, the airman will need to submit additional
testing to show stability [such as inulin clearance testing, creatinine clearance
testing, or a 24-hour urine creatinine result] and the nephrologists clinical
interpretation of results, prognosis, and plan for follow up).
LAST UPDATE November 25, 2015
320

___________________________________________________________________________
AASI FOR CHRONIC LYMPHOCYTIC LEUKEMIA

(14 CFR) part 67.

A clinical followup report from the treating physician that includes an update of
the condition of the applicant since the last examination; and
The results of any applicable laboratory results, including a complete blood count
performed within the last 90 days.
The condition currently requires treatment with a chemotherapeutic agent; or

The white blood cell count has risen above 80,000; or
LAST UPDATE November 25, 2015
321

___________________________________________________________________________
AASI FOR
CHRONIC OBSTRUCTIVE PULMONARY DISEASE

A statement regarding symptomatology of the condition;
A statement addressing any associated illnesses, such as heart failure;
The name and dosage of medication(s) used for treatment and/or prevention
with comment regarding side effects; and
A pulmonary specialist evaluation that includes the results of a current
pulmonary function test, performed within the last 90 days
The FEV1 or FEV1/FVC is less than 70%;

The applicant has developed an associated cardiac condition, or
The applicant is taking steroid doses equivalent to more than 20 mg of
prednisone per day (steroid conversion calculator)
322

___________________________________________________________________________
AASI FOR COLITIS

(ULCERATIVE OR CROHNS DISEASE) OR
IRRITABLE BOWEL SYNDROME

A statement regarding the extent of disease;
A statement regarding the frequency of exacerbation (the applicant should
cease flying with any exacerbation as warned in 61.53); and
with comment regarding side effects.
There is a current exacerbation of the illness;

The applicant is taking medications such as Lomotil, steroid doses equivalent to
more than 20 mg of prednisone per day (steroid conversion calculator),
antispasmodics, and anticholinergics; or
The pattern of exacerbations is increasing in frequency or severity; or applicant
underwent surgical intervention.
323

___________________________________________________________________________
AASI FOR COLON/COLORECTAL CANCER

re-issuance determination. If this is first-time application for an AASI for the above

An update of the status of the malignancy since the last FAA medical
examination, to include the results of a current (performed within the last 90
days) carcinoembryonic antigen (CEA), if a baseline value is available
There has been any progression of the disease or an increase in CEA or

324

___________________________________________________________________________
AASI FOR DEEP VENOUS THROMBOSIS (DVT),

PULMONARY EMBOLISM (PE), AND/ OR
HYPERCOAGULOPATHIES
(14 CFR) part 67.
disease/condition and the applicant has all the required medical information necessary

examination, including a statement regarding any further episodes of DVT, PE or
other complication of hypercoagulopathy (see below*);
A minimum of monthly International Normalized Ratio (INR) results for the
immediate prior 6 months for those being treated with warfarin (Coumadin).
* The Examiner must defer to the AMCD or Region if:
More than 20 percent of INR values are <2.0 or >3.0 for those being treated with
warfarin (Coumadin); or
The applicant develops emboli, thrombosis, bleeding that required medical
intervention, or any other cardiac or neurologic condition previously not
diagnosed or reported.
325

___________________________________________________________________________
AASI FOR DIABETES MELLITUS - TYPE II

MEDICATION CONTROLLED (NOT INSULIN)
AME Assisted Special Issuance (AASI) is a process that provides Examiners the ability to reissue an airman medical certificate under the provisions of an Authorization for Special Issuance
of a Medical Certificate (Authorization) to an applicant who has a medical condition that is
disqualifying under Title 14 of the Code of Federal Regulations (14 CFR) part 67.
accordance with 14 CFR 67.401. The Authorization letter is accompanied by attachments that
specify the information that treating physician(s) must provide for the re-issuance determination.
If this is a first-time application for an AASI for the above disease/condition, and the applicant
has all the requisite medical information necessary for a determination, the Examiner must defer
and submit all of the documentation to the AMCD or RFS for the initial determination. The
information can be submitted using the DIABETES or HYPERGLYCEMIA ON ORAL
MEDICATIONS STATUS REPORT.
Examiners may re-issue an airman medical certificate under the provisions of an Authorization,
provided that the applicant does not require insulin, remains on an acceptable oral
medication therapy according to the chart Acceptable Combinations of Diabetes
Medications, and if the applicant provides the following:
An Authorization granted by the FAA AND either
A DIABETES or HYPERGLYCEMIA ON ORAL MEDICATIONS STATUS
REPORT OR
A current status report from the physician treating the airmans diabetes,
including:
o A statement attesting that the airman is maintaining his or her diabetic
diet;
o A statement regarding any diabetic symptomatology; including any history
of hypoglycemic events and any cardiovascular, renal, neurologic, or
ophthalmologic complications; and
o The results of a current HgA1c level performed within last 30 days.
The Examiner must defer to the AMCD or Region if, since the applicants last exam:
The applicant has been placed on insulin;
The HgA1c level is greater than 9.0 mg%
The applicant has experienced:
o Severe Hypoglycemia event(s) - requiring assistance of another person to
actively administer carbohydrates, glucagon, or take other corrective
actions (plasma glucose concentrations may not be available)*;
o Documented Symptomatic Hypoglycemia event(s) - typical symptoms of
hypoglycemia accompanied by a measured plasma glucose concentration
70 mg/dL (3.9 mmol/L)*;
o Asymptomatic Hypoglycemia no reported symptoms but a measured
plasma glucose concentration 54 mg/dL (3.0 mmol/L)
The applicant has developed evidence of any of the following:
o Cardiovascular disease,
326

___________________________________________________________________________
o Neurologic disease, including any change in degree of peripheral

neuropathy,
o Ophthalmologic disease,
o Renal disease (including a Creatinine over 2.0)
The airman has been placed on any amlynomimetics, such as pramlintide
(Symlin)
The applicant is using any medication (single or in combination) that falls outside
the framework of Acceptable Combinations of Diabetes Medications
The applicant has required treatment other than routine outpatient follow-up (e.g.
emergency department, inpatient admission) for diabetes (e.g. hypoglycemia,
ketoacidosis, non-ketotic hyperglycemia) or diabetes-related conditions.
The applicant has experienced any event suggesting hypoglycemia unawareness
or hypoglycemia-associated autonomic failure.
* Reference: Hypoglycemia Workgroup of the ADA & The Endocrine Society
327

___________________________________________________________________________
AASI FOR GLAUCOMA

(14 CFR) part 67.

Certification only granted for open-angle-glaucoma and ocular hypertension;
The FAA Form 8500-14, Glaucoma Eye Evaluation Form is filled out by the
treating eye specialist; and
A set of visual fields measurements is provided.
The FAA Form 8500-14 Glaucoma Eye Evaluation Form demonstrates visual
acuity incompatible with the medical standards; or
There is a change in visual fields or adverse change in ocular pressure.
328

___________________________________________________________________________
AASI FOR HEPATITIS C


Any symptoms the applicant has developed;
with comment regarding side effects; and
A current liver function profile performed within the last 90 days.
The applicant has developed symptoms;

There has been a change in treatment regimen or the applicant has been placed
on alpha-interferon;
Any side effects from required medication; or
An adverse change in liver function studies.
329

___________________________________________________________________________
AASI FOR HYPERTENSION (HTN)

(Updated 10/28/2015)
(14 CFR) part 67.
accordance with 14 CFR 67.401. The Authorization letter is accompanied by

A current status report from the treating physician detailing:
o If the is condition stable and, if so, for how long;
o Any secondary cause for the HTN;
o Any co-morbid condition (such as diabetes, obstructive sleep apnea); and
o Any history of end organ damage (such as heart failure, myocardial
infarction, cerebrovascular accident, kidney disease, eye disease); and
o The name and dosage of medication(s) and presence or absence of any
side effects.
The condition is not stable or has become uncontrolled (per the treating physician
note);
The airman is taking a medication that is not acceptable (See Pharmaceuticals
Antihypertensive);
The airman has aeromedically significant side effects from the medication;
There is a new co-morbid condition, complication, or end organ damage; or
The end organ damage condition(s) do not meet FAA requirements. (See the
applicable section for the specific condition(s) in the AME guide)
330

___________________________________________________________________________
AASI FOR HYPERTHYROIDISM

(14 CFR) part 67.
An Authorization granted by the FAA current statement of the condition since last
FAA medical examination;
Current thyroid function studies performed within last 90 days.
The applicant has developed hypothyroidism; or

The thyroid function studies are elevated, suggesting inadequate treatment; or
The applicant developed an associated illness, such as dysrhythmia.
331

___________________________________________________________________________
AASI FOR HYPOTHYROIDISM


with comment regarding side effects;
A statement regarding any other associated problems, such as cardiac or visual;
and
A statement regarding the current thyroid stimulating hormone (TSH) level
performed within the last 90 days.
The Examiner should defer to the AMCD or Region if:
The applicant develops a related problem in another system, such as cardiac; or

The TSH level is elevated.
332

___________________________________________________________________________
AASI FOR LYMPHOMA AND HODGKINS DISEASE

(14 CFR) part 67.

An update of the status of the disease from the last FAA medical examination
and any testing deemed necessary by the treating physician.
There has been any recurrence or disease progression

333

___________________________________________________________________________
AASI FOR MELANOMA (Updated 08/26/2015)

An Authorization granted by the FAA, and

A current status report performed within the last 90 days that must include all
the required followup items and studies as listed in the Authorization letter and
that confirms absence of recurrent disease
There has been any recurrence of the cancer, or

Note:
A Special Issuance or AASI is required for any metastatic melanoma regardless of Breslow
level.
A Special Issuance or AASI is required for any melanoma which exhibits Breslow Level equal to
or deeper than 0.75 mm with or without metastasis.
A melanoma that exhibits a Breslow Level of less than 0.75 mm and no evidence of metastasis
may be regular issued.
334

___________________________________________________________________________
AASI FOR MIGRAINES

(14 CFR) part 67.

A statement regarding the frequency of headaches and/or other associated
symptoms since last followup report;
A statement regarding if the characteristics of the headaches changed; and
comment regarding side effects.
The frequency of headaches and/or other symptoms increase since the last
followup report; or
The applicant is placed on medication(s), such as isometheptene mucate,
narcotic analgesic, tramadol, tricyclic-antidepressant medication, etc.
335

___________________________________________________________________________
AASI FOR MITRAL OR AORTIC INSUFFICIENCY


examination, including a statement regarding any further episodes of atrial
fibrillation; and
A current 2-D echocardiogram with Doppler performed within the last 90 days.
The mean gradient across the valve reaches 40 mm Hg;

New symptoms occur;
An arrhythmia develops; or
The treating physician or Examiner reports the murmur is now moderate to
severe (Grade III or IV).
336

___________________________________________________________________________
AASI FOR PAROXYSMAL ATRIAL TACHYCARDIA


A statement regarding any recurrences since the last FAA medical examination;
and
with comment regarding side effects.
There have been one or more recurrences; or

The applicant has received some treatment that was not reported in the past,
such as radiofrequency ablation
337

___________________________________________________________________________
AASI FOR PROSTATE CANCER


A current status of the medical condition to include any testing deemed
necessary; and
A current PSA level performed within the last 90 days.
The PSA rises at a rate above 0.75 ng/ml per year;

A new treatment is initiated; or
Any metastasis has occurred.
338

___________________________________________________________________________
AASI FOR RENAL CALCULI


A statement from your treating physician regarding the location of the retained
stone(s), estimation as to size of stone, and likelihood of becoming
symptomatic; and
A current report of appropriate imaging study (IVP, KUB, Ultrasound, or Spiral
CT Scan) and provide a metabolic work-up, both performed within the last 90
days.
If the treating physician comments that the current stone has a likelihood of
becoming symptomatic;
If the retained stone(s) has moved when compared to previous evaluations; or
If the stone(s) has become larger when compared to previous evaluations.
339

___________________________________________________________________________
AASI FOR RENAL CARCINOMA

(14 CFR) part 67.

A current status report performed within the last 90 days that must include all the
confirms absence of recurrent disease.

340

___________________________________________________________________________
AASI FOR OBSTRUCTIVE SLEEP APNEA (OSA)

AME Assisted - All Classes Obstructive Sleep Apnea (OSA)
Examiners may re-issue an airman medical certificate to airmen currently on an AASI for OSA
if the airman provides the following:
Signed Airman Compliance with Treatment form or equivalent from the airman attesting
to absence of OSA symptoms and continued daily use of prescribed therapy; and
A current status report from the treating physician indicating that OSA treatment is still
effective.
o

A copy of the cumulative annual PAP device report which shows actual
time used (rather than a report typically generated for insurance
providers which only shows if use is greater or less than 4 hours). Target
goal should show use for at least 75% of sleep periods and an average
minimum of 6 hours use per sleep period.
For persons with an established diagnosis of OSA who do not have a

recording CPAP, a one year exception will be allowed to provide a
personal statement that they regularly use CPAP and before each shift
when performing flight or safety duties.
For Dental Devices and/or for Positional Devices:

No conditions known to be co-morbid with OSA (e.g., diabetes mellitus,
hypertension treated with more than two medications, atrial fibrillation, etc).
Once Dental Devices with recording / monitoring capability are available, reports
must be submitted.
For Surgery:
For successfully treated surgical patients, a statement attesting to the continued
absence of OSA symptoms is required.
Defer to the AMCD or the Region for further review if:
Concerns about adequacy of therapy or non-compliance;

Significant weight gain or development of conditions known to be co-morbid with
OSA (e.g., diabetes mellitus, hypertension treated with more than two medications,
atrial fibrillation, etc).
Note: The Examiner may request AMCD review to discontinue the AASI if there are
indications that the airman no longer has OSA (e.g., significant weight loss and a
negative study or surgical intervention followed by 3 years of symptom abatement and
absence of significant weight gain or co-morbid conditions). In most cases, a followup sleep study will be required to remove the AASI.
341

___________________________________________________________________________
AASI FOR TESTICULAR CARCINOMA

(14 CFR) part 67.

A current status report performed within the last 90 days that must include all the
confirms absence of recurrent disease.

LAST UPDATE April 09, 2013
342

___________________________________________________________________________

for Third-Class Airman Medical Certificate
The AASIs listed below are presently restricted to the issue of a third-class airman
re-issuance determination. If this is a first-time application for an AASI or the above
For Third-class:
Coronary Heart Disease (CHD) (to include):
Angina Pectoris
Atherectomy
Brachytherapy
Coronary Bypass Grafting
Myocardial Infarction
Percutaneous Transluminal Angioplasty (PTCA)
Rotoblation
Stent Insertion
Valve Replacement
343

___________________________________________________________________________
AASI FOR CORONARY HEART DISEASE (CHD)

AME Assisted Special Issuance (AASI) is a process that provides Examiners the ability to
reissue an airman medical certificate to an applicant who has a medical condition that is
disqualifying under Title 14 of the Code of Federal Regulations, (14 CFR) part 67. This AASI is
presently restricted to the issue of a third-class airman medical certificate for an applicant with
a history of Angina Pectoris; Atherectomy; Brachytherapy; Coronary Bypass Grafting;
Myocardial Infarction; Percutaneous Transluminal Angioplasty (PTCA); Rotoblation; or Stent
Insertion. First- and second-class applicants must be deferred to the FAA.
The FAA physicians provide the initial certification decision and grant the Authorization for
Special Issuance of a Medical Certificate (Authorization) in accordance with 14 CFR 67.401.
The Authorization letter is accompanied by attachments that specify the information that
treating physician(s) must provide for the issuance determination. If this is first-time
application for an AASI for the above disease/condition, and the airman has all the requisite
medical information necessary for a determination, you must defer and submit all of the
documentation to the AMCD or your RFS for the initial determination.
Examiners may reissue an airman medical certificate if the applicant provides the following:

A current status report performed within the past 90 days in accordance with the CHD
Protocol; and
A current maximal GXT See GXT Protocol
The Examiner must defer medical certification to AMCD or Region if:
The applicant complains of chest pain at any time (exclude chest pain with a firm
diagnosis of non-cardiac causes of chest pain);
The applicant has another event (myocardial infarction, or restenosis requiring CABG,
atherectomy, brachytherapy, PTCA, or stent);
The applicant for whatever reason is placed on a long acting nitrate;
The applicants risk factors are inadequately controlled; or
Has any reason for not renewing an AASI See GXT Protocol; or
The applicant develops bleeding that required medical intervention or other cardiac
condition not previously diagnosed or reported.
344

___________________________________________________________________________
AASI FOR SINGLE VALVE REPLACEMENT

This AASI is presently restricted to the issue of a third-class airman medical
certificate. First- and second-class applicants must be deferred to the FAA.
An Authorization granted by the FAA

A current status report performed within the past 90 days in accordance with the CHD
Protocol
A current 2D echocardiogram performed within 90 days
For Mechanical Heart Values - A minimum of monthly International Normalized Ratio
(INR) results for the immediate prior six months
The Examiner must defer medical certification to AMCD or Region if:
The airman requires another valve procedure

Evidence of perivalvular leaking via echocardiogram
The post procedure valve area is less than 1.0 cm2
New onset arrhythmia such as of atrial fibrillation/flutter, ventricular bigeminy,
ventricular tachycardia, Mobitz Type II or greater AV block, complete heart block,
RBBB, LBBB or LVH
More than 20% of INR values are less than 2.5 or greater than 3.5.
In select cases of a Bileaflet (St. Jude) valve in the aortic position, INR values between
2.0 and 3.0 may be accepted (check with FAA)
The applicant reports any other disqualifying medical condition or undergoes therapy
not previously reported
The applicant develops emboli, thrombosis, bleeding that required medical intervention,
or any other cardiac condition previously not diagnosed or reported
345
Aviation Medical Examiner

Assisted Special Issuance (AASI)
Certificate Issuance (Updated 11/25/15)
I have reviewed the enclosed medical report(s) and have determined that the report(s) is in accordance with this applicants
Authorization for Special Issuance of a Medical Certificate and the AASI Protocol established for certificate issuance.
I have issued a
-class medical certificate to the airman named below with all other limitations listed on the original
certificate. The certificate issued is timed limited by the restriction NOT VALID FOR ANY CLASS AFTER ____________
Date
Check all that apply:
Interim certificate issued for disease(s)/condition(s) below No examination performed.
ALL
AASI CONDITION
Arthritis
ALL
Asthma
Atrial Fibrillation
THIRD
CLASS
ONLY
AASI CONDITION
Diabetes Mellitus Type II
Medication Controlled
Metabolic Syndrome, Glucose
Intolerance, Impaired Glucose
Tolerance, Impaired Fasting
Glucose, Insulin Resistance, and
Pre-Diabetes
Glaucoma
ALL
AASI CONDITION
Mitral and Aortic
Insufficiency
Paroxysmal Atrial
Tachycardia
Prostate Cancer
Bladder Cancer
Breast Cancer
Chronic Kidney Disease
Chronic Lymphocytic
Leukemia
Chronic Obstructive
Pulmonary
Hepatitis C
Hypertension
Hyperthyroidism
Hypothyroidism
Renal Calculi
Renal Cancer
Sleep Apnea
Testicular Cancer
Lymphoma and Hodgkins
Warfarin (Coumadin)
Therapy for Deep Venous
Thrombosis, Pulmonary
Embolism, and/ or
Hypercoagulopathies.
Colitis
(Ulcerative or Crohns)
Colon Cancer
AASI CONDITION
Melanoma
Migraine Headaches
THIRD
CLASS
ONLY
Coronary Heart Disease (CHD)

Certificate issued - New application and examination performed.
AIRMAN INFORMATION:
Name:
PI:
DOB:
AVIATION MEDICAL EXAMINER (AME) INFORMATION:

AME Name (Print):
AME Signature:
AME Number:
Date:

__________________________________________________________________________
SUBSTANCES OF DEPENDENCE/ABUSE

____________________________________________________________________________
Substances of Dependence/Abuse
As an Examiner you are required to be aware of the regulations and Agency policy and
have a responsibility to inform airmen of the potential adverse effects of medications
and to counsel airmen regarding their use. There are numerous conditions that require
the chronic use of medications that do not compromise aviation safety and, therefore,
are permissible. Airmen who develop short-term, self-limited illnesses are best advised
to avoid performing aviation duties while medications are used.
Aeromedical decision-making includes an analysis of the underlying disease or
condition and treatment. The underlying disease has an equal and often greater
influence upon the determination of aeromedical certification. It is unlikely that a source
document could be developed and understood by airmen when considering the
underlying medical condition(s), drug interactions, medication dosages, and the shear
volume of medications that need to be considered. A list may encourage or facilitate an
airmen's self-determination of the risks posed by various medical conditions especially
when combination therapy is used. A list is subject to misuse if used as the sole factor
to determine certification eligibility or compliance with 14 CFR part 61.53, Prohibition of
Operations During Medical Deficiencies. Maintaining a published a list of "acceptable"
medications is labor intensive and in the final analysis only partially answers the
certification question and does not contribute to aviation safety.
Therefore, the list of medications referenced provides aeromedical guidance about
specific medications or classes of pharmaceutical preparations and is applied by using
sound aeromedical clinical judgment. This list is not meant to be totally inclusive or
comprehensive. No independent interpretation of the FAA's position with respect to a
medication included or excluded from the following should be assumed. See Aviation
Industry Antidrug and Alcohol Misuse Prevention Programs
348

____________________________________________________________________________
Substances of Dependence/Abuse
ALCOHOL DEPENDENCE/ABUSE
MARIJUANA
AMPHETAMINES
NARCOTICS
ANXIOLYTICS
PHENCYCLIDINE (PCP)
COCAINE
PSYCHOTROPIC
HYPNOTICS
STIMULANTS
HALLUCINOGENS
TRANQUILIZERS
The following is applicable to each Substances of Dependence/Abuse referenced

above:
II. MEDICAL HISTORY and CONVICTIONS OR ADMINISTRATIVE ACTIONS.
Medical History: Item 18.n., Substance dependence; or failed a drug test ever; or
substance abuse or use of illegal substance in the last 2 years.
"Substance" includes alcohol and other drugs (e.g., PCP, sedatives and hypnotics,
anxiolytics, marijuana, cocaine, opioids, amphetamines, hallucinogens, and other
psychoactive drugs or chemicals). For a "yes" answer to Item 18.n., the Examiner
should obtain a detailed description of the history. A history of substance dependence
or abuse is disqualifying. The Examiner must defer issuance of a certificate if there is
doubt concerning an applicant's substance use.
Convictions or Administrative Actions: Item 18.v., Conviction and/or Administrative
Action History
The events to be reported are specifically identified in Item 18.v. of FAA Form 8500-8.
If "yes" is checked, the applicant must describe the conviction(s) and/or administrative
action(s) in the EXPLANATIONS box. The description must include:
The alcohol or drug offense for which the applicant was convicted or the type of
administrative action involved (e.g., attendance at an educational or rehabilitation
program in lieu of conviction; license denial, suspension, cancellation, or
revocation for refusal to be tested; educational safe driving program for multiple
speeding convictions; etc.);
349

____________________________________________________________________________

The date of the conviction and/or administrative action
If there have been no new convictions or administrative actions since the last
application, the applicant may enter "PREVIOUSLY REPORTED, NO CHANGE."
Convictions and/or administrative actions affecting driving privileges may raise
questions about the applicant's fitness for certification and may be cause for
disqualification.
A single driving while intoxicated (DWI) conviction or administrative action usually is not
cause for denial if there are no other instances or indications of substance dependence
or abuse. The Examiner should inquire regarding the applicant's alcohol use history,
the circumstances surrounding the incident, and document those findings in Item 60.
NOTE: The Examiner should advise the applicant that the reporting of alcohol or drug offenses
(i.e., motor vehicle violation) on the history part of the medical application does not relieve the
airman of responsibility to report each motor vehicle action to the FAA within 60 days of the
occurrence to the Civil Aviation Security Division, AAC-700; P.O. Box 25810; Oklahoma City,
OK 73125-0810.

IV. PROTOCOL: See Substances of Dependence/Abuse Protocol . For specification
guidelines, see Substance of Dependence/Abuse (Drugs and Alcohol) Specification
Evaluation.
V. Aviation Industry Antidrug and Alcohol Misuse Prevention Programs
350

__________________________________________________________________________
SYNOPSIS OF MEDICAL STANDARDS

____________________________________________________________________________
SUMMARY OF MEDICAL STANDARDS Revised April 3, 2006
Medical
Certificate
Pilot Type
First-Class
Airline Transport Pilot
Second-Class
Commercial Pilot
Third-Class
Private Pilot
20/40 or better in each eye

separately, with or without
correction.
DISTANT VISION
20/20 or better in each eye separately, with or

without correction.
NEAR VISION
20/40 or better in each eye separately (Snellen equivalent), with or without correction, as
measured at 16 inches.
INTERMEDIATE VISION
20/40 or better in each eye separately (Snellen

equivalent), with or without correction at age 50 and over, No requirement.
as measured at 32 inches.
COLOR VISION
Ability to perceive those colors necessary for safe performance of airman duties.
HEARING
Demonstrate hearing of an average conversational voice in a quiet room, using both ears
at 6 feet, with the back turned to the examiner or pass one of the audiometric tests below.
AUDIOLOGY
Audiometric speech discrimination test: Score at least 70% reception in one ear.
Pure tone audiometric test. Unaided, with thresholds no worse than:
500 Hz
1,000 Hz
2,000 Hz
3,000 Hz
Better Ear
35 Db
30 dB
30 dB
40 dB
Worst Ear
35 dB
50 dB
50 dB
60 dB
ENT
No ear disease or condition manifested by, or that may reasonably be expected to

maintained by, vertigo or a disturbance of speech or equilibrium.
PULSE
Not disqualifying per se. Used to determine cardiac system status and responsiveness.
BLOOD PRESSURE
No specified values stated in the standards. The current guideline maximum value is
155/95.
ELECTROCARDIOGRAM (ECG)
At age 35 and
annually after age 40
MENTAL
No diagnosis of psychosis, or bipolar disorder, or severe personality disorders.
SUBSTANCE
DEPENDENCE AND
SUBSTANCE ABUSE
A diagnosis or medical history of "substance dependence" is disqualifying unless there is

established clinical evidence, satisfactory to the Federal Air Surgeon, of recovery, including
sustained total abstinence from the substance(s) for not less than the preceding 2 years. A
history of "substance abuse" within the preceding 2 years is disqualifying. "Substance"
includes alcohol and other drugs (i.e., PCP, sedatives and hypnotics, anxiolytics,
marijuana, cocaine, opioids, amphetamines, hallucinogens, and other psychoactive drugs
or chemicals).
DISQUALIFYING
CONDITIONS
Unless otherwise directed by the FAA, the Examiner must deny or defer if the applicant
has a history of: (1) Diabetes mellitus requiring hypoglycemic medication; (2) Angina
pectoris; (3) Coronary heart disease (CHD) that has been treated or, if untreated, that has
been symptomatic or clinically significant; (4) Myocardial infarction; (5) Cardiac valve
replacement; (6) Permanent cardiac pacemaker; (7) Heart replacement; (8) Psychosis; (9)
Bipolar disorder; (10) Personality disorder that is severe enough to have repeatedly
manifested itself by overt acts; (11) Substance dependence; (12) Substance abuse; (13)
Epilepsy; (14) Disturbance of consciousness and without satisfactory explanation of cause,
and (15) Transient loss of control of nervous system function(s) without satisfactory
explanation of cause.
Not routinely required.
NOTE: For further information, contact your Regional Flight Surgeon.
352

__________________________________________________________________________
STUDENT PILOT RULE CHANGE

____________________________________________________________________________
Student Pilot Rule Change

(Updated 04/08/16)
As of April 1, 2016, AMEs are no longer able to issue the combined FAA Medical Certificate and
Student Pilot Certificate. Student Pilots must have a separate Student Pilot Certificate and a separate
FAA Medical Certificate.
This change is due to a new Final Rule published on 01/12/16 [81 FR 1292]. It is in response to section
4012 of the Intelligence Reform and Terrorism Prevention Act and facilitates security vetting by the
Transportation Security Administration (TSA) of student pilot applicants prior to certificate issuance.
The airman, student pilot airman, and non-FAA Air Traffic Control Specialist will continue to require a
medical exam issued by an AME.
The student pilot will need a valid medical certificate prior to solo flight.
What has changed for the AME regarding the MEDICAL CERTIFICATE?
Medical Flight Test:

If the AME determines a MFT is needed (such as for a vision defect, amputation or orthopedic
condition), the AME must DEFER the exam.
Age Requirement:
There is no age requirement for a medical certificate. The exam should be timed so that the
medical certificate is valid at the time of solo flight.
Restrictions are no longer used by the AME:

Valid for flight test only; Valid for student pilot purposes only; Not valid until (date of 16th
birthday)
English Proficiency:
There is no language requirement for medical certification. However, if the AME has concerns
about the applicants English proficiency, they should contact their local FSDO and/or the RFS
and document this in Block 60. See General Information - Who May Be Certified, Language
Requirements.
Transmittal time:
The AME has 14 days to transmit exams. The previous requirement to transmit student exams
within 7 days no longer applies
Helpful Resources regarding the Student Pilot Certificate:

The student pilot certificate will now be issued by a Flight Standards District Office (FSDO), an FAAdesignated pilot examiner, an airman certification representative associated with a part 141 flight
school, or a certificated flight instructor (CFI).
The minimum age for the student pilot certificate is 16.
See FAQs for AMEs. A description of the changes can be found in the Advisory Circular/AC 61-65F.
Resident and US citizen student pilots follow Student Pilots Certificate Requirements.
Foreign student pilots (non-resident) follow the Alien Flight Student Program.
354

____________________________________________________________________________
GLOSSARY
355

____________________________________________________________________________
GLOSSARY/ACRONYMS
AAM - Office of Aerospace Medicine
AASI - AME Assisted Special Issuance - Criteria under which an Examiner may reissue a
medical certificate for a third-class applicant with a medical history of a disqualifying condition,
who has already received a Special Issuance Authorization from the FAA, and criteria to defer
issuance to AMCD or RFS for these situations.
AMCD - Aerospace Medical Certification Division - located at the Civil Aerospace Medical
Institute in Oklahoma City, Oklahoma
AMCS - Airman Medical Certification System - allows the AME to electronically submit FAA
Form 8500-8, Application for Airman Medical Certificate to AMCD.
AME - Aviation Medical Examiner - a physician designated by the FAA and given the
authority to perform airman physical examinations for issuance of second- and thirdclass medical certificates. (NOTE: Senior Examiners perform first-class airman
examinations).
ATCS - Air Traffic Control Specialist
AV - Atrioventricular
BUN - Blood Urea Nitrogen Test
CAD - Coronary Artery Disease
CAMI - Civil Aerospace Medical Institute
CAT - Computerized Axial Tomography Scan
CBC - Complete Blood Count
CEA - Carcinoembryonic Antigen
CFR - Code of Federal Regulations
CHD - Coronary Heart Disease
CT - Computed Tomography Scan
CVE - Cardiovascular Evaluation
DOT - Department of Transportation
DUI/DWI - Driving Under the Influence/Driving While Intoxicated
356

____________________________________________________________________________
ECG - Electrocardiogram
ECHO - Echocardiographic images
ENT - Ear, Nose, and Throat
FAA - Federal Aviation Administration
FAR - Federal Aviation Regulations
FSDO - Flight Standards District Office
GXT - Graded Exercise Test
HgbA1C - Hemoglobin A1C
INR- International Normalized Ratio
IVP - Intravenous Pyelography Test
KUB - Kidneys, Ureters and Bladder
MFO - Medical Field Office
MFT - Medical Flight Test
MRI - Magnetic Resonance Imaging
MVP - Mitral Valve Prolapse
NTSB - National Transportation Safety Board
OSA - Obstructive Sleep Apnea
PAC's - Premature Arterial Contractions
PET - Radioactive High-Tech Scan
PFT - Pulmonary Function Test
PSA - Prostate Specific Antigen
PT - Prothrombin Time
PTT - Partial Thromboplastin Time
357

____________________________________________________________________________
PVC's - Premature Ventricular Contractions

RF - Radio Frequency Ablation
RFS - Regional Flight Surgeon
SODA - Statement of Demonstrated Ability
TFT -Thyroid Function Test
US -Ultrasound
358

__________________________________________________________________________
ARCHIVES AND UPDATES

____________________________________________________________________________
Guide
Version
2016
Official
Date
04/08/2016
Revision
Number
1.
Description
Of Change
Medical Policy
2016
03/08/2016
1.
Medical Policy
2.
Administrative
3.
Administrative
4.
Administrative
5.
Administrative
2016
03/08/2016
1.
Administrative
2016
02/24/2016
1.
Medical Policy
Reason For Update

Update information on the
Student Pilot Rule Change
page. AMEs have 14 days to
transmit the exams.
As of April 1, 2016 (per Final
Rule [81 FR 1292]), AMEs will
no longer be able to issue the
combined FAA Medical
Certificate and Student Pilot
Certificate. Student Pilots will
have a separate Student Pilot
Certificate and a separate FAA
Medical Certificate. As such, all
AME instructions regarding the
issuance of a combined
certificate have been removed
from the AME Guide. In
addition, a section explaining
the policy change has been
added. See Student Pilot Rule
Change.
In Application Process for
Medical Certification, Applicant
History, II. Prior to the
Examination, revise to change
any MedX references to
MedXpress.
In Item 31. Eyes, General
revise language in disposition
table for Amblyopia.
In Item 42. Upper and Lower
Extremities, Item 49. Hearing,
and Disease Protocol for
Musculoskeletal, revise
language to clarify process.
In Glossary, revise entries for
AMCS and AME to clarify
definition.
In all dispositions tables for
conditions with CACIs, where
applicable, revise language in
Evaluation Data column to See
CACI and revise language in
Disposition column to Follow
CACI.
In Item 36. Heart, Valvular
360

____________________________________________________________________________
2016
01/27/2016
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
5.
Errata
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
5.
Errata
2016
01/01/2016
1.
Administrative
2015
11/25/2015
1.
Medical Policy
Disease Disposition Table,

reorganize and add entry for
Mitral Valve Repair.
In Item 36. Heart, add Mitral
Valve Repair Disposition Table.
In Item 36. Heart, add CACI
Mitral Valve Repair Worksheet.
In the PDF version of The
Guide, Item 26. Nose, revise
information on severe allergic
rhinitis and hay fever requiring
antihistamines so information is
consistent with the Web
version.
In Special Issuances, AASI for
Mitral or Aortic Insufficiency,
correct typographical error.
In Item, 41. G-U System,
Gender Identity Disorder,
rename to Gender Dysphoria,
update information, and
relocate entry to Item 48,
General Systemic, Gender
Dysphoria.
In Item 48. General Systemic,
Gender Dysphoria, add Gender
Dysphoria Mental Health Status
Report form.
In Item 41. G-U System,
Pregnancy, remove and
relocate entry to Item 48.,
General Systemic, Pregnancy.
In Pharmaceuticals,
Contraceptive and Hormone
Replacement Therapy, III
Aeromedical Considerations,
change reference from Item 41.
Gender Identity Disorder to
Item 48. General Systemic,
Gender Dysphoria.
In Synopsis of Medical
Standards, correct
typographical error.
Revise cover page to reflect the
current calendar year.
In Item 41. G-U Systems,
General Disorders, add
Dispostion Table.
361

____________________________________________________________________________
2.
Medical Policy
3.
Administrative
4.
Medical Policy
5.
Administrative
6.
Medical Policy
2015
11/06/2015
1.
Errata
2015
10/28/2015
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
5.
Medical Policy
6.
Medical Policy

General Disorders, add CACI
Worksheet.
On main CACI Certification
Worksheets page, add entry for
Chronic Kidney Disease.
In Special Issuances, add AASI
for Chronic Kidney Disease.
On main AASI page, add entry
for Chronic Kidney Disease.
In AME Assisted Special
Issuances (AASI), revise AASI
Coversheet to include box for
Chronic Kidney Disease.
In Item 48. General Systemic
CACI Pre Diabetes
Worksheet, corrected
typographical errror in
Accebtable Certification
Criteria: Oral glucose test, if
performed, should be less than
200 mg/dl at 2 hours.
In Item 36. Heart, revise
Hypertension Dispositions
Table to clarify certification
requirements.
In Item 36. Heart, revise CACI
Hypertension Worksheet to
provide example of clonidine as
a centrally acting
antihypertensive(s), which is
not acceptable.
In Item 36. Heart, add
Hypertension Frequently
Asked Questions ( FAQs).
In Pharmaceuticals
(Therapeutic Medications) Antihypertensives, revise to
include table with examples of
medications that are acceptable
and not acceptable for
treatment of hypertension.

Issuances (AASI), add AASI for
Hypertension.
362

____________________________________________________________________________
2015
09/30/2015
7.
Medical Policy
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
5.
Medical Policy
6.
Administrative
Issuances (AASI), revised AASI

Coversheet to include box for
Hypertension.
In Item 55. Blood Pressure,
Decision Considerations, revise
to include more information on
AME options if airmans blood
pressure is higher than 155/95
during the exam.
In Item 41. G-U Systems, add
Kidney Stone(s) Dispositions
Table.
In Item 41. G-U Systems, add
CACI Kidney Stone(s)
Worksheet.
Neoplastic
Disorders,Dispostions Table,
revise information for Renal
Cancer.
Neoplastic Disorder, revise the
CACI Renal Cancer
Worksheet to include disease
recurrence and stage 4
disease as part of criteria AME
must review.
Urinary System, revise
Disposition Table to include
information on Hematuria,
Proteinuria, and Glycosuria.
Removed information on renal
calculi, which is now captured
in Kidney Stone (s) Disposition
Table.
revised the list of conditions to
appear in the following order:
-General Disorders
-Gender Identity Disorders
-Inflamatory Conditions
-Kidney Stone(s)
-Neoplastic Disorders
Bladder Cancer
Prostate Cancer
Renal Cancer
Testicular Cancer
363

____________________________________________________________________________
2015
08/26/2015
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
5.
Administrative
6.
Administrative
Other G-U
Cancers/Neoplastic
Disorders
-Nephritis
-Pregnancy
-Urinary System
Neoplastic Disorders,
Dispositions Table, revise
information for Prostate
Cancer.
Neoplastic Disorders, add CACI
Prostate Cancer Worksheet.
Neoplastic Disorders, add
Prostate Conditions
Dispositions Table to include
information on BPH and
elevated PSA.
On CACI Conditions main
page, revise guidance to clarify
that if all the CACI criteria are
met and the applicant is
otherwise qualified, the AME
may issue on the first exam or
the first time the condition is
reported to the AME without
contacting AMCD/RFS. AMEs
should document the
appropriate notes in Block 60
and keep the supporting
documents in their files; they do
not need to be submitted to the
FAA at this time.
In Special Issuance, AASI for
Melanoma and in Item 40. Skin,
Disposition Table for Skin
Cancer All Classes, revise to
clarify expression of Breslow
level. (Removed < > signs.) EX:
Melanoma less than 0.75 mm
in depth or Melanoma in Situ
and "Melanoma equal to
0.75mm or greater in depth.
In Item 41. G-U System
Disposition Table Testicular
Cancer All Classes and in
364

____________________________________________________________________________
7.
Administrative
1.
Medical Policy
2.
Medical Policy
Disposition Table Bladder

Cancer All Classes, revise to
clarify - Non metastatic and
treatment completed 5 or more
years ago.
In CACI Bladder Cancer
Worksheet and CACI
Testicular Cancer Worksheet,
revise information in notes to
clarify: If it has been 5 or
more years since

2015
2015
07/29/2015
06/24/2015
6.
Medical Policy
7.
Medical Policy
8.
Medical Policy

information for Bladder Cancer.
Neoplastic Disorders, add
CACI Bladder Cancer
Worksheet.

- Endocrine Disorders,
revised CACI
Hypothyroidism Worksheet.
Changed normal TSH from
90 days to one year.
In Item 38. Abdomen and
Viscera, Dispositions, revise
to include criteria for Liver
Transplant - Recipient, Liver
Transplant - Donor, and
Combined Transplants (Liver
in combination with kidney,
heart, or other organ.)
In Protocols, add protocol for
Liver Transplant
(Recipient).
1.
Medical Policy

information for Testicular
Cancer.
2.
Medical Policy
3.
Medical Policy

Neoplastic Disorders, add CACI
Testicular Cancer Worksheet.
In Pharmaceuticals
365

____________________________________________________________________________
2015
2015
06/17/2015
05/27/2015
4.
Medical Policy
5.
Medical Policy
1.
Administrative
2.
Administrative
1.
Medical Policy
2.
Medical Policy
(Therapeutic Medications), add

guidance for use of Erectile
Dysfunction and/or Benign
Prostatic Hyperplasia
Medications, including table of
wait times.
In CACI Hypertension
Worksheet, revise to change
medication wait time from
2 weeks to 7 days.
In PDF version of the Guide,
create a page listing all CACI
worksheets. In both PDF and
Web versions of the Guide,
include instructions for the
Examiner to review the
disposition table first to verify
that a CACI is required.
In Protocols, Diabetes Mellitus
Type I and Type II Insulin
Treated, clarify diabetes
requirements by class.
In Pharmaceuticals, Diabetes
Mellitus Type I and Type II
Insulin Treated, remove
redundant language. Retain
links to applicable Diabetes
information elsewhere in the
AME Guide.
In Item 48. General Systemic,
Dispositions Table for Human
Immunodeficiency Virus (HIV),
add issuance criteria for HIV
negative airmen taking longterm prevention or PreExposure Prophylaxis (PrEP).
Also added link to the
information in Protocol for
Human Immunodeficiency Virus
(HIV).
In Protocols, Diabetes Mellitus
Type II Medication Controlled,
added PDF form DIABETES
or HYPERGLYCEMIA ON
ORAL MEDICATIONS
STATUS REPORT.
Links to the form also added in
Pharmaceuticals, Diabetes
Mellitus Type II Medication
366

____________________________________________________________________________
2015
04/29/2015
1.
Medical Policy
2.
Administrative
3.
Medical Policy
4.
Medical Policy
Controlled (Not Insulin) and in

Special Issuances AME
Assisted - All Classes Diabetes Mellitus - Type II,
Medication Controlled (Not
Insulin).
In Item 40. Skin, replace
dispositions table for Malignant
Melanoma with an expanded
table named Skin Cancers
All classes.
In all CACI worksheets, revise
note in Block 60 language to
read:
CACI qualified
(condition).
Not CACI qualified
(condition). Issued per
valid SI/AASI. (Submit
supporting documents.)
NOT CACI qualified
(condition). I have
deferred.
In Disease Protocols,
Obstructive Sleep Apnea,
Reference Materials, revise
Specification Sheet B to include
bullet: In communities where a
Level II HST is unavailable, the
FAA will accept a level III HST.
If the HST is positive for OSA,
no further testing is necessary
and treatment in accordance
with the AASI must be followed.
However, if the HST is
equivocal, a higher level test
such as an in-lab sleep study
will be needed unless a sleep
medicine specialist determines
no further study is necessary
and documents the rationale.
In Disease Protocols, Protocol
for History of Diabetes Mellitus
Type II Medication Controlled
(Non Insulin), Protocol for
Metabolic Syndrome, and CACI
Pre Diabetes, revise to add
14 day wait period for use of
Metformin only. (Any other
single diabetes medication
367

____________________________________________________________________________
requires a 60-day wait period.)
2015
2015
2015
04/21/2015
04/16/2015
04/03/2015
5.
Medical Policy
1.
Medical Policy
2.
Medical Policy
1.
Medical Policy
2.
Administrative
1.
Medical Policy
In Item 43. Spine and other

Musculoskeletal, add a
disposition table for Gout and
Pseudogout.
for Diabetes Mellitus, Type I
and Type II Insulin Treated,
revise language to remove
reference to class of
certification.
In Pharmaceuticals
(Therapeutic Medications)
Diabetes Mellitus Insulin
Treated, revise language under
III. Aeromedical Decision
Considerations. Remove
reference to class of
certification.
for History Diabetes Mellitus
Type II Medication-Controlled
(Non-Insulin) and in Protocol for
Medication Controlled
Metabolic Syndrome, remove:
An applicant who uses insulin
for the treatment of his or her
metabolic syndrome may only
be considered for an
Authorization for a third-class
To bring the PDF version of the
Guide up-to-date with the
online version: In Item 36.
Heart, C. Medication, NOT
ACCEPTABLE - Remove "A
combination of beta-adrenergic
blocking agents used with
insulin, meglitinides, or
sulfonylureas.
Reference Materials,
Frequently Asked Questions
(FAQs), add new FAQ: What
if the doctor or insurance
provider is only willing to do
a level III Home Sleep Test
(HST).
368

____________________________________________________________________________
2015
03/19/2015
1.
Medical Policy
2.
Administrative
2015
03/10/2015
1.
Administrative
2015
03/02/2015
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
5.
Medical Policy
6.
Medical Policy
7.
Administrative
Administrative
2015
02/11/2015
Obstructive Sleep Apnea, add
new section within the
Reference Materials for
Frequently Asked Questions
(FAQs).
Obstructive Sleep Apnea, add a
link for the FAA OSA screening
video.
create additional hyperlinks
within the material.
In Disease Protocols, revise
guidance to introduce Protocol
for Obstructive Sleep Apnea
(OSA).
In Disease Protocols, add new
section, Reference Materials
for Obstructive Sleep Apnea
(OSA), to the end of the
Protocols.
In AME Assisted All Classes Sleep Apnea, revise guidance
on certification criteria. Change
title to AME Assisted All
Classes Obstructive Sleep
Apnea (OSA).
In Item. 35, Lungs and Chest,
Revise guidance in Decisions
Considerations Table regarding
In Item. 25-30, Ear, Nose and
Throat, add link to Protocol for
In Item. 28, Mouth and Throat
Decision Considerations Table,
add link to Protocol for
In Protocols, revise table of
contents page to show entry for
(OSA). In the PDF version of
the AME Guide, add note to
indicate location of the
(OSA) Reference Materials.
In Item. 52, Color vision, revise
format to emphasize existing
369

____________________________________________________________________________
2.
Medical Policy
2014
12/17/2014
1.
Medical Policy
2014
12/01/2014
1.
Medical Policy
2014
12/01/2014
1.
Administrative
2014
11/24/2014
1.
Administrative
2014
10/22/2014
1.
Medical Policy
2014
10/20/2014
1.
Medical Policy
policy Color vision tests

approved for airmen ARE NOT
all acceptable for air traffic
controllers.
In Protocol for History of
Human Immunodeficiency Virus
(HIV) Related Conditions,
revise language and insert links
to specification sheets to clarify
criteria for Special Issuance
and follow-up.
In Pharmaceuticals, Antihypertensives, revise to state
that the combination use of
beta-blockers and insulin,
meglitinides, or sulfonylurea is
now allowed.
In Pharmaceuticals, Do Not
Issue Do Not Fly, remove
Concurrent use of a betablocker plus a sulfonylurea or
insulin or a meglitinide from
the Do Not Issue listing.
Review Guide and remove any
erroneous references to Titmus
II Vision (TII, TIIs) Testers.
Tester was previously removed
(09/27/13) as acceptable for
airmen.
In Disease Protocols, review
and adjust table of contents
order.
Controlled (Not Insulin), revise
chart of Acceptable
Medications to include alogliptin
(Nesina) and trade names for
metformin (Glucophage,
Fortament, Glutetza, Riomet.)
Mellitus Insulin Treated and in
Diabetes Mellitus Diabetes
Controlled (Not Insulin), revise
guidance under V.
Pharmaceutical Considerations
regarding chart of Acceptable
370

____________________________________________________________________________
2.
Medical Policy
3.
Medical Policy
2014
09/10/2014
1.
Medical Policy
2014
08/6/2014
1.
Medical Policy
2014
07/25/2014
1.
Medical Policy
2014
07/23/2014
1.
Medical Policy
2014
05/16/2014
1.
Administrative
2.
Medical Policy
Medications.
In Pharmaceuticals, revise
chart of Acceptable
Medications regarding
Bydureon and Beta-Blockers.
In AASI, Diabetes Mellitus
Type II Medication Controlled
(not insulin), revise guidance
regarding deferral criteria.
In General Information,
Equipment Requirements and
in Item. 52, Color Vision, revise
to indicate that the OPTEC
2000 vision tester (Models
2000 PM, 2000 PAME, 2000
PI) MUST contain the 2000-010
FAR color perception PIP plate
to be approved.
In General Information, Classes
of Medical Certificates and also
in Validity of Medical
Certificates, revise to include
language regarding digital
signatures of authorized FAA
physicians on certificates.
of Medical Certificates and also
in Validity of Medical
Certificates, revise to include
language regarding necessity
for original AME or FAA
physician signature on
certificates.
In AASI, Diabetes Mellitus,
Medication Controlled (Not
Insulin), revise to include that
applicant must be deferred if
taking more than 3 Diabetes
medications or is using a
combination prohibited in the
Acceptable Combinations of
Diabetes Medical Chart.
In Pharmaceuticals
(Therapeutic Medications),
Malaria, reorder category
content.
In Pharmaceuticals,
(Therapeutic Medicatins), Sleep
Aids, revise to include warning
371

____________________________________________________________________________
3.
Medical Policy
2014
05/12/2014
1.
Medical Policy
2014
05/05/2014
1.
Medical Policy
on eszopiclone.
In Item 46. Neurologic, In the
dispositions table, change
Dystonia musculorum
deformans" to "Dystonia primary or secondary.
In Acceptable Combinations of
Diabetes Medications Chart,
revise to add alogliptin (Nesina).
In Decision Considerations,
Disease Protocols - Graded

Exercise Stress Test
Requirements, revise to
remove hyperventilation
requirement from testing.
2014
04/22/2014
1.
Administrative
2014
04/17/2014
1.
Medical Policy
2.
Administrative
2014
03/28/2014
1.
Administrative
2014
03/20/2014
1.
Medical Policy
2014
03/14/2014
1.
Medical Policy
2.
Medical Policy
In Pharmaceuticals
revise Acceptable
Medications to include link to
the Pre-Diabetes CACI
Worksheet.
In Pharmaceuticals
revise to include chart of
Acceptable Combinations of
Diabetes Medications.
In Applicant History, Item 3.,
(Last Name; First Name; Middle
Name.), revise to clarify
instructions if applicant has no
middle name.
In Disease Protocols, add
acronyms to Protocol for
(CVE) and Protocol for
Evaluation of Coronary Heart
Disease (CHD).
In CACI Certification
Worksheets, add worksheet for
Colitis. Revise Colitis
Dispositions Table and Colitis
Special Issuance criteria to
reflect the change.
Cardiovascular Evaluation,
revise to clarify criteria.
In Disease Protocols, Coronary
Heart Disease, revise to clarify
372

____________________________________________________________________________
3.
Medical Policy
2014
03/14/2014
1.
Medical Policy
2014
03/10/2014
1.
Medical Policy
2014
02/05/2014
1.
Medical Policy
2014
01/16/2014
1.
Medical Policy
Medical Policy
criteria.
In Disease Protocols, Graded
Exercise Stress Test
Requirements, revise to clarify
criteria.
In Exam Techniques,
III. Aerospace Medical
Disposition, revise to clarify the
definition of Conditions AMEs
Can Issue (CACI).
In Item 47. Psychiatric, Use of
Antidepressant Medications,
revise policy to change the
required time applicant must be
on a stable dose of the SSRI
from 12 months to 6 months.
In Pharmaceuticals
Anticoagulants and in Disease
Protocols Thromboembolic
Disease, revise to policy
include required wait time after
initial start of warfarin
(Coumadin) treatment.
In Equipment Requirements
and Item 52. Color Vision,
remove APT-5 Color Vision
Tester.
2014
01/01/2014
1.
Administrative
2013
12/23/2013
1.
Administrative
2013
12/12/2013
1.
Medical Policy
2013
12/06/2013
1.
Administrative
In Pharmaceuticals
(Therapeutic Medications), add
new Do Not Issue-Do Not Fly
section.
In Pharmaceutical (Therapeutic
Medications), Sleep Aids, add a
link for FDA studies.
In Pharmaceutical (Therapeutic
Medications), Acne
Medications, revise policy to
include language on use of
topical acne medications, such
as Retin A, and oral antibiotics,
such as tretracycline.
In AASI, change title of Deep
Venous Thrombosis/Pulmonary
Embolism - Warfarin
(Coumadin) Therapy to Deep
Venous Thrombosis (DVT),
Pulmonary Embolism (PE),
373

____________________________________________________________________________
2013
11/06/2013
1.
Medical Policy
2013
09/27/2013
1.
Medical Policy
2013
09/27/2013
1.
Medical Policy
2013
09/17/2013
1.
Medical Policy
2.
Medical Policy
3.
Administrative
1.
Medical Policy
2.
Medical Policy
2013
08/16/2013
and/ or Hypercoagulopathies.
Title of block on the Certificate
Issuance sheet also changed.
In Item 46. Neurologic, revise
the Cerebrovascular Disease
dispositions table to expand on
criteria for Transient Ischemic
Attack, Completed Stroke
(ischemic or hemorrhagic), and
Subdural, Epidural or
Subarachnoid Hemorrhage.
Equipment Requirements
Color Vision Test Apparatus,
remove Titmus II Vision Tester
(Model Nos. TII and TIIS) from
the list of approved testers.
Hypertension Worksheet to
clarify criteria whereby AME
can assess current status.
test (Gordon Diagnostic System
[GDS]) to evaluation sheets for
Attention Deficit/Hyperactivity
Disorder; Depression Treated
with SSRI Medications;
Neurocognitive Impairment;
and Psychiatric and
Neuropsychological
Evaluations for Substance
Abuse/Dependence.
In Disease Protocols listing,
rename Substances of
Dependence/Abuse (Drugs and
Alcohol) to Psychiatric
Substances of
Alcohol.
Add updated link for the
International Standards on
Personnel Licensing.
In Pharmaceuticals, Malaria
Medications, update policy
information regarding the use of
mefloquine.
In Special Issuances, update
policy for prednisone usage for
treatment of Asthma, Arthritis,
Colitis, and/ or Chronic
374

____________________________________________________________________________
3.
Medical Policy
2013
08/14/2013
1,
Medical Policy
2013
07/30/2013
1.
Medical Policy
2.
Errata
2013
06/19/2013
1.
Medical Policy
2013
06/13/2013
1.
Medical Policy
Obstructive Pulmonary
Disease.
In Special Issuances, revise
introductory language to clarify
requirements for deferral.
Specifically if the applicant
does not meet the issue criteria
in the Aerospace Medicine
Dispositions Tables or the
Certification Worksheets.
Neoplastic Disorders, revise
dispositions table language
from Any other G-U Neoplastic
Disorder to All G-U cancers
when treatment was completed
less than 5 years ago or for
which there is a history of
metastatic disease. Also, direct
Examiners to reference the
specific cancers in this category
for requirements and
dispositions.
In Pharmaceuticals, add
information page on Sleep
Aids, including wait times.
In Examination Techniques,
Item 36. Heart Syncope,
correct typographical error:
bilatcarotid Ultrasound to
bilateral carotid Ultrasound.
dispositions table to include
criteria for All G-U Cancers
when treatment was completed
more than 5 years ago and
there is no history of metastatic
disease.
Revise language in all
Certification Worksheets:
(Arthritis, Asthma, Renal
Cancer, Glaucoma, Hepatitis C,
Hypertension, Hypothyroidism,
Migraine Chronic Headaches,
and Pre Diabetes) to add
Applicants for first- or secondclass must provide this
information annually; applicants
for third-class must provide the
375

____________________________________________________________________________
2.
Medical Policy
3.
Administrative
4.
Medical policy
and
Administrative
5.
Medical Policy
6.
Medical Policy
2013
06/11/2013
1.
Medical Policy
2013
06/04/2013
1.
Medical Policy
information with each required

exam.
In Item 35. Lungs and Chest,
revise Asthma Worksheet to
include FEV1, FVC, and
FEV1/FVC are all equal to or
greater than 80% predicted
before bronchodilators and
Pulmonary Function Test is not
required if the only treatment is
PRN use on one or two days a
week of a short-acting beta
agonist (e.g. albuterol).
In Item 43. Spine and Other
Musculoskeletal, revise Arthritis
Worksheet to include link to
steroid conversion calculator.
Renal Cancer Worksheet to
state ECOG performance
status or equivalent is 0.
Include link to ECOG
Performance Status definitions.
Pre-Diabetes, Diabetes,
Metabolic Syndrome, and/or
Insulin Resistance, revise
dispositions table to include
Polycystic Ovary Syndrome.
In Item 48. General Systemic Pre-Diabetes, Diabetes,
Metabolic Syndrome, and/or
Insulin Resistance, revise PreDiabetes Worksheet to include
Polycystic Ovary Syndrome.
In Dispositions Table, Item 46.
Neurologic, revise language to
reflect that Any loss of
consciousness, alteration of
consciousness, or amnesia,
regardless of duration requires
FAA Decision.
Abdomen and Viscera,
Hepatitis C, revise to show that
if disease is resolved without
sequela and need for
medications, the AME can
issue.
376

____________________________________________________________________________
2013
2013
2013
05/15/2013
05/08/2013
04/09/13
1.
Medical Policy
2.
Medical Policy
1.
Administrative
2.
Administrative
1.
Medical Policy
2.
3.
4.

Arthritis add row for
certification criteria for
Osteoarthritis and variants on
PRN NSAIDS only.
Blood Pressure, Hypertension
Worksheet, revise to treating
physician or AME findsetc.
In Archives and Modifications,
change title to Archives and
Updates.
Issuances (AASI), revise
language on the introductory
page and all 25 AASI pages
from "If this is a first time
issuance of an Authorization for
the above disease/condition
to If this is a first-time
application for an AASI for the
above disease/condition
Item 35. Lungs and Chest,
revise dispositions table for
Asthma. Introduce Asthma
Worksheet with certification
criteria under which the AME
can regular issue.
Item 43. Spine and Other
Musculoskeletal, revise
dispositions table for Arthritis.
Introduce Arthritis Worksheet
with certification criteria under
which the AME can regular
issue.
Item 41. G-U System
dispositions table for Prostatic,
Renal, and Testicular
Carcinomas. Introduce Renal
Cancer Worksheet with
certification criteria under which
the AME can regular issue.
Items 31 - 34. Eye, revise
Examination techniques and
dispositions table for
377

____________________________________________________________________________
5.
6.
7.
8.
9.
10.
11.
Glaucoma. Introduce
Glaucoma Worksheet with
Items 38. Abdomen and
Viscera, revise dispositions
table for Hepatitis C - Chronic.
Introduce Hepatitis C Chronic
can regular issue.
Items 55. Blood Pressure,
revise dispositions table for
Hypertension. Introduce
Hypertension Worksheet with
In Disease Protocols, delete
Hypertension Protocol.
Items 48. General Systemic
Endocrine Disorders, revise
dispositions table for
Hypothyroidism. Introduce
Hypothyroidism Worksheet with
Items 46. Neurologic
Headaches, revise dispositions
table for Migraine and Chronic
Headache. Introduce Migraine
and Chronic Headache
can regular issue.
Items 48. General Systemic
Diabetes, Metabolic Syndrome,
and/or Insulin Resistance,
revise dispositions table to add
Pre-Diabetes. Introduce PreDiabetes Worksheet with
In Disease Protocols, delete
protocol for Medication
Controlled Metabolic Syndrome
378

____________________________________________________________________________
12.
13.
14.
15.
16.
2013
03/05/13
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
(Glucose Intolerance, Impaired

Glucose Tolerance, Impaired
Fasting Glucose, Insulin
Resistance, and Pre-Diabetes)
Diet Controlled Diabetes
Mellitus and Metabolic
Syndrome. Change title to
Diabetes Mellitus Diet
Controlled.
title of Medication Controlled
Diabetes Mellitus - Type II.
Change name to Diabetes
Controlled (Non Insulin). Also,
in Pharmaceuticals section,
revise name of protocol link to
reflect title change.
title of Insulin Treated Diabetes
Mellitus - Type I or Type II.
Change title to Diabetes
Mellitus Type I or Type II
Insulin Treated. Also, in
Pharmaceuticals section, revise
name of protocol link to reflect
title change.
In Pharmaceuticals,
Antihypertensives, change
name of protocol link from
Hypertension Protocol to
Hypertension Worksheet.
Issuance (AASI), delete AASI
for Metabolic Syndrome,
Glucose Intolerance, Impaired
Glucose Tolerance, Impaired
Resistance, and Pre-Diabetes.
Specifications for
Neuropsychological
Evaluations for ADHD/ADD.
Specifications for
Neuropsychological
Evaluations for Treatment with
SSRI Medications.
379

____________________________________________________________________________
2013
02/15/13
4.
Medical Policy
5.
Medical Policy
6.
Medical Policy
7.
Medical Policy
8.
Medical Policy
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
2013
01/03/13
1.
Administrative
2012
12/14/12
1.
Medical Policy
Specifications for
Neuropsychological
Evaluations for Potential
Neurocognitive Impairment.
Specifications for Psychiatric
Evaluations.
and Psychological Evaluations.
and Neuropsychiatric
Evaluations for Substance
Abuse/Dependence.
In Item 47. Psychiatric
Conditions, revise table to
include reference to new
Psychiatric Specification
Sheets.
Conditions, revise SSRI
Specifications Sheet to remove
Federal Register link and
include link to Specifications
for Neuropsychological
Evaluations for Treatment with
SSRI Medications.
Conditions, revise Table of
Medical Dispositions to include
additional evaluation guidance.
In Item 52. Color Vision, revise
to state that use of computer
applications, downloaded
versions, or printed versions of
color vision tests are prohibited
for evaluation.
In Disease Protocols, Disease
Protocols - Human
Immunodeficiency Virus (HIV),
revise to include statement on
status report requirements after
the first two years of SI/SC.
Specifications sheet to change
neurocognitive testing to
380

____________________________________________________________________________
2012
12/06/12
1.
Medical Policy
2012
10/24/12
1.
Medical Policy
2012
10/01/12
1.
Administrative
2.
Medical Policy
2012
08/09/12
1.
Errata
2012
07/20/12
1.
Medical Policy
CogScreen-AE testing.
Decision Path I chart to change
application wait time from 90
days to 60 days. Also, revise
SSRI Follow Up Path chart to
change neurocognitive testing
to CogScreen-AE testing.
In Disease Protocols
Coronary Heart Disease,
remove reference to FAA Form
8500-20 Medical Exemption
Petition. Form 8500-20 is
cancelled.
Revise language throughout
the AME Guide to reflect
procedural changes as dictated
by MedXPress, the mandatory
electronic application system
for airmen. (Effective October
1, 2012)
In Special Issuances, Atrial
Fibrillation, revise to specify
INR requirement for airmen
being treated with warfarin
(Coumadin).
Item 52. Color Vision; revise
title of chart for Acceptable Test
Instruments for Color Vision
Screening of ATCS (FAA
Employee 2151 Series and
Contract) to Acceptable Test
Instruments for Color Vision
Screening of ATCS (FAA
Employee 2151 Series and
Contract Tower ATCSs.)
In accordance with the direct
final rule (14 CFR Part 67
[Docket No. FAA-2012-0056;
Amdt. No 67-21] ),Removal of
the Requirement for
Individuals Granted the
Special Issuance of a Medical
Certificate To Carry Their
Letter of Authorization While
Exercising Pilot Privileges,
references to the requirement
381

____________________________________________________________________________
2012
07/03/12
1.
Medical Policy
2012
06/30/12
1.
Medical Policy
2012
06/07/12
1.
Medical Policy
2012
05/25/12
1.
Medical Policy
2012
01/31/12
1.
Medical Policy
2012
01/26/12
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
to carry an LOA were removed

from the General Information
and Special Issuances sections
of the Guide.
remove information on
Contraceptives and Hormone
Replacement Therapy. Move
this information to a new page
of the same title within the
Pharmaceuticals section.
In Item 41. G-U System, create
new section for pregnancy.
In Item 41. G-U System, revise
guidance on Gender Identity
Disorder to specify
requirements for current status
report, psychiatric and/or
psychological evaluations, and
surgery follow-up reports.
In Item 52. Color Vision, add
chart for criteria and acceptable
tests for Air Traffic Controllers
(FAA employee 2152 series
and Contract Tower ATCS).
In Decision Considerations.
Aerospace Medical
Dispositions, Item 45.
Lymphatics, revise title from
Hodgkins Disease
Lymphoma to Lymphoma and
Hodgkins Disease.
In Examination Techniques.
Item 48. Hypothyroidism, add
note that AMES may call FAA
for verbal clearance if airman
presents current lab reports.
In Pharmaceuticals, Allergy
Desensitization Injections,
Change the title and references
to Allergy Immunotherapy.
Add note stating that sublingual
immunotherapy (SLIT) is not
acceptable.
Item 36. Heart, remove
requirement for reporting serum
potassium values if the airman
is taking diuretics.
In Protocol for Evaluation of
382

____________________________________________________________________________
2012
01/03/12
5.
Medical Policy
1.
Administrative
2.
Medical Policy
2011
12/13/11
1.
Medical Policy
2011
12/01/11
1.
Medical Policy
2.
Medical Policy
2011
11/16/11
1.
Medical Policy
2011
11/01/11
1.
Medical Policy
2011
10/24/11
1.
Administrative
2011
09/15/11
1.
Medical Policy
Hypertension, remove
requirement for reporting serum
potassium if the airman is
taking diuretics.
In Item 36. Heart Dispositions
Table, Coronary Artery
Disease, revise table to clarify
evaluation data required for
third class.
In General Information, Medical
Certificates AME Completion,
revise language to clarify
signature requirements.
Item 52. Color Vision, revise to
include Color Vision Testing
Flowchart.
In Pharmaceuticals
section, change title of
Antihistaminic and
Desensitization Injections to
include the word Allergy.
Also, change title of Diabetes
Controlled to include (Non
Insulin). This title was also
changed in the AASI.
In Pharmaceuticals
(Therapeutic Medications) Acne
Medications, revise page
format to clarify policy.
Disposition of Applications and
Medical Examinations, Clarify
to indicate that Student Pilot
Applications and Examinations
must be transmitted to AMCD
within 7 days.
In Pharmaceuticals Insulin,
revise to clarify guidance on
medication combinations.
In Aerospace Medical
Dispositions, Item 49. Hearing,
clarify guidance on hearing
aids.
Item 31 34. Eye -
383

____________________________________________________________________________
2011
2011
09/12/11
08/12/11
2.
Medical Policy
3.
Medical Policy
1.
Medical Policy
2.
Medical Policy
3.
Administrative
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
Orthokeratology, revise to
clarify policy.
Dispositions, Item 31. Eyes
General, revise to include
information on Keratoconus.
Equipment Requirements,
revise to include equipment to
measure height and weight.
Dispositions, Item 47.,
Psychiatric Conditions Use of
Antidepressants, include SSRI
Specification Sheet for
guidance.
In Pharmaceuticals,
Antidepressants, revise to
clarify medical history, protocol,
and pharmaceutical
considerations.
In Table of Contents, renumber
entries listed on pages iii and
iv.
In Special Issuances, ThirdClass AME Assisted Valve
Replacement, revise to include
additional criteria for deferral
(the applicant develops emboli,
thrombosis, etc.).
In Special Issuances, AME
Assisted All Classes Atrial
Fibrillation, revise to include
additional criteria for deferral
(bleeding that required medical
intervention).
In Special Issuances, AME
Assisted All Classes
Warfarin (Coumadin) Therapy
for Deep Venous Thrombosis
(DVT), Pulmonary Embolism
(PE), and/ or
Hypercouagulopathies, revise
to include additional criteria for
deferral (bleeding that required
medical intervention).
In Special Issuances, ThirdClass AME Assisted
Coronary Heart Disease, revise
to include additional criteria for
384

____________________________________________________________________________
2011
08/09/11
1.
Medical Policy
2.
Administrative
3.
Administrative
4.
Administrative
5.
Administrative
6.
Administrative
2011
05/25/11
1.
Administrative
2011
05/08/11
1.
Administrative
2011
03/11/11
1.
Medical Policy
2011
03/02/11
1.
Medical Policy
deferral (bleeding that required

medical intervention).
In Disease Protocols, Coronary
Heart Disease, correct in item
A.1.b., replacement to
repair.
In Pharmaceuticals
Antihypertensive, revise to
clarify unacceptable
medications.
Item 36., Heart, revise to clarify
unacceptable medications.
Dispositions, Item 55., revise to
clarify blood pressure limits.
Psychiatric Conditions, revise
table to include information on
depression requiring the use of
antidepressant medications.
Hypertension, revise to clarify
unacceptable medications.
Item 47., Psychiatric, revise
SSRI Follow Up Chart to clarify
procedure.
In Pharmaceuticals, reorganize
and clarify the page content for
Acne Medications, Antacids,
Anticoagulants, Antihistaminic,
Antihypertensive,
Desensitization Injections,
Diabetes Type II Medication
Controlled, Glaucoma
Medications, and Insulin.
Psychiatric Conditions, clarify
policy verbiage on Bipolar
Disorder and Psychosis.
Psychiatric Conditions, add
section titled Use of
Antidepressant Medication, to
state revised policy on use of
SSRIs.
385

____________________________________________________________________________
2011
02/23/11
1.
Medical Policy
2011
02/03/11
1.
Medical Policy
2011
01/31/11
1.
Errata
2011
01/07/11
1.
Administrative
2010
11/23/10
1.
Medical Policy
2.
Medical Policy
2010
10/29/10
1.
Medical Policy
2010
09/20/10
1.
Medical Policy
2010
09/03/10
1.
Medical Policy
2010
06/15/10
1.
Medical Policy
Dispositions, Item 52., Color
Vision, clarify pass criterion for
OPTEC 900 Vision Tester.
In Medical History, Item 18. v.,
History of Arrest(s),
Conviction(s), and/ or
Administrative Action(s),
reorder, revise, and clarify
deferral and issuance criteria.
Revise to correct transposed
words in title: Decision
Considerations, Disease
Protocols Graded Exercise
Stress Test Bundle Branch
Block Requirements.
Revise cover page to reflect
In Exam Techniques, Item 26.
Nose and Item 35. Lungs and
Chest, revise and clarify criteria
for hay fever medications.
In Pharmaceuticals
(Therapeutic Medications) Desensitization Injections,
revise and clarify criteria for hay
fever medications.
Dispositions, Item 52. Color
Vision, remove Titmus II Vision
Tester (Model Nos. TII and
TIIS) as an acceptable
substitute for color vision
testing.
In AASI Protocol for Arthritis,
change title to Arthritis and/ or
Psoriasis. Clarify
authorization and deferral
criteria.
In Exam Techniques, Item 2122 Height and Weight, add
Body Mass Index Chart and
Formula Table.
Dispositions, Item 48, General
Systemic, clarify disposition for
Hyperthroydism and
Hypothyrodism. First Special
Issuance requires FAA
decision. Guidance for
386

____________________________________________________________________________
2.
Administrative
2010
05/20/10
1.
Administrative
2010
03/17/10
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
1.
Administrative
2.
Medical Policy
2010
01/20/10
2009
12/08/09
1.
Medical Policy
2009
10/22/09
1.
Medical Policy
2009
10/16/09
1.
Medical Policy
Followup Special Issuance is

found in AASI Protocol.
In AASI Protocol for
Hyperthyroidism and Protocol
for Hypothyroidism, clarify
criteria for deferring and
issuing.
Dispositions, Item 47,
Psychiatric Conditions Table of
Medical Dispositions, clarify
see below information in
Evaluation Data column.
In Disease Protocols, Binocular
Multifocal and Accommodating
Devices, clarify criteria for
adaptation period before
certification.
In Applicant History, Item 17b,
revise and clarify criteria
regarding use of types of
contact lenses.
In Exam Techniques, Items 3134 Eye Contact Lenses,
revise and clarify criteria.
In Applicant History, Item 18
Medical History, v. History of
Arrest(s), Conviction(s), and/or
Administrative Action(s), revise
and clarify deferral and
issuance criteria.
Item 52. Color Vision, remove
APT-5 as an acceptable color
vision tester.
Item 52. Color Vision, add note
to Agency-Designated AMEs:
Not all tests approved for pilots
are acceptable for FAA ATCSs.
Contact RFS for current list.
In Special Issuance, Diabetes
Mellitus Type II, Medication
Controlled, revise to reflect
further criteria required for AME
re-issuance: current status
report from physician treating
diabetes to include any history
387

____________________________________________________________________________
of hypoglycemic events and
any cardiovascular, renal,
neurologic or opththalmologic
complications; and HgA1c level
performed within the last 30
days.
2009
09/30/2009
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
5.
Medical Policy
In Disease Protocols, Diabetes

Mellitus Type I or Type II,
Insulin Treated, add note to
indicate that insulin pumps are
acceptable.
main listing to reflect addition of
Diabetes Mellitus and
Metabolic Syndrome Diet
Controlled and Metabolic
Syndrome (Glucose
tolerance, Impaired Fasting
and Pre-Diabetes) - Medication
Controlled.
Dispositions, Item 48. General
Systemic Diabetes, Metabolic
Syndrome, and/or Insulin
Resistance, revise table to
reflect addition of Diabetes
Syndrome Diet Controlled
and Metabolic Syndrome
(Glucose Intolerance, Impaired
Glucose tolerance, Impaired
Resistance, and Pre-Diabetes)
- Medication Controlled.
protocol outlining Metabolic
Syndrome, Medication
Controlled.
In Disease Protocols, Diabetes
Mellitus Diet Controlled,
revise to reflect Diabetes
Syndrome (Glucose
388

____________________________________________________________________________
tolerance, Impaired Fasting
and Pre-Diabetes) - Diet
Controlled
2009
09/21/2009
1.
Errata
2.
Medical Policy
3.
Medical Policy
4.
Medical Policy
5.
Administrative
Substances of
Alcohol), change personnel
statement to personal
statement.
In Special Issuance, Colon
Cancer; Chronic Lymphocytic
Leukemia; Diabetes Mellitus
Type II, Medication Controlled;
and Lymphoma and Hodgkins
Disease, add if Any new
treatment is initiated to
criteria for deferment to AMCD
or Region.
Dispositions, Item 48. General
Systemic, Diabetes change
title to Diabetes, Metabolic
Syndrome, and/or Insulin
Resistance. Also add new
table entry to reflect criteria for
Metabolic Syndrome or Insulin
Resistance.
Issuance, All Classes added
entry and criteria for Metabolic
Syndrome (Glucose
Tolerance, Impaired Fasting
and Pre-Diabetes). Also added
entry on AASI Certificate
Issuance sheet.
In General Information, Who
May Be Certified, b. Language
Requirements added
information to clarify guidance
on certification and reporting
process.
389

____________________________________________________________________________
2009
07/30/2009
1.
Medical Policy
In Pharmaceuticals, Acne
Medications, add language to
further clarify instructions for
deferral and restrictions.
2009
07/09/2009
1.
Medical Policy
2.
Medical Policy
Mellitus Type II, Medication
Controlled, revise to remove
amlynomimetics from allowable
combinations.
Type II, Medication Controlled,
revise criteria for deferring to
AMCD or region.
Equipment Requirements and
Examination Equipment and
Techniques, Item 52. Color
Vision, add OPTEC 2500 as
acceptable vision testing
substitute.
Item 31-34. Eye, correct
typographical error in form
number. Revised to reflect
8500-7.
Type II, Medication Controlled;
and Pharmaceuticals, Diabetes
Mellitus - Type II, Medication
Controlled - revise to clarify
criteria for deferring to AMCD
or region also to clarify
allowable medication
combinations.
Item 52. Color Vision, revise
language to specify that AMEadministered aviation Signal
Light Gun test is prohibited.
In Examination Techniques and
Aerospace Medical
Dispositions, Item 52. Color
2009
05/13/2009
1.
Medical Policy
2009
04/30/2009
1.
Errata
2009
04/24/2009
1.
Medical Policy
2009
02/04/2009
1.
Administrative
2008
12/11/2008
1.
Medical Policy
2008
10/30/2008
1.
Errata
390

____________________________________________________________________________
vision, revise to list correct
testing plates for Richmond
HRR, 4th Edition.
2008
2008
2008
10/10/2008
09/17/2008
09/05/2008
1.
Administrative
2.
Administrative
3.
Medical Policy
4.
Medical Policy
1.
Medical Policy
2.
Medical Policy
3.
Medical Policy
1.
Administrative
2.
Medical Policy
In General Information, create

new section 12. Medical
Certificates AME
Completion.
In Table Of Contents, General
Information, adjust and
renumber listings to reflect
inclusion of Medical Certificates
AME Completion.
Item 52., Color Vision, add new
vision tester.
Disposition, Item 52. Color
Vision, revise section A., All
Classes, to include standard for
new vision tester.
Change Applicant History, 18.
v. Conviction and/or
Administrative Action History to
History of Arrest(s),
Conviction(s), and/or
Administrative Action(s).
Revise language within 18. v. to
include reference to arrests.
Revise Applicant History to
create a new section, 18.y.
Medical Disability Benefits.
Revise Entire Guide to replace
any usage of term Urinalysis
with Urine Test(s).
Change cover page to remove
Version V title. Change title to
reflect current calendar year.
Equipment Requirements, and
in Examination Techniques
Items 50, 51, and 54, revise
equipment requirements.
391

____________________________________________________________________________
3.
Medical Policy
V.
07/31/2008
1.
Medical Policy
V.
07/16/2008
1.
Medical Policy
2.
Medical Policy
3.
Administrative
4.
Medical Policy
Medical Policy
1.
Administrative
2.
Medical Policy
3.
Medical Policy
V.
04/1/2008
Dispositions, Item 52., Color
Vision, revise to provide
guidance on Specialized
Operational Medical Tests: the
Operational Color Vision Test
and the Medical Flight Test.
Also, update list of acceptable
and unacceptable color vision
testing equipment.
Equipment Requirements, and
in Examination Techniques
(Items 50-52 and 54), revise
equipment.
In General Information, Validity
of Medical Certificates, revise
third-class duration standards
for airmen under age 40.
Requests for Assistance, revise
to remove references to
international and military
examiners.
of Medical Certificates, revise
to clarify flying activities to
privileges.
In Special Issuances, revise to
include language requiring
airman to carry Authorization
when exercising pilot privileges.
In Applicant History, Guidance
for Positive Identification of
Airmen, revise to include link to
14 CFR 67.4. Applicants must
show proof of age and identity.
In General Information, Who
May Be Certified, add guidance
on ICAO standard for English
Proficiency, Operational Level
4.
In General information,
Equipment Requirements,
revise list of acceptable
equipment, particularly
acceptable substitute
equipment for vision testing.
In Exam Techniques, Item 50,
392

____________________________________________________________________________
4.
Medical Policy
5.
Medical Policy
V.
02/01/2008
1.
Medical Policy
V.
01/11/2008
1.
Medical Policy
2.
Medical Policy
1.
Administrative
2.
Administrative
3.
Errata
4.
Medical Policy
5.
Medical Policy
6.
Administrative
V.
11/26/2007
Distant Vision, revise

equipment list of acceptable
substitutes.
Near and Intermediate Vision,
revise equipment table of
acceptable substitutes.
Heterophoria, revise equipment
table of acceptable substitutes.
In Exam Techniques, Item. 52.
Color Vision, revise Section E.,
which clarifies unacceptable
tests.
Issuance (AASI), add section
on Warfarin (Coumadin)
Therapy for Deep Venous
Thrombosis, Pulmonary
Embolism, and/ or
Revise AASI coversheet to
include box for Warfarin
(Coumadin) Therapy for Deep
Venous Thrombosis,
Pulmonary Embolism, and/ or
In General Information, Validity
of Medical Certificates, delete
note for Flight outside the
airspace
of the United States of
America.
Conductive Keratoplasty (CK),
revise description of CK
procedure.
Dispositions, Item 31. Eye,
correct typographical error.
In Pharmaceuticals, add
Malaria Medications.
In Exam Techniques,
Item
51. Near and Intermediate
vision, add Keystone
Orthoscope and
Keystone Telebinocular.
In Airman Certification Forms,
add note regarding
International Standards on
393

____________________________________________________________________________
V.
V.
11/26/2007
09/01/2007
7.
Administrative
8.
Administrative
9.
Administrative
10.
Medical Policy
1.
Administrative
2.
Administrative
3.
Medical Policy
4.
Errata
5.
Errata
6.
Medical Policy
7.
Medical Policy
Personnel Licensing.
Equipment Requirements, add
note regarding the possession
and maintenance of equipment.
In General Information, Privacy
of Medical Information, add
note on the protection of
privacy information.
Disposition of Applications, add
note to include electronic
submission by international
AMEs.
In Exam Techniques and
Criteria, 31-34 Eye, Refractive
Procedures, revise to include
Wavefront-guided LASIK.
Revise title of Disease
Protocols, Antihistamines to
Allergies, Severe.
In Pharmaceuticals, add Acne
Medications and Glaucoma
Medications.
Add policy regarding use of
isotretinoin (Accutane) in
Pharmaceuticals; Aerospace
Medical Dispositions, Item 40.
Skin; and Examination
Techniques and Criteria for
Qualification, Item. 40 Skin
Revise Protocol for Maximal
Graded Exercise Stress Test
Requirements to change 8
minutes to 9 minutes.
Dispositions, Item. 36. Heart
Atrial Fibrillation - change
CHD Protocol with ECHO and
24-hour Holter to read See
CVE Protocol with EST, Echo,
and 24-hour Holter.
Revise Aerospace Medical
Dispositions, Item 36. Heart Syncope.
Revise Examination
Techniques and Criteria for
Qualification, Item. 36 Heart
394

____________________________________________________________________________
Auscultation.
395

____________________________________________________________________________
Guide
Version
V.
V.
Official
Date
09/01/2007
04/25/2007
Revision
Number
8.
Description
Of Change
Administrative
9.
Administrative
10.
Medical Policy
11.
Errata
1.
Administrative
Reason For Update

In Pharmaceuticals,
Antihypertensive, V.
Pharmaceutical
Considerations remove D.
AME Assisted All Classes,
Atrial Fibrillation.
In Pharmaceuticals,
Antihistaminic, V.
Pharmaceutical
Considerations add
C. Aerospace Medical
Dispositions, Item 35. Lungs
and Chest.
Revise Disease Protocols,
Coronary Heart Disease to
clarify requirements for
consideration for any class of
airman medical certification.
Revise Disease Protocols,
Coronary Heart Disease to
remove Limited to Flight
Engineer Duties.
Move Leukemia, Acute and
Chronic from Aerospace
Medical Dispositions Item 48.
General Systemic to Item 48.
General Systemic, Blood and
Blood-Forming Tissue
Disease.
396

____________________________________________________________________________
Guide
Version
V.
V.
Official
Date
04/25/2007
11/20/2006
Revision
Number
2.
Description
Of Change
Administrative
Reason For Update
3.
Administrative
4.
Administrative
1.
Medical Policy
2.
Errata
Move Breast Cancer from

Aerospace Medical
Dispositions Item 38.
Abdomen and Viscera Malignancies to Item 48.
General Systemic, Neoplasms.
Also, move Colitis (Ulcerative,
Regional Enteritis or Crohn's
disease) and Peptic Ulcer from
Aerospace Medical
Dispositions Item 38.
Abdomen and Viscera
Malignancies to Item 38.
Abdomen and Viscera and
Anus Conditions.
Update individual
Pharmaceutical pages to
include Pharmaceutical
Considerations.
Insert into Disease Protocols a
new section on Cardiac
Transplant for Class III
certificates only.
Corrected AASI on Mitral or
Aortic Insufficiency to read
mean gradient.
Revise Aerospace Medical

Dispositions Item 48. General
Systemic to include disposition
table titled Neoplasms.
397

____________________________________________________________________________
Guide
Version
V.
V.
Official
Date
08/23/2006
04/03/2006
Revision
Number
1.
Description
Of Change
Errata
2.
Administrative
3.
Errata
4.
Medical Policy
5.
Medical Policy
6.
Administrative
1.
Administrative
2.
Administrative
3.
Administrative
4.
Administrative
5.
Administrative
Reason For Update

INR values for mechanical
valves should have read
between 2.5 and 3.5, except
for certain types of bileaflet
valves in the aortic position.
Clarified the Hypertension
Protocol regarding initiation
and change of medication and
the suspension of pilot duties.
Maximal graded exercise
stress test requirement for
under age 60 corrected to 9
minutes.
Remove prohibition on bifocal
contact lenses or lenses that
correct for near and/or
intermediate vision in Items
31-34, Eyes; Section 5,
Contact Lenses.
Update Neurological
Conditions Disposition Table
and Footnote #21 with
guidance on Rolandic Seizure.
Clarified language in General
Information, Item 9. Who May
Be Certified;
a. Age Requirements.
Redesign the appearance and
navigable format of the Guide
for Aviation Medical Examiners
Install a Search Engine
located in the Navigation Bar
Revise Heading Titles for
Chapters 2, 3, and 4
Insert a Special Issuances
section located in the
Navigation Bar and into the
General Information section
Insert a Policy Updates section
to post new and revised
Administrative and Medical
Policies
398

____________________________________________________________________________
V.
04/03/2006
6.
Medical Policy
7.
8.
9.
Medical Policy
Medical Policy
Medical Policy
10.
Medical Policy
Insert into the AME Assisted

Special Issuance (AASI)
section a Testicular Carcinoma
AASI
Revise Atrial Fibrillation AASI
Revise Asthma AASI
Revise Hyperthyroidism and
Hypothyroidism AASIs
Insert a new AASI subsection
containing Coronary Heart
Disease and Single Valve
Replacement applicable for
Third-Class only
399

____________________________________________________________________________
Guide
Version
V.
IV.
Official
Date
04/03/2006
07/31/2005
Revision
Number
11.
Description
Of Change
Medical Policy
12.
Administrative
13.
Medical Policy
14.
Medical Policy
15.
Medical Policy
16.
Medical Policy
17.
Medical Policy
18.
Medical Policy
19.
Medical Policy
1.
Administrative
2.
Administrative
3.
Medical Policy
Reason For Update

Insert into the Disease
Protocols section a new
Coronary Heart Disease and
Graded Exercise Stress Test
Protocol, and revise the Valve
Replacement Protocol
Insert Items 49 58 into the
Examination Techniques
section
Revise Item 35. Lungs and
Chest, Asthma, Aerospace
Medical Disposition Table
Revise Item 36. Heart, Atrial
Fibrillation, Aerospace Medical
Disposition Table
Revise Item 36. Heart,
Coronary Heart Disease,
Aerospace Medical Disposition
Table
Revise Item 36. Heart,
Valvular Disease, Aerospace
Medical Disposition Table
Revise Item 48. General
Systemic, Hyperthyroidism
and Hypothyroidism,
Table
Revise all Oral Medications Diabetes Mellitus, Type II
references
Revise FAA Form 8500-7,
Report of Eye Evaluation
Redesign the appearance and
navigable format of the Guide
for Aviation Medical
Examiners
Revise Section 9., Refractive
Surgery heading in Items 3134. Eyes, to Refractive
Procedures
Insert Conductive Keratoplasty
into Section 9, Items 31-34,
Eyes, and into Item 31s
Table
400

____________________________________________________________________________
IV.
IV.
III.
07/31/2005
01/16/2006
11/01/2004
4.
Administrative
5.
Medical Policy
6.
Medical Policy
7.
Medical Policy
8.
Medical Policy
9.
Medical Policy
10.
Medical Policy
11.
Medical Policy
1.
Medical Policy
2.
Administrative
3.
Administrative
4.
Administrative
5.
Administrative
Replace optometrist or
ophthmologist reference(s) to
eye specialist
Insert Pulmonary Embolism
into Item 35, Lungs and Chest,
Table
Insert Deep Vein Thrombosis
and Pulmonary Embolism into
Item 37, Vascular System,
Table
Insert Deep Vein Thrombosis
and Pulmonary Embolism into
the Thromboembolic Protocol.
Protocol section a Conductive
Keratoplasty Protocol
Delete a paragraph located in
Item 31-34. EYE,
Section 4. Monocular vision
Protocol section a Binocular
Multifocal and Accommodating
Devices Protocol
Insert into the AME Assisted
Special Issuance (AASI)
section the new Bladder,
Breast, Melanoma, and Renal
Carcinoma AASIs
Revise AASI Process to
include First- and Secondclass Airman Medical
Certification
Insert into General
Information, a new Section 10
that provides Sport Pilot
Provisions
Update revised Title 14, Code
of Federal Regulations, 61.53
Insert a link to download a
revised AME Letter of Denial
Insert a link to download a
printable AASI Certificate
Coversheet
401

____________________________________________________________________________
Guide
Version
II.
Official
Date
02/13/2004
09/16/2004
I.
09/24/2003
Revision
Number
1.
Description
Of Change
Administrative
Reason For Update
Install Search Engine located

in the Navigation Bar
2.
Administrative
Insert a WHATS NEW link
located in the Navigation Bar
3.
Administrative
The Instructions site of the
2003 Guide is deleted and
incorporated into the
Introduction and Available
Downloads located in the
Navigation Bar
4.
Administrative
Insert an Available
Downloads site located in the
Navigation Bar
5.
Administrative
Insert a Table of Contents and
an Index into the pdf version of
the 2004 Guide
6.
Administrative
Insert a one-page synopsis of
the Medical Standards located
in the Navigation Bar
7.
Medical Policy
Insert Section 6.
Orthokeratology into Items 3134. Eye
8.
Administrative
Relocate Item 46. Footnote #
21 from Head Trauma to
Footnote #19, Headaches
9.
Administrative
Insert Attention Deficit
Disorder into Item 47s,
Table
10.
Medical Policy
Revise Item 60; Comments on
History and Findings
11.
Medical Policy
Revise Item 63; Disqualifying
Defects
12.
Medical Policy
Delete from AASIs a History
of Monocularity
13.
Administrative
Insert an Archives located in
the Navigation Bar
14.
Administrative
Insert CAD Ultrasound into
Item 37s, Aerospace Medical
Disposition Table
Introduction of the
2003 Guide for Aviation Medical Examiners Website
402

Guide PDF

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Guide PDF

Uploaded by

Copyright:

Available Formats

2016

GUIDE FOR AVIATION MEDICAL EXAMINERS

LAST UPDATE: April 08, 2016

LAST UPDATE: March 30, 2016

ITEMS 23-24. Statement of Demonstrated Ability (SODA); SODA Serial

LAST UPDATE: March 30, 2016

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

Guide for Aviation Medical Examiners

Guide for Aviation Medical Examiners

Guide for Aviation Medical Examiners

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

Guide for Aviation Medical Examiners

The factors leading to and surrounding the episode;

The prognosis derived from professional consideration of all available information

Limit the duration of an Authorization;

Condition the granting of a new Authorization on the results of subsequent

Condition the continued effect of an Authorization, and any second- or third-class

In determining whether an Authorization should be granted to an applicant for a

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

There is an adverse change in the holder's medical condition;

The holder fails to comply with a statement of functional limitations or operational

Public safety would be endangered by the holder's exercise of airman privileges;

A medical certificate rendered invalid pursuant to a withdrawal, in accordance

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

8. No "Alternate" Examiners Designated

Guide for Aviation Medical Examiners

Providing Part 67 Medical Qualification Standard is met, applicants for an Airman

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

10. Classes of Medical Certificates

Guide for Aviation Medical Examiners

Copies are NOT valid.

11. Operations Not Requiring a Medical Certificate

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

Only use standard limitations as contained within this document or on the

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

Guide for Aviation Medical Examiners

Airmans full name and date of birth;

Place and date of examination;

Name of the Examiner; and

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

Circumstances of the loss or destruction of the original certificate.

Questions pertaining to problem medical certification cases in which the RFS

Telephone interpretation of medical standards or policies involving an

Matters regarding designation and re-designation of Examiners and the

Attendance at Aviation Medical Examiner Seminars.

LAST UPDATE: March 30, 2016

Guide for Aviation Medical Examiners

Inquiries concerning guidance on problem medical certification cases;

Information concerning the overall airman medical certification program;

Matters involving FAA medical certification of military personnel; or

Information concerning medical certification of applicants in foreign countries

These inquiries should be made to:

Matters regarding designation and re-designation of Examiners;